1	F	NN	O	f	_	0	SENT_1	[p1l32t558r86b613],

1	RESEARCH	NN	O	research	nn	2	SENT_2	[p1l676t118r1092b158],
2	ARTICLE	NN	O	article	_	0	SENT_2	[p1l1153t118r1486b158],

1	Analysis	NN	O	analysis	_	0	SENT_3	[p1l165t276r403b334],
2	of	IN	O	of	_	0	SENT_3	[p1l428t276r483b322],
3	CYP2D6	NNP	O	CYP2D6	nn	4	SENT_3	[p1l505t275r744b322],
4	Genotype	NNP	O	Genotype	prep_of	1	SENT_3	[p1l766t275r1044b334],
5	and	CC	O	and	_	0	SENT_3	[p1l1068t276r1171b322],
6	Response	NNP	O	Response	prep_of	1	SENT_3	[p1l1200t276r1484b333],
7	to	TO	O	to	_	0	SENT_3	[p1l1507t279r1563b322],
8	Tetrabenazine	NNP	LOCATION	Tetrabenazine	prep_to	1	SENT_3	[p1l1586t276r1994b322],

1	Raja	NNP	PERSON	Raja	nn	2	SENT_4	[p1l78t409r146b444],
2	Mehanna	NNP	PERSON	Mehanna	_	0	SENT_4	[p1l161t409r317b442],
3	,	,	O	,	_	0	SENT_4	[p1l161t409r317b442],
4	MD	NNP	O	MD	appos	2	SENT_4	[p1l335t409r397b442],
5	,	,	O	,	_	0	SENT_4	[p1l335t409r397b442],
6	Christine	NNP	PERSON	Christine	nn	7	SENT_4	[p1l414t409r553b437],
7	Hunter	NNP	PERSON	Hunter	appos	4	SENT_4	[p1l569t409r683b442],
8	,	,	O	,	_	0	SENT_4	[p1l569t409r683b442],
9	RN	NNP	O	RN	appos	4	SENT_4	[p1l701t409r757b442],
10	,	,	O	,	_	0	SENT_4	[p1l701t409r757b442],
11	Anthony	NNP	PERSON	Anthony	nn	12	SENT_4	[p1l773t409r907b444],
12	Davidson	NNP	PERSON	Davidson	appos	4	SENT_4	[p1l921t409r1076b442],
13	,	,	O	,	_	0	SENT_4	[p1l921t409r1076b442],
14	MS	NN	O	m	appos	4	SENT_4	[p1l1094t409r1154b442],
15	,	,	O	,	_	0	SENT_4	[p1l1094t409r1154b442],
16	Joohi	NNP	PERSON	Joohi	nn	17	SENT_4	[p1l1170t409r1255b437],
17	Jimenez	NNP	PERSON	Jimenez	appos	4	SENT_4	[p1l1270t409r1549b442],
18	.	.	O	.	_	0	SENT_4	[p1l1270t409r1549b442],

1	—	NN	O	—	_	0	SENT_5	[p1l1270t409r1549b442],
2	.	.	O	.	_	0	SENT_5	[p1l1270t409r1549b442],

1	Shahed	NNP	PERSON	Shahed	dep	10	SENT_6	[p1l1270t409r1549b442],
2	,	,	O	,	_	0	SENT_6	[p1l1270t409r1549b442],
3	MD	NNP	O	MD	conj_and	1	SENT_6	[p1l1567t409r1629b442],
4	,	,	O	,	_	0	SENT_6	[p1l1567t409r1629b442],
5	and	CC	O	and	_	0	SENT_6	[p1l1645t409r1704b437],
6	Joseph	NNP	PERSON	Joseph	nn	9	SENT_6	[p1l1719t409r1835b444],
7	Jankovic	NNP	PERSON	Jankovic	nn	9	SENT_6	[p1l1850t409r1998b442],
8	,	,	O	,	_	0	SENT_6	[p1l1850t409r1998b442],
9	MD	NNP	O	MD	conj_and	1	SENT_6	[p1l2016t409r2083b437],
10	*	VBD	O	*	_	0	SENT_6	[p1l2016t409r2083b437],
11	Parl	NN	O	parl	dep	12	SENT_6	[p1l87t452r252b477],
12	<	JJR	O	<	dobj	10	SENT_6	[p1l87t452r252b477],
13	inson	CD	NUMBER	inson	poss	16	SENT_6	[p1l87t452r252b477],
14	’s	POS	O	’s	_	0	SENT_6	[p1l87t452r252b477],
15	Disease	NNP	O	Disease	nn	16	SENT_6	[p1l264t452r376b477],
16	Center	NNP	O	Center	dep	12	SENT_6	[p1l388t451r485b477],
17	and	CC	O	and	_	0	SENT_6	[p1l495t452r550b477],
18	Movement	NNP	ORGANIZATION	Movement	nn	20	SENT_6	[p1l560t452r713b477],
19	Disorders	NNPS	ORGANIZATION	Disorders	nn	20	SENT_6	[p1l723t452r859b477],
20	Clinic	NNP	ORGANIZATION	Clinic	dobj	10	SENT_6	[p1l872t451r953b481],
21	,	,	O	,	_	0	SENT_6	[p1l872t451r953b481],
22	Department	NNP	ORGANIZATION	Department	appos	20	SENT_6	[p1l969t452r1138b483],
23	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l1150t452r1180b477],
24	Neurology	NNP	ORGANIZATION	Neurology	prep_of	22	SENT_6	[p1l1187t452r1337b483],
25	,	,	O	,	_	0	SENT_6	[p1l1187t452r1337b483],
26	Baylor	NNP	ORGANIZATION	Baylor	nn	27	SENT_6	[p1l1353t452r1445b483],
27	College	NNP	ORGANIZATION	College	appos	20	SENT_6	[p1l1455t451r1561b483],
28	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l1573t452r1603b477],
29	Medicine	NNP	ORGANIZATION	Medicine	nn	33	SENT_6	[p1l1611t452r1745b481],
30	,	,	O	,	_	0	SENT_6	[p1l1611t452r1745b481],
31	Houston	NNP	LOCATION	Houston	appos	33	SENT_6	[p1l1761t452r1887b481],
32	,	,	O	,	_	0	SENT_6	[p1l1761t452r1887b481],
33	Texas	NNP	LOCATION	Texas	prep_of	27	SENT_6	[p1l1905t452r1992b481],
34	,	,	O	,	_	0	SENT_6	[p1l1905t452r1992b481],
35	USA	NNP	LOCATION	USA	nsubj	10	SENT_6	[p1l2009t451r2071b477],

1	ABSTRACT	NN	O	abstract	_	0	SENT_7	[p1l78t647r371b681],
2	:	:	O	:	_	0	SENT_7	[p1l78t647r371b681],
3	Tetrabenazine	NN	O	tetrabenazine	nsubj	5	SENT_7	[p1l415t653r647b681],
4	is	VBZ	O	be	cop	5	SENT_7	[p1l683t653r707b681],
5	effective	JJ	O	effective	dep	1	SENT_7	[p1l742t653r881b681],
6	in	IN	O	in	_	0	SENT_7	[p1l918t653r942b681],
7	the	DT	O	the	det	8	SENT_7	[p1l977t653r1029b681],
8	treatment	NN	O	treatment	prep_in	5	SENT_7	[p1l78t701r238b727],
9	of	IN	O	of	_	0	SENT_7	[p1l266t699r297b727],
10	the	DT	O	the	det	11	SENT_7	[p1l323t699r375b727],
11	chorea	NN	O	chorea	prep_of	8	SENT_7	[p1l403t699r516b727],
12	associated	VBN	O	associate	partmod	11	SENT_7	[p1l544t699r722b727],
13	with	IN	O	with	_	0	SENT_7	[p1l751t699r818b727],
14	Huntington	NNP	LOCATION	Huntington	nn	15	SENT_7	[p1l848t699r1028b734],
15	disease	NN	O	disease	prep_with	12	SENT_7	[p1l79t745r206b773],
16	and	CC	O	and	_	0	SENT_7	[p1l233t745r293b773],
17	other	JJ	O	other	amod	20	SENT_7	[p1l321t745r407b773],
18	hyperkinetic	JJ	O	hyperkinetic	amod	20	SENT_7	[p1l434t745r634b780],
19	movement	NN	O	movement	nn	20	SENT_7	[p1l663t747r837b773],
20	disorders	NNS	O	disorder	conj_and	15	SENT_7	[p1l864t745r1027b773],
21	.	.	O	.	_	0	SENT_7	[p1l864t745r1027b773],

1	Following	VBG	O	follow	_	0	SENT_8	[p1l80t791r235b826],
2	oral	JJ	O	oral	amod	3	SENT_8	[p1l261t791r320b819],
3	administration	NN	O	administration	prep_following	8	SENT_8	[p1l345t791r589b823],
4	,	,	O	,	_	0	SENT_8	[p1l345t791r589b823],
5	tetrabenazine	NN	O	tetrabenazine	nsubjpass	8	SENT_8	[p1l614t791r840b819],
6	is	VBZ	O	be	auxpass	8	SENT_8	[p1l865t791r889b819],
7	hepatically	RB	O	hepatically	advmod	8	SENT_8	[p1l914t791r1028b826, p1l79t837r153b872],
8	transformed	VBN	O	transform	_	0	SENT_8	[p1l179t836r380b864],
9	into	IN	O	into	_	0	SENT_8	[p1l410t837r469b864],
10	2	CD	NUMBER	2	num	12	SENT_8	[p1l496t837r514b864],
11	active	JJ	O	active	amod	12	SENT_8	[p1l543t837r640b864],
12	metabolites	NNS	O	metabolite	prep_into	8	SENT_8	[p1l669t837r861b864],
13	that	WDT	O	that	nsubj	16	SENT_8	[p1l887t837r951b864],
14	are	VBP	O	be	cop	16	SENT_8	[p1l978t844r1030b864],
15	CYP2D6	NN	O	cyp2d6	nn	16	SENT_8	[p1l79t882r220b910],
16	substrates	NNS	O	substrate	rcmod	12	SENT_8	[p1l243t883r425b910],
17	.	.	O	.	_	0	SENT_8	[p1l243t883r425b910],

1	There	EX	O	there	expl	2	SENT_9	[p1l449t883r543b910],
2	are	VBP	O	be	_	0	SENT_9	[p1l566t890r617b910],
3	4	CD	NUMBER	4	num	5	SENT_9	[p1l639t883r658b910],
4	CYP2D6	NN	O	cyp2d6	nn	5	SENT_9	[p1l681t882r822b910],
5	genotypes	NNS	O	genotype	nsubj	2	SENT_9	[p1l845t884r1027b918],
6	:	:	O	:	_	0	SENT_9	[p1l845t884r1027b918],
7	poor	JJ	O	poor	amod	8	SENT_9	[p1l80t935r156b963],
8	metabolizers	NNS	O	metabolizer	dep	5	SENT_9	[p1l172t928r392b961],
9	,	,	O	,	_	0	SENT_9	[p1l172t928r392b961],
10	intermediate	JJ	O	intermediate	amod	11	SENT_9	[p1l412t928r617b956],
11	metabolizers	NNS	O	metabolizer	dep	5	SENT_9	[p1l635t928r854b961],
12	,	,	O	,	_	0	SENT_9	[p1l635t928r854b961],
13	extensive	JJ	O	extensive	amod	14	SENT_9	[p1l873t928r1029b956],
14	metabolizers	NNS	O	metabolizer	dep	5	SENT_9	[p1l80t974r299b1007],
15	,	,	O	,	_	0	SENT_9	[p1l80t974r299b1007],
16	and	CC	O	and	_	0	SENT_9	[p1l316t974r375b1002],
17	ultrarapid	NN	O	ultrarapid	nn	18	SENT_9	[p1l392t974r547b1009],
18	metabolizers	NNS	O	metabolizer	dep	5	SENT_9	[p1l563t974r782b1002],
19	.	.	O	.	_	0	SENT_9	[p1l563t974r782b1002],

1	CYP2D6	NN	O	cyp2d6	nn	2	SENT_10	[p1l799t974r940b1002],
2	genotyping	NN	O	genotyping	nsubjpass	4	SENT_10	[p1l954t981r1029b1009, p1l79t1020r200b1055],
3	was	VBD	O	be	auxpass	4	SENT_10	[p1l222t1027r288b1048],
4	performed	VBN	O	perform	_	0	SENT_10	[p1l310t1020r480b1055],
5	on	IN	O	on	_	0	SENT_10	[p1l502t1027r541b1048],
6	sequential	JJ	O	sequential	amod	7	SENT_10	[p1l563t1020r731b1055],
7	subjects	NNS	O	subject	prep_on	4	SENT_10	[p1l753t1020r892b1055],
8	treated	VBN	O	treat	partmod	7	SENT_10	[p1l911t1020r1028b1048],
9	with	IN	O	with	_	0	SENT_10	[p1l78t1066r145b1093],
10	tetrabenazine	NN	O	tetrabenazine	prep_with	8	SENT_10	[p1l166t1066r400b1099],
11	,	,	O	,	_	0	SENT_10	[p1l166t1066r400b1099],
12	but	CC	O	but	_	0	SENT_10	[p1l424t1066r476b1094],
13	results	NNS	O	result	nsubjpass	16	SENT_10	[p1l497t1066r605b1094],
14	were	VBD	O	be	auxpass	16	SENT_10	[p1l625t1073r705b1094],
15	not	RB	O	not	neg	16	SENT_10	[p1l726t1068r777b1094],
16	known	VBN	O	know	conj_but	4	SENT_10	[p1l799t1066r906b1094],
17	at	IN	O	at	_	0	SENT_10	[p1l928t1068r958b1094],
18	the	DT	O	the	det	19	SENT_10	[p1l977t1066r1029b1094],
19	time	NN	O	time	prep_at	16	SENT_10	[p1l78t1112r149b1139],
20	of	IN	O	of	_	0	SENT_10	[p1l169t1112r201b1139],
21	titration	NN	O	titration	prep_of	19	SENT_10	[p1l218t1112r352b1139],
22	.	.	O	.	_	0	SENT_10	[p1l218t1112r352b1139],

1	Duration	NN	O	duration	nsubjpass	25	SENT_11	[p1l376t1112r513b1140],
2	of	IN	O	of	_	0	SENT_11	[p1l534t1112r566b1139],
3	titration	NN	O	titration	prep_of	1	SENT_11	[p1l584t1112r708b1139],
4	to	TO	O	to	_	0	SENT_11	[p1l728t1113r760b1139],
5	a	DT	O	a	det	7	SENT_11	[p1l780t1119r799b1140],
6	stable	JJ	O	stable	amod	7	SENT_11	[p1l818t1112r918b1140],
7	dose	NN	O	dose	prep_to	3	SENT_11	[p1l938t1112r1027b1144],
8	,	,	O	,	_	0	SENT_11	[p1l938t1112r1027b1144],
9	total	JJ	O	total	amod	11	SENT_11	[p1l78t1158r149b1185],
10	daily	JJ	SET	daily	amod	11	SENT_11	[p1l172t1158r249b1193],
11	dose	NN	O	dose	prep_to	3	SENT_11	[p1l270t1158r359b1190],
12	,	,	O	,	_	0	SENT_11	[p1l270t1158r359b1190],
13	response	NN	O	response	nn	15	SENT_11	[p1l384t1165r536b1192],
14	rating	NN	O	rating	nn	15	SENT_11	[p1l559t1158r649b1193],
15	scores	NNS	O	score	prep_to	3	SENT_11	[p1l672t1165r791b1190],
16	,	,	O	,	_	0	SENT_11	[p1l672t1165r791b1190],
17	and	CC	O	and	_	0	SENT_11	[p1l815t1158r875b1185],
18	adverse	JJ	O	adverse	amod	19	SENT_11	[p1l898t1158r1029b1185],
19	events	NNS	O	event	conj_and	7	SENT_11	[p1l79t1205r187b1231],
20	were	VBD	O	be	auxpass	22	SENT_11	[p1l204t1210r284b1231],
21	retrospectively	RB	O	retrospectively	advmod	22	SENT_11	[p1l302t1204r545b1238],
22	collected	VBN	O	collect	_	0	SENT_11	[p1l561t1204r711b1231],
23	and	CC	O	and	_	0	SENT_11	[p1l729t1203r789b1231],
24	subsequently	RB	O	subsequently	advmod	25	SENT_11	[p1l808t1204r1030b1238],
25	analyzed	VBN	O	analyze	conj_and	22	SENT_11	[p1l79t1249r234b1284],
26	.	.	O	.	_	0	SENT_11	[p1l79t1249r234b1284],

1	Of	IN	O	of	_	0	SENT_12	[p1l255t1249r293b1277],
2	127	CD	NUMBER	127	num	3	SENT_12	[p1l312t1250r370b1277],
3	patients	NNS	O	patient	prep_of	13	SENT_12	[p1l390t1249r529b1284],
4	,	,	O	,	_	0	SENT_12	[p1l390t1249r529b1284],
5	the	DT	O	the	det	8	SENT_12	[p1l548t1249r600b1277],
6	majority	NN	O	majority	nn	8	SENT_12	[p1l619t1249r750b1284],
7	(	NN	O	(	nn	8	SENT_12	[p1l768t1249r795b1284],
8	n	NN	O	n	nsubjpass	13	SENT_12	[p1l768t1249r795b1284],
9	=	JJ	O	=	amod	8	SENT_12	[p1l817t1259r840b1271],
10	100	CD	NUMBER	100	number	11	SENT_12	[p1l864t1249r931b1284],
11	)	CD	NUMBER	)	dep	9	SENT_12	[p1l864t1249r931b1284],
12	were	VBD	O	be	auxpass	13	SENT_12	[p1l949t1256r1029b1277],
13	categorized	VBN	O	categorize	_	0	SENT_12	[p1l79t1295r272b1330],
14	as	IN	O	as	_	0	SENT_12	[p1l289t1302r326b1323],
15	extensive	JJ	O	extensive	amod	16	SENT_12	[p1l342t1295r499b1323],
16	metabolizers	NNS	O	metabolizer	prep_as	13	SENT_12	[p1l516t1295r735b1328],
17	,	,	O	,	_	0	SENT_12	[p1l516t1295r735b1328],
18	14	CD	NUMBER	14	appos	16	SENT_12	[p1l755t1295r792b1323],
19	as	IN	O	as	_	0	SENT_12	[p1l808t1302r845b1323],
20	intermediate	JJ	O	intermediate	amod	21	SENT_12	[p1l862t1295r1028b1323, p1l79t1343r129b1369],
21	metabolizers	NNS	O	metabolizer	prep_as	18	SENT_12	[p1l154t1341r373b1374],
22	,	,	O	,	_	0	SENT_12	[p1l154t1341r373b1374],
23	11	CD	NUMBER	11	prep_as	13	SENT_12	[p1l400t1341r431b1368],
24	as	IN	O	as	_	0	SENT_12	[p1l461t1348r498b1369],
25	poor	JJ	O	poor	amod	26	SENT_12	[p1l522t1348r598b1376],
26	metabolizers	NNS	O	metabolizer	prep_as	23	SENT_12	[p1l621t1341r840b1374],
27	,	,	O	,	_	0	SENT_12	[p1l621t1341r840b1374],
28	and	CC	O	and	_	0	SENT_12	[p1l866t1341r925b1369],
29	2	CD	NUMBER	2	conj_and	16	SENT_12	[p1l950t1341r968b1368],
30	as	IN	O	as	_	0	SENT_12	[p1l992t1348r1029b1369],
31	ultrarapid	JJ	O	ultrarapid	amod	32	SENT_12	[p1l80t1387r234b1422],
32	metabolizers	NNS	O	metabolizer	prep_as	29	SENT_12	[p1l258t1387r477b1415],
33	.	.	O	.	_	0	SENT_12	[p1l258t1387r477b1415],

1	Ultrarapid	JJ	O	ultrarapid	amod	3	SENT_13	[p1l501t1387r661b1422],
2	metabolizer	NN	O	metabolizer	nn	3	SENT_13	[p1l684t1387r878b1415],
3	patients	NNS	O	patient	nsubj	4	SENT_13	[p1l898t1387r1029b1422],
4	needed	VBD	O	need	_	0	SENT_13	[p1l80t1433r202b1460],
5	a	DT	O	a	det	8	SENT_13	[p1l223t1440r242b1460],
6	longer	RBR	O	longer	amod	8	SENT_13	[p1l262t1433r365b1468],
7	titration	NN	O	titration	nn	8	SENT_13	[p1l383t1433r507b1460],
8	(	NN	O	(	dobj	4	SENT_13	[p1l529t1432r557b1468],
9	8	CD	NUMBER	8	dep	8	SENT_13	[p1l529t1432r557b1468],
10	vs	CC	O	vs	_	0	SENT_13	[p1l576t1440r612b1460],
11	3.3	CD	NUMBER	3.3	conj_vs	8	SENT_13	[p1l632t1433r691b1465],
12	,	,	O	,	_	0	SENT_13	[p1l632t1433r691b1465],
13	4.4	CD	NUMBER	4.4	num	11	SENT_13	[p1l712t1433r771b1465],
14	,	,	O	,	_	0	SENT_13	[p1l712t1433r771b1465],
15	and	CC	DURATION	and	_	0	SENT_13	[p1l793t1433r853b1460],
16	3	CD	DURATION	3	conj_and	11	SENT_13	[p1l874t1433r893b1460],
17	weeks	NNS	NUMBER	week	dep	11	SENT_13	[p1l913t1433r1027b1465],
18	,	,	O	,	_	0	SENT_13	[p1l913t1433r1027b1465],

1	respectively	RB	O	respectively	dep	12	SENT_14	[p1l1132t654r1337b688],
2	;	:	O	;	_	0	SENT_14	[p1l1132t654r1337b688],
3	P	NN	O	p	nsubj	12	SENT_14	[p1l1363t654r1387b681],
4	<	JJR	O	<	amod	3	SENT_14	[p1l1409t660r1430b681],
5	.01	CD	NUMBER	.01	num	6	SENT_14	[p1l1449t653r1507b688],
6	)	NN	O	)	dep	4	SENT_14	[p1l1449t653r1507b688],
7	to	TO	O	to	aux	8	SENT_14	[p1l1530t655r1562b681],
8	achieve	VB	O	achieve	infmod	6	SENT_14	[p1l1586t653r1713b681],
9	optimal	JJ	O	optimal	amod	10	SENT_14	[p1l1737t653r1858b688],
10	benefit	NN	O	benefit	dobj	8	SENT_14	[p1l1884t653r1996b681],
11	and	CC	O	and	cc	10	SENT_14	[p1l2020t654r2080b681],
12	required	VBD	O	require	_	0	SENT_14	[p1l1132t699r1266b734],
13	a	DT	O	a	det	17	SENT_14	[p1l1292t706r1311b727],
14	higher	JJR	O	higher	dep	15	SENT_14	[p1l1336t699r1438b735],
15	average	JJ	O	average	amod	17	SENT_14	[p1l1462t706r1594b735],
16	daily	JJ	SET	daily	amod	17	SENT_14	[p1l1619t699r1695b734],
17	dose	NN	O	dose	dobj	12	SENT_14	[p1l1719t699r1800b727],
18	than	IN	O	than	_	0	SENT_14	[p1l1824t699r1895b727],
19	the	DT	O	the	det	21	SENT_14	[p1l1920t699r1972b727],
20	other	JJ	O	other	amod	21	SENT_14	[p1l1997t699r2082b727],
21	patients	NNS	O	patient	prep_than	12	SENT_14	[p1l1132t745r1271b780],
22	,	,	O	,	_	0	SENT_14	[p1l1132t745r1271b780],
23	but	CC	O	but	_	0	SENT_14	[p1l1301t745r1352b773],
24	this	DT	O	this	det	25	SENT_14	[p1l1378t745r1436b773],
25	difference	NN	O	difference	nsubj	28	SENT_14	[p1l1462t745r1626b773],
26	did	VBD	O	do	aux	28	SENT_14	[p1l1652t745r1701b773],
27	not	RB	O	not	neg	28	SENT_14	[p1l1730t747r1781b773],
28	reach	VB	O	reach	conj_but	12	SENT_14	[p1l1808t745r1898b773],
29	statistical	JJ	O	statistical	amod	30	SENT_14	[p1l1925t745r2080b773],
30	significance	NN	O	significance	dobj	28	SENT_14	[p1l1131t791r1336b826],
31	.	.	O	.	_	0	SENT_14	[p1l1131t791r1336b826],

1	The	DT	O	the	det	3	SENT_15	[p1l1353t791r1414b819],
2	treatment	NN	O	treatment	nn	3	SENT_15	[p1l1429t793r1589b819],
3	response	NN	O	response	nsubj	6	SENT_15	[p1l1606t798r1757b826],
4	was	VBD	O	be	cop	6	SENT_15	[p1l1772t798r1838b819],
5	less	RBR	O	less	advmod	6	SENT_15	[p1l1855t791r1918b819],
6	robust	JJ	O	robust	_	0	SENT_15	[p1l1935t791r2039b819],
7	in	IN	O	in	_	0	SENT_15	[p1l2055t791r2080b818],
8	the	DT	O	the	det	11	SENT_15	[p1l1130t837r1182b865],
9	intermediate	JJ	O	intermediate	amod	11	SENT_15	[p1l1213t837r1418b865],
10	metabolizer	NN	O	metabolizer	nn	11	SENT_15	[p1l1448t837r1641b865],
11	group	NN	O	group	prep_in	6	SENT_15	[p1l1669t844r1765b872],
12	when	WRB	O	when	advmod	13	SENT_15	[p1l1794t837r1882b865],
13	compared	VBN	O	compare	advcl	6	SENT_15	[p1l1912t837r2080b872],
14	with	IN	O	with	_	0	SENT_15	[p1l1131t883r1197b910],
15	the	DT	O	the	det	17	SENT_15	[p1l1216t883r1268b910],
16	extensive	JJ	O	extensive	amod	17	SENT_15	[p1l1287t883r1443b910],
17	metabolizer	NN	O	metabolizer	prep_with	13	SENT_15	[p1l1464t883r1657b910],
18	patients	NNS	O	patient	nn	23	SENT_15	[p1l1676t883r1807b918],
19	(	CD	NUMBER	(	num	20	SENT_15	[p1l1826t882r1859b918],
20	P	NN	O	p	dep	18	SENT_15	[p1l1826t882r1859b918],
21	=	JJ	O	=	amod	23	SENT_15	[p1l1880t892r1903b904],
22	.013	CD	NUMBER	.013	tmod	21	SENT_15	[p1l1920t882r2007b918],
23	)	NN	O	)	dobj	13	SENT_15	[p1l1920t882r2007b918],
24	,	,	O	,	_	0	SENT_15	[p1l1920t882r2007b918],
25	but	CC	O	but	_	0	SENT_15	[p1l2030t883r2081b910],
26	there	EX	O	there	expl	27	SENT_15	[p1l1130t929r1214b956],
27	were	VBD	O	be	conj_but	6	SENT_15	[p1l1256t936r1337b956],
28	no	DT	O	no	det	31	SENT_15	[p1l1380t936r1419b956],
29	statistically	RB	O	statistically	advmod	30	SENT_15	[p1l1462t929r1646b964],
30	significant	JJ	O	significant	amod	31	SENT_15	[p1l1688t928r1856b964],
31	differences	NNS	O	difference	nsubj	27	SENT_15	[p1l1899t928r2081b956],
32	between	IN	O	between	_	0	SENT_15	[p1l1132t974r1272b1002],
33	the	DT	O	the	det	35	SENT_15	[p1l1299t974r1351b1002],
34	various	JJ	O	various	amod	35	SENT_15	[p1l1377t974r1496b1002],
35	groups	NNS	O	group	prep_between	31	SENT_15	[p1l1523t981r1638b1010],
36	with	IN	O	with	_	0	SENT_15	[p1l1664t974r1731b1002],
37	regard	NN	O	regard	prep_with	35	SENT_15	[p1l1760t974r1864b1010],
38	to	TO	O	to	_	0	SENT_15	[p1l1891t976r1923b1002],
39	adverse	JJ	O	adverse	amod	40	SENT_15	[p1l1950t974r2081b1002],
40	effects	NNS	O	effect	prep_to	27	SENT_15	[p1l1131t1020r1250b1048],
41	.	.	O	.	_	0	SENT_15	[p1l1131t1020r1250b1048],

1	Our	PRP$	O	we	poss	2	SENT_16	[p1l1273t1020r1334b1048],
2	findings	NNS	O	finding	nsubj	3	SENT_16	[p1l1352t1020r1483b1055],
3	demonstrate	VBP	O	demonstrate	_	0	SENT_16	[p1l1503t1020r1713b1048],
4	that	IN	O	that	complm	20	SENT_16	[p1l1733t1020r1804b1053],
5	,	,	O	,	_	0	SENT_16	[p1l1733t1020r1804b1053],
6	aside	RB	O	aside	_	0	SENT_16	[p1l1827t1020r1915b1048],
7	from	IN	O	from	_	0	SENT_16	[p1l1934t1020r2009b1048],
8	the	DT	O	the	det	9	SENT_16	[p1l2029t1020r2081b1048],
9	need	NN	O	need	prep_aside_from	20	SENT_16	[p1l1132t1066r1211b1094],
10	for	IN	O	for	_	0	SENT_16	[p1l1227t1066r1272b1094],
11	a	DT	O	a	det	13	SENT_16	[p1l1286t1073r1305b1094],
12	longer	RBR	O	longer	amod	13	SENT_16	[p1l1321t1066r1424b1101],
13	titration	NN	O	titration	prep_for	9	SENT_16	[p1l1437t1066r1561b1094],
14	in	IN	O	in	_	0	SENT_16	[p1l1579t1066r1604b1094],
15	the	DT	O	the	det	17	SENT_16	[p1l1619t1066r1671b1094],
16	ultrarapid	JJ	O	ultrarapid	amod	17	SENT_16	[p1l1687t1066r1842b1101],
17	metabolizers	NNS	O	metabolizer	prep_in	13	SENT_16	[p1l1860t1066r2079b1099],
18	,	,	O	,	_	0	SENT_16	[p1l1860t1066r2079b1099],
19	there	EX	O	there	expl	20	SENT_16	[p1l1130t1112r1214b1140],
20	are	VBP	O	be	ccomp	3	SENT_16	[p1l1228t1119r1279b1140],
21	no	DT	O	no	det	23	SENT_16	[p1l1294t1119r1333b1140],
22	distinguishing	JJ	O	distinguishing	amod	23	SENT_16	[p1l1348t1112r1574b1147],
23	features	NNS	O	feature	nsubj	20	SENT_16	[p1l1589t1112r1723b1140],
24	of	IN	O	of	_	0	SENT_16	[p1l1737t1112r1769b1140],
25	patients	NNS	O	patient	prep_of	23	SENT_16	[p1l1783t1112r1913b1147],
26	with	IN	O	with	_	0	SENT_16	[p1l1927t1112r1994b1139],
27	various	JJ	O	various	amod	29	SENT_16	[p1l2008t1112r2081b1140, p1l1131t1165r1190b1186],
28	CYP2D6	NN	O	cyp2d6	nn	29	SENT_16	[p1l1208t1157r1349b1186],
29	genotypes	NNS	O	genotype	prep_with	25	SENT_16	[p1l1367t1159r1549b1193],
30	,	,	O	,	_	0	SENT_16	[p1l1367t1159r1549b1193],
31	and	CC	O	and	_	0	SENT_16	[p1l1569t1158r1629b1186],
32	therefore	RB	O	therefore	advmod	50	SENT_16	[p1l1647t1158r1796b1186],
33	the	DT	O	the	det	35	SENT_16	[p1l1812t1158r1864b1186],
34	current	JJ	DATE	current	amod	35	SENT_16	[p1l1882t1159r1998b1186],
35	recommendation	NN	O	recommendation	nsubjpass	50	SENT_16	[p1l2017t1165r2081b1186, p1l1131t1204r1359b1231],
36	to	TO	O	to	_	0	SENT_16	[p1l1386t1205r1418b1231],
37	systematically	RB	O	systematically	advmod	38	SENT_16	[p1l1445t1204r1680b1239],
38	genotype	NN	O	genotype	prep_to	35	SENT_16	[p1l1706t1205r1861b1239],
39	all	DT	O	all	det	40	SENT_16	[p1l1888t1204r1921b1231],
40	patients	NNS	O	patient	dep	38	SENT_16	[p1l1950t1204r2081b1238],
41	prescribed	VBN	O	prescribe	partmod	40	SENT_16	[p1l1132t1250r1307b1284],
42	more	JJR	O	more	mwe	43	SENT_16	[p1l1342t1257r1425b1277],
43	than	IN	O	than	quantmod	44	SENT_16	[p1l1457t1250r1528b1277],
44	50	CD	NUMBER	50	num	45	SENT_16	[p1l1562t1250r1601b1277],
45	mg/day	NN	O	mg/day	dobj	41	SENT_16	[p1l1635t1249r1760b1285],
46	of	IN	O	of	_	0	SENT_16	[p1l1793t1249r1824b1277],
47	tetrabenazine	NN	O	tetrabenazine	prep_of	45	SENT_16	[p1l1855t1250r2081b1277],
48	should	MD	O	should	aux	50	SENT_16	[p1l1131t1295r1240b1323],
49	be	VB	O	be	auxpass	50	SENT_16	[p1l1271t1295r1310b1323],
50	reconsidered	VBN	O	reconsider	conj_and	20	SENT_16	[p1l1339t1295r1564b1323],
51	.	.	O	.	_	0	SENT_16	[p1l1339t1295r1564b1323],

1	©	RB	O	©	dep	2	SENT_17	[p1l1592t1297r1619b1323],
2	2012	CD	DATE	2012	dep	5	SENT_17	[p1l1641t1296r1721b1323],
3	Movement	NNP	O	Movement	nn	5	SENT_17	[p1l1749t1295r1920b1323],
4	Disorder	NNP	O	Disorder	nn	5	SENT_17	[p1l1948t1295r2082b1323],
5	Society	NNP	O	Society	_	0	SENT_17	[p1l1131t1341r1248b1376],

1	Key	NN	O	key	_	0	SENT_18	[p1l1133t1438r1203b1477],
2	Words	NNS	O	word	dep	1	SENT_18	[p1l1218t1438r1352b1469],
3	:	:	O	:	_	0	SENT_18	[p1l1218t1438r1352b1469],
4	tetrabenazine	NN	O	tetrabenazine	dep	1	SENT_18	[p1l1376t1441r1611b1474],
5	;	:	O	;	_	0	SENT_18	[p1l1376t1441r1611b1474],
6	CYP2D6	NN	O	cyp2d6	dep	4	SENT_18	[p1l1628t1441r1769b1469],
7	pharmacogenetic	JJ	O	pharmacogenetic	amod	6	SENT_18	[p1l1784t1441r2074b1476],

1	Approved	VBN	O	approve	partmod	27	SENT_19	[p1l88t1718r467b1806],
2	by	IN	O	by	_	0	SENT_19	[p1l507t1718r596b1806],
3	the	DT	O	the	det	5	SENT_19	[p1l632t1717r746b1787],
4	US	NNP	ORGANIZATION	US	nn	5	SENT_19	[p1l784t1722r889b1787],
5	Food	NNP	ORGANIZATION	Food	agent	1	SENT_19	[p1l929t1717r1122b1787],
6	and	CC	ORGANIZATION	and	_	0	SENT_19	[p1l1162t1718r1300b1787],
7	Drug	NNP	ORGANIZATION	Drug	nn	8	SENT_19	[p1l1338t1723r1532b1806],
8	Administration	NNP	ORGANIZATION	Administration	agent	1	SENT_19	[p1l1570t1718r2151b1787],
9	(	CD	NUMBER	(	num	11	SENT_19	[p1l14t1824r243b1907],
10	FDA	NNP	ORGANIZATION	FDA	nn	11	SENT_19	[p1l14t1824r243b1907],
11	)	NN	O	)	dobj	1	SENT_19	[p1l14t1824r243b1907],
12	for	IN	O	for	_	0	SENT_19	[p1l309t1821r418b1891],
13	the	DT	O	the	det	14	SENT_19	[p1l478t1821r592b1891],
14	treatment	NN	O	treatment	prep_for	11	SENT_19	[p1l653t1841r1023b1891],
15	of	IN	O	of	_	0	SENT_19	[p1l1085t1821r1162b1891],
16	chorea	NN	O	chorea	prep_of	14	SENT_19	[p1l1218t1821r1471b1891],
17	associated	VBN	O	associate	partmod	16	SENT_19	[p1l1534t1821r1921b1891],
18	with	IN	O	with	_	0	SENT_19	[p1l1980t1821r2152b1891],
19	Huntington	NNP	LOCATION	Huntington	nn	20	SENT_19	[p1l9t1930r456b2014],
20	disease	NN	O	disease	prep_with	17	SENT_19	[p1l527t1911r908b2011],
21	,	,	O	,	_	0	SENT_19	[p1l527t1911r908b2011],
22	”	NN	O	”	nn	23	SENT_19	[p1l527t1911r908b2011],
23	tetrabenazine	NN	O	tetrabenazine	nsubjpass	27	SENT_19	[p1l978t1925r1492b1995],
24	has	VBZ	O	have	aux	27	SENT_19	[p1l1563t1925r1686b1995],
25	also	RB	O	also	advmod	27	SENT_19	[p1l1759t1925r1905b1995],
26	been	VBN	O	be	auxpass	27	SENT_19	[p1l1979t1925r2152b1995],
27	found	VBN	O	find	_	0	SENT_19	[p1l10t2029r233b2099],
28	to	TO	O	to	aux	32	SENT_19	[p1l273t2049r348b2099],
29	be	VB	O	be	cop	32	SENT_19	[p1l392t2029r474b2099],
30	an	DT	O	a	det	32	SENT_19	[p1l518t2057r607b2099],
31	effective	JJ	O	effective	amod	32	SENT_19	[p1l649t2029r962b2099],
32	treatment	NN	O	treatment	xcomp	27	SENT_19	[p1l1005t2049r1374b2099],
33	in	IN	O	in	prep	32	SENT_19	[p1l1416t2034r1486b2098],
34	tardive	JJ	O	tardive	amod	35	SENT_19	[p1l1527t2029r1790b2099],
35	dysl	NN	O	dysl	dep	39	SENT_19	[p1l1834t2029r2150b2118],
36	<	JJR	O	<	dep	35	SENT_19	[p1l1834t2029r2150b2118],
37	ine	CD	NUMBER	ine	num	38	SENT_19	[p1l1834t2029r2150b2118],
38	—	NN	O	—	dep	39	SENT_19	[p1l1834t2029r2150b2118],
39	sia	NN	O	sium	dep	52	SENT_19	[p1l11t2138r132b2219],
40	,	,	O	,	_	0	SENT_19	[p1l11t2138r132b2219],
41	tics	NNS	O	tic	conj_and	39	SENT_19	[p1l184t2138r332b2219],
42	,	,	O	,	_	0	SENT_19	[p1l184t2138r332b2219],
43	dystonia	NN	O	dystonium	conj_and	39	SENT_19	[p1l387t2133r731b2222],
44	,	,	O	,	_	0	SENT_19	[p1l387t2133r731b2222],
45	myoclonus	NN	O	myoclonus	conj_and	39	SENT_19	[p1l783t2133r1218b2222],
46	,	,	O	,	_	0	SENT_19	[p1l783t2133r1218b2222],
47	and	CC	O	and	_	0	SENT_19	[p1l1273t2133r1411b2203],
48	other	JJ	O	other	amod	51	SENT_19	[p1l1462t2133r1660b2203],
49	involuntary	JJ	O	involuntary	amod	51	SENT_19	[p1l1710t2133r2153b2222],
50	movement	NN	O	movement	nn	51	SENT_19	[p1l9t2257r408b2308],
51	disorders	NNS	O	disorder	dep	52	SENT_19	[p1l443t2224r923b2308],
52	.3	NN	NUMBER	.3	dep	33	SENT_19	[p1l443t2224r923b2308],
53	"	''	O	"	punct	32	SENT_19	[p1l443t2224r923b2308],
54	7	CD	NUMBER	7	amod	32	SENT_19	[p1l443t2224r923b2308],

1	Pharmacogenomics	NNS	MISC	pharmacogenomic	nsubj	19	SENT_20	[p1l89t2342r853b2431],
2	,	,	O	,	_	0	SENT_20	[p1l89t2342r853b2431],
3	aiming	VBG	O	aim	partmod	1	SENT_20	[p1l913t2347r1172b2431],
4	to	TO	O	to	aux	5	SENT_20	[p1l1227t2362r1302b2412],
5	clarify	VB	O	clarify	xcomp	3	SENT_20	[p1l1360t2342r1600b2431],
6	the	DT	O	the	det	7	SENT_20	[p1l1656t2342r1770b2412],
7	relationship	NN	O	relationship	dobj	5	SENT_20	[p1l1827t2343r2150b2412, p1l11t2449r162b2538],
8	between	IN	O	between	_	0	SENT_20	[p1l209t2449r521b2519],
9	human	JJ	O	human	amod	12	SENT_20	[p1l564t2449r828b2519],
10	genome	NN	O	genome	nn	12	SENT_20	[p1l871t2477r1164b2538],
11	sequence	NN	O	sequence	nn	12	SENT_20	[p1l1210t2476r1546b2538],
12	Variations	NNS	O	variation	prep_between	7	SENT_20	[p1l1590t2454r1968b2519],
13	and	CC	O	and	_	0	SENT_20	[p1l2013t2449r2152b2519],
14	differential	JJ	O	differential	amod	16	SENT_20	[p1l11t2553r427b2623],
15	drug	NN	O	drug	nn	16	SENT_20	[p1l505t2554r677b2642],
16	responses	NNS	O	response	conj_and	12	SENT_20	[p1l752t2580r1137b2642],
17	,	,	O	,	_	0	SENT_20	[p1l752t2580r1137b2642],
18	has	VBZ	O	have	aux	19	SENT_20	[p1l1214t2554r1338b2623],
19	focused	VBN	O	focus	_	0	SENT_20	[p1l1414t2553r1703b2623],
20	on	IN	O	on	_	0	SENT_20	[p1l1778t2581r1872b2623],
21	genes	NNS	O	gene	prep_on	19	SENT_20	[p1l1947t2581r2151b2642],

1	*	NN	O	*	nn	2	SENT_21	[p1l8t2858r548b2920],
2	Correspondence	NN	O	correspondence	nsubjpass	43	SENT_21	[p1l8t2858r548b2920],
3	to	TO	O	to	_	0	SENT_21	[p1l573t2861r649b2908],
4	:	:	O	:	_	0	SENT_21	[p1l573t2861r649b2908],
5	Dr.	NNP	O	Dr.	nn	7	SENT_21	[p1l680t2859r756b2907],
6	Joseph	NNP	PERSON	Joseph	nn	7	SENT_21	[p1l786t2859r993b2920],
7	Jankovic	NNP	PERSON	Jankovic	prep_to	2	SENT_21	[p1l1021t2859r1286b2916],
8	,	,	O	,	_	0	SENT_21	[p1l1021t2859r1286b2916],
9	Professor	NNP	O	Professor	appos	7	SENT_21	[p1l1319t2859r1591b2908],
10	of	IN	O	of	_	0	SENT_21	[p1l1614t2859r1668b2908],
11	Neurology	NNP	O	Neurology	prep_of	9	SENT_21	[p1l1693t2859r1995b2921],
12	,	,	O	,	_	0	SENT_21	[p1l1693t2859r1995b2921],
13	Department	NNP	ORGANIZATION	Department	appos	7	SENT_21	[p1l12t2933r347b2994],
14	of	IN	ORGANIZATION	of	_	0	SENT_21	[p1l373t2933r427b2982],
15	Neurology	NNP	ORGANIZATION	Neurology	prep_of	13	SENT_21	[p1l453t2933r755b2995],
16	,	,	O	,	_	0	SENT_21	[p1l453t2933r755b2995],
17	Baylor	NNP	ORGANIZATION	Baylor	nn	18	SENT_21	[p1l789t2933r966b2994],
18	College	NNP	ORGANIZATION	College	appos	7	SENT_21	[p1l990t2932r1202b2995],
19	of	IN	ORGANIZATION	of	_	0	SENT_21	[p1l1229t2933r1283b2982],
20	Medicine	NNP	ORGANIZATION	Medicine	prep_of	18	SENT_21	[p1l1308t2933r1576b2990],
21	,	,	O	,	_	0	SENT_21	[p1l1308t2933r1576b2990],
22	6550	CD	NUMBER	6550	num	23	SENT_21	[p1l1608t2934r1752b2982],
23	Fannin	NNP	LOCATION	Fannin	appos	20	SENT_21	[p1l1780t2933r1982b2990],
24	,	,	O	,	_	0	SENT_21	[p1l1780t2933r1982b2990],
25	Suite	NNP	O	Suite	appos	20	SENT_21	[p1l9t3007r151b3057],
26	1801	CD	DATE	1801	num	25	SENT_21	[p1l181t3009r335b3065],
27	,	,	O	,	_	0	SENT_21	[p1l181t3009r335b3065],
28	Houston	NNP	LOCATION	Houston	appos	20	SENT_21	[p1l369t3008r622b3065],
29	,	,	O	,	_	0	SENT_21	[p1l369t3008r622b3065],
30	TX	NNP	LOCATION	TX	appos	20	SENT_21	[p1l651t3008r728b3056],
31	77030	CD	NUMBER	77030	num	30	SENT_21	[p1l753t3009r947b3065],
32	,	,	O	,	_	0	SENT_21	[p1l753t3009r947b3065],
33	USA	NNP	LOCATION	USA	appos	30	SENT_21	[p1l981t3007r1119b3065],
34	;	:	O	;	_	0	SENT_21	[p1l981t3007r1119b3065],
35	josephj@bcm.edu	NNP	O	josephj@bcm.edu	nn	37	SENT_21	[p1l1146t3007r1659b3069],
36	Funding	NNP	O	Funding	nn	37	SENT_21	[p1l12t3101r256b3162],
37	agencies	NNS	O	agency	dep	20	SENT_21	[p1l284t3101r573b3162],
38	:	:	O	:	_	0	SENT_21	[p1l284t3101r573b3162],
39	This	DT	O	this	det	40	SENT_21	[p1l600t3101r717b3150],
40	study	NN	O	study	dep	20	SENT_21	[p1l743t3101r899b3161],
41	was	VBD	O	be	auxpass	43	SENT_21	[p1l921t3113r1036b3150],
42	partially	RB	O	partially	advmod	43	SENT_21	[p1l1064t3101r1278b3161],
43	funded	VBN	O	fund	_	0	SENT_21	[p1l1300t3101r1498b3150],
44	by	IN	O	by	_	0	SENT_21	[p1l1528t3101r1594b3161],
45	lundbeck	NN	O	lundbeck	agent	43	SENT_21	[p1l1620t3101r1894b3150],
46	.	.	O	.	_	0	SENT_21	[p1l1620t3101r1894b3150],

1	Relevant	JJ	O	relevant	amod	2	SENT_22	[p1l12t3194r276b3243],
2	conflicts	NNS	O	conflict	_	0	SENT_22	[p1l302t3194r561b3243],
3	of	IN	O	of	_	0	SENT_22	[p1l588t3194r647b3243],
4	interest/financial	JJ	O	interest/financial	amod	5	SENT_22	[p1l672t3193r1178b3243],
5	disclosures	NNS	O	disclosure	prep_of	2	SENT_22	[p1l1207t3194r1573b3243],
6	:	:	O	:	_	0	SENT_22	[p1l1207t3194r1573b3243],
7	Christine	NNP	PERSON	Christine	nn	8	SENT_22	[p1l1602t3193r1852b3243],
8	Hunter	NNP	PERSON	Hunter	nsubj	10	SENT_22	[p1l1880t3194r2072b3243],
9	has	VBZ	O	have	aux	10	SENT_22	[p1l11t3269r109b3318],
10	received	VBN	O	receive	dep	2	SENT_22	[p1l137t3269r372b3318],
11	consulting	VBG	O	consult	amod	12	SENT_22	[p1l400t3269r690b3330],
12	fees	NNS	O	fee	dobj	10	SENT_22	[p1l715t3269r833b3318],
13	from	IN	O	from	_	0	SENT_22	[p1l857t3269r985b3318],
14	Lundbeck	NNP	PERSON	Lundbeck	prep_from	12	SENT_22	[p1l1016t3269r1301b3318],
15	for	IN	O	for	_	0	SENT_22	[p1l1323t3269r1399b3318],
16	patient	NN	O	patient	nn	17	SENT_22	[p1l1425t3269r1616b3329],
17	education	NN	O	education	prep_for	12	SENT_22	[p1l1642t3269r1937b3318],
18	.	.	O	.	_	0	SENT_22	[p1l1642t3269r1937b3318],

1	Joohi	NNP	PERSON	Joohi	nn	2	SENT_23	[p1l1968t3269r2120b3318],
2	Jimenez-Shahed	NNP	PERSON	Jimenez-Shahed	nsubj	4	SENT_23	[p1l8t3343r490b3393],
3	has	VBZ	O	have	aux	4	SENT_23	[p1l521t3344r618b3393],
4	received	VBN	O	receive	_	0	SENT_23	[p1l647t3344r881b3393],
5	honoraria	NN	O	honorarium	nn	8	SENT_23	[p1l912t3344r1178b3393],
6	and	CC	O	and	_	0	SENT_23	[p1l1204t3344r1307b3393],
7	consulting	NN	O	consulting	conj_and	5	SENT_23	[p1l1336t3344r1625b3405],
8	fees	NNS	O	fee	dobj	4	SENT_23	[p1l1651t3344r1769b3393],
9	from	IN	O	from	_	0	SENT_23	[p1l1793t3344r1921b3393],
10	Lundbeck	NNP	PERSON	Lundbeck	prep_from	4	SENT_23	[p1l12t3418r309b3467],
11	.	.	O	.	_	0	SENT_23	[p1l12t3418r309b3467],

1	Joseph	NNP	PERSON	Joseph	nn	2	SENT_24	[p1l339t3418r546b3479],
2	Jankovic	NNP	PERSON	Jankovic	nsubj	4	SENT_24	[p1l574t3418r824b3467],
3	has	VBZ	O	have	aux	4	SENT_24	[p1l853t3418r951b3467],
4	received	VBN	O	receive	_	0	SENT_24	[p1l978t3418r1214b3467],
5	research	NN	O	research	nn	6	SENT_24	[p1l1244t3418r1486b3467],
6	grants	NNS	O	grant	dobj	4	SENT_24	[p1l1515t3421r1692b3480],
7	and	CC	O	and	_	0	SENT_24	[p1l1718t3418r1823b3467],
8	consulting	VBG	O	consult	amod	9	SENT_24	[p1l1851t3418r2140b3480],
9	fees	NNS	O	fee	dobj	4	SENT_24	[p1l7t3493r125b3542],
10	from	IN	O	from	_	0	SENT_24	[p1l149t3493r276b3542],
11	Lundbeck	NNP	PERSON	Lundbeck	prep_from	9	SENT_24	[p1l307t3493r604b3542],
12	.	.	O	.	_	0	SENT_24	[p1l307t3493r604b3542],

1	Full	JJ	O	full	amod	3	SENT_25	[p1l12t3586r101b3635],
2	financial	JJ	O	financial	amod	3	SENT_25	[p1l127t3586r356b3635],
3	disclosures	NNS	O	disclosure	nsubjpass	9	SENT_25	[p1l385t3586r705b3635],
4	and	CC	O	and	_	0	SENT_25	[p1l731t3586r835b3635],
5	author	NN	O	author	nn	6	SENT_25	[p1l864t3586r1047b3635],
6	roles	NNS	O	role	conj_and	3	SENT_25	[p1l1073t3586r1205b3635],
7	may	MD	O	may	aux	9	SENT_25	[p1l1233t3598r1351b3647],
8	be	VB	O	be	auxpass	9	SENT_25	[p1l1377t3586r1445b3635],
9	found	VBN	O	find	_	0	SENT_25	[p1l1469t3586r1631b3635],
10	in	IN	O	in	_	0	SENT_25	[p1l1661t3586r1702b3634],
11	the	DT	O	the	det	13	SENT_25	[p1l1729t3586r1818b3635],
12	online	JJ	O	online	amod	13	SENT_25	[p1l1844t3586r2010b3635],
13	version	NN	O	version	prep_in	9	SENT_25	[p1l7t3661r208b3710],
14	of	IN	O	of	_	0	SENT_25	[p1l236t3661r290b3710],
15	this	DT	O	this	det	16	SENT_25	[p1l311t3661r410b3710],
16	article	NN	O	article	prep_of	13	SENT_25	[p1l436t3661r617b3710],
17	.	.	O	.	_	0	SENT_25	[p1l436t3661r617b3710],

1	Received	VBN	O	receive	_	0	SENT_26	[p2l12t45r309b94],
2	:	:	O	:	_	0	SENT_26	[p2l12t45r309b94],
3	3	CD	DATE	3	dobj	1	SENT_26	[p2l338t46r371b94],
4	July	NNP	DATE	July	tmod	3	SENT_26	[p2l397t45r509b106],
5	2012	CD	DATE	2012	num	4	SENT_26	[p2l534t46r692b102],
6	;	:	O	;	_	0	SENT_26	[p2l534t46r692b102],
7	Revised	VBN	O	revise	dep	9	SENT_26	[p2l725t45r984b94],
8	:	:	O	:	_	0	SENT_26	[p2l725t45r984b94],
9	30	CD	DATE	30	dep	3	SENT_26	[p2l1013t46r1084b94],
10	September	NNP	DATE	September	tmod	9	SENT_26	[p2l1110t44r1428b106],
11	2012	CD	DATE	2012	num	10	SENT_26	[p2l1453t46r1611b102],
12	;	:	O	;	_	0	SENT_26	[p2l1453t46r1611b102],
13	Accepted	JJ	O	accepted	dep	9	SENT_26	[p2l1640t45r1952b106],
14	:	:	O	:	_	0	SENT_26	[p2l1640t45r1952b106],
15	17	CD	DATE	17	dep	13	SENT_26	[p2l1985t46r2050b93],
16	October	NNP	DATE	October	tmod	15	SENT_26	[p2l9t119r243b169],
17	2012	CD	DATE	2012	num	16	SENT_26	[p2l267t120r410b169],

1	Published	VBN	O	publish	_	0	SENT_27	[p2l12t237r311b286],
2	online	JJ	O	online	amod	3	SENT_27	[p2l340t237r522b286],
3	26	CD	DATE	26	dobj	1	SENT_27	[p2l549t237r619b286],
4	December	NNP	DATE	December	tmod	1	SENT_27	[p2l647t237r964b286],
5	2012	CD	DATE	2012	num	4	SENT_27	[p2l988t237r1132b286],
6	in	IN	O	in	_	0	SENT_27	[p2l1160t237r1207b285],
7	Wiley	NNP	ORGANIZATION	Wiley	nn	13	SENT_27	[p2l1233t237r1401b298],
8	Online	NNP	ORGANIZATION	Online	nn	13	SENT_27	[p2l1425t236r1619b286],
9	Library	NNP	ORGANIZATION	Library	nn	13	SENT_27	[p2l1647t237r1858b298],
10	(	CD	NUMBER	(	num	13	SENT_27	[p2l10t310r749b373],
11	wi	NN	O	wus	nn	13	SENT_27	[p2l10t310r749b373],
12	|	NN	O	|	nn	13	SENT_27	[p2l10t310r749b373],
13	eyon	NN	O	eyon	prep_in	1	SENT_27	[p2l10t310r749b373],
14	|	CD	NUMBER	|	num	15	SENT_27	[p2l10t310r749b373],
15	inelibrary.com	NNP	O	inelibrary.com	dep	13	SENT_27	[p2l10t310r749b373],
16	)	CD	NUMBER	)	num	15	SENT_27	[p2l10t310r749b373],
17	.	.	O	.	_	0	SENT_27	[p2l10t310r749b373],

1	DOI	NNP	O	DOI	nsubj	35	SENT_28	[p2l781t310r909b361],
2	:	:	O	:	_	0	SENT_28	[p2l781t310r909b361],
3	10.1002	CD	NUMBER	10.1002	nsubj	35	SENT_28	[p2l939t310r1539b361],
4	/	:	O	/	punct	5	SENT_28	[p2l939t310r1539b361],
5	mds	NNS	O	md	dep	3	SENT_28	[p2l939t310r1539b361],
6	.25278	CD	NUMBER	.25278	num	5	SENT_28	[p2l939t310r1539b361],
7	whose	WP$	O	whose	poss	8	SENT_28	[p2l6t394r245b464],
8	products	NNS	O	product	nsubj	9	SENT_28	[p2l283t394r616b483],
9	affect	VBP	O	affect	rcmod	5	SENT_28	[p2l656t394r865b464],
10	absorption	NN	O	absorption	dobj	9	SENT_28	[p2l904t394r1337b483],
11	,	,	O	,	_	0	SENT_28	[p2l904t394r1337b483],
12	distribution	NN	O	distribution	conj_and	10	SENT_28	[p2l1379t394r1848b479],
13	,	,	O	,	_	0	SENT_28	[p2l1379t394r1848b479],
14	metabolism	NN	O	metabolism	conj_and	10	SENT_28	[p2l1888t394r2151b464, p2l8t498r234b584],
15	,	,	O	,	_	0	SENT_28	[p2l1888t394r2151b464, p2l8t498r234b584],
16	and	CC	O	and	_	0	SENT_28	[p2l286t498r424b568],
17	elimination	NN	O	elimination	dobj	9	SENT_28	[p2l473t498r907b568],
18	of	IN	O	of	_	0	SENT_28	[p2l955t498r1034b568],
19	a	DT	O	a	det	21	SENT_28	[p2l1078t525r1117b568],
20	given	VBN	O	give	amod	21	SENT_28	[p2l1165t503r1366b587],
21	drug	NN	O	drug	prep_of	10	SENT_28	[p2l1415t498r1588b587],
22	(	CD	NUMBER	(	num	24	SENT_28	[p2l1640t498r2151b587, p2l7t606r187b672],
23	pharmacokinetic	JJ	O	pharmacokinetic	amod	24	SENT_28	[p2l1640t498r2151b587, p2l7t606r187b672],
24	pathways	NNS	O	pathway	dep	21	SENT_28	[p2l243t602r661b691],
25	)	RB	O	)	advmod	9	SENT_28	[p2l243t602r661b691],
26	,	,	O	,	_	0	SENT_28	[p2l243t602r661b691],
27	as	RB	O	as	advmod	29	SENT_28	[p2l721t629r793b672],
28	well	RB	O	well	advmod	29	SENT_28	[p2l850t602r1007b672],
29	as	IN	O	as	dep	5	SENT_28	[p2l1066t629r1138b672],
30	on	IN	O	on	_	0	SENT_28	[p2l1197t629r1291b672],
31	identifying	VBG	O	identify	prepc_on	3	SENT_28	[p2l1348t602r1757b690],
32	potential	JJ	O	potential	amod	34	SENT_28	[p2l1813t602r2152b691],
33	drug	NN	O	drug	nn	34	SENT_28	[p2l8t706r181b795],
34	targets	NNS	O	target	dobj	31	SENT_28	[p2l234t725r488b795],
35	(	VBP	O	(	_	0	SENT_28	[p2l547t706r1283b795],
36	pharmacodynamic	JJ	O	pharmacodynamic	amod	37	SENT_28	[p2l547t706r1283b795],
37	pathways	NNS	O	pathway	nsubj	38	SENT_28	[p2l1337t706r1752b795],
38	)	VBP	O	)	ccomp	35	SENT_28	[p2l1337t706r1752b795],
39	.	.	O	.	_	0	SENT_28	[p2l1337t706r1752b795],

1	To	TO	O	to	_	0	SENT_29	[p2l1809t709r1913b776],
2	date	NN	O	date	prep_to	11	SENT_29	[p2l1969t706r2150b791],
3	,	,	O	,	_	0	SENT_29	[p2l1969t706r2150b791],
4	however	RB	O	however	advmod	11	SENT_29	[p2l7t810r354b896],
5	,	,	O	,	_	0	SENT_29	[p2l7t810r354b896],
6	pharmacogenetics	NNS	O	pharmacogenetic	nsubjpass	11	SENT_29	[p2l404t810r1092b899],
7	has	VBZ	O	have	aux	11	SENT_29	[p2l1141t810r1264b880],
8	not	RB	O	not	neg	11	SENT_29	[p2l1314t829r1439b880],
9	been	VBN	O	be	auxpass	11	SENT_29	[p2l1488t810r1662b880],
10	fully	RB	O	fully	advmod	11	SENT_29	[p2l1710t810r1881b899],
11	incorporated	VBN	O	incorporate	_	0	SENT_29	[p2l1929t815r2151b880, p2l6t914r301b1003],
12	into	IN	O	into	_	0	SENT_29	[p2l335t918r483b984],
13	clinical	JJ	O	clinical	amod	14	SENT_29	[p2l518t914r789b984],
14	algorithms	NNS	O	algorithm	prep_into	11	SENT_29	[p2l824t900r1292b1003],
15	.8	CD	NUMBER	.8	dep	14	SENT_29	[p2l824t900r1292b1003],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_30	[p2l88t1018r740b1107],
2	considerations	NNS	O	consideration	nsubj	5	SENT_30	[p2l774t1018r1326b1088],
3	are	VBP	O	be	cop	5	SENT_30	[p2l1362t1045r1475b1088],
4	particularly	RB	O	particularly	advmod	5	SENT_30	[p2l1509t1018r1954b1107],
5	relevant	JJ	O	relevant	_	0	SENT_30	[p2l1987t1018r2151b1088, p2l6t1142r172b1192],
6	to	TO	O	to	_	0	SENT_30	[p2l218t1142r292b1192],
7	tetrabenazine	NN	O	tetrabenazine	prep_to	5	SENT_30	[p2l339t1122r876b1208],
8	,	,	O	,	_	0	SENT_30	[p2l339t1122r876b1208],
9	as	IN	O	as	mark	13	SENT_30	[p2l927t1150r1000b1192],
10	the	DT	O	the	det	11	SENT_30	[p2l1047t1122r1161b1192],
11	drug	NN	O	drug	nsubjpass	13	SENT_30	[p2l1210t1122r1383b1211],
12	is	VBZ	O	be	auxpass	13	SENT_30	[p2l1429t1127r1483b1192],
13	metabolized	VBN	O	metabolize	advcl	5	SENT_30	[p2l1531t1122r1996b1192],
14	via	IN	O	via	_	0	SENT_30	[p2l2041t1127r2152b1192],
15	the	DT	O	the	det	18	SENT_30	[p2l6t1226r121b1296],
16	cytochrome	NN	O	cytochrome	nn	18	SENT_30	[p2l161t1226r608b1314],
17	P450	NN	O	p450	nn	18	SENT_30	[p2l648t1231r839b1296],
18	enzyme	NN	O	enzyme	prep_via	13	SENT_30	[p2l881t1252r1164b1314],
19	system	NN	O	system	nn	22	SENT_30	[p2l1206t1245r1458b1314],
20	(	CD	NUMBER	(	num	22	SENT_30	[p2l1502t1230r1751b1311],
21	CYP	NN	O	cyp	nn	22	SENT_30	[p2l1502t1230r1751b1311],
22	)	NN	O	)	dep	18	SENT_30	[p2l1502t1230r1751b1311],
23	.	.	O	.	_	0	SENT_30	[p2l1502t1230r1751b1311],

1	Although	IN	O	although	dep	153	SENT_31	[p2l1794t1226r2153b1315],
2	families	NNS	O	family	dep	153	SENT_31	[p2l7t1330r301b1400],
3	CYP1-3	NN	O	cyp1-3	dep	153	SENT_31	[p2l371t1334r667b1400],
4	mediate	VBP	O	mediate	dep	153	SENT_31	[p2l737t1330r1037b1400],
5	about	IN	O	about	dep	153	SENT_31	[p2l1106t1330r1324b1400],
6	70	CD	PERCENT	70	dep	153	SENT_31	[p2l1392t1334r1567b1401],
7	%	NN	PERCENT	%	dep	153	SENT_31	[p2l1392t1334r1567b1401],
8	of	IN	O	of	dep	153	SENT_31	[p2l1641t1330r1720b1400],
9	all	DT	O	all	dep	153	SENT_31	[p2l1783t1330r1872b1400],
10	phase	NN	O	phase	dep	153	SENT_31	[p2l1938t1330r2151b1419],
11	I	PRP	O	I	dep	153	SENT_31	[p2l7t1434r476b1523],
12	—	VBP	O	—	dep	153	SENT_31	[p2l7t1434r476b1523],
13	dependent	JJ	O	dependent	dep	153	SENT_31	[p2l7t1434r476b1523],
14	metabolism	NN	O	metabolism	dep	153	SENT_31	[p2l525t1434r969b1504],
15	of	IN	O	of	dep	153	SENT_31	[p2l1020t1434r1098b1504],
16	clinically	RB	O	clinically	dep	153	SENT_31	[p2l1143t1434r1485b1523],
17	used	VBN	O	use	dep	153	SENT_31	[p2l1535t1434r1704b1504],
18	drugs	NNS	O	drug	dep	153	SENT_31	[p2l1755t1434r1985b1523],
19	,	,	O	,	_	0	SENT_31	[p2l1755t1434r1985b1523],
20	the	DT	O	the	dep	153	SENT_31	[p2l2037t1434r2151b1504],
21	CYPZC9	NN	O	cypzc9	dep	153	SENT_31	[p2l10t1542r367b1623],
22	,	,	O	,	_	0	SENT_31	[p2l10t1542r367b1623],
23	CYPZCI9	NN	O	cypzci9	dep	153	SENT_31	[p2l420t1542r826b1623],
24	,	,	O	,	_	0	SENT_31	[p2l420t1542r826b1623],
25	and	CC	O	and	dep	153	SENT_31	[p2l879t1538r1017b1608],
26	CYPZD6	NN	O	cypzd6	dep	153	SENT_31	[p2l1067t1542r1405b1608],
27	enzymes	NNS	O	enzyme	dep	153	SENT_31	[p2l1455t1564r1773b1626],
28	facilitate	VBP	O	facilitate	dep	153	SENT_31	[p2l1822t1538r2152b1608],
29	about	IN	O	about	dep	153	SENT_31	[p2l8t1642r226b1712],
30	30	CD	PERCENT	30	dep	153	SENT_31	[p2l289t1646r464b1713],
31	%	NN	PERCENT	%	dep	153	SENT_31	[p2l289t1646r464b1713],
32	of	IN	O	of	dep	153	SENT_31	[p2l533t1642r611b1712],
33	P450-mediated	JJ	O	p450-mediated	dep	153	SENT_31	[p2l666t1642r1244b1712],
34	drug	NN	O	drug	dep	153	SENT_31	[p2l1306t1642r1478b1731],
35	metabolism	NN	O	metabolism	dep	153	SENT_31	[p2l1539t1628r2044b1712],
36	.9	CD	NUMBER	.9	dep	153	SENT_31	[p2l1539t1628r2044b1712],
37	-11	CD	NUMBER	-11	dep	153	SENT_31	[p2l2047t1628r2148b1670],
38	Based	VBN	O	base	dep	153	SENT_31	[p2l8t1746r227b1816],
39	on	IN	O	on	dep	153	SENT_31	[p2l264t1774r358b1816],
40	the	DT	O	the	dep	153	SENT_31	[p2l392t1746r507b1816],
41	genotype	NN	O	genotype	dep	153	SENT_31	[p2l543t1766r886b1835],
42	determination	NN	O	determination	dep	153	SENT_31	[p2l925t1746r1462b1816],
43	by	IN	O	by	dep	153	SENT_31	[p2l1499t1746r1589b1835],
44	AmpliChip	NN	O	amplichip	dep	153	SENT_31	[p2l1622t1746r2068b1835],
45	,	,	O	,	_	0	SENT_31	[p2l1622t1746r2068b1835],
46	4	CD	NUMBER	4	dep	153	SENT_31	[p2l2107t1751r2151b1815],
47	groups	NNS	O	group	dep	153	SENT_31	[p2l7t1877r264b1939],
48	of	IN	O	of	dep	153	SENT_31	[p2l310t1850r388b1920],
49	individuals	NNS	O	individual	dep	153	SENT_31	[p2l427t1850r844b1920],
50	can	MD	O	can	dep	153	SENT_31	[p2l889t1878r1020b1920],
51	be	VB	O	be	dep	153	SENT_31	[p2l1065t1851r1147b1920],
52	phenotypically	RB	O	phenotypically	dep	153	SENT_31	[p2l1191t1850r1756b1939],
53	predicted	VBN	O	predict	dep	153	SENT_31	[p2l1798t1851r2152b1939],
54	for	IN	O	for	dep	153	SENT_31	[p2l7t1954r117b2024],
55	each	DT	O	each	dep	153	SENT_31	[p2l165t1954r335b2024],
56	P450	NN	O	p450	dep	153	SENT_31	[p2l384t1959r576b2024],
57	enzyme	NN	O	enzyme	dep	153	SENT_31	[p2l627t1981r932b2043],
58	:	:	O	:	_	0	SENT_31	[p2l627t1981r932b2043],
59	(	CD	NUMBER	(	dep	153	SENT_31	[p2l990t1958r1085b2039],
60	1	CD	NUMBER	1	dep	153	SENT_31	[p2l990t1958r1085b2039],
61	)	CD	NUMBER	)	dep	153	SENT_31	[p2l990t1958r1085b2039],
62	poor	JJ	O	poor	dep	153	SENT_31	[p2l1138t1981r1318b2043],
63	metabolizers	NNS	O	metabolizer	dep	153	SENT_31	[p2l1365t1954r1849b2024],
64	(	VBP	O	(	dep	153	SENT_31	[p2l1903t1958r2150b2039],
65	PMs	NNS	O	pm	dep	153	SENT_31	[p2l1903t1958r2150b2039],
66	)	CD	NUMBER	)	dep	153	SENT_31	[p2l1903t1958r2150b2039],
67	,	,	O	,	_	0	SENT_31	[p2l1903t1958r2150b2039],
68	who	WP	O	who	dep	153	SENT_31	[p2l6t2058r171b2128],
69	lack	VBP	O	lack	dep	153	SENT_31	[p2l210t2058r365b2128],
70	the	DT	O	the	dep	153	SENT_31	[p2l403t2058r517b2128],
71	functional	JJ	O	functional	dep	153	SENT_31	[p2l557t2058r945b2128],
72	enzyme	NN	O	enzyme	dep	153	SENT_31	[p2l984t2085r1267b2147],
73	and	CC	O	and	dep	153	SENT_31	[p2l1308t2058r1447b2128],
74	as	IN	O	as	dep	153	SENT_31	[p2l1486t2086r1559b2128],
75	such	JJ	O	such	dep	153	SENT_31	[p2l1598t2058r1767b2128],
76	are	VBP	O	be	dep	153	SENT_31	[p2l1806t2086r1919b2128],
77	more	RBR	O	more	dep	153	SENT_31	[p2l1958t2086r2151b2128],
78	likely	JJ	O	likely	dep	153	SENT_31	[p2l7t2163r214b2251],
79	to	TO	O	to	dep	153	SENT_31	[p2l260t2182r334b2232],
80	develop	VB	O	develop	dep	153	SENT_31	[p2l385t2162r676b2251],
81	side	JJ	O	side	dep	153	SENT_31	[p2l727t2162r869b2232],
82	effects	NNS	O	effect	dep	153	SENT_31	[p2l919t2162r1157b2232],
83	because	IN	O	because	dep	153	SENT_31	[p2l1208t2162r1500b2232],
84	of	IN	O	of	dep	153	SENT_31	[p2l1550t2162r1628b2232],
85	high	JJ	O	high	dep	153	SENT_31	[p2l1671t2162r1836b2251],
86	plasma	NN	O	plasma	dep	153	SENT_31	[p2l1883t2163r2152b2251],
87	levels	NNS	O	level	dep	153	SENT_31	[p2l7t2266r235b2352],
88	;	:	O	;	_	0	SENT_31	[p2l7t2266r235b2352],
89	(	NN	O	(	dep	153	SENT_31	[p2l298t2270r393b2352],
90	2	CD	NUMBER	2	dep	153	SENT_31	[p2l298t2270r393b2352],
91	)	CD	NUMBER	)	dep	153	SENT_31	[p2l298t2270r393b2352],
92	intermediate	JJ	O	intermediate	dep	153	SENT_31	[p2l454t2266r932b2336],
93	metabolizers	NNS	O	metabolizer	dep	153	SENT_31	[p2l988t2266r1471b2336],
94	(	VBP	O	(	dep	153	SENT_31	[p2l1532t2270r1760b2352],
95	IMS	NNP	O	IMS	dep	153	SENT_31	[p2l1532t2270r1760b2352],
96	)	CD	NUMBER	)	dep	153	SENT_31	[p2l1532t2270r1760b2352],
97	,	,	O	,	_	0	SENT_31	[p2l1532t2270r1760b2352],
98	who	WP	O	who	dep	153	SENT_31	[p2l1816t2266r1981b2336],
99	are	VBP	O	be	dep	153	SENT_31	[p2l2039t2293r2152b2336],
100	heterozygous	JJ	O	heterozygous	dep	153	SENT_31	[p2l7t2370r509b2459],
101	for	IN	O	for	dep	153	SENT_31	[p2l563t2370r673b2440],
102	1	CD	NUMBER	1	dep	153	SENT_31	[p2l731t2375r763b2439],
103	deﬁcient	JJ	O	deﬁcient	dep	153	SENT_31	[p2l824t2370r1143b2440],
104	allele	NN	O	allele	dep	153	SENT_31	[p2l1196t2370r1390b2440],
105	or	CC	O	or	dep	153	SENT_31	[p2l1445t2397r1524b2440],
106	carry	VB	O	carry	dep	153	SENT_31	[p2l1576t2397r1772b2459],
107	2	CD	NUMBER	2	dep	153	SENT_31	[p2l1824t2375r1867b2439],
108	alleles	NNS	O	allele	dep	153	SENT_31	[p2l1923t2370r2151b2440],
109	with	IN	O	with	dep	153	SENT_31	[p2l6t2475r177b2544],
110	reduced	VBN	O	reduce	dep	153	SENT_31	[p2l265t2475r564b2544],
111	activity	NN	O	activity	dep	153	SENT_31	[p2l653t2479r954b2563],
112	;	:	O	;	_	0	SENT_31	[p2l653t2479r954b2563],
113	(	CD	NUMBER	(	dep	153	SENT_31	[p2l1049t2479r1145b2560],
114	3	CD	NUMBER	3	dep	153	SENT_31	[p2l1049t2479r1145b2560],
115	)	NN	O	)	dep	153	SENT_31	[p2l1049t2479r1145b2560],
116	extended	VBD	O	extend	dep	153	SENT_31	[p2l1238t2475r1581b2544],
117	metabolizers	NNS	O	metabolizer	dep	153	SENT_31	[p2l1668t2475r2151b2544],
118	(	CD	NUMBER	(	dep	153	SENT_31	[p2l11t2582r264b2664],
119	EMS	NNP	ORGANIZATION	EMS	dep	153	SENT_31	[p2l11t2582r264b2664],
120	)	CD	NUMBER	)	dep	153	SENT_31	[p2l11t2582r264b2664],
121	,	,	O	,	_	0	SENT_31	[p2l11t2582r264b2664],
122	who	WP	O	who	dep	153	SENT_31	[p2l308t2578r473b2648],
123	have	VBP	O	have	dep	153	SENT_31	[p2l517t2578r691b2648],
124	2	CD	NUMBER	2	dep	153	SENT_31	[p2l735t2583r779b2647],
125	normal	JJ	O	normal	dep	153	SENT_31	[p2l823t2578r1097b2648],
126	alleles	NNS	O	allele	dep	153	SENT_31	[p2l1141t2578r1393b2663],
127	;	:	O	;	_	0	SENT_31	[p2l1141t2578r1393b2663],
128	and	CC	O	and	dep	153	SENT_31	[p2l1441t2578r1579b2648],
129	(	NN	O	(	dep	153	SENT_31	[p2l1626t2582r1722b2663],
130	4	CD	NUMBER	4	dep	153	SENT_31	[p2l1626t2582r1722b2663],
131	)	NN	O	)	dep	153	SENT_31	[p2l1626t2582r1722b2663],
132	ultrarapid	NN	O	ultrarapid	dep	153	SENT_31	[p2l1770t2578r2153b2667],
133	metabolizers	NNS	O	metabolizer	dep	153	SENT_31	[p2l7t2682r490b2752],
134	(	VBP	O	(	dep	153	SENT_31	[p2l552t2686r813b2768],
135	UMS	NN	O	um	dep	153	SENT_31	[p2l552t2686r813b2768],
136	)	NN	O	)	dep	153	SENT_31	[p2l552t2686r813b2768],
137	,	,	O	,	_	0	SENT_31	[p2l552t2686r813b2768],
138	who	WP	O	who	dep	153	SENT_31	[p2l870t2682r1035b2752],
139	have	VBP	O	have	dep	153	SENT_31	[p2l1091t2682r1265b2752],
140	multiple	JJ	O	multiple	dep	153	SENT_31	[p2l1322t2682r1636b2771],
141	gene	NN	O	gene	dep	153	SENT_31	[p2l1692t2709r1861b2771],
142	copies	NNS	O	copy	dep	153	SENT_31	[p2l1918t2687r2152b2771],
143	and	CC	O	and	dep	153	SENT_31	[p2l8t2787r147b2856],
144	as	IN	O	as	dep	153	SENT_31	[p2l197t2814r270b2856],
145	such	JJ	O	such	dep	153	SENT_31	[p2l321t2787r489b2856],
146	are	VBP	O	be	dep	153	SENT_31	[p2l539t2814r652b2856],
147	likely	JJ	O	likely	dep	153	SENT_31	[p2l703t2786r909b2875],
148	to	TO	O	to	dep	153	SENT_31	[p2l957t2806r1032b2856],
149	experience	VB	O	experience	dep	153	SENT_31	[p2l1083t2791r1485b2875],
150	only	RB	O	only	dep	153	SENT_31	[p2l1537t2787r1702b2875],
151	short	JJ	O	short	dep	153	SENT_31	[p2l1751t2787r2153b2856],
152	—	NN	O	—	dep	153	SENT_31	[p2l1751t2787r2153b2856],
153	term	NN	O	term	_	0	SENT_31	[p2l1751t2787r2153b2856],

1	210	CD	NUMBER	210	num	4	SENT_32	[p2l50t2974r103b2998],
2	Movement	NNP	O	Movement	nn	4	SENT_32	[p2l196t2980r311b2998],
3	Disorders	NNP	O	Disorders	nn	4	SENT_32	[p2l320t2980r421b2998],
4	Vol	NNP	O	Vol	_	0	SENT_32	[p2l436t2980r469b2998],
5	28	CD	NUMBER	28	dep	4	SENT_32	[p2l486t2980r512b2998],
6	No	DT	O	no	det	8	SENT_32	[p2l529t2980r559b2998],
7	2	CD	NUMBER	2	num	8	SENT_32	[p2l576t2980r588b2998],
8	2013	CD	DATE	2013	dep	4	SENT_32	[p2l605t2980r658b2998],

1	%	NN	O	%	nn	2	SENT_33	[p2l6t3151r262b3316],
2	ANALYSIS	NN	O	analysis	_	0	SENT_33	[p2l363t3205r856b3249],
3	OF	IN	O	of	_	0	SENT_33	[p2l951t3205r1057b3249],
4	CYP2D6	NNP	O	CYP2D6	nn	5	SENT_33	[p2l1150t3205r1529b3249],
5	GENOTYPE	NNP	O	GENOTYPE	prep_of	2	SENT_33	[p2l1623t3205r2153b3249],

1	effects	NNS	O	effect	_	0	SENT_34	[p3l9t20r230b85],
2	from	IN	O	from	_	0	SENT_34	[p3l267t20r438b85],
3	the	DT	O	the	det	4	SENT_34	[p3l473t20r580b85],
4	drug	NN	O	drug	prep_from	1	SENT_34	[p3l619t20r779b102],
5	because	IN	O	because	prep	1	SENT_34	[p3l816t20r1087b85],
6	of	IN	O	of	_	0	SENT_34	[p3l1125t20r1198b85],
7	fast	JJ	O	fast	amod	8	SENT_34	[p3l1231t20r1356b85],
8	metabolism	NN	O	metabolism	prep_of	1	SENT_34	[p3l1391t20r1822b85],
9	.	.	O	.	_	0	SENT_34	[p3l1391t20r1822b85],

1	The	DT	O	the	det	3	SENT_35	[p3l1862t20r1997b85],
2	2	CD	NUMBER	2	num	3	SENT_35	[p3l8t121r48b180],
3	metabolites	NNS	O	metabolite	_	0	SENT_35	[p3l83t116r489b181],
4	of	IN	O	of	_	0	SENT_35	[p3l524t116r597b181],
5	tetrabenazine	NN	O	tetrabenazine	prep_of	3	SENT_35	[p3l625t116r1123b195],
6	,	,	O	,	_	0	SENT_35	[p3l625t116r1123b195],
7	oc	NN	O	oc	appos	5	SENT_35	[p3l1161t121r1324b181],
8	.	.	O	.	_	0	SENT_35	[p3l1161t121r1324b181],

1	—	NN	O	—	_	0	SENT_36	[p3l1161t121r1324b181],
2	.	.	O	.	_	0	SENT_36	[p3l1161t121r1324b181],

1	H	NN	O	h	_	0	SENT_37	[p3l1161t121r1324b181],
2	tetrabenazine	NN	O	tetrabenazine	dep	1	SENT_37	[p3l1357t116r1834b181],
3	and	CC	O	and	_	0	SENT_37	[p3l1869t116r1998b181],
4	B	NN	O	b	dep	1	SENT_37	[p3l14t216r173b294],
5	.	.	O	.	_	0	SENT_37	[p3l14t216r173b294],

1	—	NN	O	—	_	0	SENT_38	[p3l14t216r173b294],
2	.	.	O	.	_	0	SENT_38	[p3l14t216r173b294],

1	H	NN	O	h	nn	2	SENT_39	[p3l14t216r173b294],
2	tetrabenazine	NN	O	tetrabenazine	nsubjpass	5	SENT_39	[p3l221t212r719b292],
3	,	,	O	,	_	0	SENT_39	[p3l221t212r719b292],
4	are	VBP	O	be	auxpass	5	SENT_39	[p3l771t238r876b277],
5	metabolized	VBN	O	metabolize	_	0	SENT_39	[p3l924t212r1356b277],
6	in	IN	O	in	_	0	SENT_39	[p3l1404t217r1469b276],
7	the	DT	O	the	det	8	SENT_39	[p3l1516t212r1622b277],
8	liver	NN	O	liver	prep_in	5	SENT_39	[p3l1671t212r1825b277],
9	primarily	RB	O	primarily	advmod	8	SENT_39	[p3l1872t217r1996b295, p3l8t309r236b391],
10	by	IN	O	by	_	0	SENT_39	[p3l290t309r373b391],
11	CYP2D6	NN	O	cyp2d6	prep_by	8	SENT_39	[p3l428t313r765b388],
12	,	,	O	,	_	0	SENT_39	[p3l428t313r765b388],
13	and	CC	O	and	_	0	SENT_39	[p3l822t309r950b374],
14	oL	NN	O	ol	prep_in	5	SENT_39	[p3l1005t314r1168b373],
15	.	.	O	.	_	0	SENT_39	[p3l1005t314r1168b373],

1	—	NN	O	—	_	0	SENT_40	[p3l1005t314r1168b373],
2	.	.	O	.	_	0	SENT_40	[p3l1005t314r1168b373],

1	H	NN	O	h	_	0	SENT_41	[p3l1005t314r1168b373],
2	-	:	O	-	_	0	SENT_41	[p3l1005t314r1168b373],
3	tetrabenazine	NN	O	tetrabenazine	nsubj	4	SENT_41	[p3l1223t309r1698b374],
4	is	VBZ	O	be	dep	1	SENT_41	[p3l1754t313r1804b374],
5	also	RB	O	also	advmod	7	SENT_41	[p3l1860t309r1996b374],
6	partially	RB	O	partially	advmod	7	SENT_41	[p3l8t405r305b488],
7	metabolized	VBN	O	metabolize	dep	4	SENT_41	[p3l338t405r770b470],
8	by	IN	O	by	_	0	SENT_41	[p3l805t405r888b488],
9	CYP1A2	NN	O	cyp1a2	prep_by	7	SENT_41	[p3l925t393r1294b470],
10	.7	CD	NUMBER	.7	num	9	SENT_41	[p3l925t393r1294b470],
11	In	FW	O	in	nn	12	SENT_41	[p3l1327t410r1397b469],
12	vivo	FW	O	vivo	nsubj	16	SENT_41	[p3l1430t409r1579b470],
13	pharmacological	JJ	O	pharmacological	amod	14	SENT_41	[p3l1614t405r1996b488, p3l9t501r240b584],
14	studies	NNS	O	study	dep	12	SENT_41	[p3l305t501r542b566],
15	have	VBP	O	have	aux	16	SENT_41	[p3l607t501r768b566],
16	shown	VBN	O	show	rcmod	9	SENT_41	[p3l833t501r1063b566],
17	that	IN	O	that	complm	23	SENT_41	[p3l1125t501r1266b566],
18	tetrabenazine	NN	O	tetrabenazine	nsubj	29	SENT_41	[p3l1327t501r1804b566],
19	and	CC	O	and	_	0	SENT_41	[p3l1870t501r1998b566],
20	H	NN	O	h	nn	22	SENT_41	[p3l8t598r580b663],
21	—	CD	NUMBER	—	num	22	SENT_41	[p3l8t598r580b663],
22	tetrabenazine	NN	O	tetrabenazine	conj_and	18	SENT_41	[p3l8t598r580b663],
23	have	VBP	O	have	ccomp	7	SENT_41	[p3l651t598r812b663],
24	an	DT	O	a	det	27	SENT_41	[p3l883t623r966b663],
25	identical	JJ	O	identical	amod	26	SENT_41	[p3l1035t598r1336b663],
26	pharmacological	JJ	O	pharmacological	amod	27	SENT_41	[p3l1404t598r1997b681],
27	proﬁle	NN	O	proﬁle	dobj	23	SENT_41	[p3l8t695r233b778],
28	and	CC	O	and	_	0	SENT_41	[p3l283t695r411b760],
29	play	VB	O	play	ccomp	7	SENT_41	[p3l458t695r608b777],
30	an	DT	O	a	det	32	SENT_41	[p3l656t720r739b760],
31	equal	JJ	O	equal	amod	32	SENT_41	[p3l786t695r975b777],
32	role	NN	O	role	dobj	29	SENT_41	[p3l1023t695r1157b760],
33	in	IN	O	in	_	0	SENT_41	[p3l1206t699r1271b759],
34	the	DT	O	the	det	35	SENT_41	[p3l1317t695r1424b760],
35	biological	JJ	O	biological	prep_in	29	SENT_41	[p3l1474t695r1819b777],
36	and	CC	O	and	_	0	SENT_41	[p3l1869t695r1997b760],
37	thus	RB	O	thus	dep	4	SENT_41	[p3l8t791r155b856],
38	clinical	JJ	O	clinical	amod	39	SENT_41	[p3l187t792r438b856],
39	effect	NN	O	effect	dep	7	SENT_41	[p3l470t791r661b856],
40	of	IN	O	of	_	0	SENT_41	[p3l693t791r766b856],
41	the	DT	O	the	det	42	SENT_41	[p3l792t792r899b856],
42	drug	NN	O	drug	prep_of	39	SENT_41	[p3l933t779r1236b874],
43	.7	CD	NUMBER	.7	number	44	SENT_41	[p3l933t779r1236b874],
44	’12	CD	NUMBER	’12	num	42	SENT_41	[p3l933t779r1236b874],

1	The	DT	O	the	det	2	SENT_42	[p3l82t891r216b956],
2	FDA	NNP	ORGANIZATION	FDA	nsubj	3	SENT_42	[p3l275t894r442b954],
3	has	VBZ	O	have	_	0	SENT_42	[p3l499t891r613b956],
4	recommended	VBN	O	recommend	amod	5	SENT_42	[p3l672t891r1172b956],
5	CYPZD6	NN	O	cypzd6	dobj	3	SENT_42	[p3l1231t895r1546b956],
6	genotyping	VBG	O	genotype	amod	5	SENT_42	[p3l1604t895r1998b973],
7	for	IN	O	for	_	0	SENT_42	[p3l9t990r110b1055],
8	all	DT	O	all	det	9	SENT_42	[p3l161t990r244b1055],
9	patients	NNS	O	patient	prep_for	5	SENT_42	[p3l295t994r572b1073],
10	prescribed	VBN	O	prescribe	partmod	9	SENT_42	[p3l624t990r989b1073],
11	more	JJR	O	more	mwe	12	SENT_42	[p3l1039t1015r1219b1055],
12	than	IN	O	than	quantmod	13	SENT_42	[p3l1270t990r1428b1055],
13	50	CD	NUMBER	50	num	14	SENT_42	[p3l1480t994r1565b1055],
14	mg/day	NN	O	mg/day	dobj	10	SENT_42	[p3l1617t990r1878b1072],
15	of	IN	O	of	_	0	SENT_42	[p3l1929t990r2002b1055],
16	tetrabenazine	NN	O	tetrabenazine	prep_of	14	SENT_42	[p3l8t1088r505b1168],
17	,	,	O	,	_	0	SENT_42	[p3l8t1088r505b1168],
18	but	CC	O	but	_	0	SENT_42	[p3l544t1088r659b1153],
19	the	DT	O	the	det	21	SENT_42	[p3l693t1088r800b1153],
20	clinical	JJ	O	clinical	amod	21	SENT_42	[p3l835t1088r1086b1153],
21	implications	NNS	O	implication	nsubjpass	41	SENT_42	[p3l1123t1088r1557b1171],
22	of	IN	O	of	_	0	SENT_42	[p3l1594t1088r1667b1153],
23	pharmacogenetic	JJ	O	pharmacogenetic	amod	24	SENT_42	[p3l1696t1088r1996b1171, p3l8t1192r337b1270],
24	testing	NN	O	testing	prep_of	21	SENT_42	[p3l368t1192r600b1270],
25	on	IN	O	on	_	0	SENT_42	[p3l632t1213r719b1253],
26	dosing	NN	O	dosing	prep_on	24	SENT_42	[p3l751t1188r981b1270],
27	of	IN	O	of	_	0	SENT_42	[p3l1013t1187r1086b1253],
28	tetrabenazine	NN	O	tetrabenazine	prep_of	26	SENT_42	[p3l1111t1187r1587b1253],
29	or	CC	O	or	_	0	SENT_42	[p3l1621t1213r1695b1253],
30	on	IN	O	on	_	0	SENT_42	[p3l1726t1213r1813b1253],
31	clinical	JJ	O	clinical	amod	32	SENT_42	[p3l1844t1188r1996b1253, p3l9t1287r129b1352],
32	practice	NN	O	practice	prep_on	24	SENT_42	[p3l182t1291r460b1370],
33	associated	VBN	O	associate	partmod	32	SENT_42	[p3l516t1287r875b1352],
34	with	IN	O	with	_	0	SENT_42	[p3l928t1287r1087b1352],
35	tetrabenazine	NN	O	tetrabenazine	nn	36	SENT_42	[p3l1139t1287r1616b1352],
36	use	NN	O	use	prep_with	33	SENT_42	[p3l1671t1312r1780b1352],
37	have	VBP	O	have	aux	41	SENT_42	[p3l1835t1287r1997b1352],
38	not	RB	O	not	neg	41	SENT_42	[p3l8t1404r124b1450],
39	been	VBN	O	be	auxpass	41	SENT_42	[p3l171t1385r332b1450],
40	well	RB	O	well	advmod	41	SENT_42	[p3l377t1385r522b1450],
41	studied	VBN	O	study	conj_but	3	SENT_42	[p3l571t1385r842b1450],
42	.	.	O	.	_	0	SENT_42	[p3l571t1385r842b1450],

1	Furthermore	RB	O	furthermore	advmod	7	SENT_43	[p3l894t1385r1361b1465],
2	,	,	O	,	_	0	SENT_43	[p3l894t1385r1361b1465],
3	no	DT	O	no	det	4	SENT_43	[p3l1410t1411r1497b1450],
4	research	NN	O	research	nsubjpass	7	SENT_43	[p3l1544t1385r1835b1450],
5	has	VBZ	O	have	aux	7	SENT_43	[p3l1882t1385r1996b1450],
6	been	VBN	O	be	auxpass	7	SENT_43	[p3l10t1484r171b1550],
7	carried	VBN	O	carry	_	0	SENT_43	[p3l201t1485r447b1550],
8	out	RP	O	out	prt	7	SENT_43	[p3l479t1503r594b1550],
9	on	IN	O	on	_	0	SENT_43	[p3l626t1510r713b1550],
10	the	DT	O	the	det	11	SENT_43	[p3l743t1485r850b1550],
11	impact	NN	O	impact	prep_on	7	SENT_43	[p3l882t1489r1124b1567],
12	of	IN	O	of	_	0	SENT_43	[p3l1155t1484r1228b1550],
13	CYPZD6	NN	O	cypzd6	nn	14	SENT_43	[p3l1258t1489r1572b1550],
14	genotyping	NN	O	genotyping	prep_of	11	SENT_43	[p3l1605t1489r1998b1567],
15	on	IN	O	on	_	0	SENT_43	[p3l10t1609r96b1649],
16	the	DT	O	the	det	17	SENT_43	[p3l129t1584r236b1649],
17	use	NN	O	use	prep_on	7	SENT_43	[p3l272t1609r382b1649],
18	of	IN	O	of	prep	17	SENT_43	[p3l418t1584r491b1649],
19	or	CC	O	or	_	0	SENT_43	[p3l523t1609r596b1649],
20	response	NN	O	response	prep_on	7	SENT_43	[p3l630t1609r933b1667],
21	to	TO	O	to	_	0	SENT_43	[p3l969t1602r1038b1649],
22	tetrabenazine	NN	O	tetrabenazine	rel	26	SENT_43	[p3l1072t1571r1610b1649],
23	.7	CD	NUMBER	.7	num	22	SENT_43	[p3l1072t1571r1610b1649],
24	We	PRP	O	we	nsubj	26	SENT_43	[p3l1640t1589r1758b1649],
25	therefore	RB	O	therefore	advmod	26	SENT_43	[p3l1793t1584r1996b1649, p3l9t1682r146b1747],
26	examined	VBD	O	examine	rcmod	20	SENT_43	[p3l184t1682r526b1747],
27	the	DT	O	the	det	29	SENT_43	[p3l563t1682r669b1747],
28	pharmacogenetic	JJ	O	pharmacogenetic	amod	29	SENT_43	[p3l706t1682r1312b1765],
29	proﬁle	NN	O	proﬁle	dobj	26	SENT_43	[p3l1349t1682r1575b1765],
30	of	IN	O	of	_	0	SENT_43	[p3l1614t1682r1687b1747],
31	patients	NNS	O	patient	prep_of	29	SENT_43	[p3l1719t1687r1996b1765],
32	treated	VBN	O	treat	partmod	31	SENT_43	[p3l8t1781r253b1847],
33	with	IN	O	with	_	0	SENT_43	[p3l298t1782r458b1847],
34	tetrabenazine	NN	O	tetrabenazine	prep_with	32	SENT_43	[p3l502t1781r978b1847],
35	and	CC	O	and	_	0	SENT_43	[p3l1027t1782r1155b1847],
36	its	PRP$	O	its	poss	37	SENT_43	[p3l1201t1786r1279b1847],
37	impact	NN	O	impact	conj_and	34	SENT_43	[p3l1326t1786r1567b1864],
38	on	IN	O	on	_	0	SENT_43	[p3l1613t1807r1700b1847],
39	clinical	JJ	O	clinical	amod	40	SENT_43	[p3l1745t1782r1996b1847],
40	response	NN	O	response	prep_on	32	SENT_43	[p3l8t1907r311b1965],
41	and	CC	O	and	_	0	SENT_43	[p3l345t1882r473b1947],
42	care	NN	O	care	prep_on	32	SENT_43	[p3l504t1907r668b1947],
43	.	.	O	.	_	0	SENT_43	[p3l504t1907r668b1947],

1	Patients	NNS	O	patient	_	0	SENT_44	[p3l415t2115r842b2201],
2	and	CC	O	and	_	0	SENT_44	[p3l887t2115r1079b2201],
3	Methods	NNS	O	method	conj_and	1	SENT_44	[p3l1133t2115r1595b2201],

1	CYPZD6	NN	O	cypzd6	nn	2	SENT_45	[p3l90t2331r429b2397],
2	genotyping	NN	O	genotyping	nsubjpass	4	SENT_45	[p3l485t2331r908b2416],
3	was	VBD	O	be	auxpass	4	SENT_45	[p3l962t2354r1107b2397],
4	performed	VBN	O	perform	_	0	SENT_45	[p3l1163t2327r1561b2416],
5	on	IN	O	on	_	0	SENT_45	[p3l1618t2354r1711b2397],
6	sequential	JJ	O	sequential	amod	7	SENT_45	[p3l1767t2327r2149b2416],
7	subjects	NNS	O	subject	prep_on	4	SENT_45	[p3l9t2433r304b2522],
8	treated	VBN	O	treat	partmod	7	SENT_45	[p3l353t2433r619b2503],
9	with	IN	O	with	_	0	SENT_45	[p3l666t2433r837b2503],
10	tetrabenazine	NN	O	tetrabenazine	prep_with	8	SENT_45	[p3l885t2433r1397b2503],
11	at	IN	O	at	_	0	SENT_45	[p3l1450t2453r1519b2503],
12	Baylor	NNP	ORGANIZATION	Baylor	nn	13	SENT_45	[p3l1568t2433r1816b2522],
13	College	NNP	ORGANIZATION	College	prep_at	8	SENT_45	[p3l1868t2433r2148b2522],
14	of	IN	ORGANIZATION	of	_	0	SENT_45	[p3l9t2540r87b2611],
15	Medicine	NNP	ORGANIZATION	Medicine	prep_of	13	SENT_45	[p3l136t2541r490b2611],
16	(	CD	NUMBER	(	num	15	SENT_45	[p3l551t2545r806b2626],
17	BCM	NNP	O	BCM	dep	13	SENT_45	[p3l551t2545r806b2626],
18	)	CD	NUMBER	)	num	17	SENT_45	[p3l551t2545r806b2626],
19	Parkinson	NNP	ORGANIZATION	Parkinson	poss	22	SENT_45	[p3l865t2541r1306b2611],
20	’s	POS	O	’s	_	0	SENT_45	[p3l865t2541r1306b2611],
21	Disease	NNP	O	Disease	nn	22	SENT_45	[p3l1362t2545r1645b2611],
22	Center	NNP	O	Center	dep	17	SENT_45	[p3l1704t2545r1956b2611],
23	and	CC	O	and	_	0	SENT_45	[p3l2012t2541r2150b2611],
24	Movement	NNP	ORGANIZATION	Movement	nn	26	SENT_45	[p3l7t2652r421b2717],
25	Disorders	NNPS	ORGANIZATION	Disorders	nn	26	SENT_45	[p3l494t2647r860b2717],
26	Clinic	NNP	ORGANIZATION	Clinic	prep_at	8	SENT_45	[p3l937t2647r1182b2732],
27	,	,	O	,	_	0	SENT_45	[p3l937t2647r1182b2732],
28	but	CC	O	but	_	0	SENT_45	[p3l1260t2647r1383b2717],
29	results	NNS	O	result	nsubjpass	32	SENT_45	[p3l1455t2647r1698b2717],
30	were	VBD	O	be	auxpass	32	SENT_45	[p3l1770t2674r1950b2717],
31	not	RB	O	not	neg	32	SENT_45	[p3l2025t2666r2150b2717],
32	known	VBN	O	know	conj_or	32	SENT_45	[p3l7t2753r271b2823],
33	to	TO	O	to	_	0	SENT_45	[p3l319t2773r394b2823],
34	the	DT	O	the	det	35	SENT_45	[p3l444t2753r558b2823],
35	physicians	NNS	O	physician	prep_to	32	SENT_45	[p3l608t2753r1000b2842],
36	at	IN	O	at	_	0	SENT_45	[p3l1053t2773r1123b2823],
37	the	DT	O	the	det	38	SENT_45	[p3l1171t2753r1286b2823],
38	time	NN	O	time	prep_at	35	SENT_45	[p3l1336t2758r1500b2823],
39	of	IN	O	of	_	0	SENT_45	[p3l1553t2753r1631b2823],
40	initiation	NN	O	initiation	prep_of	38	SENT_45	[p3l1676t2758r2025b2823],
41	of	IN	O	of	_	0	SENT_45	[p3l2076t2753r2154b2823],
42	tetrabenazine	NN	O	tetrabenazine	nn	43	SENT_45	[p3l7t2860r518b2929],
43	therapy	NN	O	therapy	prep_of	40	SENT_45	[p3l572t2860r862b2948],
44	or	CC	O	or	_	0	SENT_45	[p3l915t2887r994b2929],
45	during	IN	O	during	_	0	SENT_45	[p3l1047t2859r1294b2948],
46	the	DT	O	the	det	48	SENT_45	[p3l1346t2860r1460b2929],
47	titration	NN	O	titration	nn	48	SENT_45	[p3l1514t2864r1828b2929],
48	period	NN	O	period	prep_during	32	SENT_45	[p3l1880t2860r2145b2948],
49	.	.	O	.	_	0	SENT_45	[p3l1880t2860r2145b2948],

1	The	DT	O	the	det	2	SENT_46	[p3l6t2965r151b3035],
2	study	NN	O	study	nsubjpass	4	SENT_46	[p3l204t2965r407b3053],
3	was	VBD	O	be	auxpass	4	SENT_46	[p3l455t2992r601b3035],
4	reviewed	VBN	O	review	_	0	SENT_46	[p3l651t2965r992b3035],
5	and	CC	O	and	_	0	SENT_46	[p3l1043t2965r1181b3035],
6	approved	VBN	O	approve	conj_and	4	SENT_46	[p3l1233t2965r1589b3054],
7	by	IN	O	by	_	0	SENT_46	[p3l1641t2965r1730b3053],
8	the	DT	O	the	det	12	SENT_46	[p3l1779t2965r1893b3035],
9	BCM	NNP	O	BCM	nn	12	SENT_46	[p3l1946t2969r2150b3035],
10	institutional	JJ	O	institutional	amod	12	SENT_46	[p3l8t3071r469b3141],
11	review	NN	O	review	nn	12	SENT_46	[p3l511t3076r763b3141],
12	board	NN	O	board	agent	4	SENT_46	[p3l805t3071r1027b3141],
13	prior	RB	O	prior	_	0	SENT_46	[p3l1068t3076r1258b3160],
14	to	TO	O	to	_	0	SENT_46	[p3l1298t3091r1373b3141],
15	the	DT	O	the	det	16	SENT_46	[p3l1415t3071r1529b3141],
16	conduct	NN	O	conduct	prep_prior_to	4	SENT_46	[p3l1573t3071r1876b3141],
17	of	IN	O	of	_	0	SENT_46	[p3l1919t3071r1997b3141],
18	the	DT	O	the	det	20	SENT_46	[p3l2034t3071r2148b3141],
19	chart	NN	O	chart	nn	20	SENT_46	[p3l7t3178r202b3247],
20	review	NN	O	review	prep_of	16	SENT_46	[p3l244t3182r495b3247],
21	for	IN	O	for	_	0	SENT_46	[p3l537t3177r647b3247],
22	this	DT	O	this	det	23	SENT_46	[p3l689t3177r823b3247],
23	study	NN	O	study	prep_for	4	SENT_46	[p3l869t3178r1091b3266],
24	.	.	O	.	_	0	SENT_46	[p3l869t3178r1091b3266],

1	All	DT	O	all	det	2	SENT_47	[p3l1138t3177r1248b3246],
2	patients	NNS	O	patient	nsubjpass	33	SENT_47	[p3l1291t3182r1590b3266],
3	or	CC	O	or	_	0	SENT_47	[p3l1635t3205r1714b3247],
4	their	PRP$	O	they	poss	6	SENT_47	[p3l1756t3178r1932b3247],
5	legal	JJ	O	legal	amod	6	SENT_47	[p3l1975t3177r2149b3266],
6	guardians	NNS	O	guardian	nsubjpass	33	SENT_47	[p3l7t3283r378b3371],
7	provided	VBN	O	provide	partmod	6	SENT_47	[p3l413t3283r752b3372],
8	written	VBN	O	write	amod	9	SENT_47	[p3l785t3287r1061b3353],
9	consent	NN	O	consent	dobj	7	SENT_47	[p3l1095t3302r1384b3353],
10	for	IN	O	for	_	0	SENT_47	[p3l1418t3283r1528b3353],
11	testing	NN	O	testing	prep_for	9	SENT_47	[p3l1561t3287r1812b3372],
12	by	IN	O	by	_	0	SENT_47	[p3l1847t3283r1936b3371],
13	signing	VBG	O	sign	agent	7	SENT_47	[p3l1971t3287r2148b3372, p3l8t3394r123b3478],
14	the	DT	O	the	det	19	SENT_47	[p3l155t3389r270b3459],
15	CYPZD6	NNP	MISC	CYPZD6	nn	19	SENT_47	[p3l307t3394r645b3459],
16	Drug	NNP	MISC	Drug	nn	19	SENT_47	[p3l681t3395r875b3478],
17	Metabolism	NNP	MISC	Metabolism	nn	19	SENT_47	[p3l908t3389r1367b3459],
18	Test	NNP	MISC	Test	nn	19	SENT_47	[p3l1399t3392r1561b3459],
19	form	NN	O	form	dobj	13	SENT_47	[p3l1595t3389r1778b3459],
20	provided	VBN	O	provide	partmod	19	SENT_47	[p3l1811t3389r2150b3478],
21	by	IN	O	by	_	0	SENT_47	[p3l9t3495r98b3584],
22	LabCorp	NNP	ORGANIZATION	LabCorp	agent	20	SENT_47	[p3l138t3495r479b3584],
23	(	CD	NUMBER	(	num	22	SENT_47	[p3l526t3499r742b3581],
24	RTP	NNP	O	RTP	nn	28	SENT_47	[p3l526t3499r742b3581],
25	,	,	O	,	_	0	SENT_47	[p3l526t3499r742b3581],
26	Burlington	NNP	LOCATION	Burlington	appos	28	SENT_47	[p3l787t3496r1216b3584],
27	,	,	O	,	_	0	SENT_47	[p3l787t3496r1216b3584],
28	NC	NNP	O	NC	dobj	20	SENT_47	[p3l1259t3500r1420b3581],
29	)	CD	NUMBER	)	num	28	SENT_47	[p3l1259t3500r1420b3581],
30	before	IN	O	before	_	0	SENT_47	[p3l1467t3495r1703b3565],
31	blood	NN	O	blood	prep_before	28	SENT_47	[p3l1747t3495r1964b3565],
32	was	VBD	O	be	auxpass	33	SENT_47	[p3l2003t3523r2149b3565],
33	drawn	VBN	O	draw	_	0	SENT_47	[p3l9t3601r271b3671],
34	.	.	O	.	_	0	SENT_47	[p3l9t3601r271b3671],

1	Both	DT	O	both	preconj	5	SENT_48	[p3l321t3601r500b3671],
2	CYP2D6	NN	O	cyp2d6	nn	5	SENT_48	[p3l547t3605r885b3671],
3	and	CC	O	and	_	0	SENT_48	[p3l933t3601r1071b3671],
4	CYP2C19	NN	O	cyp2c19	conj_and	2	SENT_48	[p3l1118t3605r1499b3671],
5	genotypes	NNS	O	genotype	nsubjpass	7	SENT_48	[p3l1546t3620r1923b3690],
6	were	VBD	O	be	auxpass	7	SENT_48	[p3l1968t3628r2148b3671],
7	determined	VBN	O	determine	dep	12	SENT_48	[p3l9t3707r435b3777],
8	using	VBG	O	use	xcomp	7	SENT_48	[p3l476t3712r675b3796],
9	the	DT	O	the	det	11	SENT_48	[p3l714t3707r829b3777],
10	FDA	NNP	O	FDA	nn	11	SENT_48	[p3l871t3707r1441b3796],
11	—	NN	O	—	dobj	8	SENT_48	[p3l871t3707r1441b3796],
12	approved	VBD	O	approve	_	0	SENT_48	[p3l871t3707r1441b3796],
13	AmpliChip	NNP	MISC	AmpliChip	nn	14	SENT_48	[p3l1482t3707r1904b3796],
14	CYP450	NNP	MISC	CYP450	nsubj	12	SENT_48	[p3l1949t3712r2148b3777, p4l7t20r149b85],

1	Test	NN	O	test	_	0	SENT_49	[p4l188t19r370b85],
2	.	.	O	.	_	0	SENT_49	[p4l188t19r370b85],

1	Each	DT	O	each	det	2	SENT_50	[p4l414t16r598b85],
2	patient	NN	O	patient	poss	4	SENT_50	[p4l636t20r959b104],
3	’s	POS	O	’s	_	0	SENT_50	[p4l636t20r959b104],
4	genotype	NN	O	genotype	nsubjpass	6	SENT_50	[p4l999t35r1341b104],
5	was	VBD	O	be	auxpass	6	SENT_50	[p4l1379t43r1525b85],
6	used	VBN	O	use	_	0	SENT_50	[p4l1565t15r1733b85],
7	to	TO	O	to	aux	8	SENT_50	[p4l1771t35r1846b85],
8	predict	VB	O	predict	xcomp	6	SENT_50	[p4l1884t16r2150b104],
9	his	PRP$	O	he	amod	12	SENT_50	[p4l7t121r111b191],
10	or	CC	O	or	_	0	SENT_50	[p4l147t148r226b191],
11	her	PRP$	O	she	amod	12	SENT_50	[p4l259t121r380b191],
12	phenotype	NN	O	phenotype	dobj	8	SENT_50	[p4l412t121r809b210],
13	as	IN	O	as	_	0	SENT_50	[p4l845t148r918b191],
14	PM	NNP	O	PM	nn	18	SENT_50	[p4l953t126r1110b206],
15	,	,	O	,	_	0	SENT_50	[p4l953t126r1110b206],
16	IM	NNP	O	IM	appos	18	SENT_50	[p4l1147t126r1285b206],
17	,	,	O	,	_	0	SENT_50	[p4l1147t126r1285b206],
18	EM	NNP	O	EM	prep_as	8	SENT_50	[p4l1321t126r1483b206],
19	,	,	O	,	_	0	SENT_50	[p4l1321t126r1483b206],
20	or	CC	O	or	_	0	SENT_50	[p4l1521t148r1600b191],
21	UM	NNP	O	UM	prep_as	8	SENT_50	[p4l1632t126r1804b191],
22	.	.	O	.	_	0	SENT_50	[p4l1632t126r1804b191],

1	The	DT	O	the	det	2	SENT_51	[p4l86t227r231b297],
2	patients	NNS	O	patient	nsubjpass	6	SENT_51	[p4l320t232r642b316],
3	’	IN	O	’	_	0	SENT_51	[p4l320t232r642b316],
4	charts	NNS	O	chart	prep_’	6	SENT_51	[p4l734t227r962b297],
5	were	VBD	O	be	auxpass	6	SENT_51	[p4l1050t255r1231b297],
6	reviewed	VBN	O	review	_	0	SENT_51	[p4l1321t227r1684b313],
7	,	,	O	,	_	0	SENT_51	[p4l1321t227r1684b313],
8	with	IN	O	with	mark	11	SENT_51	[p4l1774t227r1946b297],
9	the	DT	O	the	det	10	SENT_51	[p4l2034t227r2148b297],
10	reviewer	NN	O	reviewer	nsubj	11	SENT_51	[p4l7t338r332b403],
11	blinded	VBD	O	blind	advcl	6	SENT_51	[p4l386t333r668b403],
12	to	TO	O	to	_	0	SENT_51	[p4l720t353r794b403],
13	the	DT	O	the	det	15	SENT_51	[p4l847t334r961b403],
14	CYPZD6	NN	O	cypzd6	nn	15	SENT_51	[p4l1018t338r1356b403],
15	phenotype	NN	O	phenotype	prep_to	11	SENT_51	[p4l1409t334r1829b422],
16	.	.	O	.	_	0	SENT_51	[p4l1409t334r1829b422],

1	Indication	NN	O	indication	nsubjpass	43	SENT_52	[p4l1885t334r2148b403, p4l7t443r157b509],
2	for	IN	O	for	_	0	SENT_52	[p4l231t439r340b509],
3	tetrabenazine	NN	O	tetrabenazine	prep_for	1	SENT_52	[p4l413t439r949b524],
4	,	,	O	,	_	0	SENT_52	[p4l413t439r949b524],
5	demographic	JJ	O	demographic	amod	6	SENT_52	[p4l1027t439r1523b528],
6	data	NNS	O	datum	appos	3	SENT_52	[p4l1599t439r1785b524],
7	,	,	O	,	_	0	SENT_52	[p4l1599t439r1785b524],
8	starting	VBG	O	start	partmod	43	SENT_52	[p4l1862t443r2149b528],
9	dose	NN	O	dose	nn	15	SENT_52	[p4l9t545r199b631],
10	,	,	O	,	_	0	SENT_52	[p4l9t545r199b631],
11	titration	NN	O	titration	dep	15	SENT_52	[p4l240t550r577b631],
12	,	,	O	,	_	0	SENT_52	[p4l240t550r577b631],
13	total	JJ	O	total	amod	15	SENT_52	[p4l619t545r794b615],
14	daily	JJ	SET	daily	amod	15	SENT_52	[p4l836t545r1020b634],
15	dose	NN	O	dose	dobj	8	SENT_52	[p4l1060t545r1251b631],
16	,	,	O	,	_	0	SENT_52	[p4l1060t545r1251b631],
17	frequency	NN	O	frequency	nsubjpass	43	SENT_52	[p4l1293t545r1668b634],
18	of	IN	O	of	_	0	SENT_52	[p4l1707t545r1786b615],
19	administration	NN	O	administration	prep_of	17	SENT_52	[p4l1822t545r2148b615, p4l7t657r288b738],
20	,	,	O	,	_	0	SENT_52	[p4l1822t545r2148b615, p4l7t657r288b738],
21	concomitant	JJ	O	concomitant	amod	22	SENT_52	[p4l377t657r855b722],
22	medications	NNS	O	medication	nsubjpass	43	SENT_52	[p4l941t653r1422b738],
23	,	,	O	,	_	0	SENT_52	[p4l941t653r1422b738],
24	response	NN	O	response	nn	26	SENT_52	[p4l1511t679r1838b741],
25	rating	NN	O	rating	nn	26	SENT_52	[p4l1925t657r2150b741],
26	scores	NNS	O	score	appos	22	SENT_52	[p4l9t785r258b843],
27	,	,	O	,	_	0	SENT_52	[p4l9t785r258b843],
28	frequency	NN	O	frequency	conj_and	17	SENT_52	[p4l309t758r683b847],
29	and	CC	O	and	_	0	SENT_52	[p4l730t758r868b828],
30	severity	NN	O	severity	conj_and	28	SENT_52	[p4l916t762r1204b846],
31	of	IN	O	of	_	0	SENT_52	[p4l1252t758r1330b828],
32	adverse	JJ	O	adverse	amod	33	SENT_52	[p4l1374t758r1655b828],
33	events	NNS	O	event	prep_of	28	SENT_52	[p4l1704t777r1960b843],
34	,	,	O	,	_	0	SENT_52	[p4l1704t777r1960b843],
35	and	CC	O	and	_	0	SENT_52	[p4l2011t758r2150b828],
36	reasons	NNS	O	reason	conj_and	17	SENT_52	[p4l7t892r289b934],
37	for	IN	O	for	_	0	SENT_52	[p4l362t864r471b934],
38	any	DT	O	any	det	40	SENT_52	[p4l544t892r678b953],
39	eventual	JJ	O	eventual	amod	40	SENT_52	[p4l749t864r1067b934],
40	discontinuation	NN	O	discontinuation	prep_for	36	SENT_52	[p4l1140t864r1736b934],
41	were	VBD	O	be	auxpass	43	SENT_52	[p4l1806t892r1986b934],
42	all	DT	O	all	advmod	43	SENT_52	[p4l2060t864r2149b934],
43	extracted	VBN	O	extract	_	0	SENT_52	[p4l8t972r361b1042],
44	from	IN	O	from	_	0	SENT_52	[p4l408t971r591b1042],
45	each	DT	O	each	det	46	SENT_52	[p4l639t972r808b1042],
46	chart	NN	O	chart	prep_from	43	SENT_52	[p4l855t972r1050b1042],
47	and	CC	O	and	_	0	SENT_52	[p4l1097t972r1235b1042],
48	entered	VBD	O	enter	conj_and	43	SENT_52	[p4l1282t971r1560b1042],
49	into	IN	O	into	_	0	SENT_52	[p4l1607t976r1755b1042],
50	a	DT	O	a	det	54	SENT_52	[p4l1804t999r1843b1042],
51	secure	JJ	O	secure	amod	53	SENT_52	[p4l1891t999r2146b1057],
52	,	,	O	,	_	0	SENT_52	[p4l1891t999r2146b1057],
53	deidentiﬁed	JJ	O	deidentiﬁed	amod	54	SENT_52	[p4l9t1077r450b1147],
54	database	NN	O	database	prep_into	48	SENT_52	[p4l485t1077r816b1147],
55	before	IN	O	before	_	0	SENT_52	[p4l853t1077r1089b1147],
56	analysis	NN	O	analysis	prep_before	48	SENT_52	[p4l1126t1077r1444b1165],
57	.	.	O	.	_	0	SENT_52	[p4l1126t1077r1444b1165],

1	Demographic	JJ	O	demographic	amod	2	SENT_53	[p4l87t1183r605b1272],
2	characteristics	NNS	O	characteristic	nsubjpass	4	SENT_53	[p4l686t1183r1228b1253],
3	were	VBD	O	be	auxpass	4	SENT_53	[p4l1309t1211r1489b1253],
4	tabulated	VBN	O	tabulate	_	0	SENT_53	[p4l1571t1183r1930b1253],
5	and	CC	O	and	_	0	SENT_53	[p4l2012t1183r2150b1253],
6	evaluated	VBN	O	evaluate	conj_and	4	SENT_53	[p4l8t1290r371b1359],
7	relative	JJ	O	relative	advmod	4	SENT_53	[p4l404t1289r683b1360],
8	to	TO	O	to	_	0	SENT_53	[p4l717t1309r792b1359],
9	the	DT	O	the	det	10	SENT_53	[p4l826t1289r940b1359],
10	phenotype	NN	O	phenotype	prep_to	7	SENT_53	[p4l974t1290r1393b1378],
11	.	.	O	.	_	0	SENT_53	[p4l974t1290r1393b1378],

1	A	DT	O	a	det	4	SENT_54	[p4l1430t1293r1492b1358],
2	Pearson	NNP	O	Pearson	nn	4	SENT_54	[p4l1524t1295r1823b1359],
3	correlation	NN	O	correlation	nn	4	SENT_54	[p4l1855t1289r2149b1359, p4l7t1399r157b1465],
4	coefﬁcient	NN	O	coefﬁcient	nsubjpass	6	SENT_54	[p4l208t1395r598b1465],
5	was	VBD	O	be	auxpass	6	SENT_54	[p4l648t1422r793b1465],
6	calculated	VBN	O	calculate	_	0	SENT_54	[p4l845t1395r1230b1465],
7	within	IN	O	within	_	0	SENT_54	[p4l1280t1395r1526b1465],
8	each	DT	O	each	det	9	SENT_54	[p4l1579t1395r1748b1465],
9	group	NN	O	group	prep_within	6	SENT_54	[p4l1799t1422r2022b1484],
10	to	TO	O	to	aux	11	SENT_54	[p4l2073t1414r2148b1465],
11	search	VB	O	search	infmod	9	SENT_54	[p4l9t1501r246b1571],
12	for	IN	O	for	_	0	SENT_54	[p4l288t1501r398b1571],
13	any	DT	O	any	det	15	SENT_54	[p4l441t1529r575b1590],
14	possible	JJ	O	possible	amod	15	SENT_54	[p4l615t1501r918b1590],
15	correlations	NNS	O	correlation	prep_for	11	SENT_54	[p4l961t1501r1413b1571],
16	between	IN	O	between	_	0	SENT_54	[p4l1457t1501r1771b1571],
17	age	NN	O	age	nn	24	SENT_54	[p4l1814t1529r1960b1590],
18	,	,	O	,	_	0	SENT_54	[p4l1814t1529r1960b1590],
19	sex	NN	O	sex	dep	24	SENT_54	[p4l2006t1529r2147b1587],
20	,	,	O	,	_	0	SENT_54	[p4l2006t1529r2147b1587],
21	total	JJ	O	total	amod	24	SENT_54	[p4l7t1608r181b1677],
22	daily	JJ	SET	daily	amod	24	SENT_54	[p4l231t1607r415b1696],
23	dose	NN	O	dose	nn	24	SENT_54	[p4l464t1607r631b1677],
24	(	NN	O	(	prep_between	15	SENT_54	[p4l685t1612r781b1693],
25	in	IN	O	in	_	0	SENT_54	[p4l685t1612r781b1693],
26	milligrams	NNS	O	milligram	prep_in	15	SENT_54	[p4l829t1607r1286b1696],
27	)	RB	O	)	advmod	11	SENT_54	[p4l829t1607r1286b1696],
28	,	,	O	,	_	0	SENT_54	[p4l829t1607r1286b1696],
29	duration	NN	O	duration	conj_and	9	SENT_54	[p4l1338t1608r1664b1677],
30	of	IN	O	of	_	0	SENT_54	[p4l1714t1607r1792b1677],
31	titration	NN	O	titration	prep_of	29	SENT_54	[p4l1835t1612r2150b1677],
32	to	TO	O	to	_	0	SENT_54	[p4l7t1732r81b1783],
33	the	DT	O	the	det	35	SENT_54	[p4l126t1713r240b1783],
34	optimal	JJ	O	optimal	amod	35	SENT_54	[p4l287t1713r579b1802],
35	dose	NN	O	dose	prep_to	31	SENT_54	[p4l626t1713r793b1783],
36	(	NN	O	(	nn	37	SENT_54	[p4l843t1713r1150b1798],
37	weeks	NNS	DURATION	week	nsubj	38	SENT_54	[p4l843t1713r1150b1798],
38	)	VBP	O	)	rcmod	35	SENT_54	[p4l843t1713r1150b1798],
39	,	,	O	,	_	0	SENT_54	[p4l843t1713r1150b1798],
40	adverse	JJ	O	adverse	amod	41	SENT_54	[p4l1199t1713r1481b1783],
41	effects	NNS	O	effect	conj_and	9	SENT_54	[p4l1527t1713r1788b1798],
42	,	,	O	,	_	0	SENT_54	[p4l1527t1713r1788b1798],
43	metabolizer	NN	O	metabolizer	nn	44	SENT_54	[p4l1836t1713r2148b1783, p4l8t1819r168b1889],
44	status	NN	O	status	conj_and	9	SENT_54	[p4l215t1839r455b1905],
45	,	,	O	,	_	0	SENT_54	[p4l215t1839r455b1905],
46	and	CC	O	and	_	0	SENT_54	[p4l505t1819r644b1889],
47	response	NN	O	response	conj_and	9	SENT_54	[p4l689t1846r1015b1908],
48	to	TO	O	to	_	0	SENT_54	[p4l1062t1839r1137b1889],
49	treatment	NN	O	treatment	prep_to	47	SENT_54	[p4l1183t1839r1553b1889],
50	using	VBG	O	use	partmod	47	SENT_54	[p4l1599t1824r1798b1908],
51	a	DT	O	a	det	55	SENT_54	[p4l1845t1847r1883b1889],
52	previously	RB	DATE	previously	advmod	53	SENT_54	[p4l1929t1824r2148b1908, p4l9t1925r207b2014],
53	described	VBN	O	describe	amod	55	SENT_54	[p4l296t1925r654b1995],
54	Global	JJ	O	global	amod	55	SENT_54	[p4l745t1925r1001b1995],
55	Response	NN	O	response	dobj	50	SENT_54	[p4l1091t1931r1447b2014],
56	Scale	NNP	O	Scale	tmod	50	SENT_54	[p4l1539t1912r1799b1995],
57	”	CD	NUMBER	”	num	56	SENT_54	[p4l1539t1912r1799b1995],
58	(	CD	NUMBER	(	num	59	SENT_54	[p4l1895t1930r2148b2011],
59	scores	NNS	O	score	dep	56	SENT_54	[p4l1895t1930r2148b2011],
60	AND	CC	O	and	_	0	SENT_54	[p4l54t2046r251b2091],
61	RESPONSE	NN	O	response	conj_and	47	SENT_54	[p4l355t2045r924b2092],
62	To	TO	O	to	aux	63	SENT_54	[p4l1023t2045r1140b2092],
63	TETRABENAZINE	VB	O	tetrabenazine	infmod	61	SENT_54	[p4l1238t2046r2150b2091],

1	ranged	VBD	O	range	_	0	SENT_55	[p4l7t2201r266b2290],
2	from	IN	O	from	_	0	SENT_55	[p4l314t2201r498b2271],
3	1	CD	NUMBER	1	number	5	SENT_55	[p4l552t2206r584b2269],
4	to	TO	NUMBER	to	dep	5	SENT_55	[p4l638t2220r713b2271],
5	5	CD	NUMBER	5	prep_from	1	SENT_55	[p4l764t2207r830b2286],
6	,	,	O	,	_	0	SENT_55	[p4l764t2207r830b2286],
7	with	IN	O	with	_	0	SENT_55	[p4l879t2201r1051b2271],
8	1	CD	NUMBER	1	num	11	SENT_55	[p4l1105t2206r1137b2269],
9	=	JJ	O	=	amod	11	SENT_55	[p4l1195t2236r1255b2257],
10	marked	JJ	O	marked	amod	11	SENT_55	[p4l1305t2201r1594b2271],
11	improvement	NN	O	improvement	prep_with	1	SENT_55	[p4l1642t2205r2150b2290],
12	and	CC	O	and	_	0	SENT_55	[p4l8t2307r147b2377],
13	5	CD	NUMBER	5	number	14	SENT_55	[p4l209t2313r249b2377],
14	=	JJ	O	=	amod	17	SENT_55	[p4l316t2342r376b2364],
15	marked	JJ	O	marked	amod	17	SENT_55	[p4l438t2307r728b2377],
16	worsening	VBG	O	worsen	amod	17	SENT_55	[p4l786t2312r1232b2396],
17	)	NN	O	)	prep_with	1	SENT_55	[p4l786t2312r1232b2396],
18	.	.	O	.	_	0	SENT_55	[p4l786t2312r1232b2396],

1	Correlations	NNS	O	correlation	nsubjpass	6	SENT_56	[p4l1300t2307r1772b2377],
2	between	IN	O	between	_	0	SENT_56	[p4l1836t2307r2150b2377],
3	continuous	JJ	O	continuous	amod	4	SENT_56	[p4l7t2419r428b2485],
4	Variables	NNS	O	variable	prep_between	1	SENT_56	[p4l486t2414r824b2485],
5	were	VBD	O	be	auxpass	6	SENT_56	[p4l882t2442r1062b2485],
6	calculated	VBN	O	calculate	conj_and	6	SENT_56	[p4l1121t2414r1506b2485],
7	with	IN	O	with	_	0	SENT_56	[p4l1562t2415r1734b2485],
8	Pearson	NNP	PERSON	Pearson	poss	11	SENT_56	[p4l1792t2420r2148b2485],
9	’s	POS	O	’s	_	0	SENT_56	[p4l1792t2420r2148b2485],
10	correlation	NN	O	correlation	nn	11	SENT_56	[p4l7t2520r426b2590],
11	coefﬁcient	NN	O	coefﬁcient	prep_with	6	SENT_56	[p4l481t2520r871b2590],
12	and	CC	O	and	_	0	SENT_56	[p4l928t2520r1067b2590],
13	for	IN	O	for	_	0	SENT_56	[p4l1123t2520r1233b2590],
14	categorical	JJ	O	categorical	amod	15	SENT_56	[p4l1288t2520r1701b2609],
15	data	NNS	O	datum	prep_for	6	SENT_56	[p4l1760t2520r1922b2590],
16	with	IN	O	with	_	0	SENT_56	[p4l1978t2520r2150b2590],
17	Spearman	NNP	PERSON	Spearman	poss	21	SENT_56	[p4l9t2631r444b2715],
18	’s	POS	O	’s	_	0	SENT_56	[p4l9t2631r444b2715],
19	rank	NN	O	rank	nn	21	SENT_56	[p4l523t2626r698b2696],
20	correlation	NN	O	correlation	nn	21	SENT_56	[p4l775t2626r1195b2696],
21	coefﬁcients	NNS	O	coefﬁcients	prep_with	15	SENT_56	[p4l1273t2626r1716b2696],
22	.	.	O	.	_	0	SENT_56	[p4l1273t2626r1716b2696],

1	One-way	JJ	O	one-way	amod	2	SENT_57	[p4l1803t2630r2151b2715],
2	analysis	NN	O	analysis	nsubjpass	6	SENT_57	[p4l8t2733r305b2821],
3	of	IN	O	of	_	0	SENT_57	[p4l350t2732r428b2802],
4	variance	NN	O	variance	prep_of	2	SENT_57	[p4l466t2737r785b2803],
5	was	VBD	O	be	auxpass	6	SENT_57	[p4l828t2760r973b2802],
6	performed	VBN	O	perform	_	0	SENT_57	[p4l1017t2732r1415b2821],
7	using	VBG	O	use	xcomp	6	SENT_57	[p4l1459t2737r1657b2821],
8	metabolizer	NN	O	metabolizer	nn	9	SENT_57	[p4l1701t2733r2150b2802],
9	status	NN	O	status	dobj	7	SENT_57	[p4l8t2857r224b2908],
10	as	IN	O	as	_	0	SENT_57	[p4l272t2865r344b2908],
11	the	DT	O	the	det	14	SENT_57	[p4l390t2838r504b2908],
12	independent	JJ	O	independent	amod	14	SENT_57	[p4l551t2838r1020b2927],
13	Variable	JJ	O	variable	amod	14	SENT_57	[p4l1063t2838r1367b2908],
14	relative	JJ	O	relative	prep_as	7	SENT_57	[p4l1413t2838r1692b2908],
15	to	TO	O	to	_	0	SENT_57	[p4l1738t2857r1813b2908],
16	each	DT	O	each	prep_to	7	SENT_57	[p4l1860t2838r2029b2908],
17	of	IN	O	of	_	0	SENT_57	[p4l2076t2838r2154b2908],
18	duration	NN	O	duration	prep_of	16	SENT_57	[p4l8t2944r335b3014],
19	of	IN	O	of	_	0	SENT_57	[p4l385t2944r463b3014],
20	titration	NN	O	titration	prep_of	18	SENT_57	[p4l506t2949r842b3030],
21	,	,	O	,	_	0	SENT_57	[p4l506t2949r842b3030],
22	total	JJ	O	total	amod	24	SENT_57	[p4l893t2944r1068b3014],
23	daily	JJ	SET	daily	amod	24	SENT_57	[p4l1118t2944r1303b3033],
24	dose	NN	O	dose	prep_of	18	SENT_57	[p4l1352t2944r1542b3030],
25	,	,	O	,	_	0	SENT_57	[p4l1352t2944r1542b3030],
26	and	CC	O	and	_	0	SENT_57	[p4l1595t2944r1733b3014],
27	treatment	NN	O	treatment	nn	28	SENT_57	[p4l1780t2964r2150b3014],
28	response	NN	O	response	conj_and	20	SENT_57	[p4l7t3077r355b3139],
29	.	.	O	.	_	0	SENT_57	[p4l7t3077r355b3139],

1	Postestimation	NN	MISC	postestimation	nn	2	SENT_58	[p4l404t3055r966b3120],
2	regression	NN	O	regression	nsubjpass	12	SENT_58	[p4l1010t3055r1392b3139],
3	with	IN	O	with	_	0	SENT_58	[p4l1436t3051r1608b3120],
4	EM	NN	O	em	nn	6	SENT_58	[p4l1651t3056r1791b3120],
5	metabolizer	NN	O	metabolizer	nn	6	SENT_58	[p4l1835t3050r2148b3120, p4l7t3156r168b3226],
6	status	NN	O	status	prep_with	2	SENT_58	[p4l223t3175r439b3226],
7	as	IN	O	as	_	0	SENT_58	[p4l495t3183r568b3226],
8	the	DT	O	the	det	10	SENT_58	[p4l623t3156r737b3226],
9	constant	JJ	O	constant	amod	10	SENT_58	[p4l792t3175r1117b3226],
10	value	NN	O	value	prep_as	6	SENT_58	[p4l1169t3156r1368b3226],
11	was	VBD	O	be	auxpass	12	SENT_58	[p4l1423t3183r1568b3226],
12	performed	VBN	O	perform	_	0	SENT_58	[p4l1622t3156r2020b3245],
13	to	TO	O	to	aux	14	SENT_58	[p4l2074t3175r2149b3226],
14	determine	VB	O	determine	xcomp	12	SENT_58	[p4l8t3262r384b3332],
15	the	DT	O	the	det	16	SENT_58	[p4l435t3262r549b3332],
16	relationships	NNS	O	relationship	dobj	14	SENT_58	[p4l600t3262r1086b3351],
17	between	IN	O	between	_	0	SENT_58	[p4l1139t3262r1452b3332],
18	type	NN	O	type	prep_between	16	SENT_58	[p4l1501t3282r1660b3351],
19	of	IN	O	of	_	0	SENT_58	[p4l1712t3262r1790b3332],
20	metabolizer	NN	O	metabolizer	prep_of	18	SENT_58	[p4l1835t3262r2148b3332, p4l7t3369r168b3438],
21	and	CC	O	and	_	0	SENT_58	[p4l216t3369r355b3438],
22	each	DT	O	each	det	23	SENT_58	[p4l403t3369r573b3438],
23	response	NN	O	response	dobj	14	SENT_58	[p4l620t3395r946b3457],
24	to	TO	O	to	_	0	SENT_58	[p4l995t3388r1069b3438],
25	treatment	NN	O	treatment	prep_to	23	SENT_58	[p4l1117t3388r1510b3454],
26	,	,	O	,	_	0	SENT_58	[p4l1117t3388r1510b3454],
27	weeks	NNS	DURATION	week	conj_and	16	SENT_58	[p4l1558t3369r1788b3438],
28	of	IN	O	of	_	0	SENT_58	[p4l1838t3368r1917b3438],
29	titration	NN	O	titration	prep_of	27	SENT_58	[p4l1959t3373r2148b3438, p4l6t3479r179b3560],
30	,	,	O	,	_	0	SENT_58	[p4l1959t3373r2148b3438, p4l6t3479r179b3560],
31	and	CC	O	and	_	0	SENT_58	[p4l217t3475r355b3545],
32	dose	NN	O	dose	dobj	14	SENT_58	[p4l390t3475r578b3545],
33	.	.	O	.	_	0	SENT_58	[p4l390t3475r578b3545],

1	Results	NNS	O	result	_	0	SENT_59	[p4l871t3700r1290b3792],

1	Of	IN	O	of	_	0	SENT_60	[p5l90t111r192b181],
2	the	DT	O	the	det	4	SENT_60	[p5l225t112r339b181],
3	127	CD	NUMBER	127	num	4	SENT_60	[p5l385t116r524b181],
4	patients	NNS	O	patient	prep_of	10	SENT_60	[p5l560t116r882b200],
5	,	,	O	,	_	0	SENT_60	[p5l560t116r882b200],
6	the	DT	O	the	det	8	SENT_60	[p5l922t112r1037b181],
7	mean	NN	O	mean	nn	8	SENT_60	[p5l1076t139r1280b181],
8	age	NN	O	age	nsubj	10	SENT_60	[p5l1320t139r1442b200],
9	was	VBD	O	be	cop	10	SENT_60	[p5l1480t139r1626b181],
10	39.5	CD	NUMBER	39.5	_	0	SENT_60	[p5l1667t116r1830b181],
11	:	:	O	:	_	0	SENT_60	[p5l1880t124r1934b178],
12	22.9	CD	DURATION	22.9	num	13	SENT_60	[p5l1980t116r2147b181],
13	years	NNS	NUMBER	year	nsubj	21	SENT_60	[p5l6t245r200b306],
14	and	CC	O	and	_	0	SENT_60	[p5l249t217r387b287],
15	75	CD	PERCENT	75	number	16	SENT_60	[p5l437t223r525b287],
16	(	CD	PERCENT	(	conj_and	13	SENT_60	[p5l580t221r814b303],
17	59	CD	PERCENT	59	num	18	SENT_60	[p5l580t221r814b303],
18	%	NN	PERCENT	%	dep	16	SENT_60	[p5l580t221r814b303],
19	)	CD	NUMBER	)	dep	16	SENT_60	[p5l580t221r814b303],
20	were	VBD	O	be	cop	21	SENT_60	[p5l864t245r1044b287],
21	male	JJ	O	male	parataxis	10	SENT_60	[p5l1092t217r1295b303],
22	;	:	O	;	_	0	SENT_60	[p5l1092t217r1295b303],
23	51	CD	NUMBER	51	num	24	SENT_60	[p5l1347t222r1433b287],
24	patients	NNS	O	patient	nsubj	29	SENT_60	[p5l1485t222r1783b306],
25	(	IN	O	(	_	0	SENT_60	[p5l1836t221r2145b303],
26	40.1	CD	PERCENT	40.1	number	27	SENT_60	[p5l1836t221r2145b303],
27	%	NN	PERCENT	%	num	28	SENT_60	[p5l1836t221r2145b303],
28	)	CD	NUMBER	)	prep_(	24	SENT_60	[p5l1836t221r2145b303],
29	had	VBD	O	have	parataxis	10	SENT_60	[p5l7t323r147b393],
30	Tourette	NNP	O	Tourette	nn	31	SENT_60	[p5l192t326r520b393],
31	syndrome	NN	O	syndrome	dobj	29	SENT_60	[p5l568t323r963b412],
32	,	,	O	,	_	0	SENT_60	[p5l568t323r963b412],
33	25	CD	PERCENT	25	number	34	SENT_60	[p5l1011t328r1103b393],
34	(	CD	PERCENT	(	nsubj	38	SENT_60	[p5l1157t327r1466b409],
35	19.7	CD	PERCENT	19.7	num	36	SENT_60	[p5l1157t327r1466b409],
36	%	NN	PERCENT	%	dep	34	SENT_60	[p5l1157t327r1466b409],
37	)	CD	NUMBER	)	dep	34	SENT_60	[p5l1157t327r1466b409],
38	had	VBD	O	have	ccomp	10	SENT_60	[p5l1517t323r1656b393],
39	Huntington	NNP	O	Huntington	nn	40	SENT_60	[p5l1702t328r2150b412],
40	disease	NN	O	disease	dobj	38	SENT_60	[p5l8t430r293b515],
41	,	,	O	,	_	0	SENT_60	[p5l8t430r293b515],
42	29	CD	PERCENT	29	num	43	SENT_60	[p5l338t434r430b499],
43	(	CD	PERCENT	(	nsubj	47	SENT_60	[p5l479t434r787b515],
44	22.9	CD	PERCENT	22.9	number	45	SENT_60	[p5l479t434r787b515],
45	%	NN	PERCENT	%	amod	43	SENT_60	[p5l479t434r787b515],
46	)	CD	NUMBER	)	dep	43	SENT_60	[p5l479t434r787b515],
47	had	VBD	O	have	ccomp	10	SENT_60	[p5l833t429r973b499],
48	tardive	JJ	O	tardive	amod	49	SENT_60	[p5l1014t430r1277b500],
49	syndromes	NNS	O	syndrome	dobj	47	SENT_60	[p5l1322t430r1749b518],
50	,	,	O	,	_	0	SENT_60	[p5l1322t430r1749b518],
51	8	CD	PERCENT	8	num	52	SENT_60	[p5l1799t434r1835b499],
52	(	NN	PERCENT	(	nsubj	56	SENT_60	[p5l1886t434r2145b515],
53	6.3	CD	PERCENT	6.3	number	54	SENT_60	[p5l1886t434r2145b515],
54	%	NN	PERCENT	%	amod	52	SENT_60	[p5l1886t434r2145b515],
55	)	CD	NUMBER	)	dep	52	SENT_60	[p5l1886t434r2145b515],
56	had	VBD	O	have	ccomp	10	SENT_60	[p5l7t535r147b605],
57	non	JJ	O	non	dobj	56	SENT_60	[p5l207t540r848b624],
58	.	.	O	.	_	0	SENT_60	[p5l207t540r848b624],

1	—	NN	O	—	_	0	SENT_61	[p5l207t540r848b624],
2	.	.	O	.	_	0	SENT_61	[p5l207t540r848b624],

1	Huntington	NNP	O	Huntington	nn	3	SENT_62	[p5l207t540r848b624],
2	disease	NN	O	disease	nn	3	SENT_62	[p5l910t535r1171b605],
3	chorea	NN	O	chorea	nsubj	10	SENT_62	[p5l1234t535r1511b621],
4	,	,	O	,	_	0	SENT_62	[p5l1234t535r1511b621],
5	7	CD	PERCENT	7	num	6	SENT_62	[p5l1577t541r1620b605],
6	(	NN	PERCENT	(	appos	3	SENT_62	[p5l1685t539r1944b621],
7	5.5	CD	PERCENT	5.5	number	8	SENT_62	[p5l1685t539r1944b621],
8	%	NN	PERCENT	%	amod	6	SENT_62	[p5l1685t539r1944b621],
9	)	CD	NUMBER	)	dep	6	SENT_62	[p5l1685t539r1944b621],
10	had	VBD	O	have	_	0	SENT_62	[p5l2010t535r2150b605],
11	dystonia	NN	O	dystonium	dobj	10	SENT_62	[p5l8t641r353b730],
12	,	,	O	,	_	0	SENT_62	[p5l8t641r353b730],
13	and	CC	O	and	_	0	SENT_62	[p5l397t641r535b711],
14	the	DT	O	the	det	17	SENT_62	[p5l575t641r689b711],
15	other	JJ	O	other	amod	17	SENT_62	[p5l732t641r930b711],
16	7	CD	PERCENT	7	num	17	SENT_62	[p5l974t647r1017b711],
17	(	NN	PERCENT	(	nsubj	29	SENT_62	[p5l1061t645r1320b727],
18	5.5	CD	PERCENT	5.5	number	19	SENT_62	[p5l1061t645r1320b727],
19	%	NN	PERCENT	%	amod	17	SENT_62	[p5l1061t645r1320b727],
20	)	CD	NUMBER	)	nsubj	21	SENT_62	[p5l1061t645r1320b727],
21	had	VBD	O	have	rcmod	17	SENT_62	[p5l1366t641r1506b711],
22	akathisia	NN	O	akathisium	dobj	21	SENT_62	[p5l1547t641r1912b727],
23	,	,	O	,	_	0	SENT_62	[p5l1547t641r1912b727],
24	myoclonus	NN	O	myoclonus	dobj	21	SENT_62	[p5l1955t669r2148b730, p5l7t748r273b833],
25	,	,	O	,	_	0	SENT_62	[p5l1955t669r2148b730, p5l7t748r273b833],
26	or	CC	O	or	_	0	SENT_62	[p5l354t775r432b817],
27	nontardive	JJ	O	nontardive	amod	28	SENT_62	[p5l508t748r919b817],
28	stereotypies	NNS	O	stereotypy	dobj	21	SENT_62	[p5l999t752r1445b836],
29	(	VBP	O	(	conj_and	10	SENT_62	[p5l1526t752r1687b836],
30	Fig	NN	O	fig	dobj	29	SENT_62	[p5l1526t752r1687b836],
31	.	.	O	.	_	0	SENT_62	[p5l1526t752r1687b836],

1	1	CD	NUMBER	1	_	0	SENT_63	[p5l1774t752r1864b833],
2	)	NN	O	)	dep	1	SENT_63	[p5l1774t752r1864b833],
3	.	.	O	.	_	0	SENT_63	[p5l1774t752r1864b833],

1	Their	PRP$	O	they	poss	3	SENT_64	[p5l1943t748r2150b817],
2	CYP2D6	NN	O	cyp2d6	nn	3	SENT_64	[p5l10t858r348b923],
3	phenotypes	NNS	O	phenotype	nsubjpass	11	SENT_64	[p5l404t853r860b942],
4	,	,	O	,	_	0	SENT_64	[p5l404t853r860b942],
5	total	JJ	O	total	amod	7	SENT_64	[p5l916t853r1091b923],
6	daily	JJ	SET	daily	amod	7	SENT_64	[p5l1148t853r1333b942],
7	doses	NNS	O	dose	conj_and	3	SENT_64	[p5l1388t853r1589b923],
8	and	CC	O	and	_	0	SENT_64	[p5l1646t853r1784b923],
9	titration	NN	O	titration	conj_and	3	SENT_64	[p5l1838t858r2152b923],
10	are	VBP	O	be	auxpass	11	SENT_64	[p5l8t988r121b1030],
11	noted	VBN	O	note	_	0	SENT_64	[p5l156t960r371b1030],
12	in	IN	O	in	_	0	SENT_64	[p5l405t965r475b1029],
13	Table	NNP	O	Table	prep_in	11	SENT_64	[p5l508t960r722b1030],
14	1	CD	NUMBER	1	num	13	SENT_64	[p5l764t965r823b1030],
15	.	.	O	.	_	0	SENT_64	[p5l764t965r823b1030],

1	When	WRB	O	when	advmod	2	SENT_65	[p5l85t1067r313b1137],
2	considering	VBG	O	consider	advcl	19	SENT_65	[p5l346t1067r784b1155],
3	the	DT	O	the	det	6	SENT_65	[p5l817t1067r931b1136],
4	average	JJ	O	average	amod	6	SENT_65	[p5l967t1094r1254b1155],
5	daily	JJ	SET	daily	amod	6	SENT_65	[p5l1291t1067r1476b1155],
6	dose	NN	O	dose	dobj	2	SENT_65	[p5l1509t1067r1676b1136],
7	per	IN	O	per	_	0	SENT_65	[p5l1710t1093r1831b1155],
8	diagnosis	NN	O	diagnosis	prep_per	6	SENT_65	[p5l1865t1067r2151b1155, p5l8t1177r119b1258],
9	,	,	O	,	_	0	SENT_65	[p5l1865t1067r2151b1155, p5l8t1177r119b1258],
10	patients	NNS	O	patient	appos	8	SENT_65	[p5l162t1177r460b1261],
11	with	IN	O	with	_	0	SENT_65	[p5l500t1172r672b1242],
12	tardive	JJ	O	tardive	amod	15	SENT_65	[p5l711t1172r975b1242],
13	dyskinesia	NN	O	dyskinesium	nn	15	SENT_65	[p5l1017t1172r1409b1261],
14	(	NN	O	(	nn	15	SENT_65	[p5l1455t1177r1525b1258],
15	n	NN	O	n	prep_with	10	SENT_65	[p5l1455t1177r1525b1258],
16	=	JJ	O	=	amod	18	SENT_65	[p5l1567t1207r1627b1229],
17	29	CD	NUMBER	29	num	18	SENT_65	[p5l1669t1177r1789b1258],
18	)	NN	O	)	nsubj	19	SENT_65	[p5l1669t1177r1789b1258],
19	required	VBD	O	require	dep	38	SENT_65	[p5l1834t1172r2152b1261],
20	the	DT	O	the	det	23	SENT_65	[p5l6t1278r121b1348],
21	highest	JJS	O	highest	amod	23	SENT_65	[p5l161t1278r431b1367],
22	mean	NN	O	mean	nn	23	SENT_65	[p5l469t1306r675b1348],
23	dose	NN	O	dose	nsubj	27	SENT_65	[p5l715t1278r882b1348],
24	(	NN	O	(	nn	27	SENT_65	[p5l927t1283r1043b1364],
25	75	CD	NUMBER	75	num	27	SENT_65	[p5l927t1283r1043b1364],
26	mg	NN	O	mg	nn	27	SENT_65	[p5l1085t1283r1254b1367],
27	)	NN	O	)	xcomp	19	SENT_65	[p5l1085t1283r1254b1367],
28	,	,	O	,	_	0	SENT_65	[p5l1085t1283r1254b1367],
29	whereas	IN	O	whereas	mark	35	SENT_65	[p5l1294t1278r1604b1348],
30	patients	NNS	O	patient	nsubj	35	SENT_65	[p5l1643t1283r1942b1367],
31	with	IN	O	with	_	0	SENT_65	[p5l1981t1278r2153b1348],
32	myoclonus	NN	O	myoclonus	nn	34	SENT_65	[p5l7t1385r419b1473],
33	(	CD	NUMBER	(	num	34	SENT_65	[p5l483t1389r554b1470],
34	n	NN	O	n	prep_with	30	SENT_65	[p5l483t1389r554b1470],
35	=	JJ	O	=	dep	27	SENT_65	[p5l614t1420r674b1441],
36	3	CD	NUMBER	3	num	37	SENT_65	[p5l737t1389r805b1470],
37	)	NN	O	)	dobj	35	SENT_65	[p5l737t1389r805b1470],
38	required	VBD	O	require	_	0	SENT_65	[p5l867t1385r1186b1473],
39	the	DT	O	the	det	43	SENT_65	[p5l1243t1385r1358b1454],
40	lowest	JJS	O	lowest	amod	43	SENT_65	[p5l1418t1385r1663b1454],
41	mean	NN	O	mean	nn	43	SENT_65	[p5l1720t1412r1926b1454],
42	dose	NN	O	dose	nn	43	SENT_65	[p5l1985t1385r2151b1454],
43	(	NN	O	(	dobj	38	SENT_65	[p5l11t1495r203b1576],
44	37.5	CD	NUMBER	37.5	num	46	SENT_65	[p5l11t1495r203b1576],
45	mg	NN	O	mg	nn	46	SENT_65	[p5l240t1495r407b1579],
46	)	NN	O	)	nsubj	38	SENT_65	[p5l240t1495r407b1579],
47	.	.	O	.	_	0	SENT_65	[p5l240t1495r407b1579],

1	This	DT	O	this	det	2	SENT_66	[p5l445t1490r610b1560],
2	difference	NN	O	difference	nsubj	8	SENT_66	[p5l647t1490r1043b1576],
3	,	,	O	,	_	0	SENT_66	[p5l647t1490r1043b1576],
4	however	RB	O	however	advmod	8	SENT_66	[p5l1080t1490r1427b1576],
5	,	,	O	,	_	0	SENT_66	[p5l1080t1490r1427b1576],
6	did	VBD	O	do	aux	8	SENT_66	[p5l1466t1490r1585b1560],
7	not	RB	O	not	neg	8	SENT_66	[p5l1619t1510r1744b1560],
8	reach	VB	O	reach	_	0	SENT_66	[p5l1778t1490r1983b1560],
9	statistical	JJ	O	statistical	amod	10	SENT_66	[p5l2019t1510r2152b1560, p5l6t1596r257b1666],
10	signiﬁcance	NN	O	signiﬁcance	dobj	8	SENT_66	[p5l335t1596r771b1685],
11	and	CC	O	and	_	0	SENT_66	[p5l849t1596r987b1666],
12	is	VBZ	O	be	cop	16	SENT_66	[p5l1063t1601r1117b1666],
13	probably	RB	O	probably	advmod	16	SENT_66	[p5l1193t1596r1537b1685],
14	not	RB	O	not	neg	16	SENT_66	[p5l1611t1616r1737b1666],
15	clinically	RB	O	clinically	advmod	16	SENT_66	[p5l1811t1596r2153b1685],
16	meaningful	JJ	O	meaningful	conj_and	8	SENT_66	[p5l7t1702r457b1791],
17	.	.	O	.	_	0	SENT_66	[p5l7t1702r457b1791],

1	There	EX	O	there	expl	2	SENT_67	[p5l554t1703r773b1772],
2	was	VBD	O	be	_	0	SENT_67	[p5l867t1730r1012b1772],
3	no	DT	O	no	det	5	SENT_67	[p5l1107t1730r1201b1772],
4	signiﬁcant	NN	O	signiﬁcant	nn	5	SENT_67	[p5l1297t1702r1685b1791],
5	difference	NN	O	difference	nsubj	2	SENT_67	[p5l1779t1702r2151b1772],
6	between	IN	O	between	_	0	SENT_67	[p5l9t1808r322b1878],
7	each	DT	O	each	det	8	SENT_67	[p5l368t1808r538b1878],
8	group	NN	O	group	poss	11	SENT_67	[p5l582t1814r865b1897],
9	’s	POS	O	’s	_	0	SENT_67	[p5l582t1814r865b1897],
10	mean	NN	O	mean	nn	11	SENT_67	[p5l911t1836r1117b1878],
11	age	NN	O	age	prep_between	5	SENT_67	[p5l1163t1836r1310b1897],
12	,	,	O	,	_	0	SENT_67	[p5l1163t1836r1310b1897],
13	reducing	VBG	O	reduce	partmod	5	SENT_67	[p5l1358t1808r1687b1897],
14	the	DT	O	the	det	15	SENT_67	[p5l1732t1808r1846b1878],
15	impact	NN	O	impact	dobj	13	SENT_67	[p5l1893t1813r2153b1897],
16	of	IN	O	of	_	0	SENT_67	[p5l8t1914r87b1984],
17	age	NN	O	age	prep_of	15	SENT_67	[p5l154t1942r277b2003],
18	on	IN	O	on	_	0	SENT_67	[p5l351t1942r445b1984],
19	any	DT	O	any	det	20	SENT_67	[p5l517t1942r651b2003],
20	difference	NN	O	difference	prep_on	13	SENT_67	[p5l722t1914r1095b1984],
21	observed	VBN	O	observe	partmod	20	SENT_67	[p5l1168t1914r1506b1984],
22	between	IN	O	between	_	0	SENT_67	[p5l1579t1914r1892b1984],
23	these	DT	O	these	det	24	SENT_67	[p5l1962t1914r2151b1984],
24	groups	NNS	O	group	prep_between	21	SENT_67	[p5l7t2047r286b2109],
25	.	.	O	.	_	0	SENT_67	[p5l7t2047r286b2109],

1	Similarly	RB	O	similarly	advmod	13	SENT_68	[p5l348t2020r709b2109],
2	,	,	O	,	_	0	SENT_68	[p5l348t2020r709b2109],
3	no	DT	O	no	det	5	SENT_68	[p5l768t2048r862b2090],
4	signiﬁcant	NN	O	signiﬁcant	nn	5	SENT_68	[p5l920t2020r1308b2109],
5	correlation	NN	O	correlation	nsubjpass	13	SENT_68	[p5l1363t2021r1782b2090],
6	between	IN	O	between	_	0	SENT_68	[p5l1839t2020r2153b2090],
7	the	DT	O	the	det	8	SENT_68	[p5l6t2126r121b2196],
8	diagnosis	NN	O	diagnosis	prep_between	5	SENT_68	[p5l167t2126r518b2215],
9	and	CC	O	and	_	0	SENT_68	[p5l565t2126r703b2196],
10	phenotypes	NNS	O	phenotype	prep_between	5	SENT_68	[p5l746t2126r1178b2215],
11	could	MD	O	could	aux	13	SENT_68	[p5l1223t2126r1433b2196],
12	be	VB	O	be	auxpass	13	SENT_68	[p5l1478t2126r1560b2196],
13	demonstrated	VBN	O	demonstrate	_	0	SENT_68	[p5l1606t2126r2150b2212],
14	,	,	O	,	_	0	SENT_68	[p5l1606t2126r2150b2212],
15	possibly	RB	O	possibly	advmod	13	SENT_68	[p5l6t2232r316b2321],
16	because	IN	O	because	_	0	SENT_68	[p5l369t2232r661b2302],
17	of	IN	O	of	_	0	SENT_68	[p5l715t2232r793b2302],
18	the	DT	O	the	det	20	SENT_68	[p5l840t2232r954b2302],
19	small	JJ	O	small	amod	20	SENT_68	[p5l1009t2232r1207b2302],
20	number	NN	O	number	prep_because_of	13	SENT_68	[p5l1259t2232r1553b2302],
21	of	IN	O	of	_	0	SENT_68	[p5l1606t2232r1684b2302],
22	patients	NNS	O	patient	prep_of	20	SENT_68	[p5l1730t2237r2029b2321],
23	in	IN	O	in	_	0	SENT_68	[p5l2083t2237r2153b2301],
24	each	DT	O	each	det	25	SENT_68	[p5l7t2338r177b2407],
25	category	NN	O	category	prep_in	22	SENT_68	[p5l211t2357r557b2426],
26	.	.	O	.	_	0	SENT_68	[p5l211t2357r557b2426],

1	Dosage	NNP	O	Dosage	_	0	SENT_69	[p5l152t2556r514b2647],
2	,	,	O	,	_	0	SENT_69	[p5l152t2556r514b2647],
3	Titration	NNP	O	Titration	conj_and	1	SENT_69	[p5l554t2556r950b2642],
4	,	,	O	,	_	0	SENT_69	[p5l554t2556r950b2642],
5	and	CC	O	and	_	0	SENT_69	[p5l993t2556r1155b2628],
6	Clinical	JJ	O	clinical	amod	7	SENT_69	[p5l1198t2555r1519b2628],
7	Response	NN	O	response	conj_and	1	SENT_69	[p5l1565t2556r2012b2645],

1	Patients	NNS	O	patient	nsubj	6	SENT_70	[p5l88t2676r386b2742],
2	in	IN	O	in	_	0	SENT_70	[p5l427t2676r497b2740],
3	the	DT	O	the	det	5	SENT_70	[p5l536t2672r651b2742],
4	UM	NNP	O	UM	nn	5	SENT_70	[p5l690t2677r842b2742],
5	group	NN	O	group	prep_in	1	SENT_70	[p5l881t2699r1104b2761],
6	required	VBD	O	require	_	0	SENT_70	[p5l1144t2672r1463b2761],
7	a	DT	O	a	det	11	SENT_70	[p5l1505t2699r1543b2742],
8	higher	JJR	O	higher	dep	9	SENT_70	[p5l1583t2672r1823b2761],
9	average	JJ	O	average	amod	11	SENT_70	[p5l1864t2699r2151b2760],
10	daily	JJ	SET	daily	amod	11	SENT_70	[p5l8t2778r193b2867],
11	dose	NN	O	dose	dobj	6	SENT_70	[p5l233t2778r400b2848],
12	than	IN	O	than	mark	23	SENT_70	[p5l440t2778r611b2848],
13	those	DT	O	those	nsubj	23	SENT_70	[p5l650t2778r848b2848],
14	in	IN	O	in	_	0	SENT_70	[p5l890t2783r961b2847],
15	the	DT	O	the	det	18	SENT_70	[p5l999t2778r1114b2848],
16	EM	NNP	O	EM	nn	18	SENT_70	[p5l1155t2783r1318b2863],
17	,	,	O	,	_	0	SENT_70	[p5l1155t2783r1318b2863],
18	IM	NNP	O	IM	prep_in	13	SENT_70	[p5l1361t2783r1498b2863],
19	,	,	O	,	_	0	SENT_70	[p5l1361t2783r1498b2863],
20	and	CC	O	and	_	0	SENT_70	[p5l1542t2778r1680b2848],
21	PM	NN	O	pm	nn	22	SENT_70	[p5l1720t2783r1855b2847],
22	groups	NNS	O	group	conj_and	18	SENT_70	[p5l1895t2805r2152b2867],
23	(	VBP	O	(	advcl	6	SENT_70	[p5l11t2889r252b2970],
24	137.5	CD	NUMBER	137.5	dobj	23	SENT_70	[p5l11t2889r252b2970],
25	vs	CC	O	vs	_	0	SENT_70	[p5l299t2911r374b2954],
26	64.9	CD	NUMBER	64.9	conj_vs	24	SENT_70	[p5l422t2889r611b2970],
27	,	,	O	,	_	0	SENT_70	[p5l422t2889r611b2970],
28	66.1	CD	NUMBER	66.1	num	26	SENT_70	[p5l661t2889r850b2970],
29	,	,	O	,	_	0	SENT_70	[p5l661t2889r850b2970],
30	and	CC	O	and	_	0	SENT_70	[p5l898t2884r1036b2954],
31	40.9	CD	NUMBER	40.9	conj_vs	24	SENT_70	[p5l1080t2889r1248b2954],
32	mg	NN	O	mg	dep	26	SENT_70	[p5l1294t2911r1432b2973],
33	,	,	O	,	_	0	SENT_70	[p5l1294t2911r1432b2973],
34	respectively	RB	O	respectively	advmod	26	SENT_70	[p5l1479t2884r1946b2973],
35	;	:	O	;	_	0	SENT_70	[p5l1479t2884r1946b2973],
36	P	NN	O	p	dep	26	SENT_70	[p5l1993t2890r2044b2953],
37	=	JJ	O	=	amod	36	SENT_70	[p5l2090t2919r2151b2941],
38	.37	CD	NUMBER	.37	tmod	37	SENT_70	[p5l11t2995r128b3060],
39	when	WRB	O	when	advmod	40	SENT_70	[p5l162t2990r368b3060],
40	comparing	VBG	O	compare	advcl	23	SENT_70	[p5l404t2994r813b3079],
41	UMs	NNS	O	um	dobj	40	SENT_70	[p5l848t2995r1032b3060],
42	with	IN	O	with	_	0	SENT_70	[p5l1068t2990r1240b3060],
43	PMs	NNS	O	pm	prep_with	41	SENT_70	[p5l1276t2994r1470b3075],
44	)	RB	O	)	advmod	43	SENT_70	[p5l1276t2994r1470b3075],
45	as	RB	O	as	_	0	SENT_70	[p5l1513t3017r1585b3060],
46	well	RB	O	well	_	0	SENT_70	[p5l1621t2990r1778b3060],
47	as	IN	O	as	_	0	SENT_70	[p5l1816t3017r1889b3060],
48	a	DT	O	a	det	51	SENT_70	[p5l1928t3017r1966b3060],
49	longer	RBR	O	longer	amod	51	SENT_70	[p5l2003t2990r2151b3060, p5l7t3123r122b3185],
50	titration	NN	O	titration	nn	51	SENT_70	[p5l162t3100r477b3166],
51	(	NN	O	(	dobj	40	SENT_70	[p5l523t3100r588b3182],
52	8	CD	NUMBER	8	dep	51	SENT_70	[p5l523t3100r588b3182],
53	vs	CC	O	vs	_	0	SENT_70	[p5l633t3123r707b3166],
54	3.3	CD	NUMBER	3.3	conj_and	41	SENT_70	[p5l751t3101r891b3181],
55	,	,	O	,	_	0	SENT_70	[p5l751t3101r891b3181],
56	4.4	CD	NUMBER	4.4	num	54	SENT_70	[p5l935t3101r1077b3181],
57	,	,	O	,	_	0	SENT_70	[p5l935t3101r1077b3181],
58	and	CC	DURATION	and	_	0	SENT_70	[p5l1122t3096r1261b3166],
59	3	CD	DURATION	3	conj_vs	51	SENT_70	[p5l1303t3101r1341b3166],
60	weeks	NNS	NUMBER	week	dep	54	SENT_70	[p5l1385t3096r1639b3181],
61	,	,	O	,	_	0	SENT_70	[p5l1385t3096r1639b3181],
62	respectively	RB	O	respectively	advmod	54	SENT_70	[p5l1682t3096r2150b3185],
63	;	:	O	;	_	0	SENT_70	[p5l1682t3096r2150b3185],
64	P	NN	O	p	dep	65	SENT_70	[p5l7t3208r58b3271],
65	<	JJR	O	<	dep	54	SENT_70	[p5l117t3222r172b3274],
66	.01	CD	NUMBER	.01	num	67	SENT_70	[p5l235t3206r376b3288],
67	)	NN	O	)	dep	65	SENT_70	[p5l235t3206r376b3288],
68	to	TO	O	to	aux	69	SENT_70	[p5l434t3221r508b3272],
69	achieve	VB	O	achieve	xcomp	40	SENT_70	[p5l565t3202r843b3272],
70	optimal	JJ	O	optimal	amod	71	SENT_70	[p5l900t3202r1192b3291],
71	beneﬁt	NN	O	beneﬁt	dobj	69	SENT_70	[p5l1249t3202r1523b3288],
72	,	,	O	,	_	0	SENT_70	[p5l1249t3202r1523b3288],
73	deﬁned	VBN	O	deﬁned	dep	40	SENT_70	[p5l1582t3202r1854b3272],
74	as	IN	O	as	_	0	SENT_70	[p5l1910t3229r1983b3272],
75	the	DT	O	the	det	78	SENT_70	[p5l2037t3202r2152b3272],
76	best	JJS	O	best	amod	78	SENT_70	[p5l9t3308r157b3378],
77	possible	JJ	O	possible	amod	78	SENT_70	[p5l195t3308r499b3397],
78	efﬁcacy	NN	O	efﬁcacy	prep_as	73	SENT_70	[p5l540t3308r825b3396],
79	with	IN	O	with	_	0	SENT_70	[p5l864t3308r1035b3378],
80	no	DT	O	no	amod	84	SENT_70	[p5l1075t3335r1168b3378],
81	or	CC	O	or	_	0	SENT_70	[p5l1210t3335r1289b3378],
82	tolerable	JJ	O	tolerable	conj_or	80	SENT_70	[p5l1327t3308r1662b3378],
83	side	JJ	O	side	amod	84	SENT_70	[p5l1703t3308r1846b3378],
84	effects	NNS	O	effect	prep_with	78	SENT_70	[p5l1888t3308r2148b3378],
85	.	.	O	.	_	0	SENT_70	[p5l1888t3308r2148b3378],

1	Treatment	NN	O	treatment	nn	2	SENT_71	[p5l6t3417r407b3484],
2	response	NN	O	response	nsubj	5	SENT_71	[p5l453t3441r780b3503],
3	was	VBD	O	be	cop	5	SENT_71	[p5l827t3441r972b3484],
4	less	RBR	O	less	advmod	5	SENT_71	[p5l1021t3414r1149b3484],
5	robust	JJ	O	robust	_	0	SENT_71	[p5l1197t3414r1441b3484],
6	in	IN	O	in	_	0	SENT_71	[p5l1488t3418r1558b3483],
7	the	DT	O	the	det	9	SENT_71	[p5l1604t3414r1719b3484],
8	IM	NNP	O	IM	nn	9	SENT_71	[p5l1767t3419r1882b3483],
9	group	NN	O	group	prep_in	5	SENT_71	[p5l1929t3441r2152b3503],
10	(	CD	NUMBER	(	number	11	SENT_71	[p5l11t3526r150b3607],
11	2.1	CD	NUMBER	2.1	dep	9	SENT_71	[p5l11t3526r150b3607],
12	vs	CC	O	vs	_	0	SENT_71	[p5l208t3549r282b3591],
13	1.4	CD	NUMBER	1.4	prep_in	5	SENT_71	[p5l341t3526r478b3607],
14	,	,	O	,	_	0	SENT_71	[p5l341t3526r478b3607],
15	1.5	CD	NUMBER	1.5	num	13	SENT_71	[p5l539t3526r675b3607],
16	,	,	O	,	_	0	SENT_71	[p5l539t3526r675b3607],
17	and	CC	O	and	_	0	SENT_71	[p5l731t3521r870b3591],
18	1.5	CD	NUMBER	1.5	conj_and	13	SENT_71	[p5l927t3526r1037b3591],
19	in	IN	O	in	_	0	SENT_71	[p5l1093t3526r1164b3590],
20	the	DT	O	the	det	23	SENT_71	[p5l1214t3521r1329b3591],
21	PM	NNP	O	PM	nn	23	SENT_71	[p5l1382t3527r1540b3607],
22	,	,	O	,	_	0	SENT_71	[p5l1382t3527r1540b3607],
23	EM	NNP	O	EM	prep_in	13	SENT_71	[p5l1595t3527r1757b3607],
24	,	,	O	,	_	0	SENT_71	[p5l1595t3527r1757b3607],
25	and	CC	O	and	_	0	SENT_71	[p5l1813t3521r1951b3591],
26	UM	NN	O	um	nn	27	SENT_71	[p5l2002t3527r2153b3591],
27	groups	NNS	O	group	prep_in	13	SENT_71	[p5l7t3654r287b3716],
28	,	,	O	,	_	0	SENT_71	[p5l7t3654r287b3716],
29	respectively	RB	O	respectively	advmod	9	SENT_71	[p5l345t3627r843b3716],
30	)	CD	NUMBER	)	dep	9	SENT_71	[p5l345t3627r843b3716],
31	,	,	O	,	_	0	SENT_71	[p5l345t3627r843b3716],
32	but	CC	O	but	_	0	SENT_71	[p5l902t3627r1025b3697],
33	signiﬁcantly	RB	O	signiﬁcantly	advmod	35	SENT_71	[p5l1081t3627r1540b3716],
34	so	RB	O	so	advmod	35	SENT_71	[p5l1595t3654r1672b3697],
35	only	RB	O	only	conj_but	5	SENT_71	[p5l1730t3627r1894b3715],
36	when	WRB	O	when	advmod	37	SENT_71	[p5l1946t3627r2153b3697],
37	compared	VBN	O	compare	advcl	5	SENT_71	[p5l7t3733r386b3822],
38	with	IN	O	with	_	0	SENT_71	[p5l418t3733r590b3803],
39	the	DT	O	the	det	43	SENT_71	[p5l623t3733r738b3803],
40	EM	NNP	O	EM	nn	43	SENT_71	[p5l773t3738r914b3802],
41	group	NN	O	group	nn	43	SENT_71	[p5l947t3760r1170b3822],
42	(	CD	NUMBER	(	num	43	SENT_71	[p5l1209t3737r1286b3818],
43	P	NN	O	p	prep_with	37	SENT_71	[p5l1209t3737r1286b3818],
44	=	JJ	O	=	amod	46	SENT_71	[p5l1322t3768r1382b3790],
45	.013	CD	NUMBER	.013	tmod	44	SENT_71	[p5l1422t3737r1638b3818],
46	)	NN	O	)	dobj	37	SENT_71	[p5l1422t3737r1638b3818],
47	.	.	O	.	_	0	SENT_71	[p5l1422t3737r1638b3818],

1	Adverse	JJ	O	adverse	amod	2	SENT_72	[p6l718t130r1090b203],
2	Effects	NNS	O	effect	_	0	SENT_72	[p6l1132t130r1438b203],

1	EM	NNP	O	EM	nsubj	2	SENT_73	[p6l88t252r229b316],
2	had	VBD	O	have	_	0	SENT_73	[p6l289t247r429b317],
3	the	DT	O	the	det	6	SENT_73	[p6l489t247r604b317],
4	highest	JJS	O	highest	amod	6	SENT_73	[p6l667t247r936b336],
5	absolute	JJ	O	absolute	amod	6	SENT_73	[p6l998t247r1315b317],
6	number	NN	O	number	dobj	2	SENT_73	[p6l1377t247r1671b317],
7	of	IN	O	of	_	0	SENT_73	[p6l1734t247r1812b317],
8	adverse	JJ	O	adverse	amod	9	SENT_73	[p6l1870t247r2151b317],
9	effects	NNS	O	effect	prep_of	6	SENT_73	[p6l7t352r246b422],
10	(	VBP	O	(	rcmod	6	SENT_73	[p6l286t357r357b438],
11	n	NN	O	n	dobj	10	SENT_73	[p6l286t357r357b438],
12	=	JJ	O	=	advmod	10	SENT_73	[p6l393t387r453b409],
13	54	CD	NUMBER	54	num	14	SENT_73	[p6l491t357r636b438],
14	)	NN	O	)	dep	12	SENT_73	[p6l491t357r636b438],
15	,	,	O	,	_	0	SENT_73	[p6l491t357r636b438],
16	Whereas	IN	O	whereas	mark	22	SENT_73	[p6l671t352r980b422],
17	the	DT	O	the	det	21	SENT_73	[p6l1015t352r1130b422],
18	PM	NN	O	pm	nn	21	SENT_73	[p6l1165t358r1300b422],
19	and	CC	O	and	_	0	SENT_73	[p6l1335t352r1474b422],
20	IM	NN	O	im	conj_and	18	SENT_73	[p6l1507t358r1622b422],
21	groups	NNS	O	group	nsubj	22	SENT_73	[p6l1656t379r1913b441],
22	experienced	VBD	O	experience	dep	12	SENT_73	[p6l1949t379r2152b441, p6l7t458r283b528],
23	13	CD	NUMBER	13	num	25	SENT_73	[p6l345t463r429b528],
24	adverse	JJ	O	adverse	amod	25	SENT_73	[p6l491t458r773b529],
25	effects	NNS	O	effect	dobj	22	SENT_73	[p6l831t458r1070b528],
26	each	DT	O	each	dep	25	SENT_73	[p6l1128t458r1298b529],
27	and	CC	O	and	_	0	SENT_73	[p6l1356t459r1495b529],
28	the	DT	O	the	det	30	SENT_73	[p6l1550t458r1665b528],
29	UM	NNP	O	UM	nn	30	SENT_73	[p6l1721t464r1873b529],
30	group	NN	O	group	conj_and	25	SENT_73	[p6l1929t485r2152b547],

1	Movement	NNP	O	Movement	nn	2	SENT_74	[p6l1501t657r1615b676],
2	Disorders	NNPS	O	Disorders	_	0	SENT_74	[p6l1625t657r1731b679],
3	,	,	O	,	_	0	SENT_74	[p6l1625t657r1731b679],
4	Vol	NNP	O	Vol	appos	2	SENT_74	[p6l1741t657r1779b676],
5	.	.	O	.	_	0	SENT_74	[p6l1741t657r1779b676],

1	28	CD	NUMBER	28	_	0	SENT_75	[p6l1790t657r1822b679],
2	,	,	O	,	_	0	SENT_75	[p6l1790t657r1822b679],
3	No.	NN	O	no.	appos	1	SENT_75	[p6l1834t657r1869b676],
4	2	CD	NUMBER	2	num	3	SENT_75	[p6l1880t657r1898b679],
5	,	,	O	,	_	0	SENT_75	[p6l1880t657r1898b679],
6	2013	CD	DATE	2013	num	7	SENT_75	[p6l1909t657r1963b676],
7	211	CD	NUMBER	211	appos	1	SENT_75	[p6l2058t651r2105b676],

1	MEHANNA	NNP	O	MEHANNA	nn	3	SENT_76	[p6l31t782r269b803],
2	ET	NNP	O	ET	nn	3	SENT_76	[p6l316t782r365b803],
3	AL.	NNP	O	AL.	_	0	SENT_76	[p6l407t782r481b803],
4	j	NN	O	j	dep	3	SENT_76	[p6l538t754r2129b837],

1	Diagnostic	JJ	O	diagnostic	amod	2	SENT_77	[p6l976t1743r1104b1768],
2	category	NN	O	category	_	0	SENT_77	[p6l1113t1745r1220b1768],

1	FIG	NNP	O	FIG	_	0	SENT_78	[p6l212t1785r273b1810],
2	.	.	O	.	_	0	SENT_78	[p6l212t1785r273b1810],

1	1	LS	NUMBER	1	_	0	SENT_79	[p6l293t1786r317b1810],
2	.	.	O	.	_	0	SENT_79	[p6l293t1786r317b1810],

1	Diagnostic	JJ	MISC	diagnostic	amod	2	SENT_80	[p6l332t1787r477b1816],
2	categories	NNS	O	category	_	0	SENT_80	[p6l489t1787r641b1816],
3	.	.	O	.	_	0	SENT_80	[p6l489t1787r641b1816],

1	[	NN	O	[	nn	3	SENT_81	[p6l656t1786r738b1816],
2	Color	NN	O	color	nn	3	SENT_81	[p6l656t1786r738b1816],
3	figure	NN	O	figure	nsubjpass	6	SENT_81	[p6l748t1787r826b1816],
4	can	MD	O	can	aux	6	SENT_81	[p6l838t1793r886b1810],
5	be	VB	O	be	auxpass	6	SENT_81	[p6l900t1787r933b1810],
6	viewed	VBN	O	view	_	0	SENT_81	[p6l945t1787r1041b1810],
7	in	IN	O	in	_	0	SENT_81	[p6l1055t1787r1076b1810],
8	the	DT	O	the	det	10	SENT_81	[p6l1088t1787r1131b1810],
9	online	JJ	O	online	amod	10	SENT_81	[p6l1143t1787r1225b1810],
10	issue	NN	O	issue	prep_in	6	SENT_81	[p6l1238t1787r1315b1814],
11	,	,	O	,	_	0	SENT_81	[p6l1238t1787r1315b1814],
12	which	WDT	O	which	nsubj	14	SENT_81	[p6l1328t1787r1408b1810],
13	is	VBZ	O	be	cop	14	SENT_81	[p6l1422t1787r1442b1810],
14	available	JJ	O	available	rcmod	10	SENT_81	[p6l1454t1787r1575b1810],
15	at	IN	O	at	prep	14	SENT_81	[p6l1587t1788r1612b1810],
16	wi	FW	O	wi	nn	21	SENT_81	[p6l1624t1786r1945b1816],
17	|	FW	O	|	nn	21	SENT_81	[p6l1624t1786r1945b1816],
18	eyon	FW	O	eyon	nn	21	SENT_81	[p6l1624t1786r1945b1816],
19	|	FW	O	|	nn	21	SENT_81	[p6l1624t1786r1945b1816],
20	ine	FW	O	ine	nn	21	SENT_81	[p6l1624t1786r1945b1816],
21	|	FW	O	|	attr	14	SENT_81	[p6l1624t1786r1945b1816],
22	ibrary.com	FW	O	ibrary.com	dep	21	SENT_81	[p6l1624t1786r1945b1816],
23	.	.	O	.	_	0	SENT_81	[p6l1624t1786r1945b1816],
24	]	SYM	O	]	dep	21	SENT_81	[p6l1624t1786r1945b1816],

1	experienced	VBN	O	experience	_	0	SENT_82	[p6l8t1957r460b2046],
2	only	RB	O	only	quantmod	3	SENT_82	[p6l502t1957r665b2046],
3	1	CD	NUMBER	1	num	5	SENT_82	[p6l711t1962r743b2026],
4	adverse	JJ	O	adverse	amod	5	SENT_82	[p6l791t1957r1072b2027],
5	effect	NN	O	effect	dobj	1	SENT_82	[p6l1113t1957r1338b2027],
6	.	.	O	.	_	0	SENT_82	[p6l1113t1957r1338b2027],

1	Compared	VBN	O	compare	dep	100	SENT_83	[p6l1385t1957r1786b2046],
2	with	IN	O	with	dep	100	SENT_83	[p6l1823t1957r1995b2027],
3	the	DT	O	the	dep	100	SENT_83	[p6l2034t1957r2148b2027],
4	IM	NNP	MISC	IM	dep	100	SENT_83	[p6l7t2069r145b2149],
5	,	,	O	,	_	0	SENT_83	[p6l7t2069r145b2149],
6	EM	NNP	O	EM	dep	100	SENT_83	[p6l185t2069r348b2149],
7	,	,	O	,	_	0	SENT_83	[p6l185t2069r348b2149],
8	and	CC	O	and	dep	100	SENT_83	[p6l388t2063r527b2133],
9	UM	NN	O	um	dep	100	SENT_83	[p6l563t2068r714b2133],
10	groups	NNS	O	group	dep	100	SENT_83	[p6l751t2090r1031b2152],
11	,	,	O	,	_	0	SENT_83	[p6l751t2090r1031b2152],
12	the	DT	O	the	dep	100	SENT_83	[p6l1071t2063r1185b2133],
13	PM	NNP	O	PM	dep	100	SENT_83	[p6l1223t2069r1358b2133],
14	group	NN	O	group	dep	100	SENT_83	[p6l1395t2090r1618b2152],
15	had	VBD	O	have	dep	100	SENT_83	[p6l1656t2063r1796b2133],
16	a	DT	O	a	dep	100	SENT_83	[p6l1834t2090r1872b2133],
17	higher	JJR	O	higher	dep	100	SENT_83	[p6l1910t2063r2150b2152],
18	rate	NN	O	rate	dep	100	SENT_83	[p6l7t2189r151b2240],
19	of	IN	O	of	dep	100	SENT_83	[p6l230t2170r308b2240],
20	sedation	NN	O	sedation	dep	100	SENT_83	[p6l380t2170r698b2240],
21	(	CD	PERCENT	(	dep	100	SENT_83	[p6l779t2174r1056b2255],
22	54.5	CD	PERCENT	54.5	dep	100	SENT_83	[p6l779t2174r1056b2255],
23	%	NN	PERCENT	%	dep	100	SENT_83	[p6l779t2174r1056b2255],
24	VS	NN	O	v	dep	100	SENT_83	[p6l1138t2197r1213b2240],
25	26.7	CD	PERCENT	26.7	dep	100	SENT_83	[p6l1289t2174r1571b2255],
26	%	NN	PERCENT	%	dep	100	SENT_83	[p6l1289t2174r1571b2255],
27	,	,	O	,	_	0	SENT_83	[p6l1289t2174r1571b2255],
28	16.3	CD	PERCENT	16.3	dep	100	SENT_83	[p6l1656t2174r1931b2255],
29	%	NN	PERCENT	%	dep	100	SENT_83	[p6l1656t2174r1931b2255],
30	,	,	O	,	_	0	SENT_83	[p6l1656t2174r1931b2255],
31	and	CC	O	and	dep	100	SENT_83	[p6l2011t2170r2150b2240],
32	49.8	CD	PERCENT	49.8	dep	100	SENT_83	[p6l7t2280r288b2361],
33	%	NN	PERCENT	%	dep	100	SENT_83	[p6l7t2280r288b2361],
34	,	,	O	,	_	0	SENT_83	[p6l7t2280r288b2361],
35	respectively	RB	O	respectively	dep	100	SENT_83	[p6l374t2276r871b2365],
36	)	CD	NUMBER	)	dep	100	SENT_83	[p6l374t2276r871b2365],
37	,	,	O	,	_	0	SENT_83	[p6l374t2276r871b2365],
38	akathisia	NN	O	akathisium	dep	100	SENT_83	[p6l958t2276r1300b2346],
39	(	CD	PERCENT	(	dep	100	SENT_83	[p6l1389t2280r1666b2361],
40	18.2	CD	PERCENT	18.2	dep	100	SENT_83	[p6l1389t2280r1666b2361],
41	%	NN	PERCENT	%	dep	100	SENT_83	[p6l1389t2280r1666b2361],
42	vs	CC	O	vs	dep	100	SENT_83	[p6l1756t2303r1830b2346],
43	6.7	CD	PERCENT	6.7	dep	100	SENT_83	[p6l1918t2280r2147b2361],
44	%	NN	PERCENT	%	dep	100	SENT_83	[p6l1918t2280r2147b2361],
45	,	,	O	,	_	0	SENT_83	[p6l1918t2280r2147b2361],
46	4.8	CD	PERCENT	4.8	dep	100	SENT_83	[p6l7t2386r239b2468],
47	%	NN	PERCENT	%	dep	100	SENT_83	[p6l7t2386r239b2468],
48	,	,	O	,	_	0	SENT_83	[p6l7t2386r239b2468],
49	and	CC	O	and	dep	100	SENT_83	[p6l317t2382r456b2452],
50	o	NN	PERCENT	o	dep	100	SENT_83	[p6l532t2386r688b2468],
51	%	NN	PERCENT	%	dep	100	SENT_83	[p6l532t2386r688b2468],
52	,	,	O	,	_	0	SENT_83	[p6l532t2386r688b2468],
53	respectively	RB	O	respectively	dep	100	SENT_83	[p6l764t2382r1260b2471],
54	)	CD	NUMBER	)	dep	100	SENT_83	[p6l764t2382r1260b2471],
55	,	,	O	,	_	0	SENT_83	[p6l764t2382r1260b2471],
56	insomnia	NN	O	insomnia	dep	100	SENT_83	[p6l1338t2387r1686b2452],
57	(	CD	PERCENT	(	dep	100	SENT_83	[p6l1765t2386r1993b2468],
58	9.1	CD	PERCENT	9.1	dep	100	SENT_83	[p6l1765t2386r1993b2468],
59	%	NN	PERCENT	%	dep	100	SENT_83	[p6l1765t2386r1993b2468],
60	vs	CC	O	vs	dep	100	SENT_83	[p6l2073t2409r2148b2452],
61	6.7	CD	PERCENT	6.7	dep	100	SENT_83	[p6l10t2492r239b2573],
62	%	NN	PERCENT	%	dep	100	SENT_83	[p6l10t2492r239b2573],
63	,	,	O	,	_	0	SENT_83	[p6l10t2492r239b2573],
64	3.8	CD	PERCENT	3.8	dep	100	SENT_83	[p6l301t2492r531b2573],
65	%	NN	PERCENT	%	dep	100	SENT_83	[p6l301t2492r531b2573],
66	,	,	O	,	_	0	SENT_83	[p6l301t2492r531b2573],
67	and	CC	O	and	dep	100	SENT_83	[p6l593t2488r731b2558],
68	o	NN	PERCENT	o	dep	100	SENT_83	[p6l790t2492r945b2573],
69	%	NN	PERCENT	%	dep	100	SENT_83	[p6l790t2492r945b2573],
70	,	,	O	,	_	0	SENT_83	[p6l790t2492r945b2573],
71	respectively	RB	O	respectively	dep	100	SENT_83	[p6l1006t2488r1502b2577],
72	)	CD	NUMBER	)	dep	100	SENT_83	[p6l1006t2488r1502b2577],
73	,	,	O	,	_	0	SENT_83	[p6l1006t2488r1502b2577],
74	and	CC	O	and	dep	100	SENT_83	[p6l1564t2488r1703b2558],
75	suicidality	NN	O	suicidality	dep	100	SENT_83	[p6l1762t2488r2150b2576],
76	(	CD	PERCENT	(	dep	100	SENT_83	[p6l12t2598r289b2679],
77	18.2	CD	PERCENT	18.2	dep	100	SENT_83	[p6l12t2598r289b2679],
78	%	NN	PERCENT	%	dep	100	SENT_83	[p6l12t2598r289b2679],
79	vs	CC	O	vs	dep	100	SENT_83	[p6l350t2621r425b2664],
80	6.7	CD	PERCENT	6.7	dep	100	SENT_83	[p6l484t2598r713b2679],
81	%	NN	PERCENT	%	dep	100	SENT_83	[p6l484t2598r713b2679],
82	,	,	O	,	_	0	SENT_83	[p6l484t2598r713b2679],
83	1.9	CD	PERCENT	1.9	dep	100	SENT_83	[p6l777t2598r1003b2679],
84	%	NN	PERCENT	%	dep	100	SENT_83	[p6l777t2598r1003b2679],
85	,	,	O	,	_	0	SENT_83	[p6l777t2598r1003b2679],
86	and	CC	O	and	dep	100	SENT_83	[p6l1062t2594r1200b2664],
87	o	NN	PERCENT	o	dep	100	SENT_83	[p6l1257t2598r1412b2679],
88	%	NN	PERCENT	%	dep	100	SENT_83	[p6l1257t2598r1412b2679],
89	,	,	O	,	_	0	SENT_83	[p6l1257t2598r1412b2679],
90	respectively	RB	O	respectively	dep	100	SENT_83	[p6l1470t2594r1967b2683],
91	)	CD	NUMBER	)	dep	100	SENT_83	[p6l1470t2594r1967b2683],
92	,	,	O	,	_	0	SENT_83	[p6l1470t2594r1967b2683],
93	but	CC	O	but	dep	100	SENT_83	[p6l2027t2594r2150b2664],
94	none	NN	O	none	dep	100	SENT_83	[p6l7t2727r190b2770],
95	of	IN	O	of	dep	100	SENT_83	[p6l255t2700r333b2770],
96	these	DT	O	these	dep	100	SENT_83	[p6l391t2700r580b2770],
97	differences	NNS	O	difference	dep	100	SENT_83	[p6l645t2700r1052b2770],
98	reached	VBD	O	reach	dep	100	SENT_83	[p6l1116t2700r1410b2770],
99	statistical	JJ	O	statistical	dep	100	SENT_83	[p6l1474t2700r1832b2770],
100	signiﬁcance	NN	O	signiﬁcance	_	0	SENT_83	[p6l1896t2700r2148b2789, p6l7t2833r238b2876],
101	.	.	O	.	_	0	SENT_83	[p6l1896t2700r2148b2789, p6l7t2833r238b2876],

1	No	DT	O	no	det	2	SENT_84	[p6l287t2811r407b2876],
2	suicide	NN	O	suicide	nsubjpass	4	SENT_84	[p6l455t2806r712b2876],
3	was	VBD	O	be	auxpass	4	SENT_84	[p6l758t2833r903b2876],
4	recorded	VBN	O	record	_	0	SENT_84	[p6l950t2806r1284b2876],
5	during	IN	O	during	_	0	SENT_84	[p6l1331t2806r1578b2895],
6	the	DT	O	the	det	7	SENT_84	[p6l1623t2806r1738b2876],
7	course	NN	O	course	prep_during	4	SENT_84	[p6l1785t2833r2027b2876],
8	of	IN	O	of	_	0	SENT_84	[p6l2076t2806r2154b2876],
9	our	PRP$	O	we	poss	10	SENT_84	[p6l9t2939r137b2982],
10	study	NN	O	study	prep_of	7	SENT_84	[p6l183t2912r408b3001],
11	,	,	O	,	_	0	SENT_84	[p6l183t2912r408b3001],
12	and	CC	O	and	_	0	SENT_84	[p6l457t2912r595b2982],
13	none	NN	O	none	nsubj	22	SENT_84	[p6l639t2939r822b2982],
14	of	IN	O	of	_	0	SENT_84	[p6l870t2912r948b2982],
15	the	DT	O	the	det	17	SENT_84	[p6l987t2912r1102b2982],
16	Huntington	NNP	O	Huntington	nn	17	SENT_84	[p6l1148t2916r1595b3001],
17	disease	NN	O	disease	prep_of	13	SENT_84	[p6l1642t2912r1903b2982],
18	(	CD	NUMBER	(	num	21	SENT_84	[p6l1954t2916r2145b2998],
19	HD	NN	O	hd	nn	21	SENT_84	[p6l1954t2916r2145b2998],
20	)	NN	O	)	nn	21	SENT_84	[p6l1954t2916r2145b2998],
21	patients	NNS	O	patient	dep	17	SENT_84	[p6l7t3023r305b3107],
22	reported	VBD	O	report	conj_and	4	SENT_84	[p6l356t3018r678b3107],
23	suicidality	NN	O	suicidality	dobj	22	SENT_84	[p6l730t3018r1139b3107],
24	.	.	O	.	_	0	SENT_84	[p6l730t3018r1139b3107],

1	Similarly	RB	O	similarly	advmod	39	SENT_85	[p6l1195t3018r1555b3107],
2	,	,	O	,	_	0	SENT_85	[p6l1195t3018r1555b3107],
3	parkinsonism	NN	O	parkinsonism	nsubj	39	SENT_85	[p6l1607t3018r2147b3107],
4	,	,	O	,	_	0	SENT_85	[p6l1607t3018r2147b3107],
5	found	VBN	O	find	partmod	3	SENT_85	[p6l8t3124r231b3194],
6	in	IN	O	in	_	0	SENT_85	[p6l273t3128r343b3193],
7	13.3	CD	PERCENT	13.3	num	8	SENT_85	[p6l390t3128r637b3195],
8	%	NN	PERCENT	%	prep_in	5	SENT_85	[p6l390t3128r637b3195],
9	of	IN	O	of	_	0	SENT_85	[p6l687t3124r765b3194],
10	the	DT	O	the	det	12	SENT_85	[p6l801t3124r917b3194],
11	IM	NNP	O	IM	nn	12	SENT_85	[p6l959t3129r1075b3193],
12	group	NN	O	group	prep_of	8	SENT_85	[p6l1117t3150r1339b3213],
13	compared	VBN	O	compare	_	0	SENT_85	[p6l1382t3124r1760b3213],
14	with	IN	O	with	prepc_compared_with	5	SENT_85	[p6l1801t3124r1973b3194],
15	9	CD	PERCENT	9	num	16	SENT_85	[p6l2017t3128r2143b3195],
16	%	NN	PERCENT	%	pobj	5	SENT_85	[p6l2017t3128r2143b3195],
17	of	IN	O	of	_	0	SENT_85	[p6l9t3230r87b3300],
18	the	DT	O	the	det	20	SENT_85	[p6l123t3230r238b3300],
19	PM	NNP	O	PM	nn	20	SENT_85	[p6l281t3235r416b3299],
20	group	NN	O	group	prep_of	16	SENT_85	[p6l457t3257r704b3319],
21	,	,	O	,	_	0	SENT_85	[p6l457t3257r704b3319],
22	7.7	CD	PERCENT	7.7	num	23	SENT_85	[p6l751t3234r951b3301],
23	%	NN	PERCENT	%	appos	20	SENT_85	[p6l751t3234r951b3301],
24	in	IN	O	in	_	0	SENT_85	[p6l1000t3234r1070b3299],
25	the	DT	O	the	det	27	SENT_85	[p6l1111t3230r1226b3300],
26	EM	NNP	O	EM	nn	27	SENT_85	[p6l1269t3235r1409b3299],
27	group	NN	O	group	num	30	SENT_85	[p6l1451t3257r1673b3319],
28	and	CC	O	and	_	0	SENT_85	[p6l1717t3230r1856b3300],
29	o	NN	PERCENT	o	conj_and	27	SENT_85	[p6l1900t3234r2026b3301],
30	%	NN	PERCENT	%	prep_in	23	SENT_85	[p6l1900t3234r2026b3301],
31	of	IN	O	of	_	0	SENT_85	[p6l2076t3230r2154b3300],
32	the	DT	O	the	det	34	SENT_85	[p6l7t3336r121b3406],
33	UM	NNP	O	UM	nn	34	SENT_85	[p6l159t3341r310b3406],
34	group	NN	O	group	prep_of	30	SENT_85	[p6l348t3363r594b3425],
35	,	,	O	,	_	0	SENT_85	[p6l348t3363r594b3425],
36	did	VBD	O	do	aux	39	SENT_85	[p6l637t3336r755b3406],
37	not	RB	O	not	neg	39	SENT_85	[p6l794t3355r919b3406],
38	signiﬁcantly	RB	O	signiﬁcantly	advmod	39	SENT_85	[p6l958t3336r1415b3425],
39	correlate	VB	O	correlate	_	0	SENT_85	[p6l1453t3336r1787b3406],
40	with	IN	O	with	_	0	SENT_85	[p6l1824t3336r1996b3406],
41	the	DT	O	the	det	44	SENT_85	[p6l2033t3336r2148b3406],
42	genotype	NN	O	genotype	nn	44	SENT_85	[p6l7t3463r349b3533],
43	(	CD	NUMBER	(	num	44	SENT_85	[p6l389t3448r550b3533],
44	Fig	NN	O	fig	prep_with	39	SENT_85	[p6l389t3448r550b3533],
45	.	.	O	.	_	0	SENT_85	[p6l389t3448r550b3533],

1	2	CD	NUMBER	2	num	2	SENT_86	[p6l588t3448r684b3529],
2	)	CD	NUMBER	)	_	0	SENT_86	[p6l588t3448r684b3529],
3	.	.	O	.	_	0	SENT_86	[p6l588t3448r684b3529],

1	Other	JJ	O	other	_	0	SENT_87	[p6l472t3694r723b3768],
2	Correlative	JJ	O	correlative	amod	3	SENT_87	[p6l758t3694r1246b3768],
3	Analyses	NNS	O	analysis	dep	1	SENT_87	[p6l1279t3696r1685b3786],

1	There	EX	O	there	expl	2	SENT_88	[p7l86t20r306b90],
2	was	VBD	O	be	_	0	SENT_88	[p7l353t47r498b90],
3	a	DT	O	a	det	7	SENT_88	[p7l549t47r587b90],
4	statistically	RB	O	statistically	advmod	5	SENT_88	[p7l636t20r1066b108],
5	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_88	[p7l1114t20r1501b108],
6	overall	JJ	O	overall	amod	7	SENT_88	[p7l1549t20r1806b90],
7	correlation	NN	O	correlation	nsubj	2	SENT_88	[p7l1855t20r2148b90, p7l7t132r157b197],
8	between	IN	O	between	_	0	SENT_88	[p7l192t128r505b197],
9	total	JJ	O	total	amod	11	SENT_88	[p7l537t127r712b197],
10	daily	JJ	SET	daily	amod	11	SENT_88	[p7l748t128r933b216],
11	dose	NN	O	dose	prep_between	7	SENT_88	[p7l967t127r1133b197],
12	and	CC	O	and	_	0	SENT_88	[p7l1169t128r1307b197],
13	duration	NN	O	duration	nsubj	2	SENT_88	[p7l1342t127r1669b197],
14	of	IN	O	of	_	0	SENT_88	[p7l1703t127r1782b197],
15	titration	NN	O	titration	prep_of	13	SENT_88	[p7l1810t132r2147b213],
16	,	,	O	,	_	0	SENT_88	[p7l1810t132r2147b213],
17	with	IN	O	with	_	0	SENT_88	[p7l6t234r178b304],
18	a	DT	O	a	det	20	SENT_88	[p7l225t261r263b304],
19	higher	JJR	O	higher	amod	20	SENT_88	[p7l311t234r550b323],
20	dose	NN	O	dose	prep_with	2	SENT_88	[p7l597t234r764b304],
21	associated	VBN	O	associate	partmod	20	SENT_88	[p7l813t234r1200b304],
22	with	IN	O	with	_	0	SENT_88	[p7l1246t234r1417b304],
23	a	DT	O	a	det	25	SENT_88	[p7l1465t261r1503b304],
24	longer	RBR	O	longer	amod	25	SENT_88	[p7l1550t234r1790b323],
25	titration	NN	O	titration	prep_with	21	SENT_88	[p7l1835t238r2150b304],
26	(	CD	NUMBER	(	num	27	SENT_88	[p7l12t345r88b426],
27	P	NN	O	p	npadvmod	28	SENT_88	[p7l12t345r88b426],
28	<	JJR	O	<	amod	25	SENT_88	[p7l133t360r188b413],
29	.001	CD	NUMBER	.001	num	30	SENT_88	[p7l237t345r453b426],
30	)	NN	O	)	dep	25	SENT_88	[p7l237t345r453b426],
31	.	.	O	.	_	0	SENT_88	[p7l237t345r453b426],

1	Furthermore	RB	O	furthermore	advmod	11	SENT_89	[p7l498t341r1001b426],
2	,	,	O	,	_	0	SENT_89	[p7l498t341r1001b426],
3	in	IN	O	in	_	0	SENT_89	[p7l1045t345r1115b409],
4	the	DT	O	the	det	6	SENT_89	[p7l1154t341r1269b411],
5	UM	NNP	O	UM	nn	6	SENT_89	[p7l1309t346r1461b411],
6	group	NN	O	group	prep_in	11	SENT_89	[p7l1500t368r1746b430],
7	,	,	O	,	_	0	SENT_89	[p7l1500t368r1746b430],
8	older	JJR	O	older	amod	9	SENT_89	[p7l1791t341r1984b411],
9	age	NN	O	age	nsubjpass	11	SENT_89	[p7l2025t368r2148b429],
10	was	VBD	O	be	auxpass	11	SENT_89	[p7l6t476r151b518],
11	associated	VBN	O	associate	_	0	SENT_89	[p7l208t448r594b518],
12	with	IN	O	with	_	0	SENT_89	[p7l647t449r819b518],
13	a	DT	O	a	det	17	SENT_89	[p7l873t476r911b518],
14	higher	JJR	O	higher	dep	15	SENT_89	[p7l967t448r1206b537],
15	total	JJ	O	total	amod	17	SENT_89	[p7l1259t448r1434b518],
16	daily	RB	SET	daily	advmod	15	SENT_89	[p7l1489t448r1674b537],
17	dose	NN	O	dose	prep_with	11	SENT_89	[p7l1729t449r1895b518],
18	(	CD	NUMBER	(	num	19	SENT_89	[p7l1955t453r2031b534],
19	P	NN	O	p	npadvmod	20	SENT_89	[p7l1955t453r2031b534],
20	<	JJR	O	<	amod	17	SENT_89	[p7l2090t468r2145b520],
21	.001	CD	NUMBER	.001	num	22	SENT_89	[p7l11t559r229b640],
22	)	NN	O	)	dobj	11	SENT_89	[p7l11t559r229b640],
23	;	:	O	;	_	0	SENT_89	[p7l11t559r229b640],
24	in	IN	O	in	_	0	SENT_89	[p7l272t559r342b623],
25	the	DT	O	the	det	27	SENT_89	[p7l381t555r496b625],
26	EM	NNP	O	EM	nn	27	SENT_89	[p7l537t560r678b624],
27	group	NN	O	group	prep_in	31	SENT_89	[p7l717t582r964b644],
28	,	,	O	,	_	0	SENT_89	[p7l717t582r964b644],
29	men	NNS	O	man	nsubj	31	SENT_89	[p7l1005t582r1167b625],
30	were	VBD	O	be	cop	31	SENT_89	[p7l1205t582r1385b625],
31	older	JJR	O	older	dep	22	SENT_89	[p7l1428t555r1622b625],
32	than	IN	O	than	mark	34	SENT_89	[p7l1660t555r1830b625],
33	women	NNS	O	woman	nsubj	34	SENT_89	[p7l1869t582r2150b625],
34	(	VBP	O	(	ccomp	31	SENT_89	[p7l11t665r88b746],
35	P	NN	O	p	dobj	34	SENT_89	[p7l11t665r88b746],
36	=	JJ	O	=	advmod	34	SENT_89	[p7l147t696r207b718],
37	.016	CD	NUMBER	.016	num	38	SENT_89	[p7l269t665r459b746],
38	)	NN	O	)	dep	36	SENT_89	[p7l269t665r459b746],
39	and	CC	O	and	_	0	SENT_89	[p7l522t661r660b731],
40	required	VBD	O	require	conj_and	34	SENT_89	[p7l716t661r1035b750],
41	a	DT	O	a	det	45	SENT_89	[p7l1093t688r1131b731],
42	higher	JJR	O	higher	amod	45	SENT_89	[p7l1188t661r1428b750],
43	daily	JJ	SET	daily	amod	45	SENT_89	[p7l1485t661r1670b750],
44	dose	NN	O	dose	nn	45	SENT_89	[p7l1727t661r1893b731],
45	(	NN	O	(	nn	49	SENT_89	[p7l1956t665r2032b747],
46	P	NN	O	p	dep	45	SENT_89	[p7l1956t665r2032b747],
47	=	JJ	O	=	amod	49	SENT_89	[p7l2090t696r2151b718],
48	.044	CD	NUMBER	.044	tmod	47	SENT_89	[p7l11t771r229b852],
49	)	NN	O	)	dobj	40	SENT_89	[p7l11t771r229b852],
50	,	,	O	,	_	0	SENT_89	[p7l11t771r229b852],
51	and	CC	O	and	_	0	SENT_89	[p7l279t767r418b837],
52	younger	JJR	O	younger	amod	53	SENT_89	[p7l463t794r773b856],
53	patients	NNS	O	patient	nsubj	54	SENT_89	[p7l818t771r1117b856],
54	had	VBD	O	have	dep	22	SENT_89	[p7l1165t767r1304b837],
55	a	DT	O	a	det	57	SENT_89	[p7l1352t794r1390b837],
56	better	JJR	O	better	amod	57	SENT_89	[p7l1439t767r1657b837],
57	response	NN	O	response	nn	68	SENT_89	[p7l1703t794r2030b856],
58	to	TO	O	to	_	0	SENT_89	[p7l2077t786r2152b837],
59	treatment	NN	O	treatment	prep_to	57	SENT_89	[p7l6t892r376b943],
60	in	IN	O	in	_	0	SENT_89	[p7l415t877r486b941],
61	the	DT	O	the	det	65	SENT_89	[p7l523t873r638b943],
62	IM	NNP	O	IM	nn	65	SENT_89	[p7l678t878r793b942],
63	group	NN	O	group	nn	65	SENT_89	[p7l831t899r1055b962],
64	(	CD	NUMBER	(	num	65	SENT_89	[p7l1099t877r1175b958],
65	P	NN	O	p	prep_in	59	SENT_89	[p7l1099t877r1175b958],
66	=	JJ	O	=	amod	68	SENT_89	[p7l1216t908r1276b929],
67	.049	CD	NUMBER	.049	tmod	66	SENT_89	[p7l1321t877r1537b958],
68	)	NN	O	)	dobj	54	SENT_89	[p7l1321t877r1537b958],
69	.	.	O	.	_	0	SENT_89	[p7l1321t877r1537b958],

1	There	EX	O	there	expl	2	SENT_90	[p7l1579t873r1798b943],
2	were	VBD	O	be	_	0	SENT_90	[p7l1838t900r2018b943],
3	no	DT	O	no	det	6	SENT_90	[p7l2058t900r2152b943],
4	other	JJ	O	other	amod	6	SENT_90	[p7l8t979r206b1049],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_90	[p7l241t979r630b1068],
6	correlations	NNS	O	correlation	nsubj	2	SENT_90	[p7l663t979r1136b1049],
7	.	.	O	.	_	0	SENT_90	[p7l663t979r1136b1049],

1	Discussion	NN	O	discussion	_	0	SENT_91	[p7l772t1229r1389b1321],

1	In	IN	O	in	_	0	SENT_92	[p7l88t1452r163b1515],
2	our	PRP$	O	we	poss	3	SENT_92	[p7l199t1474r327b1517],
3	series	NN	O	series	prep_in	44	SENT_92	[p7l363t1451r565b1517],
4	of	IN	O	of	_	0	SENT_92	[p7l602t1447r681b1517],
5	127	CD	NUMBER	127	num	6	SENT_92	[p7l717t1452r856b1517],
6	patients	NNS	O	patient	prep_of	3	SENT_92	[p7l889t1451r1188b1536],
7	with	IN	O	with	_	0	SENT_92	[p7l1223t1447r1394b1517],
8	a	DT	O	a	det	9	SENT_92	[p7l1430t1474r1468b1517],
9	variety	NN	O	variety	prep_with	6	SENT_92	[p7l1503t1451r1765b1535],
10	of	IN	O	of	_	0	SENT_92	[p7l1800t1447r1879b1517],
11	hyperkinetic	JJ	O	hyperkinetic	amod	13	SENT_92	[p7l1909t1447r2151b1536, p7l7t1553r261b1623],
12	movement	NN	O	movement	nn	13	SENT_92	[p7l331t1572r731b1623],
13	disorders	NNS	O	disorder	prep_of	9	SENT_92	[p7l800t1553r1170b1638],
14	,	,	O	,	_	0	SENT_92	[p7l800t1553r1170b1638],
15	represented	VBN	O	represent	partmod	13	SENT_92	[p7l1241t1553r1680b1642],
16	chieﬂy	NN	O	chieﬂy	dobj	15	SENT_92	[p7l1748t1553r1995b1641],
17	by	IN	O	by	_	0	SENT_92	[p7l2065t1553r2154b1641],
18	Tourette	NNP	O	Tourette	nn	19	SENT_92	[p7l6t1661r335b1728],
19	syndrome	NN	O	syndrome	agent	15	SENT_92	[p7l448t1659r818b1747],
20	(	CD	PERCENT	(	number	21	SENT_92	[p7l935t1663r1271b1744],
21	40.1	CD	PERCENT	40.1	num	22	SENT_92	[p7l935t1663r1271b1744],
22	%	NN	PERCENT	%	dep	13	SENT_92	[p7l935t1663r1271b1744],
23	)	CD	NUMBER	)	dep	13	SENT_92	[p7l935t1663r1271b1744],
24	,	,	O	,	_	0	SENT_92	[p7l935t1663r1271b1744],
25	tardive	JJ	O	tardive	amod	26	SENT_92	[p7l1384t1659r1648b1728],
26	dyskinesia	NN	O	dyskinesium	appos	23	SENT_92	[p7l1760t1658r2151b1747],
27	(	CD	PERCENT	(	number	28	SENT_92	[p7l11t1769r349b1850],
28	22.9	CD	PERCENT	22.9	num	29	SENT_92	[p7l11t1769r349b1850],
29	%	NN	PERCENT	%	dep	26	SENT_92	[p7l11t1769r349b1850],
30	)	CD	NUMBER	)	dep	26	SENT_92	[p7l11t1769r349b1850],
31	,	,	O	,	_	0	SENT_92	[p7l11t1769r349b1850],
32	and	CC	O	and	_	0	SENT_92	[p7l405t1765r543b1835],
33	HD	NN	O	hd	conj_and	13	SENT_92	[p7l594t1770r732b1833],
34	(	CD	PERCENT	(	number	35	SENT_92	[p7l792t1769r1128b1850],
35	19.7	CD	PERCENT	19.7	num	36	SENT_92	[p7l792t1769r1128b1850],
36	%	NN	PERCENT	%	dep	33	SENT_92	[p7l792t1769r1128b1850],
37	)	CD	NUMBER	)	dep	33	SENT_92	[p7l792t1769r1128b1850],
38	,	,	O	,	_	0	SENT_92	[p7l792t1769r1128b1850],
39	the	DT	O	the	det	40	SENT_92	[p7l1182t1765r1296b1835],
40	majority	NN	O	majority	nsubjpass	44	SENT_92	[p7l1350t1769r1676b1853],
41	of	IN	O	of	_	0	SENT_92	[p7l1728t1765r1806b1835],
42	patients	NNS	O	patient	prep_of	40	SENT_92	[p7l1853t1769r2151b1854],
43	were	VBD	O	be	auxpass	44	SENT_92	[p7l6t1898r186b1941],
44	categorized	VBN	O	categorize	_	0	SENT_92	[p7l224t1871r659b1959],
45	as	IN	O	as	_	0	SENT_92	[p7l696t1898r769b1941],
46	EMS	NNP	O	EMS	prep_as	44	SENT_92	[p7l807t1876r980b1941],
47	(	CD	PERCENT	(	num	46	SENT_92	[p7l1023t1875r1360b1956],
48	78.7	CD	PERCENT	78.7	num	49	SENT_92	[p7l1023t1875r1360b1956],
49	%	NN	PERCENT	%	dobj	44	SENT_92	[p7l1023t1875r1360b1956],
50	)	CD	NUMBER	)	dep	49	SENT_92	[p7l1023t1875r1360b1956],
51	,	,	O	,	_	0	SENT_92	[p7l1023t1875r1360b1956],
52	11	CD	PERCENT	11	num	53	SENT_92	[p7l1405t1875r1577b1941],
53	%	NN	PERCENT	%	dobj	44	SENT_92	[p7l1405t1875r1577b1941],
54	as	IN	O	as	_	0	SENT_92	[p7l1621t1898r1694b1941],
55	IMs	NNS	O	im	prep_as	53	SENT_92	[p7l1731t1876r1904b1956],
56	,	,	O	,	_	0	SENT_92	[p7l1731t1876r1904b1956],
57	8.7	CD	PERCENT	8.7	num	58	SENT_92	[p7l1948t1875r2146b1941],
58	%	NN	PERCENT	%	dobj	44	SENT_92	[p7l1948t1875r2146b1941],
59	as	IN	O	as	_	0	SENT_92	[p7l8t2004r81b2046],
60	PMs	NNS	O	pm	prep_as	58	SENT_92	[p7l126t1982r318b2062],
61	,	,	O	,	_	0	SENT_92	[p7l126t1982r318b2062],
62	and	CC	O	and	_	0	SENT_92	[p7l366t1977r504b2046],
63	1.6	CD	PERCENT	1.6	num	64	SENT_92	[p7l554t1981r751b2047],
64	%	NN	PERCENT	%	conj_and	49	SENT_92	[p7l554t1981r751b2047],
65	as	IN	O	as	_	0	SENT_92	[p7l803t2004r876b2046],
66	UMs	NNS	O	um	prep_as	64	SENT_92	[p7l920t1982r1126b2046],
67	.	.	O	.	_	0	SENT_92	[p7l920t1982r1126b2046],

1	Although	IN	O	although	mark	9	SENT_93	[p7l1174t1976r1533b2065],
2	the	DT	O	the	det	3	SENT_93	[p7l1576t1976r1691b2046],
3	proportion	NN	O	proportion	nsubj	9	SENT_93	[p7l1735t1981r2153b2065],
4	of	IN	O	of	_	0	SENT_93	[p7l8t2083r87b2153],
5	UM	NN	O	um	nn	6	SENT_93	[p7l132t2088r283b2153],
6	patients	NNS	O	patient	prep_of	3	SENT_93	[p7l333t2087r632b2172],
7	was	VBD	O	be	cop	9	SENT_93	[p7l683t2110r829b2153],
8	somewhat	RB	O	somewhat	advmod	9	SENT_93	[p7l882t2083r1270b2153],
9	lower	JJR	O	lower	advcl	26	SENT_93	[p7l1321t2083r1536b2153],
10	in	IN	O	in	_	0	SENT_93	[p7l1587t2087r1657b2151],
11	our	PRP$	O	we	poss	12	SENT_93	[p7l1709t2110r1838b2153],
12	sample	NN	O	sample	prep_in	9	SENT_93	[p7l1889t2083r2152b2172],
13	(	CD	PERCENT	(	number	14	SENT_93	[p7l11t2193r239b2274],
14	1.6	CD	PERCENT	1.6	num	15	SENT_93	[p7l11t2193r239b2274],
15	%	NN	PERCENT	%	dep	12	SENT_93	[p7l11t2193r239b2274],
16	vs	CC	O	vs	_	0	SENT_93	[p7l280t2216r355b2259],
17	5.5	CD	PERCENT	5.5	num	18	SENT_93	[p7l392t2193r652b2274],
18	%	NN	PERCENT	%	conj_vs	15	SENT_93	[p7l392t2193r652b2274],
19	)	CD	NUMBER	)	tmod	9	SENT_93	[p7l392t2193r652b2274],
20	,	,	O	,	_	0	SENT_93	[p7l392t2193r652b2274],
21	the	DT	O	the	det	22	SENT_93	[p7l689t2189r804b2259],
22	proportion	NN	O	proportion	nsubj	26	SENT_93	[p7l838t2193r1256b2278],
23	of	IN	O	of	_	0	SENT_93	[p7l1292t2189r1370b2259],
24	PMs	NNS	O	pm	prep_of	22	SENT_93	[p7l1400t2194r1568b2259],
25	was	VBD	O	be	cop	26	SENT_93	[p7l1602t2216r1748b2259],
26	similar	JJ	O	similar	_	0	SENT_93	[p7l1784t2189r2044b2259],
27	to	TO	O	to	_	0	SENT_93	[p7l2077t2208r2152b2259],
28	what	WP	O	what	nsubjpass	31	SENT_93	[p7l6t2294r198b2364],
29	has	VBZ	O	have	aux	31	SENT_93	[p7l257t2295r381b2364],
30	been	VBN	O	be	auxpass	31	SENT_93	[p7l444t2295r617b2364],
31	reported	VBN	O	report	prepc_to	26	SENT_93	[p7l677t2294r1001b2383],
32	in	IN	O	in	_	0	SENT_93	[p7l1062t2299r1132b2363],
33	the	DT	O	the	det	35	SENT_93	[p7l1192t2295r1306b2364],
34	literature	NN	O	literature	nn	35	SENT_93	[p7l1368t2294r1716b2364],
35	(	NN	O	(	prep_in	31	SENT_93	[p7l1783t2299r2011b2380],
36	8.7	CD	PERCENT	8.7	num	37	SENT_93	[p7l1783t2299r2011b2380],
37	%	NN	PERCENT	%	dobj	31	SENT_93	[p7l1783t2299r2011b2380],
38	vs	CC	O	vs	_	0	SENT_93	[p7l2077t2322r2152b2365],
39	7	CD	PERCENT	7	num	40	SENT_93	[p7l10t2434r135b2501],
40	%	NN	PERCENT	%	conj_vs	37	SENT_93	[p7l10t2434r135b2501],
41	)	CD	NUMBER	)	number	42	SENT_93	[p7l151t2416r381b2515],
42	.14	CD	NUMBER	.14	num	40	SENT_93	[p7l151t2416r381b2515],
43	—	NN	O	—	dep	40	SENT_93	[p7l151t2416r381b2515],
44	17	CD	NUMBER	17	num	43	SENT_93	[p7l151t2416r381b2515],

1	UM	NN	O	um	nn	2	SENT_94	[p7l86t2543r238b2608],
2	patients	NNS	O	patient	nsubjpass	19	SENT_94	[p7l335t2542r658b2627],
3	,	,	O	,	_	0	SENT_94	[p7l335t2542r658b2627],
4	who	WP	O	who	nsubj	6	SENT_94	[p7l758t2538r923b2608],
5	presumably	RB	O	presumably	advmod	6	SENT_94	[p7l1022t2538r1466b2627],
6	have	VBP	O	have	rcmod	2	SENT_94	[p7l1564t2538r1738b2608],
7	multiple	JJ	O	multiple	amod	10	SENT_94	[p7l1838t2538r2152b2627],
8	CYPZD6	NN	O	cypzd6	nn	10	SENT_94	[p7l10t2648r348b2713],
9	gene	NN	O	gene	nn	10	SENT_94	[p7l420t2671r589b2732],
10	copies	NNS	O	copy	dobj	6	SENT_94	[p7l660t2648r893b2732],
11	and	CC	O	and	_	0	SENT_94	[p7l966t2643r1105b2713],
12	hence	RB	O	hence	advmod	13	SENT_94	[p7l1174t2644r1388b2713],
13	metabolize	VBZ	O	metabolize	rcmod	2	SENT_94	[p7l1459t2644r1873b2713],
14	drugs	NNS	O	drug	dobj	13	SENT_94	[p7l1945t2643r2152b2732],
15	more	RBR	O	more	advmod	16	SENT_94	[p7l7t2777r200b2820],
16	rapidly	RB	O	rapidly	advmod	13	SENT_94	[p7l253t2750r545b2839],
17	,	,	O	,	_	0	SENT_94	[p7l253t2750r545b2839],
18	are	VBP	O	be	auxpass	19	SENT_94	[p7l601t2777r714b2820],
19	expected	VBN	O	expect	_	0	SENT_94	[p7l767t2750r1101b2839],
20	to	TO	O	to	aux	21	SENT_94	[p7l1152t2769r1227b2820],
21	require	VB	O	require	xcomp	19	SENT_94	[p7l1279t2754r1547b2839],
22	a	DT	O	a	det	24	SENT_94	[p7l1601t2777r1639b2820],
23	higher	JJR	O	higher	amod	24	SENT_94	[p7l1692t2750r1932b2839],
24	dose	NN	O	dose	dobj	21	SENT_94	[p7l1984t2750r2151b2820],
25	than	IN	O	than	_	0	SENT_94	[p7l6t2856r176b2926],
26	the	DT	O	the	det	28	SENT_94	[p7l229t2856r344b2926],
27	other	JJ	O	other	amod	28	SENT_94	[p7l401t2856r599b2926],
28	groups	NNS	O	group	prep_than	21	SENT_94	[p7l653t2883r910b2945],
29	to	TO	O	to	aux	30	SENT_94	[p7l965t2875r1039b2926],
30	achieve	VB	O	achieve	xcomp	21	SENT_94	[p7l1096t2856r1374b2926],
31	the	DT	O	the	det	33	SENT_94	[p7l1428t2856r1543b2926],
32	optimal	JJ	O	optimal	amod	33	SENT_94	[p7l1599t2856r1892b2945],
33	effect	NN	O	effect	nsubj	34	SENT_94	[p7l1948t2856r2153b2926],
34	form	VBP	O	form	ccomp	30	SENT_94	[p7l7t2961r191b3031],
35	the	DT	O	the	det	36	SENT_94	[p7l254t2962r369b3031],
36	drug	NN	O	drug	dobj	34	SENT_94	[p7l436t2962r629b3050],
37	.	.	O	.	_	0	SENT_94	[p7l436t2962r629b3050],

1	Indeed	RB	O	indeed	advmod	8	SENT_95	[p7l696t2962r974b3047],
2	,	,	O	,	_	0	SENT_95	[p7l696t2962r974b3047],
3	patients	NNS	O	patient	nsubj	8	SENT_95	[p7l1039t2966r1338b3050],
4	in	IN	O	in	_	0	SENT_95	[p7l1403t2966r1474b3030],
5	the	DT	O	the	det	7	SENT_95	[p7l1536t2961r1651b3031],
6	UM	NNP	O	UM	nn	7	SENT_95	[p7l1714t2967r1866b3031],
7	group	NN	O	group	prep_in	3	SENT_95	[p7l1929t2988r2152b3050],
8	required	VBD	O	require	_	0	SENT_95	[p7l7t3068r326b3157],
9	a	DT	O	a	det	13	SENT_95	[p7l368t3095r406b3138],
10	higher	JJR	O	higher	dep	11	SENT_95	[p7l448t3068r688b3157],
11	average	JJ	O	average	amod	13	SENT_95	[p7l730t3095r1017b3156],
12	daily	JJ	SET	daily	amod	13	SENT_95	[p7l1061t3068r1246b3156],
13	dose	NN	O	dose	dobj	8	SENT_95	[p7l1287t3068r1454b3138],
14	of	IN	O	of	_	0	SENT_95	[p7l1497t3068r1576b3138],
15	137.5	CD	NUMBER	137.5	prep_of	13	SENT_95	[p7l1618t3073r1828b3138],
16	i	FW	O	i	nn	17	SENT_95	[p7l1880t3081r1934b3134],
17	88.4	FW	NUMBER	88.4	dep	15	SENT_95	[p7l1988t3073r2151b3138],

1	TABLE	NN	O	table	_	0	SENT_96	[p7l676t3233r794b3261],
2	1	CD	NUMBER	1	dep	1	SENT_96	[p7l810t3234r836b3261],
3	.	.	O	.	_	0	SENT_96	[p7l810t3234r836b3261],

1	Demographics	NNS	MISC	demographic	_	0	SENT_97	[p7l854t3232r1118b3269],
2	,	,	O	,	_	0	SENT_97	[p7l854t3232r1118b3269],
3	dosing	NN	O	dosing	conj_and	1	SENT_97	[p7l1135t3232r1262b3269],
4	,	,	O	,	_	0	SENT_97	[p7l1135t3232r1262b3269],
5	and	CC	O	and	_	0	SENT_97	[p7l1279t3232r1342b3261],
6	response	NN	O	response	conj_and	1	SENT_97	[p7l1360t3239r1521b3269],

1	UM	NNP	O	UM	nn	5	SENT_98	[p7l563t3320r605b3342],
2	EM	NNP	O	EM	nn	5	SENT_98	[p7l888t3320r927b3342],
3	IM	NNP	O	IM	nn	5	SENT_98	[p7l1208t3320r1237b3342],
4	PM	NNP	O	PM	nn	5	SENT_98	[p7l1518t3320r1558b3342],
5	Pvalue	NNP	O	Pvalue	_	0	SENT_98	[p7l1910t3320r2006b3342],

1	Number	NN	O	number	dep	125	SENT_99	[p7l50t3395r152b3422],
2	of	IN	O	of	dep	125	SENT_99	[p7l164t3395r188b3422],
3	patients	NNS	O	patient	dep	125	SENT_99	[p7l201t3395r302b3428],
4	2	CD	NUMBER	2	dep	125	SENT_99	[p7l577t3396r592b3422],
5	100	CD	NUMBER	100	dep	125	SENT_99	[p7l885t3396r932b3422],
6	14	CD	NUMBER	14	dep	125	SENT_99	[p7l1208t3396r1239b3422],
7	11	CD	NUMBER	11	dep	125	SENT_99	[p7l1523t3396r1549b3422],
8	Sex	NN	O	sex	dep	125	SENT_99	[p7l50t3437r96b3464],
9	(	NN	O	(	dep	125	SENT_99	[p7l109t3437r173b3470],
10	M/F	NN	O	m/f	dep	125	SENT_99	[p7l109t3437r173b3470],
11	)	CD	NUMBER	)	dep	125	SENT_99	[p7l109t3437r173b3470],
12	2/0	CD	NUMBER	2/0	dep	125	SENT_99	[p7l564t3437r605b3464],
13	59/40	CD	NUMBER	59/40	dep	125	SENT_99	[p7l870t3437r946b3464],
14	6/8	CD	NUMBER	6/8	dep	125	SENT_99	[p7l1202t3437r1244b3464],
15	8/3	CD	NUMBER	8/3	dep	125	SENT_99	[p7l1517t3437r1559b3464],
16	Age	NNP	O	Age	dep	125	SENT_99	[p7l48t3478r97b3511],
17	(	CD	NUMBER	(	dep	125	SENT_99	[p7l111t3478r139b3511],
18	y	NN	O	y	dep	125	SENT_99	[p7l111t3478r139b3511],
19	)	CD	NUMBER	)	dep	125	SENT_99	[p7l111t3478r139b3511],
20	:	:	O	:	_	0	SENT_99	[p7l157t3482r178b3503],
21	SD	NN	O	sd	dep	125	SENT_99	[p7l195t3478r230b3505],
22	35.6	CD	NUMBER	35.6	dep	125	SENT_99	[p7l508t3479r565b3505],
23	:	:	O	:	_	0	SENT_99	[p7l582t3482r603b3503],
24	26.0	CD	NUMBER	26.0	dep	125	SENT_99	[p7l621t3479r678b3505],
25	41.0	CD	NUMBER	41.0	dep	125	SENT_99	[p7l823t3478r880b3505],
26	:	:	O	:	_	0	SENT_99	[p7l897t3482r919b3503],
27	23.6	CD	NUMBER	23.6	dep	125	SENT_99	[p7l936t3479r993b3505],
28	50.5	CD	NUMBER	50.5	dep	125	SENT_99	[p7l1138t3479r1195b3505],
29	:	:	O	:	_	0	SENT_99	[p7l1212t3482r1234b3503],
30	22.8	CD	NUMBER	22.8	dep	125	SENT_99	[p7l1251t3479r1308b3505],
31	48.9	CD	NUMBER	48.9	dep	125	SENT_99	[p7l1453t3479r1510b3505],
32	:	:	O	:	_	0	SENT_99	[p7l1527t3482r1549b3503],
33	21.6	CD	NUMBER	21.6	dep	125	SENT_99	[p7l1566t3478r1623b3505],
34	NS	NN	O	n	dep	125	SENT_99	[p7l1941t3478r1976b3505],
35	Total	JJ	O	total	dep	125	SENT_99	[p7l49t3520r110b3546],
36	daily	JJ	SET	daily	dep	125	SENT_99	[p7l124t3520r183b3552],
37	dose	NN	O	dose	dep	125	SENT_99	[p7l196t3520r256b3546],
38	:	:	O	:	_	0	SENT_99	[p7l272t3523r294b3545],
39	SD	NN	O	sd	dep	125	SENT_99	[p7l311t3519r346b3546],
40	137.5	CD	NUMBER	137.5	dep	125	SENT_99	[p7l492t3520r565b3546],
41	:	:	O	:	_	0	SENT_99	[p7l582t3523r603b3545],
42	88.4	CD	NUMBER	88.4	dep	125	SENT_99	[p7l621t3520r678b3546],
43	64.9	CD	NUMBER	64.9	dep	125	SENT_99	[p7l823t3520r881b3546],
44	:	:	O	:	_	0	SENT_99	[p7l897t3523r919b3545],
45	35.5	CD	NUMBER	35.5	dep	125	SENT_99	[p7l936t3520r993b3546],
46	66.1	CD	NUMBER	66.1	dep	125	SENT_99	[p7l1138t3520r1190b3546],
47	:	:	O	:	_	0	SENT_99	[p7l1212t3523r1234b3545],
48	23.7	CD	NUMBER	23.7	dep	125	SENT_99	[p7l1251t3520r1308b3546],
49	40.9	CD	NUMBER	40.9	dep	125	SENT_99	[p7l1453t3520r1510b3546],
50	:	:	O	:	_	0	SENT_99	[p7l1527t3523r1549b3545],
51	19.4	CD	NUMBER	19.4	dep	125	SENT_99	[p7l1567t3520r1623b3546],
52	.370	CD	NUMBER	.370	dep	125	SENT_99	[p7l1848t3520r1904b3546],
53	(	CD	NUMBER	(	dep	125	SENT_99	[p7l1918t3520r1967b3552],
54	UM	NN	O	um	dep	125	SENT_99	[p7l1918t3520r1967b3552],
55	vs	CC	O	vs	dep	125	SENT_99	[p7l1980t3526r2008b3546],
56	PM	NN	O	pm	dep	125	SENT_99	[p7l2022t3520r2069b3552],
57	)	NN	O	)	dep	125	SENT_99	[p7l2022t3520r2069b3552],
58	Titration	NN	O	titration	dep	125	SENT_99	[p7l49t3561r152b3588],
59	(	CD	NUMBER	(	dep	125	SENT_99	[p7l167t3561r220b3594],
60	wk	NN	DURATION	wk	dep	125	SENT_99	[p7l167t3561r220b3594],
61	)	NN	O	)	dep	125	SENT_99	[p7l167t3561r220b3594],
62	:	:	O	:	_	0	SENT_99	[p7l237t3565r258b3586],
63	SD	NN	O	sd	dep	125	SENT_99	[p7l275t3561r310b3588],
64	8.0	CD	NUMBER	8.0	dep	125	SENT_99	[p7l525t3561r565b3588],
65	:	:	O	:	_	0	SENT_99	[p7l582t3565r603b3586],
66	o.o	CD	NUMBER	o.o	dep	125	SENT_99	[p7l621t3561r661b3588],
67	3.3	CD	NUMBER	3.3	dep	125	SENT_99	[p7l840t3561r880b3588],
68	:	:	O	:	_	0	SENT_99	[p7l897t3565r919b3586],
69	1.2	CD	NUMBER	1.2	dep	125	SENT_99	[p7l937t3561r976b3587],
70	4.4	CD	NUMBER	4.4	dep	125	SENT_99	[p7l1155t3561r1196b3587],
71	:	:	O	:	_	0	SENT_99	[p7l1212t3565r1234b3586],
72	2.3	CD	NUMBER	2.3	dep	125	SENT_99	[p7l1251t3561r1291b3588],
73	3.0	CD	NUMBER	3.0	dep	125	SENT_99	[p7l1470t3561r1510b3588],
74	:	:	O	:	_	0	SENT_99	[p7l1527t3565r1549b3586],
75	0.8	CD	NUMBER	0.8	dep	125	SENT_99	[p7l1566t3561r1606b3588],
76	<	JJR	O	<	dep	125	SENT_99	[p7l1770t3568r1792b3589],
77	.01	CD	NUMBER	.01	dep	125	SENT_99	[p7l1809t3561r1843b3588],
78	(	NN	O	(	dep	125	SENT_99	[p7l1862t3561r1897b3594],
79	all	DT	O	all	dep	125	SENT_99	[p7l1862t3561r1897b3594],
80	groups	NNS	O	group	dep	125	SENT_99	[p7l1911t3567r1998b3594],
81	compared	VBN	O	compare	dep	125	SENT_99	[p7l2012t3561r2148b3594],
82	)	CD	NUMBER	)	dep	125	SENT_99	[p7l2012t3561r2148b3594],
83	Treatment	NN	O	treatment	dep	125	SENT_99	[p7l49t3602r181b3628],
84	response	NN	O	response	dep	125	SENT_99	[p7l194t3608r310b3634],
85	1.5	CD	NUMBER	1.5	dep	125	SENT_99	[p7l526t3602r565b3628],
86	:	:	O	:	_	0	SENT_99	[p7l582t3606r604b3627],
87	0.7	CD	NUMBER	0.7	dep	125	SENT_99	[p7l621t3603r661b3628],
88	1.5	CD	NUMBER	1.5	dep	125	SENT_99	[p7l841t3602r880b3628],
89	:	:	O	:	_	0	SENT_99	[p7l897t3606r919b3627],
90	0.7	CD	NUMBER	0.7	dep	125	SENT_99	[p7l936t3603r976b3628],
91	2.1	CD	NUMBER	2.1	dep	125	SENT_99	[p7l1155t3602r1191b3628],
92	:	:	O	:	_	0	SENT_99	[p7l1212t3606r1234b3627],
93	1.4	CD	NUMBER	1.4	dep	125	SENT_99	[p7l1252t3602r1291b3628],
94	1.4	CD	NUMBER	1.4	dep	125	SENT_99	[p7l1471t3602r1511b3628],
95	:	:	O	:	_	0	SENT_99	[p7l1527t3606r1549b3627],
96	0.5	CD	NUMBER	0.5	dep	125	SENT_99	[p7l1566t3603r1606b3628],
97	NS	NN	O	n	dep	125	SENT_99	[p7l1941t3602r1976b3628],
98	Adverse	JJ	O	adverse	dep	125	SENT_99	[p7l48t3644r151b3670],
99	events	NNS	O	event	dep	125	SENT_99	[p7l165t3644r254b3675],
100	,	,	O	,	_	0	SENT_99	[p7l165t3644r254b3675],
101	n	NN	O	n	dep	125	SENT_99	[p7l270t3649r283b3670],
102	(	CD	PERCENT	(	dep	125	SENT_99	[p7l298t3644r339b3676],
103	%	NN	PERCENT	%	dep	125	SENT_99	[p7l298t3644r339b3676],
104	)	CD	NUMBER	)	dep	125	SENT_99	[p7l298t3644r339b3676],
105	1	CD	NUMBER	1	dep	125	SENT_99	[p7l533t3644r542b3670],
106	(	NN	O	(	dep	125	SENT_99	[p7l561t3644r636b3676],
107	50	CD	PERCENT	50	dep	125	SENT_99	[p7l561t3644r636b3676],
108	%	NN	PERCENT	%	dep	125	SENT_99	[p7l561t3644r636b3676],
109	)	CD	NUMBER	)	dep	125	SENT_99	[p7l561t3644r636b3676],
110	54	CD	NUMBER	54	dep	125	SENT_99	[p7l848t3644r880b3670],
111	(	NN	O	(	dep	125	SENT_99	[p7l893t3644r968b3676],
112	54	CD	PERCENT	54	dep	125	SENT_99	[p7l893t3644r968b3676],
113	%	NN	PERCENT	%	dep	125	SENT_99	[p7l893t3644r968b3676],
114	)	CD	NUMBER	)	dep	125	SENT_99	[p7l893t3644r968b3676],
115	13	CD	NUMBER	13	dep	125	SENT_99	[p7l1142t3644r1173b3670],
116	(	NN	O	(	dep	125	SENT_99	[p7l1187t3644r1305b3676],
117	93.86	CD	PERCENT	93.86	dep	125	SENT_99	[p7l1187t3644r1305b3676],
118	%	NN	PERCENT	%	dep	125	SENT_99	[p7l1187t3644r1305b3676],
119	)	CD	NUMBER	)	dep	125	SENT_99	[p7l1187t3644r1305b3676],
120	13	CD	NUMBER	13	dep	125	SENT_99	[p7l1457t3644r1488b3670],
121	(	NN	O	(	dep	125	SENT_99	[p7l1502t3644r1620b3676],
122	118.1	CD	PERCENT	118.1	dep	125	SENT_99	[p7l1502t3644r1620b3676],
123	%	NN	PERCENT	%	dep	125	SENT_99	[p7l1502t3644r1620b3676],
124	)	CD	NUMBER	)	dep	125	SENT_99	[p7l1502t3644r1620b3676],
125	NS	NN	O	n	_	0	SENT_99	[p7l1941t3643r1976b3670],

1	UM	RB	O	um	dep	4	SENT_100	[p7l51t3728r101b3753],
2	,	,	O	,	_	0	SENT_100	[p7l51t3728r101b3753],
3	ultrarapid	JJ	O	ultrarapid	amod	4	SENT_100	[p7l115t3728r235b3755],
4	metabolizer	NN	O	metabolizer	_	0	SENT_100	[p7l248t3728r405b3753],
5	;	:	O	;	_	0	SENT_100	[p7l248t3728r405b3753],
6	EM	NNP	O	EM	dep	4	SENT_100	[p7l419t3728r466b3753],
7	,	,	O	,	_	0	SENT_100	[p7l419t3728r466b3753],
8	extensive	JJ	O	extensive	amod	9	SENT_100	[p7l479t3728r601b3749],
9	metabolizer	NN	O	metabolizer	appos	6	SENT_100	[p7l613t3728r769b3753],
10	;	:	O	;	_	0	SENT_100	[p7l613t3728r769b3753],
11	IM	NNP	O	IM	dep	6	SENT_100	[p7l784t3728r821b3753],
12	,	,	O	,	_	0	SENT_100	[p7l784t3728r821b3753],
13	intermediate	JJ	O	intermediate	amod	14	SENT_100	[p7l835t3728r995b3749],
14	metabolizer	NN	O	metabolizer	appos	11	SENT_100	[p7l1007t3728r1163b3753],
15	;	:	O	;	_	0	SENT_100	[p7l1007t3728r1163b3753],
16	PM	NNP	O	PM	dep	6	SENT_100	[p7l1177t3728r1225b3753],
17	,	,	O	,	_	0	SENT_100	[p7l1177t3728r1225b3753],
18	poor	JJ	O	poor	amod	19	SENT_100	[p7l1239t3733r1298b3755],
19	metabolizer	NN	O	metabolizer	appos	16	SENT_100	[p7l1310t3728r1466b3753],
20	;	:	O	;	_	0	SENT_100	[p7l1310t3728r1466b3753],
21	SD	NN	O	sd	dep	6	SENT_100	[p7l1479t3727r1523b3753],
22	,	,	O	,	_	0	SENT_100	[p7l1479t3727r1523b3753],
23	standard	JJ	O	standard	amod	24	SENT_100	[p7l1536t3728r1650b3749],
24	deviation	NN	O	deviation	appos	21	SENT_100	[p7l1662t3728r1785b3753],
25	;	:	O	;	_	0	SENT_100	[p7l1662t3728r1785b3753],
26	NS	NN	O	n	dep	6	SENT_100	[p7l1799t3727r1843b3753],
27	,	,	O	,	_	0	SENT_100	[p7l1799t3727r1843b3753],
28	nonsignificant	JJ	O	nonsignificant	appos	26	SENT_100	[p7l1857t3727r2042b3755],
29	.	.	O	.	_	0	SENT_100	[p7l1857t3727r2042b3755],

1	212	CD	NUMBER	212	num	3	SENT_101	[p8l50t68r103b92],
2	Movement	NNP	O	Movement	nn	3	SENT_101	[p8l196t74r311b92],
3	Disorders	NNPS	O	Disorders	_	0	SENT_101	[p8l320t74r426b95],
4	,	,	O	,	_	0	SENT_101	[p8l320t74r426b95],
5	Vol	NNP	O	Vol	appos	3	SENT_101	[p8l436t74r475b92],
6	.	.	O	.	_	0	SENT_101	[p8l436t74r475b92],

1	28	CD	NUMBER	28	_	0	SENT_102	[p8l486t74r518b95],
2	,	,	O	,	_	0	SENT_102	[p8l486t74r518b95],
3	No.	NN	O	no.	appos	1	SENT_102	[p8l529t74r564b92],
4	2	CD	NUMBER	2	num	3	SENT_102	[p8l576t74r594b95],
5	,	,	O	,	_	0	SENT_102	[p8l576t74r594b95],
6	2013	CD	DATE	2013	appos	1	SENT_102	[p8l605t74r658b92],

1	%	NN	O	%	nn	2	SENT_103	[p8l30t170r158b253],
2	ANALYSIS	NN	O	analysis	_	0	SENT_103	[p8l209t197r457b219],
3	OF	IN	O	of	_	0	SENT_103	[p8l504t197r557b219],
4	CYP2D6	NNP	O	CYP2D6	nn	5	SENT_103	[p8l604t197r794b219],
5	GENOTYPE	NNP	O	GENOTYPE	prep_of	2	SENT_103	[p8l841t197r1107b219],
6	AND	CC	O	and	_	0	SENT_103	[p8l1153t198r1245b219],
7	RESPONSE	NNP	O	RESPONSE	conj_and	5	SENT_103	[p8l1293t197r1558b219],
8	TO	TO	O	to	infmod	5	SENT_103	[p8l1604t197r1659b219],
9	TETRABENAZINE	NNP	O	TETRABENAZINE	dep	2	SENT_103	[p8l1704t198r2129b219],

1	I	PRP	O	I	dep	3	SENT_104	[p8l625t1132r628b1142],
2	I	PRP	O	I	dep	1	SENT_104	[p8l889t1132r894b1142],
3	’	VBP	O	’	_	0	SENT_104	[p8l889t1132r894b1142],
4	‘	CD	NUMBER	‘	nsubj	5	SENT_104	[p8l1151t1132r1158b1142],
5	I	PRP	O	I	xcomp	3	SENT_104	[p8l1151t1132r1158b1142],
6	I	PRP	O	I	nsubj	3	SENT_104	[p8l1419t1132r1422b1142],

1	Sedation	NNP	O	Sedation	nn	5	SENT_105	[p8l444t1155r545b1177],
2	Parkinsonism	NNP	O	Parkinsonism	nn	5	SENT_105	[p8l678t1155r837b1177],
3	Akathisia	NNP	O	Akathisia	nn	5	SENT_105	[p8l968t1155r1080b1177],
4	Insomnia	NNP	O	Insomnia	nn	5	SENT_105	[p8l1234t1156r1343b1177],
5	Suicidality	NNP	O	Suicidality	_	0	SENT_105	[p8l1491t1155r1616b1183],

1	FIG	NNP	O	FIG	_	0	SENT_106	[p8l32t1201r92b1226],
2	.	.	O	.	_	0	SENT_106	[p8l32t1201r92b1226],

1	2	LS	NUMBER	2	_	0	SENT_107	[p8l111t1202r136b1226],
2	.	.	O	.	_	0	SENT_107	[p8l111t1202r136b1226],

1	Frequenc	NN	O	frequenc	_	0	SENT_108	[p8l154t1203r283b1232],
2	f	SYM	O	f	dep	1	SENT_108	[p8l331t1203r340b1226],
3	adverse	JJ	O	adverse	amod	4	SENT_108	[p8l354t1203r463b1226],
4	effects	NNS	O	effect	dep	2	SENT_108	[p8l478t1203r570b1226],
5	(	CD	PERCENT	(	num	6	SENT_108	[p8l585t1202r630b1232],
6	%	NN	PERCENT	%	dep	2	SENT_108	[p8l585t1202r630b1232],
7	)	CD	NUMBER	)	dep	1	SENT_108	[p8l585t1202r630b1232],
8	by	IN	O	by	_	0	SENT_108	[p8l646t1203r678b1232],
9	genotype	NN	O	genotype	nn	11	SENT_108	[p8l693t1204r822b1232],
10	(	CD	NUMBER	(	num	11	SENT_108	[p8l837t1202r900b1232],
11	UM	NNP	O	UM	prep_by	7	SENT_108	[p8l837t1202r900b1232],
12	,	,	O	,	_	0	SENT_108	[p8l837t1202r900b1232],
13	ultrarapid	JJ	O	ultrarapid	amod	14	SENT_108	[p8l917t1203r1046b1232],
14	metabolizer	NN	O	metabolizer	appos	11	SENT_108	[p8l1063t1203r1230b1230],
15	;	:	O	;	_	0	SENT_108	[p8l1063t1203r1230b1230],
16	EM	NNP	O	EM	dep	7	SENT_108	[p8l1248t1203r1299b1230],
17	,	,	O	,	_	0	SENT_108	[p8l1248t1203r1299b1230],
18	extensive	JJ	O	extensive	amod	19	SENT_108	[p8l1315t1203r1446b1226],
19	metabolizer	NN	O	metabolizer	appos	16	SENT_108	[p8l1461t1203r1629b1230],
20	;	:	O	;	_	0	SENT_108	[p8l1461t1203r1629b1230],
21	IM	NNP	O	IM	dep	7	SENT_108	[p8l1647t1203r1686b1230],
22	,	,	O	,	_	0	SENT_108	[p8l1647t1203r1686b1230],
23	intermediate	JJ	O	intermediate	amod	24	SENT_108	[p8l1704t1203r1875b1226],
24	metabolizer	NN	O	metabolizer	appos	21	SENT_108	[p8l1890t1203r2058b1230],
25	;	:	O	;	_	0	SENT_108	[p8l1890t1203r2058b1230],
26	PM	NNP	O	PM	dep	7	SENT_108	[p8l2075t1203r2127b1230],
27	,	,	O	,	_	0	SENT_108	[p8l2075t1203r2127b1230],
28	poor	JJ	O	poor	amod	30	SENT_108	[p8l32t1244r95b1268],
29	metabolizer	NN	O	metabolizer	nn	30	SENT_108	[p8l108t1238r284b1268],
30	)	NN	O	)	appos	26	SENT_108	[p8l108t1238r284b1268],
31	.	.	O	.	_	0	SENT_108	[p8l108t1238r284b1268],

1	ere	NN	O	ere	nsubj	5	SENT_109	[p8l334t1244r377b1262],
2	was	VBD	O	be	cop	5	SENT_109	[p8l390t1244r445b1262],
3	no	DT	O	no	det	5	SENT_109	[p8l460t1244r492b1262],
4	statistical	JJ	O	statistical	amod	5	SENT_109	[p8l506t1238r635b1262],
5	significance	NN	O	significance	_	0	SENT_109	[p8l649t1238r813b1268],
6	between	IN	O	between	_	0	SENT_109	[p8l828t1238r945b1262],
7	the	DT	O	the	det	8	SENT_109	[p8l958t1238r1002b1262],
8	groups	NNS	O	group	prep_between	5	SENT_109	[p8l1015t1244r1111b1268],
9	in	IN	O	in	_	0	SENT_109	[p8l1125t1238r1146b1262],
10	the	DT	O	the	det	11	SENT_109	[p8l1159t1238r1203b1262],
11	frequency	NN	O	frequency	prep_in	8	SENT_109	[p8l1215t1238r1354b1268],
12	of	IN	O	of	_	0	SENT_109	[p8l1367t1238r1394b1262],
13	adverse	JJ	O	adverse	amod	14	SENT_109	[p8l1406t1238r1515b1262],
14	effects	NNS	O	effect	prep_of	11	SENT_109	[p8l1529t1238r1629b1262],
15	.	.	O	.	_	0	SENT_109	[p8l1529t1238r1629b1262],

1	[	NN	O	[	nn	3	SENT_110	[p8l1645t1238r1727b1268],
2	Color	NN	O	color	nn	3	SENT_110	[p8l1645t1238r1727b1268],
3	figure	NN	O	figure	nsubjpass	6	SENT_110	[p8l1739t1238r1816b1268],
4	can	MD	O	can	aux	6	SENT_110	[p8l1830t1244r1878b1262],
5	be	VB	O	be	auxpass	6	SENT_110	[p8l1894t1238r1926b1262],
6	viewed	VBN	O	view	_	0	SENT_110	[p8l1940t1238r2036b1262],
7	in	IN	O	in	_	0	SENT_110	[p8l2052t1238r2072b1262],
8	the	DT	O	the	det	10	SENT_110	[p8l2086t1238r2129b1262],
9	online	JJ	O	online	amod	10	SENT_110	[p8l7t1286r181b1335],
10	issue	NN	O	issue	prep_in	6	SENT_110	[p8l210t1286r374b1344],
11	,	,	O	,	_	0	SENT_110	[p8l210t1286r374b1344],
12	which	WDT	O	which	nsubj	14	SENT_110	[p8l403t1286r575b1335],
13	is	VBZ	O	be	cop	14	SENT_110	[p8l605t1286r647b1335],
14	available	JJ	O	available	rcmod	10	SENT_110	[p8l674t1286r933b1335],
15	at	IN	O	at	prep	14	SENT_110	[p8l958t1289r1012b1335],
16	wi	FW	O	wi	nn	21	SENT_110	[p8l1037t1285r1727b1348],
17	|	FW	O	|	nn	21	SENT_110	[p8l1037t1285r1727b1348],
18	eyon	FW	O	eyon	nn	21	SENT_110	[p8l1037t1285r1727b1348],
19	|	FW	O	|	nn	21	SENT_110	[p8l1037t1285r1727b1348],
20	ine	FW	O	ine	nn	21	SENT_110	[p8l1037t1285r1727b1348],
21	|	FW	O	|	attr	14	SENT_110	[p8l1037t1285r1727b1348],
22	ibrary.com	FW	O	ibrary.com	dep	21	SENT_110	[p8l1037t1285r1727b1348],
23	.	.	O	.	_	0	SENT_110	[p8l1037t1285r1727b1348],
24	]	SYM	O	]	dep	21	SENT_110	[p8l1037t1285r1727b1348],

1	mg	NN	O	mg	nsubj	44	SENT_111	[p8l7t1485r145b1546],
2	,	,	O	,	_	0	SENT_111	[p8l7t1485r145b1546],
3	compared	VBN	O	compare	nsubj	44	SENT_111	[p8l181t1457r560b1546],
4	with	IN	O	with	pcomp	3	SENT_111	[p8l593t1457r765b1527],
5	the	DT	O	the	det	6	SENT_111	[p8l798t1457r913b1527],
6	EM	NNP	O	EM	pobj	4	SENT_111	[p8l949t1463r1112b1543],
7	,	,	O	,	_	0	SENT_111	[p8l949t1463r1112b1543],
8	IM	NNP	O	IM	conj_and	1	SENT_111	[p8l1149t1463r1287b1543],
9	,	,	O	,	_	0	SENT_111	[p8l1149t1463r1287b1543],
10	and	CC	O	and	_	0	SENT_111	[p8l1325t1457r1464b1527],
11	PM	NN	O	pm	nn	12	SENT_111	[p8l1498t1463r1633b1527],
12	groups	NNS	O	group	conj_and	1	SENT_111	[p8l1667t1484r1948b1546],
13	,	,	O	,	_	0	SENT_111	[p8l1667t1484r1948b1546],
14	who	WP	O	who	nsubj	15	SENT_111	[p8l1983t1457r2148b1527],
15	required	VBD	O	require	rcmod	12	SENT_111	[p8l7t1564r325b1652],
16	a	DT	O	a	det	18	SENT_111	[p8l375t1591r413b1634],
17	daily	JJ	SET	daily	amod	18	SENT_111	[p8l464t1563r649b1652],
18	dose	NN	O	dose	dobj	15	SENT_111	[p8l698t1563r865b1634],
19	of	IN	O	of	_	0	SENT_111	[p8l916t1563r995b1634],
20	64.9	CD	NUMBER	64.9	num	22	SENT_111	[p8l1041t1568r1205b1634],
21	:	:	O	:	_	0	SENT_111	[p8l1265t1576r1318b1630],
22	35.5	CD	NUMBER	35.5	prep_of	18	SENT_111	[p8l1378t1568r1567b1649],
23	,	,	O	,	_	0	SENT_111	[p8l1378t1568r1567b1649],
24	66.1	CD	NUMBER	66.1	appos	22	SENT_111	[p8l1621t1568r1781b1634],
25	i	FW	O	i	dep	24	SENT_111	[p8l1844t1576r1898b1630],
26	23.7	CD	NUMBER	23.7	amod	12	SENT_111	[p8l1955t1568r2147b1649],
27	,	,	O	,	_	0	SENT_111	[p8l1955t1568r2147b1649],
28	and	CC	O	and	cc	29	SENT_111	[p8l9t1669r147b1739],
29	40.9	CD	NUMBER	40.9	appos	12	SENT_111	[p8l190t1673r357b1739],
30	:	:	O	:	_	0	SENT_111	[p8l412t1682r465b1735],
31	19.4	CD	NUMBER	19.4	num	32	SENT_111	[p8l523t1673r685b1739],
32	mg	NN	O	mg	dep	29	SENT_111	[p8l730t1696r868b1758],
33	,	,	O	,	_	0	SENT_111	[p8l730t1696r868b1758],
34	respectively	RB	O	respectively	advmod	32	SENT_111	[p8l915t1669r1381b1758],
35	,	,	O	,	_	0	SENT_111	[p8l915t1669r1381b1758],
36	but	CC	O	but	prep	12	SENT_111	[p8l1430t1669r1553b1739],
37	this	DT	O	this	det	38	SENT_111	[p8l1596t1669r1730b1739],
38	difference	NN	O	difference	dep	36	SENT_111	[p8l1777t1669r2149b1739],
39	was	VBD	O	be	cop	44	SENT_111	[p8l6t1803r151b1845],
40	not	RB	O	not	neg	44	SENT_111	[p8l185t1795r310b1845],
41	statistically	RB	O	statistically	advmod	42	SENT_111	[p8l344t1775r773b1864],
42	signiﬁcant	JJ	O	signiﬁcant	amod	44	SENT_111	[p8l807t1775r1195b1864],
43	(	NN	O	(	nn	44	SENT_111	[p8l1233t1780r1309b1861],
44	P	NN	O	p	_	0	SENT_111	[p8l1233t1780r1309b1861],
45	=	JJ	O	=	amod	44	SENT_111	[p8l1345t1810r1405b1832],
46	.37	CD	NUMBER	.37	tmod	45	SENT_111	[p8l1444t1780r1561b1845],
47	when	WRB	O	when	advmod	48	SENT_111	[p8l1591t1775r1798b1845],
48	comparing	VBG	O	compare	advcl	44	SENT_111	[p8l1831t1802r2148b1864, p8l8t1886r123b1970],
49	UMs	NNS	O	um	dobj	48	SENT_111	[p8l155t1887r340b1951],
50	and	CC	O	and	_	0	SENT_111	[p8l377t1882r515b1952],
51	PMs	NNS	O	pm	dobj	48	SENT_111	[p8l550t1886r769b1967],
52	)	CD	NUMBER	)	tmod	48	SENT_111	[p8l550t1886r769b1967],
53	.	.	O	.	_	0	SENT_111	[p8l550t1886r769b1967],

1	Consistent	JJ	O	consistent	nsubj	31	SENT_112	[p8l812t1886r1212b1952],
2	with	IN	O	with	_	0	SENT_112	[p8l1245t1882r1417b1951],
3	the	DT	O	the	det	4	SENT_112	[p8l1450t1881r1565b1951],
4	need	NN	O	need	prep_with	1	SENT_112	[p8l1601t1882r1776b1952],
5	for	IN	O	for	_	0	SENT_112	[p8l1811t1881r1920b1951],
6	more	JJR	O	more	amod	7	SENT_112	[p8l1954t1909r2148b1952],
7	time	NN	O	time	prep_for	4	SENT_112	[p8l7t1991r172b2057],
8	to	TO	O	to	aux	9	SENT_112	[p8l213t2006r288b2057],
9	titrate	VB	O	titrate	infmod	4	SENT_112	[p8l330t1991r559b2057],
10	to	TO	O	to	_	0	SENT_112	[p8l601t2006r676b2057],
11	a	DT	O	a	det	13	SENT_112	[p8l720t2014r758b2057],
12	higher	JJR	O	higher	amod	13	SENT_112	[p8l800t1987r1040b2076],
13	dose	NN	O	dose	prep_to	9	SENT_112	[p8l1083t1987r1273b2072],
14	,	,	O	,	_	0	SENT_112	[p8l1083t1987r1273b2072],
15	the	DT	O	the	det	16	SENT_112	[p8l1316t1987r1431b2057],
16	duration	NN	O	duration	appos	13	SENT_112	[p8l1475t1987r1802b2057],
17	of	IN	O	of	_	0	SENT_112	[p8l1845t1987r1922b2057],
18	titration	NN	O	titration	prep_of	16	SENT_112	[p8l1959t1991r2148b2057, p8l7t2098r157b2163],
19	to	TO	O	to	_	0	SENT_112	[p8l190t2113r265b2163],
20	the	DT	O	the	det	22	SENT_112	[p8l300t2093r415b2163],
21	optimal	JJ	O	optimal	amod	22	SENT_112	[p8l452t2093r744b2182],
22	dose	NN	O	dose	prep_to	9	SENT_112	[p8l781t2093r948b2163],
23	was	VBD	O	be	cop	31	SENT_112	[p8l982t2121r1127b2163],
24	signiﬁcantly	RB	O	signiﬁcantly	advmod	31	SENT_112	[p8l1164t2093r1622b2182],
25	longer	RBR	O	longer	advmod	31	SENT_112	[p8l1656t2093r1895b2182],
26	in	IN	O	in	_	0	SENT_112	[p8l1929t2098r2000b2162],
27	the	DT	O	the	det	29	SENT_112	[p8l2034t2093r2148b2163],
28	UM	NNP	O	UM	nn	29	SENT_112	[p8l6t2205r157b2269],
29	group	NN	O	group	prep_in	25	SENT_112	[p8l198t2226r420b2288],
30	(	CD	NUMBER	(	number	31	SENT_112	[p8l467t2204r532b2285],
31	8	CD	NUMBER	8	dep	48	SENT_112	[p8l467t2204r532b2285],
32	i	FW	O	i	dep	31	SENT_112	[p8l587t2212r640b2266],
33	o	NN	O	o	nn	34	SENT_112	[p8l692t2204r733b2269],
34	Weeks	NNS	DURATION	week	nsubj	35	SENT_112	[p8l775t2199r1030b2285],
35	)	VBP	O	)	rcmod	31	SENT_112	[p8l775t2199r1030b2285],
36	compared	VBN	O	compare	_	0	SENT_112	[p8l1077t2200r1455b2288],
37	with	IN	O	with	prepc_compared_with	35	SENT_112	[p8l1495t2200r1666b2269],
38	each	DT	O	each	pobj	35	SENT_112	[p8l1708t2199r1877b2270],
39	of	IN	O	of	_	0	SENT_112	[p8l1920t2199r1998b2269],
40	the	DT	O	the	det	43	SENT_112	[p8l2034t2200r2148b2269],
41	EM	NNP	O	EM	nn	43	SENT_112	[p8l8t2310r170b2390],
42	,	,	O	,	_	0	SENT_112	[p8l8t2310r170b2390],
43	IM	NNP	O	IM	prep_of	38	SENT_112	[p8l214t2310r352b2390],
44	,	,	O	,	_	0	SENT_112	[p8l214t2310r352b2390],
45	and	CC	O	and	_	0	SENT_112	[p8l399t2305r537b2375],
46	PM	NN	O	pm	nn	47	SENT_112	[p8l579t2310r714b2374],
47	groups	NNS	O	group	conj_and	43	SENT_112	[p8l756t2332r1013b2394],
48	(	VBP	O	(	_	0	SENT_112	[p8l1061t2309r1201b2390],
49	3.3	CD	NUMBER	3.3	num	51	SENT_112	[p8l1061t2309r1201b2390],
50	:	:	O	:	_	0	SENT_112	[p8l1256t2318r1310b2371],
51	1.2	CD	NUMBER	1.2	dobj	48	SENT_112	[p8l1367t2310r1503b2390],
52	,	,	O	,	_	0	SENT_112	[p8l1367t2310r1503b2390],
53	4.4	CD	NUMBER	4.4	num	55	SENT_112	[p8l1547t2309r1666b2375],
54	:	:	O	:	_	0	SENT_112	[p8l1718t2318r1772b2371],
55	2.3	CD	NUMBER	2.3	dobj	48	SENT_112	[p8l1822t2310r1965b2390],
56	,	,	O	,	_	0	SENT_112	[p8l1822t2310r1965b2390],
57	and	CC	O	and	_	0	SENT_112	[p8l2011t2305r2150b2375],
58	3.0	CD	NUMBER	3.0	dobj	48	SENT_112	[p8l9t2416r125b2481],
59	i	FW	O	i	nsubj	48	SENT_112	[p8l173t2424r227b2478],
60	0.8	CD	DURATION	0.8	num	61	SENT_112	[p8l276t2416r389b2481],
61	Weeks	NNS	DURATION	week	dep	59	SENT_112	[p8l430t2411r684b2497],
62	,	,	O	,	_	0	SENT_112	[p8l430t2411r684b2497],
63	respectively	RB	O	respectively	advmod	59	SENT_112	[p8l725t2411r1192b2500],
64	,	,	O	,	_	0	SENT_112	[p8l725t2411r1192b2500],
65	P	NN	O	p	dep	66	SENT_112	[p8l1233t2417r1284b2480],
66	<	JJR	O	<	appos	59	SENT_112	[p8l1327t2431r1382b2483],
67	.01	CD	NUMBER	.01	num	68	SENT_112	[p8l1429t2416r1595b2497],
68	)	NN	O	)	dep	66	SENT_112	[p8l1429t2416r1595b2497],
69	.	.	O	.	_	0	SENT_112	[p8l1429t2416r1595b2497],

1	Although	IN	O	although	mark	13	SENT_113	[p8l1638t2411r1996b2500],
2	the	DT	O	the	det	4	SENT_113	[p8l2034t2411r2148b2481],
3	clinical	JJ	O	clinical	amod	4	SENT_113	[p8l7t2517r277b2588],
4	response	NN	O	response	nsubj	13	SENT_113	[p8l315t2544r642b2606],
5	in	IN	O	in	_	0	SENT_113	[p8l681t2522r752b2586],
6	the	DT	O	the	det	10	SENT_113	[p8l789t2518r904b2588],
7	UM	NNP	O	UM	nn	10	SENT_113	[p8l942t2523r1093b2587],
8	and	CC	O	and	_	0	SENT_113	[p8l1132t2518r1270b2587],
9	EM	NNP	O	EM	nn	10	SENT_113	[p8l1308t2523r1448b2587],
10	groups	NNS	O	group	prep_in	4	SENT_113	[p8l1486t2544r1743b2606],
11	was	VBD	O	be	cop	13	SENT_113	[p8l1780t2545r1926b2587],
12	similar	JJ	O	similar	amod	13	SENT_113	[p8l1966t2522r2148b2587, p8l8t2623r108b2693],
13	(	NN	O	(	advcl	29	SENT_113	[p8l145t2627r287b2708],
14	1.5	CD	NUMBER	1.5	num	13	SENT_113	[p8l145t2627r287b2708],
15	i	FW	O	i	dep	13	SENT_113	[p8l332t2636r386b2689],
16	0.7	CD	NUMBER	0.7	num	17	SENT_113	[p8l430t2627r599b2708],
17	)	NN	O	)	dep	15	SENT_113	[p8l430t2627r599b2708],
18	,	,	O	,	_	0	SENT_113	[p8l430t2627r599b2708],
19	the	DT	O	the	det	20	SENT_113	[p8l635t2623r749b2693],
20	response	NN	O	response	nsubj	29	SENT_113	[p8l783t2650r1110b2712],
21	was	VBD	O	be	cop	29	SENT_113	[p8l1143t2650r1289b2693],
22	best	RB	O	best	advmod	29	SENT_113	[p8l1325t2623r1474b2693],
23	in	IN	O	in	_	0	SENT_113	[p8l1507t2627r1577b2692],
24	the	DT	O	the	det	26	SENT_113	[p8l1609t2623r1724b2693],
25	PM	NN	O	pm	nn	26	SENT_113	[p8l1759t2628r1893b2692],
26	group	NN	O	group	prep_in	22	SENT_113	[p8l1926t2650r2149b2712],
27	(	CD	NUMBER	(	number	28	SENT_113	[p8l12t2734r155b2815],
28	1.4	CD	NUMBER	1.4	num	29	SENT_113	[p8l12t2734r155b2815],
29	i	FW	O	i	_	0	SENT_113	[p8l212t2742r266b2796],
30	0.5	CD	NUMBER	0.5	num	31	SENT_113	[p8l324t2734r467b2815],
31	)	NN	O	)	rcmod	29	SENT_113	[p8l324t2734r467b2815],
32	and	CC	O	and	_	0	SENT_113	[p8l520t2729r659b2799],
33	signiﬁcantly	RB	O	signiﬁcantly	advmod	34	SENT_113	[p8l707t2729r1165b2818],
34	worse	JJR	O	worse	rcmod	29	SENT_113	[p8l1210t2757r1434b2799],
35	in	IN	O	in	_	0	SENT_113	[p8l1483t2734r1554b2798],
36	the	DT	O	the	det	38	SENT_113	[p8l1600t2729r1715b2799],
37	IM	NNP	O	IM	nn	38	SENT_113	[p8l1763t2735r1879b2799],
38	group	NN	O	group	prep_in	34	SENT_113	[p8l1926t2756r2149b2818],
39	when	WRB	O	when	advmod	31	SENT_113	[p8l6t2836r212b2905],
40	compared	VBN	O	compare	_	0	SENT_113	[p8l249t2835r628b2924],
41	with	IN	O	with	_	0	SENT_113	[p8l664t2836r835b2905],
42	the	DT	O	the	det	44	SENT_113	[p8l872t2836r986b2906],
43	EM	NNP	O	EM	nn	44	SENT_113	[p8l1026t2841r1166b2905],
44	group	NN	O	group	prep_compared_with	31	SENT_113	[p8l1203t2862r1425b2924],
45	(	CD	NUMBER	(	number	46	SENT_113	[p8l1469t2840r1607b2921],
46	2.1	CD	NUMBER	2.1	dep	44	SENT_113	[p8l1469t2840r1607b2921],
47	:	:	O	:	_	0	SENT_113	[p8l1660t2848r1714b2902],
48	1.4	CD	NUMBER	1.4	num	49	SENT_113	[p8l1766t2840r1878b2905],
49	VS	NN	O	v	dep	44	SENT_113	[p8l1916t2863r1991b2906],
50	1.5	CD	NUMBER	1.5	dep	49	SENT_113	[p8l2036t2841r2146b2905],
51	i	FW	O	i	dep	44	SENT_113	[p8l15t2954r69b3007],
52	0.7	CD	NUMBER	0.7	dep	51	SENT_113	[p8l113t2946r253b3026],
53	,	,	O	,	_	0	SENT_113	[p8l113t2946r253b3026],
54	P	NN	O	p	appos	44	SENT_113	[p8l289t2946r340b3010],
55	=	JJ	O	=	amod	57	SENT_113	[p8l376t2976r436b2998],
56	.013	CD	NUMBER	.013	tmod	55	SENT_113	[p8l476t2945r691b3026],
57	)	NN	O	)	dep	54	SENT_113	[p8l476t2945r691b3026],
58	.	.	O	.	_	0	SENT_113	[p8l476t2945r691b3026],

1	The	DT	O	the	det	2	SENT_114	[p8l728t2941r873b3011],
2	difference	NN	O	difference	nsubjpass	7	SENT_114	[p8l909t2941r1281b3011],
3	in	IN	O	in	_	0	SENT_114	[p8l1316t2945r1387b3009],
4	treatment	NN	O	treatment	nn	5	SENT_114	[p8l1419t2960r1789b3011],
5	response	NN	O	response	prep_in	2	SENT_114	[p8l1821t2968r2148b3030],
6	is	VBZ	O	be	auxpass	7	SENT_114	[p8l8t3052r62b3117],
7	difﬁcult	VBN	O	difﬁcult	_	0	SENT_114	[p8l112t3047r405b3117],
8	to	TO	O	to	aux	9	SENT_114	[p8l452t3067r526b3117],
9	interpret	VB	O	interpret	xcomp	7	SENT_114	[p8l576t3052r905b3136],
10	because	IN	O	because	mark	13	SENT_114	[p8l954t3047r1245b3117],
11	patients	NNS	O	patient	nsubjpass	13	SENT_114	[p8l1294t3052r1593b3136],
12	were	VBD	O	be	auxpass	13	SENT_114	[p8l1641t3075r1821b3117],
13	titrated	VBN	O	titrate	advcl	9	SENT_114	[p8l1869t3047r2149b3117],
14	to	TO	O	to	_	0	SENT_114	[p8l7t3173r81b3223],
15	their	PRP$	O	they	poss	17	SENT_114	[p8l124t3153r299b3224],
16	optimal	JJ	O	optimal	amod	17	SENT_114	[p8l343t3154r635b3242],
17	dose	NN	O	dose	prep_to	13	SENT_114	[p8l679t3153r869b3239],
18	,	,	O	,	_	0	SENT_114	[p8l679t3153r869b3239],
19	deﬁned	VBN	O	deﬁned	partmod	17	SENT_114	[p8l916t3153r1188b3224],
20	as	IN	O	as	_	0	SENT_114	[p8l1232t3181r1304b3223],
21	that	DT	O	that	prep_as	19	SENT_114	[p8l1347t3153r1498b3224],
22	which	WDT	O	which	nsubj	23	SENT_114	[p8l1538t3154r1769b3223],
23	provided	VBD	O	provide	rcmod	21	SENT_114	[p8l1811t3153r2150b3242],
24	the	DT	O	the	det	27	SENT_114	[p8l7t3259r121b3329],
25	best	JJS	O	best	dep	26	SENT_114	[p8l165t3259r313b3329],
26	possible	JJ	O	possible	amod	27	SENT_114	[p8l353t3259r656b3348],
27	efﬁcacy	NN	O	efﬁcacy	dobj	23	SENT_114	[p8l698t3259r983b3347],
28	with	IN	O	with	_	0	SENT_114	[p8l1022t3259r1194b3329],
29	no	DT	O	no	amod	33	SENT_114	[p8l1234t3286r1328b3329],
30	or	CC	O	or	_	0	SENT_114	[p8l1371t3286r1450b3329],
31	tolerable	JJ	O	tolerable	amod	33	SENT_114	[p8l1490t3259r1823b3329],
32	adverse	JJ	O	adverse	amod	33	SENT_114	[p8l1867t3259r2148b3329],
33	effects	NNS	O	effect	prep_with	23	SENT_114	[p8l8t3353r311b3451],
34	,7	CD	NUMBER	,7	tmod	23	SENT_114	[p8l8t3353r311b3451],
35	rather	RB	O	rather	_	0	SENT_114	[p8l350t3365r580b3435],
36	than	IN	O	than	_	0	SENT_114	[p8l621t3365r791b3435],
37	to	TO	O	to	_	0	SENT_114	[p8l832t3385r907b3435],
38	a	DT	O	a	det	40	SENT_114	[p8l951t3392r989b3435],
39	ﬁxed	JJ	O	ﬁxed	amod	40	SENT_114	[p8l1032t3365r1216b3435],
40	dose	NN	O	dose	prep_to	23	SENT_114	[p8l1259t3365r1447b3435],
41	.	.	O	.	_	0	SENT_114	[p8l1259t3365r1447b3435],

1	Interestingly	RB	O	interestingly	advmod	6	SENT_115	[p8l1494t3365r1990b3454],
2	,	,	O	,	_	0	SENT_115	[p8l1494t3365r1990b3454],
3	the	DT	O	the	det	5	SENT_115	[p8l2034t3365r2148b3435],
4	PM	NN	O	pm	nn	5	SENT_115	[p8l7t3477r142b3541],
5	patients	NNS	O	patient	nsubj	6	SENT_115	[p8l179t3476r478b3560],
6	had	VBD	O	have	_	0	SENT_115	[p8l517t3471r657b3541],
7	the	DT	O	the	det	9	SENT_115	[p8l694t3471r808b3542],
8	best	JJS	O	best	amod	9	SENT_115	[p8l849t3472r998b3542],
9	response	NN	O	response	dobj	6	SENT_115	[p8l1035t3498r1361b3560],
10	(	CD	NUMBER	(	number	11	SENT_115	[p8l1406t3476r1549b3557],
11	1.4	CD	NUMBER	1.4	dep	9	SENT_115	[p8l1406t3476r1549b3557],
12	:	:	O	:	_	0	SENT_115	[p8l1597t3484r1651b3538],
13	0.5	CD	NUMBER	0.5	number	14	SENT_115	[p8l1700t3476r1814b3541],
14	)	CD	NUMBER	)	dep	9	SENT_115	[p8l1826t3476r1842b3557],
15	despite	IN	O	despite	_	0	SENT_115	[p8l1886t3471r2148b3560],
16	having	VBG	O	have	prepc_despite	14	SENT_115	[p8l7t3577r262b3666],
17	the	DT	O	the	det	21	SENT_115	[p8l305t3577r420b3647],
18	smallest	JJS	O	smallest	amod	21	SENT_115	[p8l468t3577r771b3647],
19	mean	NN	O	mean	nn	21	SENT_115	[p8l816t3604r1021b3647],
20	daily	JJ	SET	daily	amod	21	SENT_115	[p8l1067t3577r1253b3666],
21	dose	NN	O	dose	dobj	16	SENT_115	[p8l1298t3577r1489b3662],
22	,	,	O	,	_	0	SENT_115	[p8l1298t3577r1489b3662],
23	possibly	RB	O	possibly	advmod	9	SENT_115	[p8l1535t3577r1845b3666],
24	reﬂect	JJ	O	reﬂect	amod	26	SENT_115	[p8l1890t3577r2148b3647],
25	—	NN	O	—	nn	26	SENT_115	[p8l1890t3577r2148b3647],
26	ing	NN	O	ing	dep	9	SENT_115	[p8l8t3688r123b3772],
27	slower	JJR	O	slower	amod	29	SENT_115	[p8l157t3683r405b3753],
28	tetrabenazine	NN	O	tetrabenazine	nn	29	SENT_115	[p8l438t3683r951b3753],
29	metabolism	NN	O	metabolism	dep	26	SENT_115	[p8l986t3683r1450b3753],
30	.	.	O	.	_	0	SENT_115	[p8l986t3683r1450b3753],

1	The	DT	O	the	det	6	SENT_116	[p9l86t16r231b85],
2	most	RBS	O	most	advmod	4	SENT_116	[p9l268t35r453b85],
3	commonly	RB	O	commonly	advmod	4	SENT_116	[p9l488t15r893b104],
4	reported	VBN	O	report	amod	6	SENT_116	[p9l928t16r1251b104],
5	side	JJ	O	side	amod	6	SENT_116	[p9l1289t16r1431b85],
6	effects	NNS	O	effect	nsubj	10	SENT_116	[p9l1469t15r1707b85],
7	of	IN	O	of	_	0	SENT_116	[p9l1746t15r1824b85],
8	tetrabenazine	NN	O	tetrabenazine	prep_of	6	SENT_116	[p9l1854t16r2148b85, p9l7t125r250b191],
9	are	VBP	O	be	cop	10	SENT_116	[p9l290t148r403b191],
10	drowsiness	NN	O	drowsiness	_	0	SENT_116	[p9l443t121r881b206],
11	,	,	O	,	_	0	SENT_116	[p9l443t121r881b206],
12	akathisia	NN	O	akathisium	conj_and	10	SENT_116	[p9l922t121r1287b206],
13	,	,	O	,	_	0	SENT_116	[p9l922t121r1287b206],
14	parkinsonism	NN	O	parkinsonism	conj_and	10	SENT_116	[p9l1326t121r1865b210],
15	,	,	O	,	_	0	SENT_116	[p9l1326t121r1865b210],
16	confusion	NN	O	confusion	conj_and	10	SENT_116	[p9l1906t121r2148b191, p9l9t232r184b313],
17	,	,	O	,	_	0	SENT_116	[p9l1906t121r2148b191, p9l9t232r184b313],
18	anxiety	NN	O	anxiety	conj_and	10	SENT_116	[p9l223t232r523b316],
19	,	,	O	,	_	0	SENT_116	[p9l223t232r523b316],
20	insomnia	NN	O	insomnia	conj_and	10	SENT_116	[p9l561t232r931b313],
21	,	,	O	,	_	0	SENT_116	[p9l561t232r931b313],
22	irritability	NN	O	irritability	conj_and	10	SENT_116	[p9l969t227r1380b316],
23	,	,	O	,	_	0	SENT_116	[p9l969t227r1380b316],
24	and	CC	O	and	_	0	SENT_116	[p9l1419t227r1557b297],
25	depression	NN	O	depression	conj_and	10	SENT_116	[p9l1593t214r2147b316],
26	.4	CD	NUMBER	.4	number	27	SENT_116	[p9l1593t214r2147b316],
27	’18	CD	NUMBER	’18	num	29	SENT_116	[p9l1593t214r2147b316],
28	Side	NN	O	side	nn	29	SENT_116	[p9l9t334r161b403],
29	effects	NNS	O	effect	nsubj	34	SENT_116	[p9l208t333r446b403],
30	of	IN	O	of	_	0	SENT_116	[p9l494t333r573b403],
31	tetrabenazine	NN	O	tetrabenazine	prep_of	29	SENT_116	[p9l612t334r1125b403],
32	are	VBP	O	be	cop	34	SENT_116	[p9l1173t361r1285b403],
33	dose	NN	O	dose	dep	34	SENT_116	[p9l1334t334r1500b403],
34	dependent	JJ	O	dependent	rcmod	10	SENT_116	[p9l1548t333r1962b422],
35	,	,	O	,	_	0	SENT_116	[p9l1548t333r1962b422],
36	and	CC	O	and	_	0	SENT_116	[p9l2011t333r2150b403],
37	no	DT	O	no	det	40	SENT_116	[p9l7t466r101b509],
38	permanent	JJ	O	permanent	amod	40	SENT_116	[p9l142t458r551b528],
39	adverse	JJ	O	adverse	amod	40	SENT_116	[p9l593t439r875b509],
40	effects	NNS	O	effect	nsubjpass	49	SENT_116	[p9l918t439r1156b509],
41	such	JJ	O	such	_	0	SENT_116	[p9l1200t439r1368b509],
42	as	IN	O	as	_	0	SENT_116	[p9l1410t466r1483b509],
43	tardive	JJ	O	tardive	amod	46	SENT_116	[p9l1525t439r1789b509],
44	dyskine	NN	O	dyskine	nn	46	SENT_116	[p9l1833t439r2148b527],
45	—	CD	NUMBER	—	num	46	SENT_116	[p9l1833t439r2148b527],
46	sia	NN	O	sium	prep_such_as	40	SENT_116	[p9l9t550r106b615],
47	have	VBP	O	have	aux	49	SENT_116	[p9l143t545r316b615],
48	been	VBN	O	be	auxpass	49	SENT_116	[p9l354t545r528b615],
49	reported	VBN	O	report	conj_and	10	SENT_116	[p9l563t545r906b634],
50	.	.	O	.	_	0	SENT_116	[p9l563t545r906b634],

1	The	DT	O	the	det	3	SENT_117	[p9l945t545r1090b615],
2	PM	NN	O	pm	nn	3	SENT_117	[p9l1126t551r1261b615],
3	group	NN	O	group	nsubj	4	SENT_117	[p9l1296t572r1519b634],
4	had	VBD	O	have	_	0	SENT_117	[p9l1556t545r1695b615],
5	the	DT	O	the	det	7	SENT_117	[p9l1729t545r1844b615],
6	highest	JJS	O	highest	amod	7	SENT_117	[p9l1881t545r2150b634],
7	rate	NN	O	rate	dobj	4	SENT_117	[p9l7t671r151b721],
8	of	IN	O	of	_	0	SENT_117	[p9l212t651r290b721],
9	adverse	JJ	O	adverse	amod	10	SENT_117	[p9l346t652r628b722],
10	effects	NNS	O	effect	prep_of	7	SENT_117	[p9l688t651r926b721],
11	(	VBP	O	(	rcmod	7	SENT_117	[p9l991t656r1349b737],
12	118.1	CD	PERCENT	118.1	num	13	SENT_117	[p9l991t656r1349b737],
13	%	NN	PERCENT	%	dobj	11	SENT_117	[p9l991t656r1349b737],
14	)	CD	NUMBER	)	tmod	11	SENT_117	[p9l991t656r1349b737],
15	despite	IN	O	despite	_	0	SENT_117	[p9l1414t651r1675b740],
16	taking	VBG	O	take	prepc_despite	11	SENT_117	[p9l1736t652r1976b740],
17	the	DT	O	the	det	20	SENT_117	[p9l2034t652r2148b721],
18	smallest	JJS	O	smallest	amod	20	SENT_117	[p9l9t757r312b827],
19	daily	JJ	SET	daily	amod	20	SENT_117	[p9l357t757r541b845],
20	dose	NN	O	dose	dobj	16	SENT_117	[p9l586t757r776b842],
21	,	,	O	,	_	0	SENT_117	[p9l586t757r776b842],
22	possibly	RB	O	possibly	advmod	4	SENT_117	[p9l822t757r1131b846],
23	because	IN	O	because	_	0	SENT_117	[p9l1176t757r1467b827],
24	of	IN	O	of	_	0	SENT_117	[p9l1514t757r1592b827],
25	a	DT	O	a	det	27	SENT_117	[p9l1633t784r1671b827],
26	slower	JJR	O	slower	amod	27	SENT_117	[p9l1717t757r1965b827],
27	metabolism	NN	O	metabolism	prep_because_of	4	SENT_117	[p9l2009t784r2148b827, p9l7t863r336b933],
28	and	CC	O	and	_	0	SENT_117	[p9l373t863r512b933],
29	higher	JJR	O	higher	amod	31	SENT_117	[p9l547t863r786b952],
30	serum	NN	O	serum	nn	31	SENT_117	[p9l824t891r1051b933],
31	concentration	NN	O	concentration	prep_because_of	4	SENT_117	[p9l1087t868r1615b933],
32	of	IN	O	of	_	0	SENT_117	[p9l1652t863r1730b933],
33	tetrabenazine	NN	O	tetrabenazine	prep_of	31	SENT_117	[p9l1760t863r2148b933, p9l7t974r156b1039],
34	and	CC	O	and	_	0	SENT_117	[p9l202t970r341b1039],
35	its	PRP$	O	its	poss	36	SENT_117	[p9l385t974r468b1039],
36	metabolites	NNS	O	metabolite	prep_of	31	SENT_117	[p9l513t970r972b1039],
37	.	.	O	.	_	0	SENT_117	[p9l513t970r972b1039],

1	Similarly	RB	O	similarly	advmod	13	SENT_118	[p9l1022t969r1383b1058],
2	,	,	O	,	_	0	SENT_118	[p9l1022t969r1383b1058],
3	despite	IN	O	despite	_	0	SENT_118	[p9l1430t969r1692b1058],
4	having	VBG	O	have	prepc_despite	13	SENT_118	[p9l1736t970r1991b1058],
5	the	DT	O	the	det	8	SENT_118	[p9l2034t970r2148b1039],
6	highest	JJS	O	highest	amod	8	SENT_118	[p9l7t1075r277b1164],
7	daily	JJ	SET	daily	amod	8	SENT_118	[p9l331t1075r516b1163],
8	dose	NN	O	dose	dobj	4	SENT_118	[p9l570t1075r761b1160],
9	,	,	O	,	_	0	SENT_118	[p9l570t1075r761b1160],
10	the	DT	O	the	det	12	SENT_118	[p9l816t1075r931b1145],
11	UM	NN	O	um	nn	12	SENT_118	[p9l985t1080r1136b1145],
12	patients	NNS	O	patient	nsubj	13	SENT_118	[p9l1189t1079r1487b1164],
13	had	VBD	O	have	_	0	SENT_118	[p9l1542t1075r1682b1145],
14	the	DT	O	the	det	16	SENT_118	[p9l1735t1075r1849b1145],
15	lowest	JJS	O	lowest	amod	16	SENT_118	[p9l1905t1075r2150b1145],
16	rate	NN	O	rate	dobj	13	SENT_118	[p9l7t1201r151b1251],
17	of	IN	O	of	_	0	SENT_118	[p9l199t1181r277b1251],
18	adverse	JJ	O	adverse	amod	19	SENT_118	[p9l319t1181r601b1251],
19	effects	NNS	O	effect	nsubj	20	SENT_118	[p9l648t1181r886b1251],
20	(	VBP	O	(	prep_of	16	SENT_118	[p9l938t1185r1199b1267],
21	50	CD	PERCENT	50	num	22	SENT_118	[p9l938t1185r1199b1267],
22	%	NN	PERCENT	%	dobj	20	SENT_118	[p9l938t1185r1199b1267],
23	)	CD	NUMBER	)	tmod	20	SENT_118	[p9l938t1185r1199b1267],
24	,	,	O	,	_	0	SENT_118	[p9l938t1185r1199b1267],
25	presumably	RB	O	presumably	advmod	20	SENT_118	[p9l1247t1181r1690b1270],
26	because	IN	O	because	_	0	SENT_118	[p9l1737t1181r2028b1251],
27	of	IN	O	of	_	0	SENT_118	[p9l2076t1181r2154b1251],
28	their	PRP$	O	they	poss	30	SENT_118	[p9l7t1288r182b1359],
29	fast	JJ	O	fast	amod	30	SENT_118	[p9l248t1288r383b1359],
30	metabolism	NN	O	metabolism	prep_because_of	20	SENT_118	[p9l449t1288r893b1359],
31	and	CC	O	and	_	0	SENT_118	[p9l960t1288r1099b1359],
32	lower	JJR	O	lower	amod	33	SENT_118	[p9l1165t1289r1380b1359],
33	concentrations	NNS	O	concentration	conj_and	20	SENT_118	[p9l1446t1293r2007b1359],
34	of	IN	O	of	_	0	SENT_118	[p9l2076t1288r2154b1359],
35	tetrabenazine	NN	O	tetrabenazine	prep_of	33	SENT_118	[p9l6t1395r519b1465],
36	and	CC	O	and	_	0	SENT_118	[p9l579t1395r717b1465],
37	its	PRP$	O	its	poss	38	SENT_118	[p9l774t1400r858b1465],
38	metabolites	NNS	O	metabolite	conj_and	35	SENT_118	[p9l915t1395r1375b1465],
39	.	.	O	.	_	0	SENT_118	[p9l915t1395r1375b1465],

1	Thus	RB	O	thus	advmod	5	SENT_119	[p9l1436t1395r1648b1481],
2	,	,	O	,	_	0	SENT_119	[p9l1436t1395r1648b1481],
3	side	JJ	O	side	amod	4	SENT_119	[p9l1708t1395r1851b1465],
4	effects	NNS	O	effect	nsubj	5	SENT_119	[p9l1910t1395r2148b1465],
5	reported	VBD	O	report	_	0	SENT_119	[p9l7t1502r330b1590],
6	per	IN	O	per	mark	9	SENT_119	[p9l382t1528r503b1590],
7	patient	NN	O	patient	nsubj	9	SENT_119	[p9l554t1506r821b1590],
8	were	VBD	O	be	cop	9	SENT_119	[p9l871t1529r1051b1571],
9	more	JJR	O	more	advcl	5	SENT_119	[p9l1105t1529r1299b1571],
10	frequent	JJ	O	frequent	amod	9	SENT_119	[p9l1353t1501r1671b1590],
11	in	IN	O	in	_	0	SENT_119	[p9l1724t1506r1795b1570],
12	the	DT	O	the	det	14	SENT_119	[p9l1846t1501r1961b1571],
13	PM	NNP	O	PM	nn	14	SENT_119	[p9l2014t1507r2150b1571],
14	group	NN	O	group	prep_in	9	SENT_119	[p9l7t1634r253b1696],
15	,	,	O	,	_	0	SENT_119	[p9l7t1634r253b1696],
16	followed	VBN	O	follow	_	0	SENT_119	[p9l301t1607r635b1677],
17	by	IN	O	by	prepc_followed_by	9	SENT_119	[p9l682t1607r771b1695],
18	the	DT	O	the	det	21	SENT_119	[p9l814t1607r929b1677],
19	IM	NNP	O	IM	nn	21	SENT_119	[p9l975t1612r1113b1692],
20	,	,	O	,	_	0	SENT_119	[p9l975t1612r1113b1692],
21	EM	NNP	O	EM	pobj	9	SENT_119	[p9l1162t1612r1324b1692],
22	,	,	O	,	_	0	SENT_119	[p9l1162t1612r1324b1692],
23	and	CC	O	and	_	0	SENT_119	[p9l1373t1607r1511b1677],
24	UM	NN	O	um	nn	25	SENT_119	[p9l1555t1612r1706b1677],
25	groups	NNS	O	group	conj_and	21	SENT_119	[p9l1751t1634r2031b1696],
26	,	,	O	,	_	0	SENT_119	[p9l1751t1634r2031b1696],
27	in	IN	O	in	_	0	SENT_119	[p9l2080t1611r2150b1675],
28	that	DT	O	that	det	29	SENT_119	[p9l6t1713r157b1783],
29	order	NN	O	order	prep_in	9	SENT_119	[p9l202t1713r426b1783],
30	.	.	O	.	_	0	SENT_119	[p9l202t1713r426b1783],

1	Although	IN	O	although	mark	5	SENT_120	[p9l473t1713r832b1802],
2	these	DT	O	these	det	3	SENT_120	[p9l875t1713r1064b1783],
3	results	NNS	O	result	nsubj	5	SENT_120	[p9l1109t1713r1352b1783],
4	are	VBP	O	be	cop	5	SENT_120	[p9l1399t1741r1512b1783],
5	consistent	JJ	O	consistent	advcl	18	SENT_120	[p9l1557t1718r1935b1783],
6	with	IN	O	with	_	0	SENT_120	[p9l1978t1713r2150b1783],
7	our	PRP$	O	we	poss	8	SENT_120	[p9l8t1848r136b1890],
8	expectation	NN	O	expectation	prep_with	5	SENT_120	[p9l193t1825r635b1909],
9	based	VBN	O	base	partmod	8	SENT_120	[p9l693t1820r905b1890],
10	on	IN	O	on	_	0	SENT_120	[p9l962t1848r1056b1890],
11	the	DT	O	the	det	13	SENT_120	[p9l1111t1821r1225b1890],
12	pharmacogenetic	JJ	O	pharmacogenetic	amod	13	SENT_120	[p9l1281t1821r1934b1909],
13	proﬁles	NNS	O	proﬁles	prep_on	9	SENT_120	[p9l1990t1847r2148b1909, p9l7t1926r174b2011],
14	,	,	O	,	_	0	SENT_120	[p9l1990t1847r2148b1909, p9l7t1926r174b2011],
15	they	PRP	O	they	nsubj	18	SENT_120	[p9l210t1926r371b2014],
16	did	VBD	O	do	aux	18	SENT_120	[p9l406t1926r525b1996],
17	not	RB	O	not	neg	18	SENT_120	[p9l558t1945r683b1996],
18	reach	VB	O	reach	_	0	SENT_120	[p9l716t1926r921b1996],
19	statistical	JJ	O	statistical	amod	20	SENT_120	[p9l956t1926r1314b1996],
20	signiﬁcance	NN	O	signiﬁcance	dobj	18	SENT_120	[p9l1350t1926r1807b2014],
21	.	.	O	.	_	0	SENT_120	[p9l1350t1926r1807b2014],

1	Many	JJ	O	many	amod	2	SENT_121	[p9l87t2038r312b2121],
2	studies	NNS	O	study	nsubj	4	SENT_121	[p9l374t2032r630b2102],
3	have	VBP	O	have	aux	4	SENT_121	[p9l692t2032r865b2102],
4	shown	VBN	O	show	_	0	SENT_121	[p9l929t2032r1176b2102],
5	that	IN	O	that	complm	10	SENT_121	[p9l1236t2032r1387b2102],
6	cytochrome	NN	O	cytochrome	nn	8	SENT_121	[p9l1447t2032r1893b2121],
7	P450	NN	O	p450	nn	8	SENT_121	[p9l1956t2037r2148b2102],
8	polymorphisms	NNS	O	polymorphism	nsubj	10	SENT_121	[p9l6t2139r597b2227],
9	may	MD	O	may	aux	10	SENT_121	[p9l645t2166r806b2227],
10	explain	VB	O	explain	ccomp	4	SENT_121	[p9l853t2138r1131b2227],
11	the	DT	O	the	det	16	SENT_121	[p9l1178t2138r1292b2208],
12	marked	JJ	O	marked	amod	16	SENT_121	[p9l1340t2138r1629b2208],
13	interindivid	NN	O	interindivid	nn	16	SENT_121	[p9l1677t2138r2149b2209],
14	—	NN	O	—	nn	16	SENT_121	[p9l1677t2138r2149b2209],
15	ual	JJ	O	ual	amod	16	SENT_121	[p9l7t2244r121b2314],
16	variability	NN	O	variability	dobj	10	SENT_121	[p9l193t2244r584b2332],
17	of	IN	O	of	_	0	SENT_121	[p9l657t2244r735b2314],
18	drug	NN	O	drug	nn	19	SENT_121	[p9l804t2244r977b2332],
19	response	NN	O	response	prep_of	16	SENT_121	[p9l1048t2230r1567b2333],
20	.	.	O	.	_	0	SENT_121	[p9l1048t2230r1567b2333],

1	“’	NN	O	“’	nsubj	12	SENT_122	[p9l1048t2230r1567b2333],
2	19	CD	NUMBER	19	num	1	SENT_122	[p9l1048t2230r1567b2333],
3	The	DT	O	the	det	4	SENT_122	[p9l1640t2244r1784b2314],
4	rate	NN	O	rate	dep	1	SENT_122	[p9l1857t2263r2001b2314],
5	of	IN	O	of	_	0	SENT_122	[p9l2076t2244r2154b2314],
6	metabolism	NN	O	metabolism	prep_of	1	SENT_122	[p9l7t2350r451b2420],
7	for	IN	O	for	_	0	SENT_122	[p9l508t2350r618b2420],
8	a	DT	O	a	det	10	SENT_122	[p9l677t2378r715b2420],
9	certain	JJ	O	certain	amod	10	SENT_122	[p9l773t2355r1034b2420],
10	drug	NN	O	drug	prep_for	6	SENT_122	[p9l1092t2350r1264b2439],
11	can	MD	O	can	aux	12	SENT_122	[p9l1322t2378r1453b2420],
12	differ	VB	O	differ	_	0	SENT_122	[p9l1512t2350r1715b2420],
13	1000-fold	RB	O	1000-fold	advmod	12	SENT_122	[p9l1778t2350r2150b2420],
14	between	IN	O	between	_	0	SENT_122	[p9l9t2457r322b2526],
15	phenotypes	NNS	O	phenotype	prep_between	12	SENT_122	[p9l387t2457r841b2545],
16	.	.	O	.	_	0	SENT_122	[p9l387t2457r841b2545],

1	Thus	RB	O	thus	advmod	24	SENT_123	[p9l911t2456r1123b2542],
2	,	,	O	,	_	0	SENT_123	[p9l911t2456r1123b2542],
3	the	DT	O	the	det	4	SENT_123	[p9l1192t2456r1306b2526],
4	dosing	NN	O	dosing	nsubj	24	SENT_123	[p9l1376t2457r1623b2545],
5	required	VBN	O	require	partmod	4	SENT_123	[p9l1689t2457r2008b2545],
6	to	TO	O	to	aux	7	SENT_123	[p9l2074t2476r2148b2526],
7	achieve	VB	O	achieve	xcomp	5	SENT_123	[p9l8t2562r285b2632],
8	the	DT	O	the	det	11	SENT_123	[p9l328t2562r442b2632],
9	same	JJ	O	same	amod	11	SENT_123	[p9l486t2589r673b2632],
10	plasma	NN	O	plasma	nn	11	SENT_123	[p9l715t2562r983b2651],
11	levels	NNS	O	level	dobj	7	SENT_123	[p9l1026t2562r1230b2632],
12	of	IN	O	of	_	0	SENT_123	[p9l1274t2562r1352b2632],
13	a	DT	O	a	det	14	SENT_123	[p9l1390t2589r1428b2632],
14	drug	NN	O	drug	prep_of	11	SENT_123	[p9l1472t2562r1644b2650],
15	metabolized	VBN	O	metabolize	partmod	14	SENT_123	[p9l1685t2562r2150b2632],
16	mainly	RB	O	mainly	advmod	15	SENT_123	[p9l7t2668r267b2757],
17	by	IN	O	by	_	0	SENT_123	[p9l312t2668r401b2757],
18	CYPZD6	NN	O	cypzd6	agent	15	SENT_123	[p9l448t2673r810b2754],
19	,	,	O	,	_	0	SENT_123	[p9l448t2673r810b2754],
20	such	JJ	O	such	_	0	SENT_123	[p9l858t2668r1027b2738],
21	as	IN	O	as	_	0	SENT_123	[p9l1072t2696r1144b2738],
22	nortriptyline	NN	O	nortriptyline	prep_such_as	4	SENT_123	[p9l1189t2668r1695b2757],
23	,	,	O	,	_	0	SENT_123	[p9l1189t2668r1695b2757],
24	differs	VBZ	O	differ	_	0	SENT_123	[p9l1743t2668r1979b2738],
25	10to	CD	NUMBER	10to	dobj	24	SENT_123	[p9l2031t2673r2148b2738, p9l6t2794r81b2844],
26	20-fold	JJ	O	20-fold	amod	25	SENT_123	[p9l119t2774r398b2844],
27	among	IN	O	among	_	0	SENT_123	[p9l437t2802r694b2863],
28	individuals	NNS	O	individual	prep_among	26	SENT_123	[p9l732t2761r1245b2844],
29	.	.	O	.	_	0	SENT_123	[p9l732t2761r1245b2844],

1	“	NN	O	“	nn	3	SENT_124	[p9l732t2761r1245b2844],
2	UM	NN	O	um	nn	3	SENT_124	[p9l1285t2780r1437b2844],
3	individuals	NNS	O	individual	nsubj	5	SENT_124	[p9l1474t2774r1891b2845],
4	might	MD	O	might	aux	5	SENT_124	[p9l1929t2775r2150b2863],
5	require	VB	O	require	_	0	SENT_124	[p9l7t2884r274b2969],
6	up	RP	O	up	dep	8	SENT_124	[p9l314t2906r407b2969],
7	to	TO	O	to	dep	8	SENT_124	[p9l444t2899r518b2950],
8	250	CD	PERCENT	250	num	9	SENT_124	[p9l556t2884r783b2950],
9	%	NN	PERCENT	%	dobj	5	SENT_124	[p9l556t2884r783b2950],
10	of	IN	O	of	_	0	SENT_124	[p9l829t2880r907b2950],
11	the	DT	O	the	det	13	SENT_124	[p9l939t2880r1053b2950],
12	usual	JJ	O	usual	amod	13	SENT_124	[p9l1092t2880r1290b2950],
13	dose	NN	O	dose	prep_of	9	SENT_124	[p9l1329t2880r1496b2950],
14	without	IN	O	without	_	0	SENT_124	[p9l1533t2880r1833b2950],
15	beneﬁt	NN	O	beneﬁt	prep_without	5	SENT_124	[p9l1872t2880r2147b2965],
16	,	,	O	,	_	0	SENT_124	[p9l1872t2880r2147b2965],
17	whereas	IN	O	whereas	mark	20	SENT_124	[p9l6t2986r314b3056],
18	PMs	NNS	O	pm	nsubj	20	SENT_124	[p9l361t2992r530b3056],
19	might	MD	O	might	aux	20	SENT_124	[p9l576t2986r796b3075],
20	develop	VB	O	develop	advcl	5	SENT_124	[p9l843t2986r1134b3075],
21	side	JJ	O	side	amod	22	SENT_124	[p9l1183t2986r1325b3056],
22	effects	NNS	O	effect	dobj	20	SENT_124	[p9l1373t2986r1611b3056],
23	at	IN	O	at	_	0	SENT_124	[p9l1659t3005r1729b3056],
24	a	DT	O	a	det	25	SENT_124	[p9l1775t3014r1813b3056],
25	dose	NN	O	dose	prep_at	20	SENT_124	[p9l1861t2986r2027b3056],
26	as	RB	O	as	quantmod	30	SENT_124	[p9l2076t3014r2149b3056],
27	low	JJ	O	low	quantmod	30	SENT_124	[p9l7t3094r148b3164],
28	as	IN	O	as	quantmod	30	SENT_124	[p9l182t3121r255b3164],
29	30	CD	PERCENT	30	number	30	SENT_124	[p9l292t3098r467b3164],
30	%	NN	PERCENT	%	num	25	SENT_124	[p9l292t3098r467b3164],
31	of	IN	O	of	_	0	SENT_124	[p9l509t3093r587b3164],
32	the	DT	O	the	det	33	SENT_124	[p9l616t3094r730b3164],
33	usual	JJ	O	usual	prep_of	25	SENT_124	[p9l766t3080r1059b3164],
34	.	.	O	.	_	0	SENT_124	[p9l766t3080r1059b3164],

1	“	NN	O	“	_	0	SENT_125	[p9l766t3080r1059b3164],

1	During	IN	O	during	_	0	SENT_126	[p10l88t28r357b112],
2	the	DT	DURATION	the	det	5	SENT_126	[p10l400t24r514b94],
3	past	JJ	DURATION	past	amod	5	SENT_126	[p10l559t43r715b113],
4	10	CD	DURATION	10	num	5	SENT_126	[p10l764t29r851b94],
5	years	NNS	NUMBER	year	prep_during	12	SENT_126	[p10l896t51r1089b112],
6	the	DT	O	the	det	8	SENT_126	[p10l1134t24r1249b94],
7	increased	VBN	O	increase	amod	8	SENT_126	[p10l1294t24r1648b94],
8	advances	NNS	O	advance	nsubj	12	SENT_126	[p10l1693t24r2034b94],
9	in	IN	O	in	_	0	SENT_126	[p10l2080t28r2150b92],
10	pharmacogenetics	NNS	O	pharmacogenetic	prep_in	8	SENT_126	[p10l6t130r692b219],
11	have	VBP	O	have	aux	12	SENT_126	[p10l742t130r916b200],
12	led	VBN	O	lead	_	0	SENT_126	[p10l966t130r1076b200],
13	some	DT	O	some	nsubj	15	SENT_126	[p10l1125t158r1317b200],
14	to	TO	O	to	aux	15	SENT_126	[p10l1366t150r1441b200],
15	suggest	VB	O	suggest	xcomp	12	SENT_126	[p10l1492t150r1764b219],
16	that	IN	O	that	complm	27	SENT_126	[p10l1812t130r1963b200],
17	systematic	JJ	O	systematic	amod	18	SENT_126	[p10l2011t158r2148b219, p10l6t241r287b306],
18	determination	NN	O	determination	nsubj	27	SENT_126	[p10l330t237r866b306],
19	of	IN	O	of	_	0	SENT_126	[p10l909t236r986b306],
20	the	DT	O	the	det	21	SENT_126	[p10l1022t237r1137b306],
21	genotype	NN	O	genotype	prep_of	18	SENT_126	[p10l1178t256r1522b325],
22	of	IN	O	of	_	0	SENT_126	[p10l1565t236r1643b306],
23	the	DT	O	the	det	25	SENT_126	[p10l1679t237r1793b306],
24	metabolizing	VBG	O	metabolize	amod	25	SENT_126	[p10l1835t236r2149b306, p10l7t342r212b430],
25	enzymes	NNS	O	enzyme	prep_of	21	SENT_126	[p10l254t368r571b430],
26	will	MD	O	will	aux	27	SENT_126	[p10l612t342r754b412],
27	improve	VB	O	improve	ccomp	15	SENT_126	[p10l796t346r1108b431],
28	the	DT	O	the	det	30	SENT_126	[p10l1149t342r1264b412],
29	clinical	JJ	O	clinical	amod	30	SENT_126	[p10l1305t342r1575b412],
30	efﬁcacy	NN	O	efﬁcacy	dobj	27	SENT_126	[p10l1618t342r1903b430],
31	of	IN	O	of	_	0	SENT_126	[p10l1945t342r2023b412],
32	all	DT	O	all	det	34	SENT_126	[p10l2060t342r2149b412],
33	drug	NN	O	drug	nn	34	SENT_126	[p10l8t448r181b537],
34	therapy	NN	O	therapy	prep_of	30	SENT_126	[p10l222t448r512b537],
35	by	IN	O	by	_	0	SENT_126	[p10l556t448r645b537],
36	10	CD	PERCENT	10	num	37	SENT_126	[p10l692t452r1096b519],
37	%	NN	PERCENT	%	prep_by	27	SENT_126	[p10l692t452r1096b519],
38	.	.	O	.	_	0	SENT_126	[p10l692t452r1096b519],

1	—	NN	O	—	_	0	SENT_127	[p10l692t452r1096b519],
2	.	.	O	.	_	0	SENT_127	[p10l692t452r1096b519],

1	20	CD	PERCENT	20	num	2	SENT_128	[p10l692t452r1096b519],
2	%	NN	PERCENT	%	_	0	SENT_128	[p10l692t452r1096b519],
3	and	CC	O	and	_	0	SENT_128	[p10l1147t448r1285b518],
4	reduce	VB	O	reduce	conj_and	2	SENT_128	[p10l1326t448r1575b518],
5	the	DT	O	the	det	6	SENT_128	[p10l1618t448r1732b518],
6	frequency	NN	O	frequency	dobj	4	SENT_128	[p10l1777t448r2150b537],
7	of	IN	O	of	_	0	SENT_128	[p10l8t554r86b624],
8	adverse	JJ	O	adverse	amod	9	SENT_128	[p10l124t555r405b624],
9	events	NNS	O	event	prep_of	6	SENT_128	[p10l447t574r680b624],
10	by	IN	O	by	_	0	SENT_128	[p10l723t554r812b643],
11	1O	CD	PERCENT	1o	num	12	SENT_128	[p10l858t541r1368b625],
12	%	NN	PERCENT	%	prep_by	4	SENT_128	[p10l858t541r1368b625],
13	.	.	O	.	_	0	SENT_128	[p10l858t541r1368b625],

1	—	NN	O	—	_	0	SENT_129	[p10l858t541r1368b625],
2	.	.	O	.	_	0	SENT_129	[p10l858t541r1368b625],

1	15	CD	PERCENT	15	num	2	SENT_130	[p10l858t541r1368b625],
2	%	NN	PERCENT	%	_	0	SENT_130	[p10l858t541r1368b625],
3	.14	CD	NUMBER	.14	nsubj	40	SENT_130	[p10l858t541r1368b625],
4	However	RB	O	however	advmod	3	SENT_130	[p10l1409t560r1780b640],
5	,	,	O	,	_	0	SENT_130	[p10l1409t560r1780b640],
6	with	IN	O	with	mark	13	SENT_130	[p10l1823t554r1994b624],
7	the	DT	O	the	det	8	SENT_130	[p10l2034t555r2148b624],
8	emergence	NN	O	emergence	nsubj	13	SENT_130	[p10l7t687r405b749],
9	of	IN	O	of	_	0	SENT_130	[p10l450t660r528b730],
10	pharmacogenetic	JJ	O	pharmacogenetic	amod	11	SENT_130	[p10l565t660r1217b749],
11	proﬁling	NN	O	proﬁling	prep_of	8	SENT_130	[p10l1260t660r1583b749],
12	has	VBZ	O	have	aux	13	SENT_130	[p10l1626t660r1749b730],
13	come	VBN	O	come	dep	3	SENT_130	[p10l1792t687r1991b730],
14	the	DT	O	the	det	15	SENT_130	[p10l2034t660r2148b730],
15	realization	NN	O	realization	dobj	13	SENT_130	[p10l7t766r411b836],
16	that	WDT	O	that	nsubj	18	SENT_130	[p10l445t766r596b836],
17	correctly	RB	O	correctly	advmod	18	SENT_130	[p10l630t766r966b855],
18	predicting	VBG	O	predict	rcmod	15	SENT_130	[p10l999t766r1383b855],
19	the	DT	O	the	det	20	SENT_130	[p10l1417t766r1532b836],
20	response	NN	O	response	dobj	18	SENT_130	[p10l1567t793r1918b855],
21	,	,	O	,	_	0	SENT_130	[p10l1567t793r1918b855],
22	dose	NN	O	dose	conj_or	20	SENT_130	[p10l1957t766r2147b852],
23	,	,	O	,	_	0	SENT_130	[p10l1957t766r2147b852],
24	or	CC	O	or	_	0	SENT_130	[p10l8t900r87b942],
25	adverse	JJ	O	adverse	amod	26	SENT_130	[p10l142t872r424b943],
26	effects	NNS	O	effect	conj_or	20	SENT_130	[p10l480t872r718b942],
27	related	VBN	O	relate	partmod	26	SENT_130	[p10l774t872r1034b942],
28	to	TO	O	to	_	0	SENT_130	[p10l1088t892r1162b942],
29	the	DT	O	the	det	30	SENT_130	[p10l1218t873r1332b942],
30	drug	NN	O	drug	prep_to	27	SENT_130	[p10l1390t872r1562b961],
31	based	VBN	O	base	partmod	30	SENT_130	[p10l1618t872r1830b942],
32	on	IN	O	on	_	0	SENT_130	[p10l1887t900r1980b942],
33	the	DT	O	the	det	36	SENT_130	[p10l2034t873r2148b942],
34	known	JJ	O	known	amod	36	SENT_130	[p10l7t978r271b1048],
35	CYPZD6	NN	O	cypzd6	nn	36	SENT_130	[p10l312t982r650b1048],
36	genotype	NN	O	genotype	prep_on	31	SENT_130	[p10l691t997r1034b1067],
37	may	MD	O	may	aux	40	SENT_130	[p10l1074t1005r1235b1066],
38	be	VB	O	be	cop	40	SENT_130	[p10l1276t978r1358b1048],
39	quite	RB	O	quite	advmod	40	SENT_130	[p10l1399t982r1586b1067],
40	difﬁcult	JJ	O	difﬁcult	rcmod	2	SENT_130	[p10l1628t978r1921b1048],
41	for	IN	O	for	_	0	SENT_130	[p10l1961t978r2070b1048],
42	a	DT	O	a	det	46	SENT_130	[p10l2110t1005r2148b1048],
43	given	VBN	O	give	amod	46	SENT_130	[p10l7t1089r207b1173],
44	individual	JJ	O	individual	amod	46	SENT_130	[p10l259t1071r740b1154],
45	.2	NN	NUMBER	.2	nn	46	SENT_130	[p10l259t1071r740b1154],
46	O	NN	O	o	prep_for	40	SENT_130	[p10l259t1071r740b1154],
47	Some	DT	O	some	det	48	SENT_130	[p10l795t1088r996b1154],
48	studies	NNS	O	study	nsubj	50	SENT_130	[p10l1050t1084r1306b1154],
49	have	VBP	O	have	aux	50	SENT_130	[p10l1359t1084r1532b1154],
50	suggested	VBN	O	suggest	rcmod	46	SENT_130	[p10l1586t1084r1949b1173],
51	that	IN	O	that	complm	61	SENT_130	[p10l1999t1084r2150b1154],
52	patients	NNS	O	patient	nsubj	61	SENT_130	[p10l6t1196r305b1280],
53	who	WP	O	who	nsubj	58	SENT_130	[p10l347t1191r512b1261],
54	are	VBP	O	be	cop	58	SENT_130	[p10l556t1219r669b1261],
55	poor	JJ	O	poor	amod	58	SENT_130	[p10l711t1218r891b1280],
56	or	CC	O	or	_	0	SENT_130	[p10l935t1219r1014b1261],
57	rapid	JJ	O	rapid	conj_or	55	SENT_130	[p10l1055t1191r1255b1280],
58	metabolizers	NNS	O	metabolizer	rcmod	52	SENT_130	[p10l1296t1192r1780b1261],
59	may	MD	O	may	aux	61	SENT_130	[p10l1822t1219r1984b1280],
60	not	RB	O	not	neg	61	SENT_130	[p10l2025t1211r2150b1261],
61	derive	VB	O	derive	ccomp	50	SENT_130	[p10l8t1297r235b1367],
62	optimal	JJ	O	optimal	amod	63	SENT_130	[p10l285t1297r576b1386],
63	beneﬁt	NN	O	beneﬁt	dobj	61	SENT_130	[p10l626t1297r879b1367],
64	from	IN	O	from	_	0	SENT_130	[p10l925t1297r1109b1367],
65	drugs	NNS	O	drug	prep_from	61	SENT_130	[p10l1157t1297r1363b1386],
66	if	IN	O	if	mark	74	SENT_130	[p10l1411t1297r1466b1365],
67	the	DT	O	the	det	69	SENT_130	[p10l1507t1297r1622b1367],
68	parent	NN	O	parent	nn	69	SENT_130	[p10l1669t1316r1914b1386],
69	compound	NN	O	compound	nsubjpass	74	SENT_130	[p10l1960t1324r2148b1367, p10l6t1403r250b1492],
70	or	CC	O	or	_	0	SENT_130	[p10l291t1431r370b1473],
71	its	PRP$	O	its	poss	72	SENT_130	[p10l411t1408r495b1473],
72	metabolites	NNS	O	metabolite	conj_or	69	SENT_130	[p10l536t1403r974b1473],
73	are	VBP	O	be	auxpass	74	SENT_130	[p10l1017t1431r1130b1473],
74	metabolized	VBN	O	metabolize	advcl	40	SENT_130	[p10l1172t1403r1636b1473],
75	by	IN	O	by	_	0	SENT_130	[p10l1678t1403r1767b1492],
76	CYPZD6	NN	O	cypzd6	agent	74	SENT_130	[p10l1809t1408r2148b1473],
77	or	CC	O	or	_	0	SENT_130	[p10l8t1538r87b1580],
78	by	IN	O	by	_	0	SENT_130	[p10l133t1511r222b1599],
79	other	JJ	O	other	amod	84	SENT_130	[p10l267t1510r465b1580],
80	cytochrome	NN	O	cytochrome	nn	84	SENT_130	[p10l508t1510r955b1599],
81	P	NN	O	p	nn	84	SENT_130	[p10l1002t1515r1223b1580],
82	—	CD	NUMBER	—	num	84	SENT_130	[p10l1002t1515r1223b1580],
83	45O	NN	O	45o	nn	84	SENT_130	[p10l1002t1515r1223b1580],
84	enzymes	NNS	O	enzyme	conj_or	76	SENT_130	[p10l1270t1497r1797b1599],
85	,21	CD	NUMBER	,21	num	86	SENT_130	[p10l1270t1497r1797b1599],
86	_	CD	NUMBER	_	dep	74	SENT_130	[p10l1270t1497r1797b1599],
87	27	CD	NUMBER	27	dep	2	SENT_130	[p10l1270t1497r1797b1599],
88	whereas	IN	O	whereas	mark	91	SENT_130	[p10l1839t1510r2148b1580],
89	others	NNS	O	other	nsubj	91	SENT_130	[p10l8t1617r239b1687],
90	have	VBP	O	have	aux	91	SENT_130	[p10l299t1617r472b1687],
91	found	VBN	O	find	dep	87	SENT_130	[p10l532t1617r756b1687],
92	little	JJ	O	little	amod	95	SENT_130	[p10l814t1617r983b1687],
93	or	CC	O	or	_	0	SENT_130	[p10l1044t1644r1123b1687],
94	no	DT	O	no	amod	95	SENT_130	[p10l1181t1644r1274b1687],
95	evidence	NN	O	evidence	dobj	91	SENT_130	[p10l1335t1617r1657b1687],
96	for	IN	O	for	_	0	SENT_130	[p10l1718t1617r1827b1687],
97	recommending	VBG	O	recommend	prepc_for	91	SENT_130	[p10l1885t1644r2148b1687, p10l7t1723r336b1812],

1	CYPZD6	NN	O	cypzd6	_	0	SENT_131	[p10l380t1728r742b1809],
2	,	,	O	,	_	0	SENT_131	[p10l380t1728r742b1809],
3	CYPZCI9	NN	O	cypzci9	appos	1	SENT_131	[p10l788t1728r1195b1809],
4	,	,	O	,	_	0	SENT_131	[p10l788t1728r1195b1809],
5	or	CC	O	or	_	0	SENT_131	[p10l1240t1751r1319b1793],
6	other	JJ	O	other	amod	7	SENT_131	[p10l1362t1723r1559b1793],
7	P	NN	O	p	conj_or	1	SENT_131	[p10l1600t1728r1821b1793],
8	—	CD	NUMBER	—	num	10	SENT_131	[p10l1600t1728r1821b1793],
9	45O	NN	O	45o	nn	10	SENT_131	[p10l1600t1728r1821b1793],
10	enzyme	NN	O	enzyme	dep	7	SENT_131	[p10l1865t1750r2148b1812],
11	genotyping	VBG	O	genotype	partmod	1	SENT_131	[p10l7t1834r430b1918],
12	for	IN	O	for	_	0	SENT_131	[p10l474t1829r584b1899],
13	patients	NNS	O	patient	prep_for	11	SENT_131	[p10l625t1834r924b1918],
14	taking	VBG	O	take	dep	13	SENT_131	[p10l968t1829r1209b1918],
15	these	DT	O	these	det	16	SENT_131	[p10l1251t1830r1440b1899],
16	drugs	NNS	O	drug	dobj	14	SENT_131	[p10l1486t1830r1693b1918],
17	or	CC	O	or	_	0	SENT_131	[p10l1738t1857r1817b1899],
18	even	RB	O	even	advmod	14	SENT_131	[p10l1861t1857r2031b1900],
19	to	TO	O	to	dep	13	SENT_131	[p10l2074t1849r2148b1899],

1	Movement	NNP	O	Movement	nn	2	SENT_132	[p10l1501t2028r1615b2047],
2	Disorders	NNPS	O	Disorders	_	0	SENT_132	[p10l1625t2028r1731b2050],
3	,	,	O	,	_	0	SENT_132	[p10l1625t2028r1731b2050],
4	Vol	NNP	O	Vol	appos	2	SENT_132	[p10l1741t2028r1779b2047],
5	.	.	O	.	_	0	SENT_132	[p10l1741t2028r1779b2047],

1	28	CD	NUMBER	28	_	0	SENT_133	[p10l1790t2028r1822b2050],
2	,	,	O	,	_	0	SENT_133	[p10l1790t2028r1822b2050],
3	No.	NN	O	no.	appos	1	SENT_133	[p10l1834t2028r1869b2047],
4	2	CD	NUMBER	2	num	3	SENT_133	[p10l1880t2028r1898b2050],
5	,	,	O	,	_	0	SENT_133	[p10l1880t2028r1898b2050],
6	2013	CD	DATE	2013	num	7	SENT_133	[p10l1909t2028r1963b2047],
7	213	CD	NUMBER	213	appos	1	SENT_133	[p10l2058t2022r2111b2047],

1	MEHANNA	NNP	O	MEHANNA	nn	3	SENT_134	[p10l31t2153r269b2174],
2	ET	NNP	O	ET	nn	3	SENT_134	[p10l316t2153r365b2174],
3	AL.	NNP	O	AL.	nsubj	20	SENT_134	[p10l408t2153r481b2174],
4	j	NN	O	j	nsubj	5	SENT_134	[p10l538t2125r2129b2208],
5	avoid	VB	O	avoid	rcmod	3	SENT_134	[p10l9t2245r217b2315],
6	inhibitors	NNS	O	inhibitor	dobj	5	SENT_134	[p10l260t2245r626b2315],
7	of	IN	O	of	_	0	SENT_134	[p10l672t2245r750b2315],
8	the	DT	O	the	det	10	SENT_134	[p10l788t2245r903b2315],
9	metabolizing	VBG	O	metabolize	amod	10	SENT_134	[p10l947t2245r1441b2333],
10	enzymes	NNS	O	enzyme	prep_of	6	SENT_134	[p10l1485t2271r1802b2333],
11	in	IN	O	in	_	0	SENT_134	[p10l1847t2249r1917b2313],
12	these	DT	O	these	det	13	SENT_134	[p10l1959t2245r2148b2315],
13	patients	NNS	O	patient	prep_in	10	SENT_134	[p10l7t2338r511b2440],
14	.28	CD	NUMBER	.28	number	15	SENT_134	[p10l7t2338r511b2440],
15	’35	CD	NUMBER	’35	dep	13	SENT_134	[p10l7t2338r511b2440],
16	A	DT	O	a	det	18	SENT_134	[p10l570t2354r632b2420],
17	recent	JJ	O	recent	amod	18	SENT_134	[p10l690t2371r920b2421],
18	review8	NN	O	review8	dep	15	SENT_134	[p10l977t2338r1262b2421],
19	has	VBZ	O	have	aux	20	SENT_134	[p10l1324t2351r1447b2421],
20	analyzed	VBN	O	analyze	_	0	SENT_134	[p10l1508t2351r1841b2440],
21	limitations	NNS	O	limitation	dobj	20	SENT_134	[p10l1900t2351r2148b2421, p10l7t2491r190b2556],

1	in	IN	O	in	_	0	SENT_135	[p10l226t2491r296b2555],
2	pharmacogenomics	NNS	O	pharmacogenomic	prep_in	33	SENT_135	[p10l330t2487r1071b2575],
3	for	IN	O	for	_	0	SENT_135	[p10l1107t2486r1217b2556],
4	agents	NNS	O	agent	prep_for	2	SENT_135	[p10l1252t2506r1489b2575],
5	used	VBN	O	use	dep	4	SENT_135	[p10l1526t2486r1695b2556],
6	in	IN	O	in	_	0	SENT_135	[p10l1730t2491r1800b2555],
7	multiple	JJ	O	multiple	amod	9	SENT_135	[p10l1835t2487r2148b2575],
8	neurological	JJ	O	neurological	amod	9	SENT_135	[p10l7t2592r479b2681],
9	conditions	NNS	O	condition	prep_in	5	SENT_135	[p10l536t2592r932b2662],
10	and	CC	O	and	_	0	SENT_135	[p10l991t2592r1129b2662],
11	concluded	VBD	O	conclude	dep	4	SENT_135	[p10l1185t2592r1573b2662],
12	that	IN	O	that	complm	18	SENT_135	[p10l1628t2592r1779b2662],
13	most	JJS	O	most	nsubj	18	SENT_135	[p10l1834t2611r2019b2662],
14	of	IN	O	of	_	0	SENT_135	[p10l2076t2592r2154b2662],
15	the	DT	O	the	det	17	SENT_135	[p10l7t2698r121b2768],
16	proposed	VBN	O	propose	amod	17	SENT_135	[p10l159t2698r512b2787],
17	associations	NNS	O	association	prep_of	13	SENT_135	[p10l552t2703r1007b2768],
18	lacked	VBD	O	lack	ccomp	11	SENT_135	[p10l1047t2698r1291b2768],
19	adequate	JJ	O	adequate	amod	20	SENT_135	[p10l1331t2698r1671b2787],
20	evidence	NN	O	evidence	dobj	18	SENT_135	[p10l1712t2698r2034b2768],
21	of	IN	O	of	_	0	SENT_135	[p10l2076t2698r2154b2768],
22	clinical	JJ	O	clinical	amod	23	SENT_135	[p10l7t2804r277b2874],
23	validity	NN	O	validity	prep_of	20	SENT_135	[p10l327t2804r613b2893],
24	and	CC	O	and	_	0	SENT_135	[p10l663t2805r801b2874],
25	underlined	VBD	O	underline	conj_and	18	SENT_135	[p10l851t2804r1259b2874],
26	the	DT	O	the	det	27	SENT_135	[p10l1307t2805r1421b2874],
27	need	NN	O	need	dobj	25	SENT_135	[p10l1472t2804r1647b2874],
28	to	TO	O	to	aux	29	SENT_135	[p10l1696t2824r1771b2874],
29	establish	VB	O	establish	xcomp	25	SENT_135	[p10l1821t2805r2150b2874],
30	biomarkers	NNS	O	biomarker	dobj	29	SENT_135	[p10l9t2910r438b2980],
31	that	WDT	O	that	nsubj	33	SENT_135	[p10l479t2910r631b2980],
32	could	MD	O	could	aux	33	SENT_135	[p10l671t2910r881b2980],
33	help	VB	O	help	_	0	SENT_135	[p10l922t2910r1081b2999],
34	select	JJ	O	select	amod	35	SENT_135	[p10l1124t2910r1329b2980],
35	patients	NNS	O	patient	dobj	33	SENT_135	[p10l1369t2914r1667b2999],
36	for	IN	O	for	_	0	SENT_135	[p10l1711t2910r1820b2980],
37	therapy	NN	O	therapy	prep_for	35	SENT_135	[p10l1860t2910r2150b2999],
38	with	IN	O	with	_	0	SENT_135	[p10l6t3016r178b3086],
39	an	DT	O	a	det	42	SENT_135	[p10l212t3044r301b3086],
40	optimal	JJ	O	optimal	amod	42	SENT_135	[p10l336t3016r628b3105],
41	beneﬁt	NN	O	beneﬁt	nn	42	SENT_135	[p10l664t3016r1200b3086],
42	—	NN	O	—	prep_with	33	SENT_135	[p10l664t3016r1200b3086],
43	to	TO	O	to	_	0	SENT_135	[p10l664t3016r1200b3086],
44	—	CD	NUMBER	—	num	46	SENT_135	[p10l664t3016r1200b3086],
45	risk	NN	O	risk	nn	46	SENT_135	[p10l664t3016r1200b3086],
46	ratio	NN	O	ratio	prep_to	33	SENT_135	[p10l1233t3021r1433b3086],
47	.	.	O	.	_	0	SENT_135	[p10l1233t3021r1433b3086],

1	We	PRP	O	we	nsubj	3	SENT_136	[p10l85t3128r211b3193],
2	are	VBP	O	be	cop	3	SENT_136	[p10l261t3150r373b3192],
3	aware	JJ	O	aware	_	0	SENT_136	[p10l423t3150r650b3192],
4	that	IN	O	that	complm	7	SENT_136	[p10l698t3123r849b3192],
5	this	DT	O	this	det	6	SENT_136	[p10l895t3123r1029b3192],
6	study	NN	O	study	nsubj	7	SENT_136	[p10l1078t3122r1282b3211],
7	has	VBZ	O	have	ccomp	3	SENT_136	[p10l1328t3123r1451b3192],
8	some	DT	O	some	det	9	SENT_136	[p10l1500t3150r1692b3192],
9	limitations	NNS	O	limitation	dobj	7	SENT_136	[p10l1741t3123r2149b3192],
10	such	JJ	O	such	_	0	SENT_136	[p10l9t3228r177b3298],
11	as	IN	O	as	_	0	SENT_136	[p10l224t3255r297b3298],
12	its	PRP$	O	its	poss	14	SENT_136	[p10l345t3232r428b3298],
13	retrospective	JJ	O	retrospective	amod	14	SENT_136	[p10l476t3232r964b3317],
14	nature	NN	O	nature	prep_such_as	9	SENT_136	[p10l1011t3247r1254b3298],
15	and	CC	O	and	_	0	SENT_136	[p10l1303t3228r1441b3298],
16	small	JJ	O	small	amod	17	SENT_136	[p10l1489t3228r1687b3298],
17	number	NN	O	number	conj_and	14	SENT_136	[p10l1734t3228r2028b3298],
18	of	IN	O	of	_	0	SENT_136	[p10l2076t3228r2154b3298],
19	patients	NNS	O	patient	prep_of	17	SENT_136	[p10l7t3339r326b3423],
20	.	.	O	.	_	0	SENT_136	[p10l7t3339r326b3423],

1	Speciﬁcally	RB	O	speciﬁcally	dep	19	SENT_137	[p10l378t3334r824b3423],
2	,	,	O	,	_	0	SENT_137	[p10l378t3334r824b3423],
3	the	DT	O	the	det	5	SENT_137	[p10l871t3334r985b3404],
4	small	JJ	O	small	amod	5	SENT_137	[p10l1033t3334r1231b3404],
5	number	NN	O	number	dep	15	SENT_137	[p10l1277t3334r1570b3404],
6	of	IN	O	of	_	0	SENT_137	[p10l1616t3334r1695b3404],
7	patients	NNS	O	patient	prep_of	5	SENT_137	[p10l1734t3339r2033b3423],
8	in	IN	O	in	_	0	SENT_137	[p10l2079t3339r2150b3403],
9	the	DT	O	the	det	11	SENT_137	[p10l7t3440r121b3510],
10	UM	NNP	O	UM	nn	11	SENT_137	[p10l164t3446r315b3510],
11	group	NN	O	group	prep_in	7	SENT_137	[p10l358t3467r581b3529],
12	(	CD	NUMBER	(	num	13	SENT_137	[p10l630t3445r701b3526],
13	n	NN	O	n	dep	15	SENT_137	[p10l630t3445r701b3526],
14	=	JJ	O	=	amod	15	SENT_137	[p10l746t3476r806b3497],
15	2	CD	NUMBER	2	dep	19	SENT_137	[p10l852t3445r922b3526],
16	)	CD	NUMBER	)	num	17	SENT_137	[p10l852t3445r922b3526],
17	limits	NNS	O	limit	dep	15	SENT_137	[p10l971t3440r1179b3510],
18	the	DT	O	the	det	19	SENT_137	[p10l1223t3441r1337b3510],
19	generalizability	NN	O	generalizability	_	0	SENT_137	[p10l1382t3440r1967b3529],
20	and	CC	O	and	_	0	SENT_137	[p10l2012t3441r2150b3510],
21	usefulness	NN	O	usefulness	conj_and	19	SENT_137	[p10l8t3546r388b3616],
22	of	IN	O	of	_	0	SENT_137	[p10l442t3546r520b3616],
23	the	DT	O	the	det	24	SENT_137	[p10l565t3546r680b3616],
24	results	NNS	O	result	prep_of	19	SENT_137	[p10l731t3546r975b3616],
25	from	IN	O	from	_	0	SENT_137	[p10l1027t3546r1211b3616],
26	this	DT	O	this	det	27	SENT_137	[p10l1261t3546r1395b3616],
27	group	NN	O	group	prep_from	24	SENT_137	[p10l1447t3573r1691b3635],
28	.	.	O	.	_	0	SENT_137	[p10l1447t3573r1691b3635],

1	Moreover	RB	O	moreover	advmod	4	SENT_138	[p10l1746t3551r2147b3631],
2	,	,	O	,	_	0	SENT_138	[p10l1746t3551r2147b3631],
3	there	EX	O	there	expl	4	SENT_138	[p10l7t3652r195b3722],
4	is	VBZ	O	be	_	0	SENT_138	[p10l244t3657r298b3722],
5	an	DT	O	a	det	6	SENT_138	[p10l347t3680r436b3722],
6	imbalance	NN	O	imbalance	nsubj	4	SENT_138	[p10l482t3652r870b3722],
7	in	IN	O	in	_	0	SENT_138	[p10l918t3657r989b3721],
8	group	NN	O	group	nn	9	SENT_138	[p10l1034t3679r1257b3741],
9	size	NN	O	size	prep_in	6	SENT_138	[p10l1307t3657r1439b3722],
10	that	WDT	O	that	nsubj	12	SENT_138	[p10l1486t3652r1637b3722],
11	could	MD	O	could	aux	12	SENT_138	[p10l1683t3652r1893b3722],
12	affect	VB	O	affect	rcmod	6	SENT_138	[p10l1941t3652r2150b3722],
13	the	DT	O	the	det	14	SENT_138	[p11l7t15r121b85],
14	power	NN	O	power	dobj	12	SENT_138	[p11l160t42r401b104],
15	to	TO	O	to	aux	16	SENT_138	[p11l439t35r514b85],
16	detect	VB	O	detect	infmod	14	SENT_138	[p11l556t16r780b85],
17	statistically	RB	O	statistically	advmod	18	SENT_138	[p11l821t15r1249b104],
18	signiﬁcant	JJ	O	signiﬁcant	amod	19	SENT_138	[p11l1289t15r1676b104],
19	differences	NNS	O	difference	dobj	16	SENT_138	[p11l1717t15r2147b101],
20	,	,	O	,	_	0	SENT_138	[p11l1717t15r2147b101],
21	but	CC	O	but	_	0	SENT_138	[p11l9t121r132b191],
22	our	PRP$	O	we	poss	24	SENT_138	[p11l179t148r307b191],
23	phenotype	NN	O	phenotype	nn	24	SENT_138	[p11l352t121r749b210],
24	distribution	NN	O	distribution	nsubj	26	SENT_138	[p11l798t121r1244b191],
25	seems	VBZ	O	seem	cop	26	SENT_138	[p11l1291t148r1508b191],
26	consistent	JJ	O	consistent	conj_but	4	SENT_138	[p11l1555t125r1934b191],
27	with	IN	O	with	_	0	SENT_138	[p11l1978t121r2150b191],
28	the	DT	O	the	det	30	SENT_138	[p11l7t227r121b297],
29	published	VBN	O	publish	amod	30	SENT_138	[p11l155t227r524b316],
30	literature	NN	O	literature	prep_with	26	SENT_138	[p11l558t214r1006b297],
31	.	.	O	.	_	0	SENT_138	[p11l558t214r1006b297],

1	“	NNP	O	“	nsubj	6	SENT_139	[p11l558t214r1006b297],
2	Last	JJ	O	last	amod	1	SENT_139	[p11l1041t233r1222b313],
3	,	,	O	,	_	0	SENT_139	[p11l1041t233r1222b313],
4	we	PRP	O	we	nsubj	6	SENT_139	[p11l1258t255r1364b297],
5	have	VBP	O	have	aux	6	SENT_139	[p11l1399t227r1572b297],
6	used	VBN	O	use	_	0	SENT_139	[p11l1608t227r1777b297],
7	a	DT	O	a	det	9	SENT_139	[p11l1812t255r1850b297],
8	subjective	JJ	O	subjective	amod	9	SENT_139	[p11l1887t227r2148b316, p11l7t338r141b403],
9	scale	NN	O	scale	dobj	6	SENT_139	[p11l185t334r363b403],
10	to	TO	O	to	aux	11	SENT_139	[p11l405t353r480b403],
11	assess	VB	O	assess	dep	6	SENT_139	[p11l524t361r740b403],
12	the	DT	O	the	det	14	SENT_139	[p11l782t334r896b403],
13	clinical	JJ	O	clinical	amod	14	SENT_139	[p11l939t333r1208b403],
14	response	NN	O	response	dobj	11	SENT_139	[p11l1251t360r1601b422],
15	,	,	O	,	_	0	SENT_139	[p11l1251t360r1601b422],
16	but	CC	O	but	_	0	SENT_139	[p11l1647t333r1771b403],
17	although	IN	O	although	mark	39	SENT_139	[p11l1813t334r2150b422],
18	formal	JJ	O	formal	dep	28	SENT_139	[p11l8t439r260b509],
19	and	CC	O	and	cc	18	SENT_139	[p11l301t439r440b509],
20	ideally	RB	O	ideally	advmod	18	SENT_139	[p11l479t439r729b527],
21	disease	NN	O	disease	nn	25	SENT_139	[p11l769t439r1340b528],
22	—	NN	O	—	nn	25	SENT_139	[p11l769t439r1340b528],
23	speciﬁc	NN	O	speciﬁc	nn	25	SENT_139	[p11l769t439r1340b528],
24	rating	NN	O	rating	nn	25	SENT_139	[p11l1379t443r1604b528],
25	scales	NNS	O	scale	nsubjpass	28	SENT_139	[p11l1644t439r1856b509],
26	should	MD	O	should	aux	28	SENT_139	[p11l1898t439r2150b509],
27	be	VB	O	be	auxpass	28	SENT_139	[p11l9t545r91b615],
28	used	VBN	O	use	dep	39	SENT_139	[p11l136t545r305b615],
29	in	IN	O	in	_	0	SENT_139	[p11l349t550r419b614],
30	future	JJ	DATE	future	amod	31	SENT_139	[p11l463t545r690b615],
31	studies	NNS	O	study	prep_in	28	SENT_139	[p11l736t545r1016b631],
32	,	,	O	,	_	0	SENT_139	[p11l736t545r1016b631],
33	the	DT	O	the	det	35	SENT_139	[p11l1061t545r1176b615],
34	current	JJ	DATE	current	amod	35	SENT_139	[p11l1221t565r1495b615],
35	scale	NN	O	scale	nsubjpass	39	SENT_139	[p11l1540t545r1717b615],
36	has	VBZ	O	have	aux	39	SENT_139	[p11l1762t545r1885b615],
37	previously	RB	DATE	previously	advmod	39	SENT_139	[p11l1929t550r2148b634, p11l9t651r207b740],
38	been	VBN	O	be	auxpass	39	SENT_139	[p11l260t651r434b721],
39	used	VBN	O	use	dep	6	SENT_139	[p11l487t651r656b721],
40	with	IN	O	with	_	0	SENT_139	[p11l707t652r879b721],
41	good	JJ	O	good	amod	42	SENT_139	[p11l931t652r1121b740],
42	reproducibility	NN	O	reproducibility	prep_with	39	SENT_139	[p11l1173t638r1837b740],
43	.	.	O	.	_	0	SENT_139	[p11l1173t638r1837b740],

1	”	NN	O	”	npadvmod	11	SENT_140	[p11l1173t638r1837b740],
2	In	IN	O	in	_	0	SENT_140	[p11l1893t657r1968b720],
3	our	PRP$	O	we	poss	4	SENT_140	[p11l2022t679r2150b721],
4	study	NN	O	study	prep_in	11	SENT_140	[p11l9t757r233b845],
5	,	,	O	,	_	0	SENT_140	[p11l9t757r233b845],
6	the	DT	O	the	det	7	SENT_140	[p11l288t757r403b827],
7	titration	NN	O	titration	nsubjpass	11	SENT_140	[p11l457t761r771b827],
8	of	IN	O	of	_	0	SENT_140	[p11l826t757r904b827],
9	tetrabenazine	NN	O	tetrabenazine	prep_of	7	SENT_140	[p11l952t757r1465b827],
10	was	VBD	O	be	auxpass	11	SENT_140	[p11l1518t784r1664b827],
11	undertaken	VBN	O	undertake	_	0	SENT_140	[p11l1718t757r2149b827],
12	blindly	RB	O	blindly	advmod	11	SENT_140	[p11l9t863r272b952],
13	without	IN	O	without	_	0	SENT_140	[p11l324t863r625b933],
14	knowledge	NN	O	knowledge	prep_without	12	SENT_140	[p11l678t863r1091b952],
15	of	IN	O	of	_	0	SENT_140	[p11l1148t863r1226b933],
16	CYPZD6	NN	O	cypzd6	nn	17	SENT_140	[p11l1278t868r1616b933],
17	genotype	NN	O	genotype	prep_of	14	SENT_140	[p11l1672t883r2014b952],
18	or	CC	O	or	_	0	SENT_140	[p11l2071t891r2150b933],
19	phenotype	NN	O	phenotype	prep_of	14	SENT_140	[p11l6t970r425b1058],
20	.	.	O	.	_	0	SENT_140	[p11l6t970r425b1058],

1	Regardless	RB	O	regardless	_	0	SENT_141	[p11l471t970r877b1058],
2	of	IN	O	of	_	0	SENT_141	[p11l919t969r998b1039],
3	indication	NN	O	indication	prep_regardless_of	9	SENT_141	[p11l1033t969r1417b1039],
4	for	IN	O	for	_	0	SENT_141	[p11l1457t969r1567b1039],
5	therapy	NN	O	therapy	prep_for	3	SENT_141	[p11l1605t970r1917b1058],
6	,	,	O	,	_	0	SENT_141	[p11l1605t970r1917b1058],
7	titration	NN	O	titration	nsubjpass	9	SENT_141	[p11l1959t974r2148b1039, p11l7t1079r157b1145],
8	was	VBD	O	be	auxpass	9	SENT_141	[p11l190t1102r336b1145],
9	conducted	VBN	O	conduct	_	0	SENT_141	[p11l372t1075r765b1145],
10	with	IN	O	with	_	0	SENT_141	[p11l799t1075r970b1145],
11	the	DT	O	the	det	12	SENT_141	[p11l1004t1075r1119b1145],
12	goal	NN	O	goal	prep_with	9	SENT_141	[p11l1155t1075r1315b1164],
13	of	IN	O	of	_	0	SENT_141	[p11l1352t1075r1430b1145],
14	achieving	VBG	O	achieve	prepc_of	12	SENT_141	[p11l1462t1075r1820b1163],
15	optimal	JJ	O	optimal	amod	16	SENT_141	[p11l1857t1075r2149b1164],
16	beneﬁt	NN	O	beneﬁt	dobj	14	SENT_141	[p11l9t1182r262b1252],
17	with	IN	O	with	_	0	SENT_141	[p11l295t1182r467b1252],
18	the	DT	O	the	det	21	SENT_141	[p11l503t1182r617b1252],
19	fewest	JJS	O	fewest	amod	21	SENT_141	[p11l655t1182r895b1252],
20	side	JJ	O	side	amod	21	SENT_141	[p11l931t1182r1073b1252],
21	effects	NNS	O	effect	prep_with	14	SENT_141	[p11l1112t1182r1372b1252],
22	.	.	O	.	_	0	SENT_141	[p11l1112t1182r1372b1252],

1	At	IN	O	at	_	0	SENT_142	[p11l1411t1185r1503b1252],
2	the	DT	O	the	det	3	SENT_142	[p11l1538t1182r1652b1252],
3	initiation	NN	O	initiation	prep_at	12	SENT_142	[p11l1690t1187r2039b1252],
4	of	IN	O	of	_	0	SENT_142	[p11l2076t1182r2154b1252],
5	therapy	NN	O	therapy	prep_of	3	SENT_142	[p11l7t1288r318b1377],
6	,	,	O	,	_	0	SENT_142	[p11l7t1288r318b1377],
7	patients	NNS	O	patient	nsubjpass	12	SENT_142	[p11l358t1293r657b1377],
8	in	IN	O	in	_	0	SENT_142	[p11l697t1293r767b1357],
9	our	PRP$	O	we	poss	10	SENT_142	[p11l806t1316r935b1358],
10	clinic	NN	O	clinic	prep_in	7	SENT_142	[p11l973t1289r1173b1358],
11	are	VBP	O	be	auxpass	12	SENT_142	[p11l1213t1316r1326b1358],
12	counseled	VBN	O	counsel	_	0	SENT_142	[p11l1365t1288r1740b1358],
13	about	IN	O	about	_	0	SENT_142	[p11l1779t1288r1997b1358],
14	the	DT	O	the	det	18	SENT_142	[p11l2034t1289r2148b1358],
15	most	RBS	O	most	advmod	16	SENT_142	[p11l7t1413r192b1464],
16	common	JJ	O	common	amod	18	SENT_142	[p11l234t1421r569b1464],
17	side	NN	O	side	nn	18	SENT_142	[p11l613t1394r755b1464],
18	effects	NNS	O	effect	prep_about	12	SENT_142	[p11l800t1394r1039b1464],
19	of	IN	O	of	_	0	SENT_142	[p11l1085t1394r1163b1464],
20	this	DT	O	this	det	21	SENT_142	[p11l1201t1394r1335b1464],
21	drug	NN	O	drug	prep_of	18	SENT_142	[p11l1381t1394r1554b1482],
22	as	RB	O	as	_	0	SENT_142	[p11l1599t1421r1671b1464],
23	well	RB	O	well	_	0	SENT_142	[p11l1715t1394r1872b1464],
24	as	IN	O	as	_	0	SENT_142	[p11l1918t1421r1990b1464],
25	the	DT	O	the	det	28	SENT_142	[p11l2034t1394r2148b1464],
26	black	JJ	O	black	amod	28	SENT_142	[p11l9t1500r212b1570],
27	box	NN	O	box	nn	28	SENT_142	[p11l262t1500r406b1570],
28	warning	NN	O	warning	conj_and	18	SENT_142	[p11l453t1505r768b1589],
29	for	IN	O	for	_	0	SENT_142	[p11l817t1500r927b1570],
30	depression/suicidality	NN	O	depression/suicidality	prep_for	28	SENT_142	[p11l977t1500r1797b1589],
31	and	CC	O	and	_	0	SENT_142	[p11l1848t1500r1986b1570],
32	are	VBP	O	be	auxpass	33	SENT_142	[p11l2036t1528r2148b1570],
33	asked	VBN	O	ask	conj_and	12	SENT_142	[p11l9t1607r221b1676],
34	to	TO	O	to	aux	35	SENT_142	[p11l267t1626r341b1676],
35	contact	VB	O	contact	xcomp	33	SENT_142	[p11l389t1626r669b1676],
36	us	PRP	O	we	dobj	35	SENT_142	[p11l715t1634r793b1676],
37	immediately	RB	O	immediately	advmod	35	SENT_142	[p11l841t1607r1311b1695],
38	should	MD	O	should	dep	42	SENT_142	[p11l1358t1606r1610b1676],
39	any	DT	O	any	nsubj	42	SENT_142	[p11l1658t1634r1792b1695],
40	of	IN	O	of	_	0	SENT_142	[p11l1839t1606r1918b1676],
41	these	DT	O	these	prep_of	39	SENT_142	[p11l1959t1607r2148b1676],
42	occur	VBP	O	occur	dep	35	SENT_142	[p11l9t1739r237b1782],
43	.	.	O	.	_	0	SENT_142	[p11l9t1739r237b1782],

1	Dosage	NN	O	dosage	nn	4	SENT_143	[p11l317t1717r595b1800],
2	or	CC	O	or	_	0	SENT_143	[p11l675t1739r754b1782],
3	titration	NN	O	titration	nn	4	SENT_143	[p11l828t1716r1144b1782],
4	adjustments	NNS	O	adjustment	nsubjpass	6	SENT_143	[p11l1221t1712r1675b1800],
5	are	VBP	O	be	auxpass	6	SENT_143	[p11l1755t1739r1867b1782],
6	made	VBN	O	make	_	0	SENT_143	[p11l1945t1712r2148b1782],
7	accordingly	RB	O	accordingly	advmod	6	SENT_143	[p11l9t1818r473b1907],
8	,	,	O	,	_	0	SENT_143	[p11l9t1818r473b1907],
9	or	CC	O	or	_	0	SENT_143	[p11l556t1846r635b1888],
10	concomitant	JJ	O	concomitant	amod	11	SENT_143	[p11l712t1823r1190b1888],
11	medications	NNS	O	medication	nsubjpass	13	SENT_143	[p11l1269t1818r1726b1888],
12	are	VBP	O	be	auxpass	13	SENT_143	[p11l1807t1846r1920b1888],
13	prescribed	VBN	O	prescribe	conj_or	6	SENT_143	[p11l1999t1845r2148b1907, p11l9t1925r276b1994],
14	to	TO	O	to	aux	15	SENT_143	[p11l318t1944r393b1994],
15	combat	VB	O	combat	xcomp	13	SENT_143	[p11l437t1925r722b1994],
16	certain	JJ	O	certain	amod	18	SENT_143	[p11l765t1929r1025b1994],
17	side	JJ	O	side	amod	18	SENT_143	[p11l1069t1925r1211b1994],
18	effects	NNS	O	effect	dobj	15	SENT_143	[p11l1256t1924r1494b1994],
19	when	WRB	O	when	advmod	20	SENT_143	[p11l1538t1925r1744b1994],
20	appropriate	JJ	O	appropriate	advcl	15	SENT_143	[p11l1789t1929r2148b2013, p11l9t2049r138b2100],
21	.	.	O	.	_	0	SENT_143	[p11l1789t1929r2148b2013, p11l9t2049r138b2100],

1	In	IN	O	in	_	0	SENT_144	[p11l179t2035r254b2099],
2	our	PRP$	O	we	poss	3	SENT_144	[p11l291t2057r420b2100],
3	cohort	NN	O	cohort	prep_in	7	SENT_144	[p11l456t2030r727b2115],
4	,	,	O	,	_	0	SENT_144	[p11l456t2030r727b2115],
5	clinical	JJ	O	clinical	amod	6	SENT_144	[p11l766t2030r1036b2100],
6	beneﬁt	NN	O	beneﬁt	nsubj	20	SENT_144	[p11l1075t2030r1328b2100],
7	remained	VBD	O	remain	_	0	SENT_144	[p11l1364t2030r1717b2100],
8	high	JJ	O	high	amod	9	SENT_144	[p11l1754t2030r1919b2119],
9	(	NN	O	(	nsubj	11	SENT_144	[p11l1960t2034r2152b2115, p11l7t2141r152b2222],
10	1.32.2	CD	NUMBER	1.32.2	num	11	SENT_144	[p11l1960t2034r2152b2115, p11l7t2141r152b2222],
11	)	NN	O	)	xcomp	7	SENT_144	[p11l1960t2034r2152b2115, p11l7t2141r152b2222],
12	on	IN	O	on	_	0	SENT_144	[p11l192t2164r285b2206],
13	our	PRP$	O	we	poss	17	SENT_144	[p11l320t2164r448b2206],
14	5-point	JJ	O	5-point	amod	17	SENT_144	[p11l484t2141r761b2225],
15	response	NN	O	response	nn	17	SENT_144	[p11l794t2163r1120b2225],
16	rating	NN	O	rating	nn	17	SENT_144	[p11l1156t2141r1380b2225],
17	scale	NN	O	scale	prep_on	11	SENT_144	[p11l1415t2136r1617b2222],
18	,	,	O	,	_	0	SENT_144	[p11l1415t2136r1617b2222],
19	and	CC	O	and	_	0	SENT_144	[p11l1655t2136r1793b2206],
20	reported	VBD	O	report	conj_and	7	SENT_144	[p11l1826t2136r2149b2225],
21	side	JJ	O	side	amod	22	SENT_144	[p11l9t2242r151b2312],
22	effects	NNS	O	effect	nsubj	23	SENT_144	[p11l193t2242r431b2312],
23	were	VBD	O	be	ccomp	20	SENT_144	[p11l472t2270r652b2312],
24	in	IN	O	in	_	0	SENT_144	[p11l695t2247r765b2311],
25	keeping	VBG	O	keep	prepc_in	23	SENT_144	[p11l806t2243r1099b2331],
26	with	IN	O	with	_	0	SENT_144	[p11l1139t2242r1310b2312],
27	the	DT	O	the	det	31	SENT_144	[p11l1350t2243r1464b2312],
28	known	JJ	O	known	amod	31	SENT_144	[p11l1506t2243r1771b2312],
29	potential	JJ	O	potential	amod	31	SENT_144	[p11l1810t2242r2149b2331],
30	side	NN	O	side	nn	31	SENT_144	[p11l9t2348r151b2418],
31	effects	NNS	O	effect	prep_with	25	SENT_144	[p11l220t2348r458b2418],
32	of	IN	O	of	_	0	SENT_144	[p11l529t2348r606b2418],
33	this	DT	O	this	det	34	SENT_144	[p11l668t2348r803b2418],
34	drug	NN	O	drug	prep_of	31	SENT_144	[p11l873t2348r1066b2437],
35	.	.	O	.	_	0	SENT_144	[p11l873t2348r1066b2437],

1	More	RBR	O	more	advmod	2	SENT_145	[p11l1137t2353r1346b2418],
2	importantly	RB	O	importantly	advmod	10	SENT_145	[p11l1415t2348r1889b2437],
3	,	,	O	,	_	0	SENT_145	[p11l1415t2348r1889b2437],
4	these	DT	O	these	det	6	SENT_145	[p11l1959t2348r2148b2418],
5	side	JJ	O	side	amod	6	SENT_145	[p11l9t2454r151b2524],
6	effects	NNS	O	effect	nsubj	10	SENT_145	[p11l216t2454r454b2524],
7	were	VBD	O	be	cop	10	SENT_145	[p11l518t2482r698b2524],
8	readily	RB	O	readily	advmod	10	SENT_145	[p11l763t2454r1023b2543],
9	clinically	RB	O	clinically	advmod	10	SENT_145	[p11l1086t2454r1427b2543],
10	apparent	JJ	O	apparent	_	0	SENT_145	[p11l1492t2474r1848b2543],
11	.	.	O	.	_	0	SENT_145	[p11l1492t2474r1848b2543],

1	In	IN	O	in	_	0	SENT_146	[p11l1917t2460r1992b2523],
2	no	DT	O	no	det	3	SENT_146	[p11l2055t2482r2149b2524],
3	circumstance	NN	O	circumstance	prep_in	4	SENT_146	[p11l7t2565r503b2630],
4	was	VBD	O	be	_	0	SENT_146	[p11l545t2588r690b2630],
5	knowledge	NN	O	knowledge	nsubj	4	SENT_146	[p11l732t2561r1144b2649],
6	of	IN	O	of	_	0	SENT_146	[p11l1188t2560r1266b2630],
7	CYPZD6	NN	O	cypzd6	nn	8	SENT_146	[p11l1305t2565r1643b2630],
8	genotype	NN	O	genotype	prep_of	5	SENT_146	[p11l1685t2580r2028b2649],
9	or	CC	O	or	_	0	SENT_146	[p11l2071t2588r2150b2630],
10	phenotype	NN	O	phenotype	prep_of	5	SENT_146	[p11l7t2666r403b2755],
11	required	VBN	O	require	partmod	5	SENT_146	[p11l455t2666r774b2755],
12	to	TO	O	to	aux	13	SENT_146	[p11l824t2685r898b2736],
13	manage	VB	O	manage	xcomp	11	SENT_146	[p11l950t2693r1243b2754],
14	a	DT	O	a	det	15	SENT_146	[p11l1297t2693r1335b2736],
15	patient	NN	O	patient	poss	17	SENT_146	[p11l1386t2670r1709b2755],
16	’s	POS	O	’s	_	0	SENT_146	[p11l1386t2670r1709b2755],
17	condition	NN	O	condition	dobj	13	SENT_146	[p11l1761t2666r2145b2736],
18	.	.	O	.	_	0	SENT_146	[p11l1761t2666r2145b2736],

1	Although	IN	O	although	mark	2	SENT_147	[p11l6t2772r365b2861],
2	larger	JJR	O	larger	advcl	7	SENT_147	[p11l399t2772r640b2861],
3	,	,	O	,	_	0	SENT_147	[p11l399t2772r640b2861],
4	prospective	JJ	O	prospective	amod	5	SENT_147	[p11l676t2777r1108b2861],
5	studies	NNS	O	study	nsubjpass	7	SENT_147	[p11l1145t2772r1401b2842],
6	are	VBP	O	be	auxpass	7	SENT_147	[p11l1437t2800r1549b2842],
7	needed	VBN	O	need	_	0	SENT_147	[p11l1584t2772r1849b2842],
8	to	TO	O	to	aux	9	SENT_147	[p11l1881t2792r1956b2842],
9	provide	VB	O	provide	xcomp	7	SENT_147	[p11l1990t2799r2148b2861, p11l7t2879r161b2948],
10	a	DT	O	a	det	13	SENT_147	[p11l213t2906r252b2948],
11	more	RBR	O	more	advmod	12	SENT_147	[p11l301t2906r495b2948],
12	deﬁnitive	JJ	O	deﬁnitive	amod	13	SENT_147	[p11l548t2878r894b2948],
13	assessment	NN	O	assessment	dobj	9	SENT_147	[p11l946t2898r1358b2948],
14	of	IN	O	of	_	0	SENT_147	[p11l1409t2878r1487b2948],
15	the	DT	O	the	det	16	SENT_147	[p11l1531t2879r1646b2948],
16	relationship	NN	O	relationship	prep_of	13	SENT_147	[p11l1697t2879r2148b2967],
17	between	IN	O	between	_	0	SENT_147	[p11l9t2984r322b3054],
18	the	DT	O	the	det	20	SENT_147	[p11l404t2984r519b3054],
19	CYPZD6	NN	O	cypzd6	nn	20	SENT_147	[p11l606t2988r945b3054],
20	genotype	NN	O	genotype	prep_between	16	SENT_147	[p11l1030t3003r1372b3073],
21	and	CC	O	and	_	0	SENT_147	[p11l1458t2984r1597b3054],
22	the	DT	O	the	det	24	SENT_147	[p11l1679t2984r1794b3054],
23	clinical	JJ	O	clinical	amod	24	SENT_147	[p11l1878t2984r2148b3054],
24	response	NN	O	response	conj_and	20	SENT_147	[p11l7t3117r357b3179],
25	,	,	O	,	_	0	SENT_147	[p11l7t3117r357b3179],
26	these	DT	O	these	det	27	SENT_147	[p11l397t3090r586b3160],
27	results	NNS	O	result	nsubj	30	SENT_147	[p11l625t3090r868b3160],
28	do	VBP	O	do	aux	30	SENT_147	[p11l908t3090r1000b3160],
29	not	RB	O	not	neg	30	SENT_147	[p11l1039t3110r1164b3160],
30	support	VB	O	support	dep	7	SENT_147	[p11l1203t3110r1494b3179],
31	the	DT	O	the	det	32	SENT_147	[p11l1531t3090r1645b3160],
32	need	NN	O	need	dobj	30	SENT_147	[p11l1685t3090r1860b3160],
33	to	TO	O	to	_	0	SENT_147	[p11l1897t3110r1971b3160],
34	systematically	RB	O	systematically	advmod	35	SENT_147	[p11l2011t3118r2148b3179, p11l7t3197r428b3285],
35	genotype	NN	O	genotype	prep_to	30	SENT_147	[p11l465t3216r808b3285],
36	all	DT	O	all	det	37	SENT_147	[p11l849t3197r938b3266],
37	patients	NNS	O	patient	dep	35	SENT_147	[p11l977t3201r1275b3285],
38	prescribed	VBN	O	prescribe	partmod	37	SENT_147	[p11l1314t3196r1709b3285],
39	more	JJR	O	more	mwe	40	SENT_147	[p11l1747t3224r1940b3266],
40	than	IN	O	than	quantmod	41	SENT_147	[p11l1980t3197r2150b3266],
41	50	CD	NUMBER	50	num	42	SENT_147	[p11l9t3307r100b3372],
42	mg/day	NN	O	mg/day	dobj	38	SENT_147	[p11l140t3302r421b3390],
43	of	IN	O	of	_	0	SENT_147	[p11l460t3302r539b3372],
44	tetrabenazine	NN	O	tetrabenazine	prep_of	42	SENT_147	[p11l573t3302r1108b3387],
45	,	,	O	,	_	0	SENT_147	[p11l573t3302r1108b3387],
46	and	CC	O	and	_	0	SENT_147	[p11l1152t3302r1290b3372],
47	this	DT	O	this	det	48	SENT_147	[p11l1328t3302r1462b3372],
48	recommendation	NN	O	recommendation	nsubjpass	51	SENT_147	[p11l1502t3302r2150b3372],
49	should	MD	O	should	aux	51	SENT_147	[p11l9t3409r260b3479],
50	be	VB	O	be	auxpass	51	SENT_147	[p11l296t3409r378b3479],
51	reconsidered	VBN	O	reconsider	conj_and	7	SENT_147	[p11l413t3409r916b3479],
52	.	.	O	.	_	0	SENT_147	[p11l413t3409r916b3479],

1	I	PRP	O	I	_	0	SENT_148	[p11l952t3432r1001b3480],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_149	[p11l113t3613r769b3694],
2	:	:	O	:	_	0	SENT_149	[p11l113t3613r769b3694],
3	Dr.	NNP	O	Dr.	nn	5	SENT_149	[p11l819t3628r910b3676],
4	William	NNP	PERSON	William	nn	5	SENT_149	[p11l954t3623r1184b3676],
5	Ondo	NNP	PERSON	Ondo	nsubj	9	SENT_149	[p11l1230t3623r1391b3676],
6	offered	VBD	O	offer	dep	1	SENT_149	[p11l1435t3623r1636b3676],
7	suggestions	NNS	O	suggestion	dobj	6	SENT_149	[p11l1679t3627r2002b3691],
8	and	CC	O	and	_	0	SENT_149	[p11l2046t3623r2150b3676],
9	referred	VBD	O	refer	dep	1	SENT_149	[p11l6t3694r231b3747],
10	some	DT	O	some	det	11	SENT_149	[p11l257t3715r401b3747],
11	patients	NNS	O	patient	dobj	9	SENT_149	[p11l427t3698r651b3761],
12	for	IN	O	for	_	0	SENT_149	[p11l678t3694r760b3747],
13	the	DT	O	the	det	14	SENT_149	[p11l784t3694r870b3747],
14	study	NN	O	study	prep_for	9	SENT_149	[p11l898t3694r1065b3761],
15	.	.	O	.	_	0	SENT_149	[p11l898t3694r1065b3761],

1	References	NNS	O	reference	_	0	SENT_150	[p12l760t115r1403b206],

1	Frank	NNP	PERSON	Frank	nn	3	SENT_151	[p12l173t269r341b322],
2	S.	NNP	PERSON	S.	nn	3	SENT_151	[p12l375t272r420b322],
3	Tetrabenazine	NNP	PERSON	Tetrabenazine	_	0	SENT_151	[p12l455t269r863b322],
4	as	IN	O	as	_	0	SENT_151	[p12l898t289r952b322],
5	anti-chorea	JJ	O	anti-chorea	amod	6	SENT_151	[p12l987t269r1310b322],
6	therapy	NN	O	therapy	prep_as	3	SENT_151	[p12l1344t269r1561b336],
7	in	IN	O	in	_	0	SENT_151	[p12l1595t272r1648b321],
8	Huntington	NNP	LOCATION	Huntington	nn	9	SENT_151	[p12l1680t272r2017b336],
9	disease	NN	O	disease	prep_in	6	SENT_151	[p12l2050t269r2149b322, p12l173t360r305b393],
10	:	:	O	:	_	0	SENT_151	[p12l2050t269r2149b322, p12l173t360r305b393],
11	an	DT	O	a	det	14	SENT_151	[p12l343t360r410b393],
12	open-label	JJ	O	open-label	amod	14	SENT_151	[p12l444t340r742b407],
13	continuation	NN	O	continuation	nn	14	SENT_151	[p12l776t343r1142b393],
14	study	NN	O	study	dep	3	SENT_151	[p12l1177t340r1344b407],
15	.	.	O	.	_	0	SENT_151	[p12l1177t340r1344b407],

1	Huntington	NNP	ORGANIZATION	Huntington	nn	3	SENT_152	[p12l1381t343r1717b407],
2	Study	NNP	ORGANIZATION	Study	nn	3	SENT_152	[p12l1751t340r1911b407],
3	Group	NNP	ORGANIZATION	Group	_	0	SENT_152	[p12l1947t343r2152b407],
4	/	:	O	/	punct	3	SENT_152	[p12l1947t343r2152b407],
5	TETRA-HD	NNP	O	TETRA-HD	dep	3	SENT_152	[p12l172t413r525b462],
6	Investigators	NNS	O	investigator	dep	5	SENT_152	[p12l553t414r934b478],
7	.	.	O	.	_	0	SENT_152	[p12l553t414r934b478],

1	BMC	NNP	O	BMC	nn	2	SENT_153	[p12l963t414r1116b463],
2	Neurol	NNP	O	Neurol	_	0	SENT_153	[p12l1142t410r1343b463],
3	2009	CD	DATE	2009	num	2	SENT_153	[p12l1369t414r1679b475],
4	;	:	O	;	_	0	SENT_153	[p12l1369t414r1679b475],
5	9:62	CD	NUMBER	9:62	dep	2	SENT_153	[p12l1369t414r1679b475],
6	.	.	O	.	_	0	SENT_153	[p12l1369t414r1679b475],

1	Huntington	NNP	O	Huntington	nn	3	SENT_154	[p12l173t498r508b561],
2	Study	NNP	O	Study	nn	3	SENT_154	[p12l544t494r704b561],
3	Group	NNP	O	Group	_	0	SENT_154	[p12l739t497r939b561],
4	.	.	O	.	_	0	SENT_154	[p12l739t497r939b561],

1	Tetrabenazine	NN	O	tetrabenazine	_	0	SENT_155	[p12l976t494r1383b547],
2	as	IN	O	as	_	0	SENT_155	[p12l1420t515r1475b547],
3	antichorea	NN	O	antichorea	nn	4	SENT_155	[p12l1510t494r1812b547],
4	therapy	NN	O	therapy	prep_as	1	SENT_155	[p12l1846t494r2064b561],
5	in	IN	O	in	_	0	SENT_155	[p12l2097t498r2150b546],
6	Huntington	NNP	LOCATION	Huntington	nn	7	SENT_155	[p12l173t568r508b632],
7	disease	NN	O	disease	prep_in	4	SENT_155	[p12l563t565r776b618],
8	:	:	O	:	_	0	SENT_155	[p12l563t565r776b618],
9	a	DT	O	a	dep	1	SENT_155	[p12l834t585r863b618],
10	randomized	VBN	O	randomize	partmod	9	SENT_155	[p12l917t565r1256b618],
11	controlled	JJ	O	controlled	amod	12	SENT_155	[p12l1310t565r1601b618],
12	trial	NN	O	trial	dobj	10	SENT_155	[p12l1654t565r1787b618],
13	.	.	O	.	_	0	SENT_155	[p12l1654t565r1787b618],

1	Neurology	NNP	O	Neurology	_	0	SENT_156	[p12l1843t565r2151b632],
2	2006	CD	DATE	2006	num	1	SENT_156	[p12l172t640r702b699],
3	;	:	O	;	_	0	SENT_156	[p12l172t640r702b699],
4	66:366	CD	NUMBER	66:366	number	5	SENT_156	[p12l172t640r702b699],
5	-372	CD	NUMBER	-372	dep	1	SENT_156	[p12l172t640r702b699],
6	.	.	O	.	_	0	SENT_156	[p12l172t640r702b699],

1	Jankovic	NNP	PERSON	Jankovic	nn	2	SENT_157	[p12l169t706r422b773],
2	J.	NNP	O	J.	_	0	SENT_157	[p12l448t710r490b773],
3	Treatment	NN	O	treatment	dep	2	SENT_157	[p12l522t709r822b759],
4	of	IN	O	of	_	0	SENT_157	[p12l853t706r911b759],
5	hyperkinetic	JJ	O	hyperkinetic	amod	7	SENT_157	[p12l937t706r1291b774],
6	movement	NN	O	movement	nn	7	SENT_157	[p12l1321t721r1621b759],
7	disorders	NNS	O	disorder	prep_of	3	SENT_157	[p12l1651t707r1926b759],
8	.	.	O	.	_	0	SENT_157	[p12l1651t707r1926b759],

1	Lancet	NNP	O	Lancet	nn	2	SENT_158	[p12l1960t710r2151b759],
2	Neurol	NNP	O	Neurol	_	0	SENT_158	[p12l172t777r373b829],
3	2009	CD	DATE	2009	num	2	SENT_158	[p12l400t781r892b841],
4	;	:	O	;	_	0	SENT_158	[p12l400t781r892b841],
5	8:844	CD	NUMBER	8:844	number	6	SENT_158	[p12l400t781r892b841],
6	-856	CD	NUMBER	-856	dep	2	SENT_158	[p12l400t781r892b841],
7	.	.	O	.	_	0	SENT_158	[p12l400t781r892b841],

1	Kenney	NNP	PERSON	Kenney	nn	2	SENT_159	[p12l172t892r386b955],
2	C	NNP	O	C	_	0	SENT_159	[p12l454t891r514b952],
3	,	,	O	,	_	0	SENT_159	[p12l454t891r514b952],
4	Jankovic	NNP	PERSON	Jankovic	nn	6	SENT_159	[p12l578t888r831b954],
5	J.	NNP	PERSON	J.	nn	6	SENT_159	[p12l895t892r937b954],
6	Tetrabenazine	NNP	PERSON	Tetrabenazine	appos	2	SENT_159	[p12l1005t888r1412b940],
7	in	IN	O	in	_	0	SENT_159	[p12l1480t891r1533b940],
8	the	DT	O	the	det	9	SENT_159	[p12l1598t888r1684b940],
9	treatment	NN	O	treatment	prep_in	6	SENT_159	[p12l1750t902r2028b940],
10	of	IN	O	of	_	0	SENT_159	[p12l2095t887r2153b940],
11	hyperkinetic	JJ	O	hyperkinetic	amod	13	SENT_159	[p12l172t958r528b1025],
12	movement	NN	O	movement	nn	13	SENT_159	[p12l565t973r865b1011],
13	disorders	NNS	O	disorder	prep_of	9	SENT_159	[p12l903t958r1178b1011],
14	.	.	O	.	_	0	SENT_159	[p12l903t958r1178b1011],

1	Expert	NN	O	expert	nn	2	SENT_160	[p12l1220t962r1410b1025],
2	Rev	NN	O	rev	_	0	SENT_160	[p12l1448t962r1557b1011],
3	Neurother	NNP	O	Neurother	dep	2	SENT_160	[p12l1593t958r1892b1011],
4	2006	CD	DATE	2006	num	3	SENT_160	[p12l1930t962r2147b1023],
5	;	:	O	;	_	0	SENT_160	[p12l1930t962r2147b1023],
6	6	CD	NUMBER	6	num	8	SENT_160	[p12l1930t962r2147b1023],
7	:	:	O	:	_	0	SENT_160	[p12l1930t962r2147b1023],
8	7-17	CD	NUMBER	7-17	dep	2	SENT_160	[p12l175t1033r330b1081],
9	.	.	O	.	_	0	SENT_160	[p12l175t1033r330b1081],

1	Jain	NNP	PERSON	Jain	nn	2	SENT_161	[p12l169t1142r285b1204],
2	S	NNP	O	S	_	0	SENT_161	[p12l322t1141r369b1203],
3	,	,	O	,	_	0	SENT_161	[p12l322t1141r369b1203],
4	Greene	NNP	PERSON	Greene	nn	5	SENT_161	[p12l409t1141r608b1191],
5	PE	NNP	O	PE	appos	2	SENT_161	[p12l646t1142r738b1203],
6	,	,	O	,	_	0	SENT_161	[p12l646t1142r738b1203],
7	Frucht	NNP	PERSON	Frucht	nn	8	SENT_161	[p12l777t1138r963b1191],
8	SJ	NNP	O	SJ	appos	5	SENT_161	[p12l1000t1141r1070b1204],
9	.	.	O	.	_	0	SENT_161	[p12l1000t1141r1070b1204],

1	Tetrabenazine	NN	O	tetrabenazine	nn	2	SENT_162	[p12l1110t1138r1516b1191],
2	therapy	NN	O	therapy	_	0	SENT_162	[p12l1554t1138r1771b1205],
3	of	IN	O	of	_	0	SENT_162	[p12l1808t1138r1866b1191],
4	pediatric	JJ	O	pediatric	amod	7	SENT_162	[p12l1899t1138r2150b1205],
5	hyperkinetic	JJ	O	hyperkinetic	amod	7	SENT_162	[p12l172t1209r528b1276],
6	movement	NN	O	movement	nn	7	SENT_162	[p12l619t1224r919b1262],
7	disorders	NNS	O	disorder	prep_of	2	SENT_162	[p12l1011t1209r1286b1262],
8	.	.	O	.	_	0	SENT_162	[p12l1011t1209r1286b1262],

1	Mov	NNP	O	Mov	nn	2	SENT_163	[p12l1381t1213r1516b1262],
2	Disord	NNP	O	Disord	_	0	SENT_163	[p12l1607t1209r1801b1262],
3	2006	CD	DATE	2006	num	2	SENT_163	[p12l1892t1213r2147b1274],
4	;	:	O	;	_	0	SENT_163	[p12l1892t1213r2147b1274],
5	21	CD	NUMBER	21	num	7	SENT_163	[p12l1892t1213r2147b1274],
6	:	:	O	:	_	0	SENT_163	[p12l1892t1213r2147b1274],
7	1966-1972	CD	DATE	1966-1972	dep	2	SENT_163	[p12l177t1284r515b1332],
8	.	.	O	.	_	0	SENT_163	[p12l177t1284r515b1332],

1	Fasano	NNP	PERSON	Fasano	nn	2	SENT_164	[p12l173t1393r373b1442],
2	A	NNP	O	A	_	0	SENT_164	[p12l407t1392r470b1454],
3	,	,	O	,	_	0	SENT_164	[p12l407t1392r470b1454],
4	Bentivoglio	NNP	PERSON	Bentivoglio	nn	5	SENT_164	[p12l507t1389r831b1457],
5	AR	NNS	O	ar	appos	2	SENT_164	[p12l865t1392r975b1442],
6	.	.	O	.	_	0	SENT_164	[p12l865t1392r975b1442],

1	Tetrabenazine	NN	O	tetrabenazine	_	0	SENT_165	[p12l1012t1389r1435b1442],
2	.	.	O	.	_	0	SENT_165	[p12l1012t1389r1435b1442],

1	Expert	NN	O	expert	nn	3	SENT_166	[p12l1473t1393r1664b1457],
2	Opin	NNP	O	Opin	nn	3	SENT_166	[p12l1700t1393r1844b1457],
3	Pharmacother	NNP	O	Pharmacother	_	0	SENT_166	[p12l1878t1390r2149b1442, p12l173t1460r322b1512],
4	2009	CD	DATE	2009	num	3	SENT_166	[p12l347t1464r951b1524],
5	;	:	O	;	_	0	SENT_166	[p12l347t1464r951b1524],
6	10:2883	CD	NUMBER	10:2883	number	7	SENT_166	[p12l347t1464r951b1524],
7	—	CD	NUMBER	—	dep	3	SENT_166	[p12l347t1464r951b1524],
8	2896	CD	DATE	2896	dep	7	SENT_166	[p12l347t1464r951b1524],
9	.	.	O	.	_	0	SENT_166	[p12l347t1464r951b1524],

1	Jankovic	JJ	PERSON	jankovic	amod	2	SENT_167	[p12l169t1570r422b1637],
2	J	NN	PERSON	j	_	0	SENT_167	[p12l453t1574r496b1637],
3	,	,	O	,	_	0	SENT_167	[p12l453t1574r496b1637],
4	Clarence-Smith	NNP	PERSON	Clarence-Smith	nn	6	SENT_167	[p12l534t1570r973b1623],
5	K.	NNP	PERSON	K.	nn	6	SENT_167	[p12l1007t1574r1068b1623],
6	Tetrabenazine	NNP	PERSON	Tetrabenazine	appos	2	SENT_167	[p12l1104t1570r1511b1623],
7	for	IN	O	for	_	0	SENT_167	[p12l1547t1570r1629b1623],
8	the	DT	O	the	det	9	SENT_167	[p12l1662t1571r1748b1623],
9	treatment	NN	O	treatment	prep_for	6	SENT_167	[p12l1783t1585r2060b1623],
10	of	IN	O	of	_	0	SENT_167	[p12l2095t1570r2153b1623],
11	chorea	NN	O	chorea	prep_of	9	SENT_167	[p12l172t1641r362b1694],
12	and	CC	O	and	_	0	SENT_167	[p12l407t1641r512b1694],
13	other	JJ	O	other	amod	16	SENT_167	[p12l554t1641r703b1694],
14	hyperkinetic	JJ	O	hyperkinetic	amod	16	SENT_167	[p12l746t1641r1100b1708],
15	movement	NN	O	movement	nn	16	SENT_167	[p12l1144t1656r1443b1694],
16	disorders	NNS	O	disorder	prep_of	9	SENT_167	[p12l1487t1641r1761b1694],
17	.	.	O	.	_	0	SENT_167	[p12l1487t1641r1761b1694],

1	Expert	NN	O	expert	nn	2	SENT_168	[p12l1808t1645r1999b1708],
2	Rev	NN	O	rev	_	0	SENT_168	[p12l2042t1645r2151b1694],
3	Neurother	NNP	O	Neurother	dep	2	SENT_168	[p12l172t1712r472b1764],
4	2011	CD	DATE	2011	num	3	SENT_168	[p12l496t1716r1100b1776],
5	;	:	O	;	_	0	SENT_168	[p12l496t1716r1100b1776],
6	11:1509	CD	NUMBER	11:1509	number	7	SENT_168	[p12l496t1716r1100b1776],
7	—	CD	NUMBER	—	dep	2	SENT_168	[p12l496t1716r1100b1776],
8	1523	CD	DATE	1523	dep	7	SENT_168	[p12l496t1716r1100b1776],
9	.	.	O	.	_	0	SENT_168	[p12l496t1716r1100b1776],

1	Chan	NNP	MISC	Chan	nn	2	SENT_169	[p12l175t1823r326b1875],
2	A	NNP	MISC	A	_	0	SENT_169	[p12l369t1825r432b1887],
3	,	,	O	,	_	0	SENT_169	[p12l369t1825r432b1887],
4	Pirmohamed	NNP	O	Pirmohamed	nn	5	SENT_169	[p12l478t1823r844b1875],
5	M	NNP	O	M	appos	2	SENT_169	[p12l888t1827r969b1887],
6	,	,	O	,	_	0	SENT_169	[p12l888t1827r969b1887],
7	Comabella	NNP	O	Comabella	nn	9	SENT_169	[p12l1018t1823r1324b1875],
8	M.	NNP	O	M.	nn	9	SENT_169	[p12l1370t1827r1449b1875],
9	Pharmacogenomics	NNP	O	Pharmacogenomics	appos	2	SENT_169	[p12l1497t1823r2051b1890],
10	in	IN	O	in	_	0	SENT_169	[p12l2097t1826r2150b1875],
11	Neurology	NNP	O	Neurology	prep_in	9	SENT_169	[p12l172t1893r495b1960],
12	:	:	O	:	_	0	SENT_169	[p12l172t1893r495b1960],
13	Current	JJ	DATE	current	amod	14	SENT_169	[p12l535t1896r757b1946],
14	state	NN	O	state	dep	2	SENT_169	[p12l794t1908r923b1946],
15	and	CC	O	and	_	0	SENT_169	[p12l961t1893r1065b1946],
16	future	JJ	DATE	future	amod	17	SENT_169	[p12l1101t1893r1271b1946],
17	steps	NNS	O	step	conj_and	14	SENT_169	[p12l1309t1908r1461b1960],
18	.	.	O	.	_	0	SENT_169	[p12l1309t1908r1461b1960],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_170	[p12l1500t1895r1620b1945],
2	Neurol	NNP	PERSON	Neurol	_	0	SENT_170	[p12l1655t1893r1857b1946],
3	2011	CD	DATE	2011	num	2	SENT_170	[p12l1892t1897r2147b1958],
4	;	:	O	;	_	0	SENT_170	[p12l1892t1897r2147b1958],
5	70	CD	NUMBER	70	num	7	SENT_170	[p12l1892t1897r2147b1958],
6	:	:	O	:	_	0	SENT_170	[p12l1892t1897r2147b1958],
7	684-697	CD	NUMBER	684-697	dep	2	SENT_170	[p12l175t1967r441b2016],
8	.	.	O	.	_	0	SENT_170	[p12l175t1967r441b2016],

1	Bertz	NNP	PERSON	Bertz	nn	2	SENT_171	[p12l173t2077r319b2125],
2	R.	NNP	PERSON	R.	_	0	SENT_171	[p12l352t2077r432b2137],
3	,	,	O	,	_	0	SENT_171	[p12l352t2077r432b2137],
4	Granneman	NNP	PERSON	Granneman	nn	6	SENT_171	[p12l469t2077r807b2126],
5	G.	NNP	PERSON	G.	nn	6	SENT_171	[p12l841t2077r904b2126],
6	Use	NNP	PERSON	Use	appos	2	SENT_171	[p12l939t2077r1040b2126],
7	of	IN	O	of	_	0	SENT_171	[p12l1074t2073r1133b2126],
8	in	FW	O	in	nn	9	SENT_171	[p12l1162t2077r1215b2125],
9	vitro	FW	O	vitro	dep	13	SENT_171	[p12l1247t2077r1381b2126],
10	and	CC	O	and	_	0	SENT_171	[p12l1415t2073r1519b2126],
11	in	FW	O	in	dep	13	SENT_171	[p12l1551t2077r1604b2125],
12	vivo	FW	O	vivo	pobj	11	SENT_171	[p12l1636t2077r1756b2126],
13	data	NNS	O	datum	prep_of	6	SENT_171	[p12l1790t2073r1912b2126],
14	to	TO	O	to	aux	15	SENT_171	[p12l1944t2088r2000b2125],
15	estimate	VB	O	estimate	infmod	6	SENT_171	[p12l2034t2077r2149b2125, p12l172t2158r310b2196],
16	the	DT	O	the	det	17	SENT_171	[p12l360t2144r445b2196],
17	likelihood	NN	O	likelihood	dobj	15	SENT_171	[p12l495t2143r782b2196],
18	of	IN	O	of	_	0	SENT_171	[p12l832t2143r891b2196],
19	metabolic	JJ	O	metabolic	amod	21	SENT_171	[p12l936t2143r1216b2196],
20	pharmacokinetic	JJ	O	pharmacokinetic	amod	21	SENT_171	[p12l1264t2143r1746b2211],
21	interactions	NNS	O	interaction	prep_of	17	SENT_171	[p12l1795t2147r2147b2196],
22	.	.	O	.	_	0	SENT_171	[p12l1795t2147r2147b2196],

1	Clin	NNP	O	Clin	nn	2	SENT_172	[p12l175t2214r293b2266],
2	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_172	[p12l318t2214r751b2266],
3	1997	CD	DATE	1997	num	2	SENT_172	[p12l781t2218r1305b2278],
4	;	:	O	;	_	0	SENT_172	[p12l781t2218r1305b2278],
5	32:210	CD	NUMBER	32:210	number	6	SENT_172	[p12l781t2218r1305b2278],
6	-258	CD	NUMBER	-258	dep	2	SENT_172	[p12l781t2218r1305b2278],
7	.	.	O	.	_	0	SENT_172	[p12l781t2218r1305b2278],

1	Evans	NNP	PERSON	Evans	nn	2	SENT_173	[p12l173t2328r340b2377],
2	WE	NNP	O	WE	_	0	SENT_173	[p12l369t2328r493b2389],
3	,	,	O	,	_	0	SENT_173	[p12l369t2328r493b2389],
4	Relling	NNP	O	Relling	nn	5	SENT_173	[p12l526t2324r728b2392],
5	MV	NNP	O	MV	appos	2	SENT_173	[p12l757t2328r885b2377],
6	.	.	O	.	_	0	SENT_173	[p12l757t2328r885b2377],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_174	[p12l918t2325r1490b2392],
2	:	:	O	:	_	0	SENT_174	[p12l918t2325r1490b2392],
3	translating	VBG	O	translate	dep	1	SENT_174	[p12l1522t2325r1829b2392],
4	functional	JJ	O	functional	amod	5	SENT_174	[p12l1859t2324r2150b2377],
5	genomics	NNS	O	genomic	dobj	3	SENT_174	[p12l172t2398r438b2462],
6	into	IN	O	into	_	0	SENT_174	[p12l464t2398r575b2448],
7	rational	JJ	O	rational	amod	8	SENT_174	[p12l602t2395r825b2448],
8	therapeutics	NNS	O	therapeutics	prep_into	3	SENT_174	[p12l851t2395r1214b2462],
9	.	.	O	.	_	0	SENT_174	[p12l851t2395r1214b2462],

1	Science	NNP	O	Science	_	0	SENT_175	[p12l1244t2398r1448b2448],
2	1996	CD	DATE	1996	num	1	SENT_175	[p12l1480t2399r2041b2460],
3	;	:	O	;	_	0	SENT_175	[p12l1480t2399r2041b2460],
4	286:487	CD	NUMBER	286:487	num	5	SENT_175	[p12l1480t2399r2041b2460],
5	—	NN	O	—	dep	1	SENT_175	[p12l1480t2399r2041b2460],
6	491	CD	NUMBER	491	dep	5	SENT_175	[p12l1480t2399r2041b2460],
7	.	.	O	.	_	0	SENT_175	[p12l1480t2399r2041b2460],

1	Ingelman-Sundberg	NNP	O	Ingelman-Sundberg	nn	4	SENT_176	[p12l172t2507r732b2574],
2	M.	NNP	O	M.	nn	4	SENT_176	[p12l788t2511r868b2559],
3	Human	NNP	O	Human	nn	4	SENT_176	[p12l928t2511r1144b2559],
4	drug	NN	O	drug	_	0	SENT_176	[p12l1202t2507r1331b2574],
5	metabolizing	VBG	O	metabolize	partmod	4	SENT_176	[p12l1387t2507r1757b2574],
6	cytochrome	NN	O	cytochrome	nn	8	SENT_176	[p12l1814t2507r2149b2574],
7	P450	NN	O	p450	nn	8	SENT_176	[p12l172t2581r316b2630],
8	enzymes	NNS	O	enzyme	dobj	5	SENT_176	[p12l351t2597r605b2644],
9	:	:	O	:	_	0	SENT_176	[p12l351t2597r605b2644],
10	properties	NNS	O	property	dep	4	SENT_176	[p12l641t2581r928b2644],
11	and	CC	O	and	_	0	SENT_176	[p12l963t2577r1067b2630],
12	polymorphisms	NNS	O	polymorphism	conj_and	10	SENT_176	[p12l1099t2577r1558b2644],
13	.	.	O	.	_	0	SENT_176	[p12l1099t2577r1558b2644],

1	Naunyn	NNP	O	Naunyn	nn	4	SENT_177	[p12l1593t2581r1826b2644],
2	Schmiedebergs	NNP	O	Schmiedebergs	nn	4	SENT_177	[p12l1859t2577r2149b2630, p12l174t2648r321b2715],
3	Arch	NNP	O	Arch	nn	4	SENT_177	[p12l347t2648r486b2701],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_177	[p12l511t2648r817b2701],
5	2004	CD	DATE	2004	num	4	SENT_177	[p12l842t2652r1372b2713],
6	;	:	O	;	_	0	SENT_177	[p12l842t2652r1372b2713],
7	369:89	CD	NUMBER	369:89	num	8	SENT_177	[p12l842t2652r1372b2713],
8	—	NN	O	—	dep	4	SENT_177	[p12l842t2652r1372b2713],
9	104	CD	NUMBER	104	dep	8	SENT_177	[p12l842t2652r1372b2713],
10	.	.	O	.	_	0	SENT_177	[p12l842t2652r1372b2713],

1	Mehvar	JJ	O	mehvar	amod	2	SENT_178	[p12l172t2760r398b2813],
2	R	NN	O	r	_	0	SENT_178	[p12l427t2764r488b2824],
3	,	,	O	,	_	0	SENT_178	[p12l427t2764r488b2824],
4	Jamali	NNP	PERSON	Jamali	nn	9	SENT_178	[p12l516t2760r703b2826],
5	F.	NNP	O	F.	nn	9	SENT_178	[p12l733t2764r782b2813],
6	Concentration	NN	O	concentration	nn	9	SENT_178	[p12l816t2760r1420b2813],
7	—	NN	O	—	nn	9	SENT_178	[p12l816t2760r1420b2813],
8	effect	NN	O	effect	nn	9	SENT_178	[p12l816t2760r1420b2813],
9	relationships	NNS	O	relationship	appos	2	SENT_178	[p12l1449t2760r1814b2827],
10	of	IN	O	of	_	0	SENT_178	[p12l1845t2760r1904b2813],
11	tetrabenazine	NN	O	tetrabenazine	prep_of	9	SENT_178	[p12l1929t2760r2149b2813, p12l172t2834r355b2883],
12	and	CC	O	and	_	0	SENT_178	[p12l390t2830r494b2883],
13	dihydrotetrabenazine	NN	O	dihydrotetrabenazine	conj_and	11	SENT_178	[p12l528t2830r1138b2897],
14	in	IN	O	in	_	0	SENT_178	[p12l1172t2834r1225b2882],
15	the	DT	O	the	det	16	SENT_178	[p12l1256t2830r1342b2883],
16	rat	NN	O	rat	prep_in	9	SENT_178	[p12l1375t2845r1470b2883],
17	.	.	O	.	_	0	SENT_178	[p12l1375t2845r1470b2883],

1	J	NNP	O	J	nn	3	SENT_179	[p12l1502t2834r1529b2897],
2	Pharm	NNP	O	Pharm	nn	3	SENT_179	[p12l1561t2830r1748b2883],
3	Sci	NNP	O	Sci	_	0	SENT_179	[p12l1782t2834r1860b2883],
4	1987,76	CD	NUMBER	1987,76	num	3	SENT_179	[p12l1897t2834r2147b2895],
5	:	:	O	:	_	0	SENT_179	[p12l1897t2834r2147b2895],
6	461-465	CD	NUMBER	461-465	dep	3	SENT_179	[p12l172t2905r441b2953],
7	.	.	O	.	_	0	SENT_179	[p12l172t2905r441b2953],

1	Jankovic	JJ	PERSON	jankovic	amod	7	SENT_180	[p12l169t3010r422b3077],
2	J	NN	PERSON	j	nn	7	SENT_180	[p12l448t3014r491b3077],
3	,	,	O	,	_	0	SENT_180	[p12l448t3014r491b3077],
4	Beach	NNP	O	Beach	dep	7	SENT_180	[p12l522t3011r691b3063],
5	J.	NNP	O	J.	nn	7	SENT_180	[p12l716t3014r758b3077],
6	Long-term	JJ	O	long-term	amod	7	SENT_180	[p12l791t3014r1093b3078],
7	effects	NNS	O	effect	_	0	SENT_180	[p12l1122t3010r1301b3063],
8	of	IN	O	of	_	0	SENT_180	[p12l1332t3010r1390b3063],
9	tetrabenazine	NN	O	tetrabenazine	prep_of	7	SENT_180	[p12l1415t3010r1799b3063],
10	in	IN	O	in	_	0	SENT_180	[p12l1830t3014r1883b3062],
11	hyperkinetic	JJ	O	hyperkinetic	amod	13	SENT_180	[p12l1911t3010r2149b3078, p12l172t3084r307b3134],
12	movement	NN	O	movement	nn	13	SENT_180	[p12l333t3096r633b3134],
13	disorders	NNS	O	disorder	prep_in	7	SENT_180	[p12l659t3081r934b3134],
14	.	.	O	.	_	0	SENT_180	[p12l659t3081r934b3134],

1	Neurology	NNP	O	Neurology	_	0	SENT_181	[p12l962t3081r1270b3148],
2	1997	CD	DATE	1997	num	1	SENT_181	[p12l1299t3085r1624b3146],
3	;	:	O	;	_	0	SENT_181	[p12l1299t3085r1624b3146],
4	48:35	CD	NUMBER	48:35	number	5	SENT_181	[p12l1299t3085r1624b3146],
5	8-362	CD	NUMBER	8-362	dep	1	SENT_181	[p12l1633t3085r1823b3134],
6	.	.	O	.	_	0	SENT_181	[p12l1633t3085r1823b3134],

1	Ingelman-Sundberg	NNP	O	Ingelman-Sundberg	nn	3	SENT_182	[p12l172t3193r732b3260],
2	M.	NNP	O	M.	nn	3	SENT_182	[p12l761t3197r841b3246],
3	Pharmacogenetics	NNP	O	Pharmacogenetics	_	0	SENT_182	[p12l874t3193r1389b3260],
4	of	IN	O	of	_	0	SENT_182	[p12l1420t3193r1479b3246],
5	cytochrome	NN	O	cytochrome	nn	6	SENT_182	[p12l1505t3193r1840b3260],
6	P450	NN	O	p450	prep_of	3	SENT_182	[p12l1870t3197r2014b3246],
7	and	CC	O	and	_	0	SENT_182	[p12l2047t3193r2150b3246],
8	its	PRP$	O	its	poss	9	SENT_182	[p12l173t3267r236b3316],
9	applications	NNS	O	application	conj_and	3	SENT_182	[p12l285t3264r630b3331],
10	in	IN	O	in	_	0	SENT_182	[p12l679t3267r732b3316],
11	drug	NN	O	drug	nn	12	SENT_182	[p12l780t3264r909b3331],
12	therapy	NN	O	therapy	prep_in	9	SENT_182	[p12l956t3264r1188b3331],
13	:	:	O	:	_	0	SENT_182	[p12l956t3264r1188b3331],
14	the	DT	DATE	the	det	15	SENT_182	[p12l1238t3264r1324b3316],
15	past	NN	DATE	past	dep	3	SENT_182	[p12l1372t3278r1506b3331],
16	,	,	DATE	,	_	0	SENT_182	[p12l1372t3278r1506b3331],
17	present	JJ	DATE	present	dep	3	SENT_182	[p12l1555t3278r1761b3331],
18	and	CC	O	and	_	0	SENT_182	[p12l1809t3264r1913b3316],
19	future	JJ	DATE	future	dep	3	SENT_182	[p12l1960t3263r2147b3316],
20	.	.	O	.	_	0	SENT_182	[p12l1960t3263r2147b3316],

1	Trends	NNS	O	trend	_	0	SENT_183	[p12l172t3334r369b3386],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_183	[p12l395t3334r702b3386],
3	Sci	NNP	O	Sci	dep	1	SENT_183	[p12l729t3337r806b3386],
4	2004	CD	DATE	2004	num	3	SENT_183	[p12l832t3338r1361b3398],
5	;	:	O	;	_	0	SENT_183	[p12l832t3338r1361b3398],
6	25:193	CD	NUMBER	25:193	num	7	SENT_183	[p12l832t3338r1361b3398],
7	-200	CD	NUMBER	-200	dep	1	SENT_183	[p12l832t3338r1361b3398],
8	.	.	O	.	_	0	SENT_183	[p12l832t3338r1361b3398],

1	Agundez	NNP	O	Agundez	nn	2	SENT_184	[p12l172t3445r423b3512],
2	JA	NNP	O	JA	dep	19	SENT_184	[p12l449t3447r541b3511],
3	,	,	O	,	_	0	SENT_184	[p12l449t3447r541b3511],
4	Martinez	NNP	PERSON	Martinez	nn	5	SENT_184	[p12l572t3449r834b3497],
5	C	NNP	O	C	appos	2	SENT_184	[p12l866t3448r926b3509],
6	,	,	O	,	_	0	SENT_184	[p12l866t3448r926b3509],
7	Ledesma	NNP	PERSON	Ledesma	nn	8	SENT_184	[p12l958t3445r1207b3497],
8	MC	NNP	O	MC	appos	2	SENT_184	[p12l1237t3448r1367b3509],
9	,	,	O	,	_	0	SENT_184	[p12l1237t3448r1367b3509],
10	Ladona	NNP	ORGANIZATION	Ladona	nn	11	SENT_184	[p12l1399t3445r1614b3497],
11	MG	NN	ORGANIZATION	mg	appos	2	SENT_184	[p12l1644t3448r1778b3509],
12	,	,	O	,	_	0	SENT_184	[p12l1644t3448r1778b3509],
13	Ladero	NNP	PERSON	Ladero	nn	14	SENT_184	[p12l1810t3445r2011b3497],
14	JM	NN	O	jm	appos	2	SENT_184	[p12l2038t3449r2148b3511],
15	,	,	O	,	_	0	SENT_184	[p12l2038t3449r2148b3511],
16	Benitez	NNP	PERSON	Benitez	nn	18	SENT_184	[p12l173t3519r379b3568],
17	J.	NNP	O	J.	nn	18	SENT_184	[p12l417t3519r459b3581],
18	Genetic	NNP	O	Genetic	appos	2	SENT_184	[p12l505t3518r721b3568],
19	basis	NN	O	basis	_	0	SENT_184	[p12l763t3515r899b3568],
20	for	IN	O	for	_	0	SENT_184	[p12l941t3515r1024b3568],
21	differences	NNS	O	difference	prep_for	19	SENT_184	[p12l1065t3515r1370b3568],
22	in	IN	O	in	_	0	SENT_184	[p12l1412t3519r1465b3567],
23	debrisoquin	NN	O	debrisoquin	nn	24	SENT_184	[p12l1507t3515r1845b3582],
24	polymorphism	NN	O	polymorphism	prep_in	21	SENT_184	[p12l1884t3515r2149b3582, p12l172t3586r344b3653],
25	between	IN	O	between	_	0	SENT_184	[p12l373t3586r608b3639],
26	Spanish	JJ	LOCATION	spanish	amod	30	SENT_184	[p12l636t3586r855b3653],
27	and	CC	O	and	_	0	SENT_184	[p12l883t3586r987b3639],
28	other	JJ	O	other	conj_and	26	SENT_184	[p12l1015t3586r1164b3639],
29	white	JJ	O	white	amod	30	SENT_184	[p12l1190t3586r1347b3639],
30	populations	NNS	O	population	prep_between	24	SENT_184	[p12l1375t3586r1730b3653],
31	.	.	O	.	_	0	SENT_184	[p12l1375t3586r1730b3653],

1	Clin	NNP	O	Clin	nn	3	SENT_185	[p12l1763t3586r1881b3639],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_185	[p12l1907t3586r2149b3639, p12l172t3672r255b3724],
3	Ther	NNP	O	Ther	_	0	SENT_185	[p12l281t3672r416b3724],
4	1994	CD	DATE	1994	num	3	SENT_185	[p12l446t3676r970b3736],
5	;	:	O	;	_	0	SENT_185	[p12l446t3676r970b3736],
6	55:412	CD	NUMBER	55:412	number	7	SENT_185	[p12l446t3676r970b3736],
7	-417	CD	NUMBER	-417	dep	3	SENT_185	[p12l446t3676r970b3736],
8	.	.	O	.	_	0	SENT_185	[p12l446t3676r970b3736],

1	Aklillu	NNP	PERSON	Aklillu	nn	2	SENT_186	[p13l172t30r368b83],
2	E	NNP	PERSON	E	_	0	SENT_186	[p13l398t34r452b95],
3	,	,	O	,	_	0	SENT_186	[p13l398t34r452b95],
4	Persson	NNP	PERSON	Persson	nn	5	SENT_186	[p13l484t34r700b83],
5	I	NNP	O	I	appos	2	SENT_186	[p13l730t34r766b95],
6	,	,	O	,	_	0	SENT_186	[p13l730t34r766b95],
7	Bertilsson	NNP	PERSON	Bertilsson	nn	8	SENT_186	[p13l798t30r1078b83],
8	L	NNP	PERSON	L	appos	2	SENT_186	[p13l1108t35r1163b95],
9	,	,	O	,	_	0	SENT_186	[p13l1108t35r1163b95],
10	Johansson	NNP	PERSON	Johansson	nn	11	SENT_186	[p13l1191t30r1488b97],
11	I	NNP	O	I	appos	2	SENT_186	[p13l1517t34r1554b95],
12	,	,	O	,	_	0	SENT_186	[p13l1517t34r1554b95],
13	Rodrigues	NNP	PERSON	Rodrigues	nn	14	SENT_186	[p13l1586t30r1876b98],
14	F	NN	O	f	appos	2	SENT_186	[p13l1906t34r1957b95],
15	,	,	O	,	_	0	SENT_186	[p13l1906t34r1957b95],
16	Ingelman-Sundberg	NNP	O	Ingelman-Sundberg	nn	19	SENT_186	[p13l1989t30r2149b98, p13l172t101r590b168],
17	M.	NNP	O	M.	nn	19	SENT_186	[p13l620t105r700b154],
18	Frequent	JJ	O	frequent	amod	19	SENT_186	[p13l734t105r987b168],
19	distribution	NN	O	distribution	appos	2	SENT_186	[p13l1018t101r1353b154],
20	of	IN	O	of	_	0	SENT_186	[p13l1384t101r1443b154],
21	ultrarapid	JJ	O	ultrarapid	amod	22	SENT_186	[p13l1470t101r1757b168],
22	metabolizers	NNS	O	metabolizer	prep_of	19	SENT_186	[p13l1787t101r2149b154],
23	of	IN	O	of	_	0	SENT_186	[p13l173t172r232b224],
24	debrisoquine	NN	O	debrisoquine	prep_of	22	SENT_186	[p13l273t172r640b239],
25	in	IN	O	in	_	0	SENT_186	[p13l685t175r738b224],
26	an	DT	O	a	det	28	SENT_186	[p13l782t192r849b224],
27	Ethiopian	JJ	MISC	ethiopian	amod	28	SENT_186	[p13l893t172r1172b239],
28	population	NN	O	population	prep_in	2	SENT_186	[p13l1215t172r1529b239],
29	carrying	VBG	O	carry	partmod	2	SENT_186	[p13l1572t175r1808b239],
30	duplicated	JJ	O	duplicated	dep	33	SENT_186	[p13l1852t172r2151b239],
31	and	CC	O	and	_	0	SENT_186	[p13l173t243r278b296],
32	multiduplicated	JJ	O	multiduplicated	conj_and	33	SENT_186	[p13l311t243r763b310],
33	functional	JJ	O	functional	amod	35	SENT_186	[p13l798t243r1088b296],
34	CYP2D6	NN	O	cyp2d6	nn	35	SENT_186	[p13l1126t246r1379b296],
35	alleles	NNS	O	allele	dobj	29	SENT_186	[p13l1416t243r1603b296],
36	.	.	O	.	_	0	SENT_186	[p13l1416t243r1603b296],

1	J	NNP	O	J	nn	4	SENT_187	[p13l1637t247r1664b309],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_187	[p13l1698t243r2003b296],
3	Exp	NNP	O	Exp	nn	4	SENT_187	[p13l2038t247r2149b310],
4	Ther	NNP	O	Ther	_	0	SENT_187	[p13l172t315r308b367],
5	1996	CD	DATE	1996	num	4	SENT_187	[p13l337t318r899b378],
6	;	:	O	;	_	0	SENT_187	[p13l337t318r899b378],
7	278:441	CD	NUMBER	278:441	num	8	SENT_187	[p13l337t318r899b378],
8	—	NN	O	—	dep	4	SENT_187	[p13l337t318r899b378],
9	446	CD	NUMBER	446	dep	8	SENT_187	[p13l337t318r899b378],
10	.	.	O	.	_	0	SENT_187	[p13l337t318r899b378],

1	Ingelman-Sundberg	NNP	O	Ingelman-Sundberg	nn	2	SENT_188	[p13l172t426r732b493],
2	M	NNP	O	M	_	0	SENT_188	[p13l770t430r851b490],
3	,	,	O	,	_	0	SENT_188	[p13l770t430r851b490],
4	Oscarson	NNP	O	Oscarson	nn	5	SENT_188	[p13l895t429r1160b479],
5	M	NNP	O	M	appos	2	SENT_188	[p13l1199t430r1281b490],
6	,	,	O	,	_	0	SENT_188	[p13l1199t430r1281b490],
7	McLellan	NNP	PERSON	McLellan	nn	8	SENT_188	[p13l1321t426r1595b479],
8	RA	NN	O	ra	appos	5	SENT_188	[p13l1634t428r1742b479],
9	.	.	O	.	_	0	SENT_188	[p13l1634t428r1742b479],

1	Polymorphic	JJ	MISC	polymorphic	amod	5	SENT_189	[p13l1784t426r2150b493],
2	human	JJ	O	human	amod	5	SENT_189	[p13l172t497r370b549],
3	cytochrome	NN	O	cytochrome	nn	5	SENT_189	[p13l404t496r739b564],
4	P450	NN	O	p450	nn	5	SENT_189	[p13l774t500r918b549],
5	enzymes	NNS	O	enzyme	_	0	SENT_189	[p13l954t516r1208b564],
6	:	:	O	:	_	0	SENT_189	[p13l954t516r1208b564],
7	an	DT	O	a	det	8	SENT_189	[p13l1247t517r1314b549],
8	opportunity	NN	O	opportunity	dep	5	SENT_189	[p13l1348t500r1690b564],
9	for	IN	O	for	_	0	SENT_189	[p13l1724t496r1806b549],
10	individualized	VBN	O	individualize	prepc_for	8	SENT_189	[p13l1840t496r2149b549, p13l173t567r286b620],
11	drug	NN	O	drug	nn	12	SENT_189	[p13l312t567r442b634],
12	treatment	NN	O	treatment	dobj	10	SENT_189	[p13l467t582r759b620],
13	.	.	O	.	_	0	SENT_189	[p13l467t582r759b620],

1	Trends	NNS	O	trend	_	0	SENT_190	[p13l787t567r985b620],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_190	[p13l1012t567r1317b620],
3	Sci	NNP	O	Sci	dep	1	SENT_190	[p13l1344t570r1421b620],
4	1999	CD	DATE	1999	num	3	SENT_190	[p13l1452t571r1977b632],
5	;	:	O	;	_	0	SENT_190	[p13l1452t571r1977b632],
6	20:342	CD	NUMBER	20:342	num	7	SENT_190	[p13l1452t571r1977b632],
7	-349	CD	NUMBER	-349	dep	1	SENT_190	[p13l1452t571r1977b632],
8	.	.	O	.	_	0	SENT_190	[p13l1452t571r1977b632],

1	Xenazine	NNP	O	Xenazine	_	0	SENT_191	[p13l172t678r692b746],
2	,	,	O	,	_	0	SENT_191	[p13l172t678r692b746],
3	package	NN	O	package	nn	4	SENT_191	[p13l172t678r692b746],
4	insert	NN	O	insert	appos	1	SENT_191	[p13l719t682r892b743],
5	,	,	O	,	_	0	SENT_191	[p13l719t682r892b743],
6	Lundbeck	NNP	PERSON	Lundbeck	appos	1	SENT_191	[p13l920t678r1220b743],
7	,	,	O	,	_	0	SENT_191	[p13l920t678r1220b743],
8	Deerﬁeld	NNP	O	Deerﬁeld	appos	1	SENT_191	[p13l1248t678r1523b743],
9	,	,	O	,	_	0	SENT_191	[p13l1248t678r1523b743],
10	IL	NN	O	il	appos	1	SENT_191	[p13l1551t682r1627b731],
11	.	.	O	.	_	0	SENT_191	[p13l1551t682r1627b731],

1	Weinshilboum	NNP	PERSON	Weinshilboum	_	0	SENT_192	[p13l171t790r590b843],
2	R.	NNP	PERSON	R.	nn	3	SENT_192	[p13l620t794r680b843],
3	Inheritance	NNP	PERSON	Inheritance	dep	1	SENT_192	[p13l712t790r1032b843],
4	and	CC	O	and	_	0	SENT_192	[p13l1063t790r1167b843],
5	drug	NN	O	drug	nn	6	SENT_192	[p13l1196t790r1326b857],
6	response	NN	O	response	dep	1	SENT_192	[p13l1354t810r1615b857],
7	.	.	O	.	_	0	SENT_192	[p13l1354t810r1615b857],

1	New	NNP	O	New	nn	3	SENT_193	[p13l1646t794r1784b843],
2	Engl	NNP	O	Engl	nn	3	SENT_193	[p13l1811t790r1938b857],
3	J	NNP	O	J	nsubj	4	SENT_193	[p13l1964t794r1991b856],
4	Med	VBD	O	med	_	0	SENT_193	[p13l2019t790r2151b843],
5	2003	CD	DATE	2003	dobj	4	SENT_193	[p13l172t866r738b926],
6	;	:	O	;	_	0	SENT_193	[p13l172t866r738b926],
7	348:529	CD	NUMBER	348:529	num	8	SENT_193	[p13l172t866r738b926],
8	—	NN	O	—	dep	5	SENT_193	[p13l172t866r738b926],
9	537	CD	NUMBER	537	dep	8	SENT_193	[p13l172t866r738b926],
10	.	.	O	.	_	0	SENT_193	[p13l172t866r738b926],

1	Kirchheiner	NNP	O	Kirchheiner	nn	5	SENT_194	[p13l172t973r510b1025],
2	J.	NNP	O	J.	nn	5	SENT_194	[p13l561t977r603b1039],
3	CYP2D6	NNP	O	CYP2D6	nn	5	SENT_194	[p13l665t976r919b1025],
4	phenotype	NN	O	phenotype	nn	5	SENT_194	[p13l976t973r1273b1040],
5	prediction	NN	O	prediction	_	0	SENT_194	[p13l1331t973r1623b1040],
6	from	IN	O	from	_	0	SENT_194	[p13l1679t972r1817b1025],
7	genotype	NN	O	genotype	prep_from	5	SENT_194	[p13l1874t987r2147b1040],
8	:	:	O	:	_	0	SENT_194	[p13l1874t987r2147b1040],
9	which	WDT	O	which	det	10	SENT_194	[p13l172t1043r345b1096],
10	system	NN	O	system	nsubj	13	SENT_194	[p13l372t1058r561b1110],
11	is	VBZ	O	be	cop	13	SENT_194	[p13l587t1047r628b1096],
12	the	DT	O	the	det	13	SENT_194	[p13l653t1043r739b1096],
13	best	JJS	O	best	rcmod	5	SENT_194	[p13l767t1043r904b1096],
14	?	.	O	?	_	0	SENT_194	[p13l767t1043r904b1096],

1	Clin	NNP	O	Clin	nn	3	SENT_195	[p13l936t1043r1054b1096],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_195	[p13l1079t1043r1385b1096],
3	Ther	NNP	O	Ther	_	0	SENT_195	[p13l1410t1043r1546b1096],
4	2008	CD	DATE	2008	num	3	SENT_195	[p13l1570t1047r2100b1108],
5	;	:	O	;	_	0	SENT_195	[p13l1570t1047r2100b1108],
6	83:225	CD	NUMBER	83:225	number	7	SENT_195	[p13l1570t1047r2100b1108],
7	-227	CD	NUMBER	-227	dep	3	SENT_195	[p13l1570t1047r2100b1108],
8	.	.	O	.	_	0	SENT_195	[p13l1570t1047r2100b1108],

1	Wang	NNP	PERSON	Wang	nn	2	SENT_196	[p13l171t1159r341b1222],
2	L	NNP	PERSON	L	_	0	SENT_196	[p13l383t1159r438b1219],
3	,	,	O	,	_	0	SENT_196	[p13l383t1159r438b1219],
4	McLeod	NNP	PERSON	McLeod	nn	5	SENT_196	[p13l480t1155r720b1207],
5	HL	NNS	O	hl	appos	2	SENT_196	[p13l762t1159r873b1219],
6	,	,	O	,	_	0	SENT_196	[p13l762t1159r873b1219],
7	Weinshilboum	NNP	O	Weinshilboum	nn	8	SENT_196	[p13l914t1155r1334b1207],
8	RM	NN	O	rm	appos	5	SENT_196	[p13l1376t1159r1503b1207],
9	.	.	O	.	_	0	SENT_196	[p13l1376t1159r1503b1207],

1	Genomics	NNS	O	genomic	_	0	SENT_197	[p13l1550t1158r1831b1207],
2	and	CC	O	and	_	0	SENT_197	[p13l1875t1155r1978b1207],
3	drug	NN	O	drug	conj_and	1	SENT_197	[p13l2021t1155r2150b1222],
4	response	NN	O	response	dep	1	SENT_197	[p13l172t1245r434b1292],
5	.	.	O	.	_	0	SENT_197	[p13l172t1245r434b1292],

1	N	NN	O	n	nn	3	SENT_198	[p13l462t1229r517b1278],
2	Engl	NNP	O	Engl	nn	3	SENT_198	[p13l541t1225r668b1292],
3	J	NNP	O	J	nsubj	4	SENT_198	[p13l691t1229r718b1291],
4	Med	VBD	O	med	_	0	SENT_198	[p13l742t1225r874b1278],
5	2011	CD	DATE	2011	dobj	4	SENT_198	[p13l899t1229r1539b1290],
6	;	:	O	;	_	0	SENT_198	[p13l899t1229r1539b1290],
7	364:1144	CD	DURATION	364:1144	num	8	SENT_198	[p13l899t1229r1539b1290],
8	-1153	CD	DURATION	-1153	dep	5	SENT_198	[p13l899t1229r1539b1290],
9	.	.	O	.	_	0	SENT_198	[p13l899t1229r1539b1290],

1	Singh	NNP	PERSON	Singh	nn	2	SENT_199	[p13l174t1337r330b1404],
2	MS	NN	O	m	_	0	SENT_199	[p13l363t1340r478b1402],
3	,	,	O	,	_	0	SENT_199	[p13l363t1340r478b1402],
4	Francis	NNP	PERSON	Francis	nn	5	SENT_199	[p13l514t1341r718b1390],
5	PA	NN	PERSON	pa	appos	2	SENT_199	[p13l752t1340r851b1402],
6	,	,	O	,	_	0	SENT_199	[p13l752t1340r851b1402],
7	Michael	NNP	PERSON	Michael	nn	9	SENT_199	[p13l886t1337r1118b1390],
8	M.	NNP	PERSON	M.	nn	9	SENT_199	[p13l1152t1341r1233b1390],
9	Tamoxifen	NN	PERSON	tamoxifen	appos	2	SENT_199	[p13l1268t1337r1600b1402],
10	,	,	O	,	_	0	SENT_199	[p13l1268t1337r1600b1402],
11	cytochrome	NN	O	cytochrome	nn	13	SENT_199	[p13l1635t1337r1971b1404],
12	P450	NN	O	p450	nn	13	SENT_199	[p13l2005t1341r2149b1390],
13	genes	NNS	O	gene	conj_and	5	SENT_199	[p13l172t1428r325b1475],
14	and	CC	O	and	_	0	SENT_199	[p13l390t1408r494b1461],
15	breast	NN	O	breast	nn	18	SENT_199	[p13l557t1408r728b1461],
16	cancer	NN	O	cancer	nn	18	SENT_199	[p13l790t1428r974b1461],
17	clinical	JJ	O	clinical	amod	18	SENT_199	[p13l1035t1408r1239b1461],
18	outcomes	NNS	O	outcome	conj_and	5	SENT_199	[p13l1302t1423r1590b1461],
19	.	.	O	.	_	0	SENT_199	[p13l1302t1423r1590b1461],

1	Breast	NN	O	breast	_	0	SENT_200	[p13l1655t1412r1831b1461],
2	2011,20	CD	NUMBER	2011,20	num	1	SENT_200	[p13l1893t1411r2147b1472],
3	:	:	O	:	_	0	SENT_200	[p13l1893t1411r2147b1472],
4	111-118	CD	NUMBER	111-118	dep	1	SENT_200	[p13l177t1482r441b1530],
5	.	.	O	.	_	0	SENT_200	[p13l177t1482r441b1530],

1	Rae	NNP	PERSON	Rae	nn	2	SENT_201	[p13l173t1593r281b1642],
2	JM	NN	PERSON	jm	_	0	SENT_201	[p13l303t1593r414b1655],
3	,	,	O	,	_	0	SENT_201	[p13l303t1593r414b1655],
4	Sikora	NNP	ORGANIZATION	Sikora	nn	5	SENT_201	[p13l442t1589r623b1642],
5	MJ	NNP	ORGANIZATION	MJ	appos	2	SENT_201	[p13l649t1593r756b1655],
6	,	,	O	,	_	0	SENT_201	[p13l649t1593r756b1655],
7	Henry	NNP	ORGANIZATION	Henry	nn	8	SENT_201	[p13l783t1593r963b1656],
8	NL	NNP	ORGANIZATION	NL	appos	2	SENT_201	[p13l987t1593r1099b1654],
9	,	,	O	,	_	0	SENT_201	[p13l987t1593r1099b1654],
10	et	FW	O	et	nn	11	SENT_201	[p13l1127t1604r1176b1642],
11	al.	FW	O	al.	appos	2	SENT_201	[p13l1202t1589r1265b1642],
12	.	.	O	.	_	0	SENT_201	[p13l1202t1589r1265b1642],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_202	[p13l1296t1589r1647b1656],
2	P45	NN	O	p45	nsubj	6	SENT_202	[p13l1673t1592r1779b1642],
3	o	NN	O	o	nn	5	SENT_202	[p13l1786t1592r1817b1642],
4	2D6	NN	O	2d6	nn	5	SENT_202	[p13l1844t1592r1966b1642],
5	activity	NN	O	activity	dep	2	SENT_202	[p13l1993t1592r2150b1642, p13l173t1663r245b1726],
6	predicts	VBZ	O	predict	_	0	SENT_202	[p13l276t1659r500b1727],
7	discontinuation	NN	O	discontinuation	dobj	6	SENT_202	[p13l535t1659r981b1712],
8	of	IN	O	of	_	0	SENT_202	[p13l1015t1659r1074b1712],
9	tamoxifen	NN	O	tamoxifen	nn	10	SENT_202	[p13l1103t1659r1394b1712],
10	therapy	NN	O	therapy	prep_of	7	SENT_202	[p13l1427t1660r1644b1727],
11	in	IN	O	in	_	0	SENT_202	[p13l1677t1663r1729b1711],
12	breast	NN	O	breast	nn	14	SENT_202	[p13l1763t1660r1934b1712],
13	cancer	NN	O	cancer	nn	14	SENT_202	[p13l1966t1680r2150b1712],
14	patients	NNS	O	patient	prep_in	10	SENT_202	[p13l172t1733r413b1797],
15	.	.	O	.	_	0	SENT_202	[p13l172t1733r413b1797],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_203	[p13l441t1730r997b1797],
2	J	NNP	O	J	dep	1	SENT_203	[p13l1019t1734r1046b1796],
3	2009	CD	DATE	2009	num	2	SENT_203	[p13l1071t1734r1362b1795],
4	;	:	O	;	_	0	SENT_203	[p13l1071t1734r1362b1795],
5	9:25	CD	TIME	9:25	num	6	SENT_203	[p13l1071t1734r1362b1795],
6	8-264	CD	NUMBER	8-264	dep	1	SENT_203	[p13l1371t1734r1563b1783],
7	.	.	O	.	_	0	SENT_203	[p13l1371t1734r1563b1783],

1	Guay	NNP	PERSON	Guay	nn	3	SENT_204	[p13l175t1845r327b1909],
2	DR.	NNP	O	DR.	nn	3	SENT_204	[p13l355t1846r468b1895],
3	Tetrabenazine	NNP	O	Tetrabenazine	_	0	SENT_204	[p13l499t1842r924b1907],
4	,	,	O	,	_	0	SENT_204	[p13l499t1842r924b1907],
5	a	DT	O	a	det	7	SENT_204	[p13l955t1862r984b1895],
6	monoamine-depleting	JJ	O	monoamine-depleting	amod	7	SENT_204	[p13l1013t1842r1640b1909],
7	drug	NN	O	drug	appos	3	SENT_204	[p13l1669t1842r1799b1909],
8	used	VBN	O	use	partmod	7	SENT_204	[p13l1828t1842r1955b1895],
9	in	IN	O	in	_	0	SENT_204	[p13l1983t1845r2036b1894],
10	the	DT	O	the	det	11	SENT_204	[p13l2064t1842r2149b1895],
11	treatment	NN	O	treatment	prep_in	8	SENT_204	[p13l172t1927r450b1965],
12	of	IN	O	of	_	0	SENT_204	[p13l479t1912r538b1965],
13	hyperkinetic	JJ	O	hyperkinetic	amod	15	SENT_204	[p13l562t1913r918b1980],
14	movement	NN	O	movement	nn	15	SENT_204	[p13l946t1927r1246b1965],
15	disorders	NNS	O	disorder	prep_of	11	SENT_204	[p13l1275t1913r1550b1965],
16	.	.	O	.	_	0	SENT_204	[p13l1275t1913r1550b1965],

1	Am	NNP	O	Am	nn	4	SENT_205	[p13l1581t1915r1683b1965],
2	J	NNP	O	J	nn	4	SENT_205	[p13l1707t1917r1734b1979],
3	Geriatr	NNP	O	Geriatr	nn	4	SENT_205	[p13l1764t1916r1970b1965],
4	Pharmacother	NNP	O	Pharmacother	_	0	SENT_205	[p13l1997t1913r2149b1965, p13l172t1983r442b2035],
5	2010	CD	DATE	2010	num	4	SENT_205	[p13l467t1987r959b2047],
6	;	:	O	;	_	0	SENT_205	[p13l467t1987r959b2047],
7	8:331	CD	NUMBER	8:331	num	8	SENT_205	[p13l467t1987r959b2047],
8	—	NN	O	—	dep	4	SENT_205	[p13l467t1987r959b2047],
9	373	CD	NUMBER	373	dep	8	SENT_205	[p13l467t1987r959b2047],
10	.	.	O	.	_	0	SENT_205	[p13l467t1987r959b2047],

1	Teh	NN	O	teh	nn	2	SENT_206	[p13l172t2094r282b2146],
2	LK	NN	O	lk	_	0	SENT_206	[p13l310t2098r413b2157],
3	,	,	O	,	_	0	SENT_206	[p13l310t2098r413b2157],
4	Mohamed	NNP	PERSON	Mohamed	nn	5	SENT_206	[p13l442t2094r738b2146],
5	NI	NNP	O	NI	appos	2	SENT_206	[p13l765t2098r858b2157],
6	,	,	O	,	_	0	SENT_206	[p13l765t2098r858b2157],
7	Salleh	NNP	PERSON	Salleh	appos	2	SENT_206	[p13l889t2094r1057b2146],
8	MZ	JJ	O	mz	dep	7	SENT_206	[p13l1084t2097r1214b2157],
9	,	,	O	,	_	0	SENT_206	[p13l1084t2097r1214b2157],
10	et	FW	O	et	nn	11	SENT_206	[p13l1244t2108r1293b2146],
11	al.	FW	O	al.	appos	2	SENT_206	[p13l1322t2094r1386b2146],
12	.	.	O	.	_	0	SENT_206	[p13l1322t2094r1386b2146],

1	The	DT	O	the	det	2	SENT_207	[p13l1416t2094r1524b2146],
2	risk	NN	O	risk	_	0	SENT_207	[p13l1553t2094r1658b2146],
3	of	IN	O	of	_	0	SENT_207	[p13l1687t2093r1746b2146],
4	recurrence	NN	O	recurrence	prep_of	2	SENT_207	[p13l1770t2114r2069b2146],
5	in	IN	O	in	_	0	SENT_207	[p13l2097t2097r2150b2145],
6	breast	NN	O	breast	nn	8	SENT_207	[p13l174t2163r345b2216],
7	cancer	NN	O	cancer	nn	8	SENT_207	[p13l382t2184r566b2216],
8	patients	NNS	O	patient	prep_in	4	SENT_207	[p13l603t2167r826b2230],
9	treated	VBN	O	treat	partmod	8	SENT_207	[p13l864t2163r1064b2216],
10	with	IN	O	with	_	0	SENT_207	[p13l1099t2163r1228b2216],
11	tamoxifen	NN	O	tamoxifen	prep_with	9	SENT_207	[p13l1265t2163r1572b2216],
12	:	:	O	:	_	0	SENT_207	[p13l1265t2163r1572b2216],
13	polymorphisms	NNS	O	polymorphism	dep	2	SENT_207	[p13l1612t2163r2056b2230],
14	of	IN	O	of	_	0	SENT_207	[p13l2095t2163r2153b2216],
15	CYPZD6	NN	O	cypzd6	prep_of	13	SENT_207	[p13l175t2237r428b2286],
16	and	CC	O	and	_	0	SENT_207	[p13l456t2234r560b2286],
17	ABCB1	NN	O	abcb1	conj_and	15	SENT_207	[p13l585t2236r814b2286],
18	.	.	O	.	_	0	SENT_207	[p13l585t2236r814b2286],

1	AAPS	NN	O	aap	nn	2	SENT_208	[p13l842t2236r1005b2286],
2	J	NN	O	j	_	0	SENT_208	[p13l1028t2238r1055b2299],
3	2012	CD	DATE	2012	dep	2	SENT_208	[p13l1080t2238r1535b2298],
4	;	:	O	;	_	0	SENT_208	[p13l1080t2238r1535b2298],
5	14:52	CD	TIME	14:52	number	6	SENT_208	[p13l1080t2238r1535b2298],
6	—	CD	NUMBER	—	dep	2	SENT_208	[p13l1080t2238r1535b2298],
7	59	CD	NUMBER	59	dep	6	SENT_208	[p13l1080t2238r1535b2298],
8	.	.	O	.	_	0	SENT_208	[p13l1080t2238r1535b2298],

1	Krauter	NNP	PERSON	Krauter	nn	2	SENT_209	[p13l172t2349r393b2398],
2	RR	NNP	O	RR	_	0	SENT_209	[p13l425t2349r534b2409],
3	,	,	O	,	_	0	SENT_209	[p13l425t2349r534b2409],
4	Cook	NNP	PERSON	Cook	nn	5	SENT_209	[p13l570t2345r725b2398],
5	SS	NNP	O	SS	appos	2	SENT_209	[p13l758t2348r836b2398],
6	.	.	O	.	_	0	SENT_209	[p13l758t2348r836b2398],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_210	[p13l871t2345r1386b2412],
2	and	CC	O	and	_	0	SENT_210	[p13l1419t2345r1523b2398],
3	the	DT	O	the	det	5	SENT_210	[p13l1554t2345r1640b2398],
4	pharmacological	JJ	O	pharmacological	amod	5	SENT_210	[p13l1671t2345r2150b2412],
5	management	NN	O	management	conj_and	1	SENT_210	[p13l172t2430r540b2483],
6	of	IN	O	of	_	0	SENT_210	[p13l566t2415r624b2468],
7	depression	NN	O	depression	prep_of	5	SENT_210	[p13l647t2415r963b2483],
8	.	.	O	.	_	0	SENT_210	[p13l647t2415r963b2483],

1	Nurse	NN	O	nurse	nn	2	SENT_211	[p13l992t2419r1163b2468],
2	Pract	NN	O	pract	_	0	SENT_211	[p13l1189t2419r1336b2468],
3	2011	CD	DATE	2011	dep	2	SENT_211	[p13l1361t2419r1816b2480],
4	;	:	O	;	_	0	SENT_211	[p13l1361t2419r1816b2480],
5	36:14	CD	NUMBER	36:14	number	6	SENT_211	[p13l1361t2419r1816b2480],
6	—	CD	NUMBER	—	dep	2	SENT_211	[p13l1361t2419r1816b2480],
7	21	CD	NUMBER	21	dep	6	SENT_211	[p13l1361t2419r1816b2480],
8	.	.	O	.	_	0	SENT_211	[p13l1361t2419r1816b2480],

1	Van	NNP	PERSON	Van	nn	3	SENT_212	[p13l172t2547r274b2580],
2	Schaik	NNP	PERSON	Schaik	nn	3	SENT_212	[p13l306t2527r492b2580],
3	RH	NNP	O	RH	_	0	SENT_212	[p13l523t2531r641b2592],
4	,	,	O	,	_	0	SENT_212	[p13l523t2531r641b2592],
5	Kok	NNP	PERSON	Kok	nn	6	SENT_212	[p13l673t2527r793b2580],
6	M	NNP	O	M	appos	3	SENT_212	[p13l823t2531r904b2592],
7	,	,	O	,	_	0	SENT_212	[p13l823t2531r904b2592],
8	Sweep	NNP	O	Sweep	nn	9	SENT_212	[p13l938t2530r1116b2594],
9	FC	NNP	O	FC	appos	3	SENT_212	[p13l1148t2530r1247b2592],
10	,	,	O	,	_	0	SENT_212	[p13l1148t2530r1247b2592],
11	et	FW	O	et	nn	12	SENT_212	[p13l1280t2542r1330b2580],
12	al.	FW	O	al.	appos	3	SENT_212	[p13l1361t2527r1425b2580],
13	.	.	O	.	_	0	SENT_212	[p13l1361t2527r1425b2580],

1	The	DT	O	the	det	6	SENT_213	[p13l1458t2527r1566b2580],
2	CYP2C19	NN	O	cyp2c19	nn	6	SENT_213	[p13l1600t2530r1961b2580],
3	°	CD	NUMBER	°	num	6	SENT_213	[p13l1600t2530r1961b2580],
4	“	NN	O	“	nn	6	SENT_213	[p13l1600t2530r1961b2580],
5	2	CD	NUMBER	2	num	6	SENT_213	[p13l1600t2530r1961b2580],
6	genotype	NN	O	genotype	nsubj	7	SENT_213	[p13l1993t2547r2149b2594, p13l172t2612r292b2665],
7	predicts	VBZ	O	predict	_	0	SENT_213	[p13l317t2598r542b2665],
8	tamoxifen	NN	O	tamoxifen	nn	10	SENT_213	[p13l567t2597r860b2650],
9	treatment	NN	O	treatment	nn	10	SENT_213	[p13l885t2612r1162b2650],
10	outcome	NN	O	outcome	dobj	7	SENT_213	[p13l1189t2612r1433b2650],
11	in	IN	O	in	_	0	SENT_213	[p13l1460t2601r1513b2650],
12	advanced	JJ	O	advanced	amod	15	SENT_213	[p13l1539t2598r1807b2650],
13	breast	NN	O	breast	nn	15	SENT_213	[p13l1834t2598r2005b2650],
14	cancer	NN	O	cancer	nn	15	SENT_213	[p13l2030t2618r2149b2650, p13l172t2689r256b2721],
15	patients	NNS	O	patient	prep_in	10	SENT_213	[p13l281t2672r520b2735],
16	.	.	O	.	_	0	SENT_213	[p13l281t2672r520b2735],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_214	[p13l550t2668r1104b2735],
2	2011	CD	DATE	2011	num	1	SENT_214	[p13l1131t2672r1734b2733],
3	;	:	O	;	_	0	SENT_214	[p13l1131t2672r1734b2733],
4	12:1137	CD	NUMBER	12:1137	number	5	SENT_214	[p13l1131t2672r1734b2733],
5	—	CD	NUMBER	—	dep	1	SENT_214	[p13l1131t2672r1734b2733],
6	1146	CD	DATE	1146	dep	5	SENT_214	[p13l1131t2672r1734b2733],
7	.	.	O	.	_	0	SENT_214	[p13l1131t2672r1734b2733],

1	Rae	NNP	PERSON	Rae	nn	2	SENT_215	[p13l173t2784r280b2833],
2	JM	NN	PERSON	jm	_	0	SENT_215	[p13l317t2784r428b2846],
3	,	,	O	,	_	0	SENT_215	[p13l317t2784r428b2846],
4	Drury	NNP	PERSON	Drury	nn	5	SENT_215	[p13l469t2784r641b2847],
5	S	NNP	O	S	appos	2	SENT_215	[p13l681t2783r727b2845],
6	,	,	O	,	_	0	SENT_215	[p13l681t2783r727b2845],
7	Hayes	NNP	PERSON	Hayes	nn	8	SENT_215	[p13l768t2784r943b2847],
8	DF	NNP	O	DF	appos	2	SENT_215	[p13l983t2784r1086b2845],
9	,	,	O	,	_	0	SENT_215	[p13l983t2784r1086b2845],
10	et	FW	O	et	nn	12	SENT_215	[p13l1128t2795r1177b2833],
11	al.	FW	O	al.	nn	12	SENT_215	[p13l1217t2780r1426b2833],
12	Lack	NN	O	lack	appos	2	SENT_215	[p13l1217t2780r1426b2833],
13	of	IN	O	of	_	0	SENT_215	[p13l1466t2780r1525b2833],
14	correlation	NN	O	correlation	prep_of	12	SENT_215	[p13l1561t2780r1875b2833],
15	between	IN	O	between	_	0	SENT_215	[p13l1916t2780r2150b2833],
16	gene	NN	O	gene	nn	17	SENT_215	[p13l172t2871r299b2918],
17	variants	NNS	O	variant	prep_between	14	SENT_215	[p13l344t2854r572b2903],
18	in	IN	O	in	_	0	SENT_215	[p13l618t2854r671b2903],
19	tamoxifen	NN	O	tamoxifen	prep_in	17	SENT_215	[p13l714t2850r1006b2903],
20	metabolizing	VBG	O	metabolize	partmod	12	SENT_215	[p13l1051t2851r1421b2918],
21	enzymes	NNS	O	enzyme	dobj	20	SENT_215	[p13l1467t2871r1704b2918],
22	with	IN	O	with	_	0	SENT_215	[p13l1749t2851r1878b2903],
23	primary	JJ	O	primary	amod	24	SENT_215	[p13l1922t2854r2151b2918],
24	endpoints	NNS	O	endpoint	prep_with	20	SENT_215	[p13l173t2921r451b2989],
25	in	IN	O	in	_	0	SENT_215	[p13l522t2925r575b2973],
26	the	DT	O	the	det	28	SENT_215	[p13l644t2921r730b2974],
27	ATAC	NN	ORGANIZATION	atac	nn	28	SENT_215	[p13l800t2924r987b2974],
28	trial	NN	O	trial	prep_in	12	SENT_215	[p13l1057t2922r1189b2974],
29	.	.	O	.	_	0	SENT_215	[p13l1057t2922r1189b2974],

1	33rd	JJ	ORDINAL	33rd	amod	2	SENT_216	[p13l1264t2921r1396b2974],
2	Annual	JJ	SET	annual	_	0	SENT_216	[p13l1465t2921r1674b2974],
3	San	NNP	LOCATION	San	amod	4	SENT_216	[p13l1746t2925r1846b2974],
4	Antonio	NNP	LOCATION	Antonio	dep	2	SENT_216	[p13l1915t2924r2149b2974],

1	Movement	NNP	O	Movement	nn	2	SENT_217	[p13l196t3094r311b3112],
2	Disorders	NNPS	O	Disorders	_	0	SENT_217	[p13l320t3094r426b3115],
3	,	,	O	,	_	0	SENT_217	[p13l320t3094r426b3115],
4	Vol	NNP	O	Vol	appos	2	SENT_217	[p13l436t3094r475b3112],
5	.	.	O	.	_	0	SENT_217	[p13l436t3094r475b3112],

1	28	CD	NUMBER	28	_	0	SENT_218	[p13l486t3094r518b3115],
2	,	,	O	,	_	0	SENT_218	[p13l486t3094r518b3115],
3	No.	NN	O	no.	appos	1	SENT_218	[p13l529t3094r564b3112],
4	2	CD	NUMBER	2	num	3	SENT_218	[p13l576t3094r594b3115],
5	,	,	O	,	_	0	SENT_218	[p13l576t3094r594b3115],
6	2013	CD	DATE	2013	appos	1	SENT_218	[p13l605t3094r658b3112],

1	%	NN	O	%	nn	2	SENT_219	[p13l6t3265r262b3430],
2	ANALYSIS	NN	O	analysis	_	0	SENT_219	[p13l363t3319r856b3363],
3	OF	IN	O	of	_	0	SENT_219	[p13l951t3319r1057b3363],
4	CYP2D6	NNP	O	CYP2D6	nn	5	SENT_219	[p13l1150t3319r1529b3363],
5	GENOTYPE	NNP	O	GENOTYPE	prep_of	2	SENT_219	[p13l1623t3319r2153b3363],

1	Breast	NN	O	breast	_	0	SENT_220	[p13l162t3468r326b3513],
2	Cancer	NN	O	cancer	nn	3	SENT_220	[p13l358t3467r544b3513],
3	Symposium	NN	O	symposium	dep	1	SENT_220	[p13l576t3467r897b3527],
4	.	.	O	.	_	0	SENT_220	[p13l576t3467r897b3527],

1	Abstract	JJ	O	abstract	amod	3	SENT_221	[p13l931t3464r1157b3513],
2	S1	NN	O	s1	nn	3	SENT_221	[p13l1189t3467r1331b3513],
3	—	NN	O	—	_	0	SENT_221	[p13l1189t3467r1331b3513],
4	7	CD	NUMBER	7	dep	3	SENT_221	[p13l1189t3467r1331b3513],
5	.	.	O	.	_	0	SENT_221	[p13l1189t3467r1331b3513],

1	Presented	VBN	O	present	_	0	SENT_222	[p13l1365t3464r1619b3513],
2	December	NNP	DATE	December	tmod	1	SENT_222	[p13l1650t3464r1917b3513],
3	9	CD	DATE	9	num	2	SENT_222	[p13l1950t3468r1996b3524],
4	,	,	DATE	,	_	0	SENT_222	[p13l1950t3468r1996b3524],
5	2010	CD	DATE	2010	num	2	SENT_222	[p13l161t3534r311b3579],
6	.	.	O	.	_	0	SENT_222	[p13l161t3534r311b3579],

1	Leyland-Jones	JJ	O	leyland-jones	amod	2	SENT_223	[p14l162t32r538b94],
2	B	NN	O	b	_	0	SENT_223	[p14l566t36r617b91],
3	,	,	O	,	_	0	SENT_223	[p14l566t36r617b91],
4	Regan	NNP	PERSON	Regan	nn	5	SENT_223	[p14l646t36r813b94],
5	MM	NN	O	mm	appos	2	SENT_223	[p14l839t36r977b92],
6	,	,	O	,	_	0	SENT_223	[p14l839t36r977b92],
7	Bouzk	NN	O	bouzk	nn	8	SENT_223	[p14l1005t32r1172b81],
8	M	NN	O	m	appos	2	SENT_223	[p14l1198t36r1274b92],
9	,	,	O	,	_	0	SENT_223	[p14l1198t36r1274b92],
10	et	FW	O	et	nn	11	SENT_223	[p14l1303t46r1349b81],
11	al.	FW	O	al.	appos	2	SENT_223	[p14l1375t32r1435b81],
12	.	.	O	.	_	0	SENT_223	[p14l1375t32r1435b81],

1	Outcome	NN	O	outcome	_	0	SENT_224	[p14l1466t35r1710b81],
2	according	VBG	O	accord	_	0	SENT_224	[p14l1738t32r1999b94],
3	to	TO	O	to	prepc_according_to	1	SENT_224	[p14l161t112r214b147],
4	CYP2D6	NNP	O	CYP2D6	nn	5	SENT_224	[p14l249t101r485b147],
5	genotype	NN	O	genotype	pobj	1	SENT_224	[p14l519t112r757b161],
6	among	IN	O	among	_	0	SENT_224	[p14l792t117r972b161],
7	postmenopausal	JJ	O	postmenopausal	amod	8	SENT_224	[p14l1004t99r1437b161],
8	women	NNS	O	woman	prep_among	1	SENT_224	[p14l1469t117r1665b147],
9	with	IN	O	with	_	0	SENT_224	[p14l1696t98r1816b147],
10	endocrine	JJ	O	endocrine	amod	11	SENT_224	[p14l1849t99r1997b147, p14l162t168r590b227],
11	—	NN	O	—	npadvmod	14	SENT_224	[p14l1849t99r1997b147, p14l162t168r590b227],
12	responsive	JJ	O	responsive	amod	13	SENT_224	[p14l1849t99r1997b147, p14l162t168r590b227],
13	early	JJ	O	early	amod	11	SENT_224	[p14l633t164r763b227],
14	invasive	JJ	O	invasive	amod	16	SENT_224	[p14l803t168r1014b213],
15	breast	NN	O	breast	nn	16	SENT_224	[p14l1058t165r1217b213],
16	cancer	NN	O	cancer	prep_with	1	SENT_224	[p14l1258t183r1429b213],
17	randomized	VBN	O	randomize	partmod	1	SENT_224	[p14l1470t164r1785b213],
18	in	IN	O	in	_	0	SENT_224	[p14l1827t168r1876b212],
19	the	DT	O	the	det	22	SENT_224	[p14l1917t164r1997b213],
20	BIG	NNP	O	BIG	nn	22	SENT_224	[p14l162t233r267b279],
21	1-98	CD	NUMBER	1-98	num	22	SENT_224	[p14l303t234r427b279],
22	trial	NN	O	trial	prep_in	17	SENT_224	[p14l462t230r585b279],
23	.	.	O	.	_	0	SENT_224	[p14l462t230r585b279],

1	33rd	JJ	ORDINAL	33rd	amod	5	SENT_225	[p14l623t230r746b279],
2	Annual	JJ	SET	annual	amod	5	SENT_225	[p14l777t230r971b279],
3	San	NNP	LOCATION	San	nn	5	SENT_225	[p14l1006t233r1099b279],
4	Antonio	NNP	LOCATION	Antonio	nn	5	SENT_225	[p14l1130t232r1348b279],
5	Breast	NN	O	breast	_	0	SENT_225	[p14l1381t234r1545b279],
6	Cancer	NN	O	cancer	nn	7	SENT_225	[p14l1579t233r1764b279],
7	Symposium	NN	O	symposium	dep	5	SENT_225	[p14l1798t233r1997b292, p14l163t299r301b344],
8	.	.	O	.	_	0	SENT_225	[p14l1798t233r1997b292, p14l163t299r301b344],

1	Abstract	JJ	O	abstract	amod	3	SENT_226	[p14l328t296r553b344],
2	S1	NN	O	s1	nn	3	SENT_226	[p14l578t299r720b344],
3	—	NN	O	—	_	0	SENT_226	[p14l578t299r720b344],
4	8	CD	NUMBER	8	dep	3	SENT_226	[p14l578t299r720b344],
5	.	.	O	.	_	0	SENT_226	[p14l578t299r720b344],

1	Presented	VBN	O	present	_	0	SENT_227	[p14l746t296r999b344],
2	December	NNP	DATE	December	tmod	1	SENT_227	[p14l1023t296r1291b344],
3	9	CD	DATE	9	num	2	SENT_227	[p14l1315t299r1362b355],
4	,	,	DATE	,	_	0	SENT_227	[p14l1315t299r1362b355],
5	2010	CD	DATE	2010	num	2	SENT_227	[p14l1387t299r1536b344],
6	.	.	O	.	_	0	SENT_227	[p14l1387t299r1536b344],

1	Paré	NN	O	paré	nn	2	SENT_228	[p14l162t397r275b443],
2	G	NN	O	g	_	0	SENT_228	[p14l310t397r370b454],
3	,	,	O	,	_	0	SENT_228	[p14l310t397r370b454],
4	Mehta	NNP	ORGANIZATION	Mehta	nn	5	SENT_228	[p14l402t394r575b443],
5	SR	NN	ORGANIZATION	sr	appos	2	SENT_228	[p14l609t397r696b454],
6	,	,	O	,	_	0	SENT_228	[p14l609t397r696b454],
7	Yusuf	NNP	PERSON	Yusuf	nn	8	SENT_228	[p14l729t394r888b443],
8	S	NNP	PERSON	S	appos	2	SENT_228	[p14l918t397r960b454],
9	,	,	O	,	_	0	SENT_228	[p14l918t397r960b454],
10	et	FW	O	et	nn	11	SENT_228	[p14l994t408r1040b443],
11	al.	FW	O	al.	appos	2	SENT_228	[p14l1072t395r1131b443],
12	.	.	O	.	_	0	SENT_228	[p14l1072t395r1131b443],

1	Effects	NNS	O	effect	_	0	SENT_229	[p14l1166t394r1342b443],
2	of	IN	O	of	_	0	SENT_229	[p14l1375t394r1430b443],
3	CYP2C19	NN	O	cyp2c19	nn	4	SENT_229	[p14l1460t397r1725b443],
4	genotype	NN	O	genotype	prep_of	1	SENT_229	[p14l1758t408r1997b457],
5	on	IN	O	on	_	0	SENT_229	[p14l163t479r228b509],
6	outcomes	NNS	O	outcome	prep_on	1	SENT_229	[p14l263t474r515b509],
7	of	IN	O	of	_	0	SENT_229	[p14l550t460r605b509],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_229	[p14l636t460r934b523],
9	treatment	NN	O	treatment	prep_of	6	SENT_229	[p14l968t474r1240b509],
10	.	.	O	.	_	0	SENT_229	[p14l968t474r1240b509],

1	N	NN	O	n	nn	3	SENT_230	[p14l1276t464r1327b509],
2	Engl	NNP	O	Engl	nn	3	SENT_230	[p14l1360t460r1478b523],
3	J	NNP	O	J	nsubj	4	SENT_230	[p14l1510t464r1535b522],
4	Med	VBD	O	med	_	0	SENT_230	[p14l1568t461r1690b509],
5	2010	CD	DATE	2010	dobj	4	SENT_230	[p14l1724t464r1994b520],
6	;	:	O	;	_	0	SENT_230	[p14l1724t464r1994b520],
7	363	CD	NUMBER	363	num	9	SENT_230	[p14l1724t464r1994b520],
8	:	:	O	:	_	0	SENT_230	[p14l1724t464r1994b520],
9	1704-1714	CD	DATE	1704-1714	dep	5	SENT_230	[p14l166t529r480b575],
10	.	.	O	.	_	0	SENT_230	[p14l166t529r480b575],

1	Holmes	NNP	ORGANIZATION	Holmes	nn	2	SENT_231	[p14l162t625r366b674],
2	MV	NNP	ORGANIZATION	MV	_	0	SENT_231	[p14l393t629r514b684],
3	,	,	O	,	_	0	SENT_231	[p14l393t629r514b684],
4	Perel	NNP	PERSON	Perel	nn	5	SENT_231	[p14l542t625r671b674],
5	P	NN	PERSON	p	appos	2	SENT_231	[p14l698t629r746b684],
6	,	,	O	,	_	0	SENT_231	[p14l698t629r746b684],
7	Shah	NNP	ORGANIZATION	Shah	nn	8	SENT_231	[p14l776t625r903b674],
8	T	NN	ORGANIZATION	t	appos	2	SENT_231	[p14l929t627r984b684],
9	,	,	O	,	_	0	SENT_231	[p14l929t627r984b684],
10	Hingorani	JJ	PERSON	hingorani	amod	11	SENT_231	[p14l1013t628r1287b687],
11	AD	NN	O	ad	appos	2	SENT_231	[p14l1313t627r1420b684],
12	,	,	O	,	_	0	SENT_231	[p14l1313t627r1420b684],
13	Casas	NNP	ORGANIZATION	Casas	nn	14	SENT_231	[p14l1451t628r1601b674],
14	JP	NNP	ORGANIZATION	JP	appos	2	SENT_231	[p14l1625t629r1699b686],
15	.	.	O	.	_	0	SENT_231	[p14l1625t629r1699b686],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_232	[p14l1731t628r1996b674],
2	genotype	NN	O	genotype	_	0	SENT_232	[p14l162t704r417b753],
3	,	,	O	,	_	0	SENT_232	[p14l162t704r417b753],
4	clopidogrel	NN	O	clopidogrel	nn	5	SENT_232	[p14l443t690r742b753],
5	metabolism	NN	O	metabolism	conj_and	2	SENT_232	[p14l766t690r1091b750],
6	,	,	O	,	_	0	SENT_232	[p14l766t690r1091b750],
7	platelet	NN	O	platelet	nn	8	SENT_232	[p14l1117t690r1314b753],
8	function	NN	O	function	conj_and	2	SENT_232	[p14l1338t690r1575b750],
9	,	,	O	,	_	0	SENT_232	[p14l1338t690r1575b750],
10	and	CC	O	and	_	0	SENT_232	[p14l1603t691r1700b739],
11	cardiovascular	JJ	O	cardiovascular	amod	12	SENT_232	[p14l1724t690r1997b739, p14l162t756r294b805],
12	events	NNS	O	event	conj_and	2	SENT_232	[p14l325t770r502b805],
13	:	:	O	:	_	0	SENT_232	[p14l325t770r502b805],
14	a	DT	O	a	det	16	SENT_232	[p14l537t775r564b805],
15	systematic	JJ	O	systematic	amod	16	SENT_232	[p14l596t760r869b819],
16	review	NN	O	review	dep	2	SENT_232	[p14l900t760r1075b805],
17	and	CC	O	and	_	0	SENT_232	[p14l1106t756r1202b805],
18	meta	NN	O	meta	nn	20	SENT_232	[p14l1233t756r1608b819],
19	—	NN	O	—	nn	20	SENT_232	[p14l1233t756r1608b819],
20	analysis	NN	O	analysis	dep	2	SENT_232	[p14l1233t756r1608b819],
21	.	.	O	.	_	0	SENT_232	[p14l1233t756r1608b819],

1	JAMA	NNP	O	JAMA	_	0	SENT_233	[p14l1638t759r1815b818],
2	2011	CD	DATE	2011	num	1	SENT_233	[p14l1845t760r1996b816],
3	;	:	O	;	_	0	SENT_233	[p14l1845t760r1996b816],
4	306:2704	CD	NUMBER	306:2704	number	5	SENT_233	[p14l163t826r600b871],
5	—	CD	NUMBER	—	dep	1	SENT_233	[p14l163t826r600b871],
6	2714	CD	DATE	2714	dep	5	SENT_233	[p14l163t826r600b871],
7	.	.	O	.	_	0	SENT_233	[p14l163t826r600b871],

1	AND	CC	O	and	cc	2	SENT_234	[p14l52t922r249b967],
2	RESPONSE	NN	O	response	_	0	SENT_234	[p14l353t921r923b968],
3	TO	TO	O	to	infmod	2	SENT_234	[p14l1023t921r1139b968],
4	TETRABENAZINE	NN	O	tetrabenazine	dep	2	SENT_234	[p14l1238t922r2151b967],

1	32	CD	NUMBER	32	_	0	SENT_235	[p14l6t1081r91b1130],
2	.	.	O	.	_	0	SENT_235	[p14l6t1081r91b1130],

1	Nissen	NNP	O	Nissen	_	0	SENT_236	[p14l170t1081r362b1130],
2	SE	NN	O	se	dep	1	SENT_236	[p14l398t1081r484b1130],
3	.	.	O	.	_	0	SENT_236	[p14l398t1081r484b1130],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_237	[p14l523t1078r1078b1145],
2	and	CC	O	and	_	0	SENT_237	[p14l1115t1078r1219b1130],
3	clopidogrel	NN	O	clopidogrel	conj_and	1	SENT_237	[p14l1254t1077r1591b1145],
4	:	:	O	:	_	0	SENT_237	[p14l1254t1077r1591b1145],
5	irrational	JJ	O	irrational	amod	6	SENT_237	[p14l1630t1077r1898b1130],
6	exuberance	NN	O	exuberance	dep	1	SENT_237	[p14l1935t1077r2150b1130, p14l172t1153r324b1201],
7	?	.	O	?	_	0	SENT_237	[p14l1935t1077r2150b1130, p14l172t1153r324b1201],

1	JAMA	NNP	O	JAMA	_	0	SENT_238	[p14l351t1151r542b1214],
2	2011	CD	DATE	2011	num	1	SENT_238	[p14l566t1153r1207b1213],
3	;	:	O	;	_	0	SENT_238	[p14l566t1153r1207b1213],
4	306:2727	CD	DURATION	306:2727	number	5	SENT_238	[p14l566t1153r1207b1213],
5	-2728	CD	DURATION	-2728	dep	1	SENT_238	[p14l566t1153r1207b1213],
6	.	.	O	.	_	0	SENT_238	[p14l566t1153r1207b1213],

1	33	CD	NUMBER	33	_	0	SENT_239	[p14l6t1283r91b1332],
2	.	.	O	.	_	0	SENT_239	[p14l6t1283r91b1332],

1	Fleeman	NNP	PERSON	Fleeman	nn	2	SENT_240	[p14l171t1279r411b1332],
2	N	NNP	O	N	_	0	SENT_240	[p14l439t1283r510b1344],
3	,	,	O	,	_	0	SENT_240	[p14l439t1283r510b1344],
4	Martin	NNP	PERSON	Martin	nn	6	SENT_240	[p14l542t1282r744b1332],
5	Saborido	NNP	PERSON	Saborido	nn	6	SENT_240	[p14l776t1279r1031b1332],
6	C	NNP	O	C	appos	2	SENT_240	[p14l1063t1282r1123b1344],
7	,	,	O	,	_	0	SENT_240	[p14l1063t1282r1123b1344],
8	Payne	NNP	PERSON	Payne	nn	9	SENT_240	[p14l1155t1283r1322b1346],
9	K	NNP	O	K	appos	2	SENT_240	[p14l1353t1283r1416b1344],
10	,	,	O	,	_	0	SENT_240	[p14l1353t1283r1416b1344],
11	et	FW	O	et	nn	12	SENT_240	[p14l1448t1294r1497b1332],
12	al.	FW	O	al.	appos	2	SENT_240	[p14l1527t1279r1591b1332],
13	.	.	O	.	_	0	SENT_240	[p14l1527t1279r1591b1332],

1	The	DT	O	the	det	3	SENT_241	[p14l1624t1279r1732b1332],
2	clinical	JJ	O	clinical	amod	3	SENT_241	[p14l1764t1279r1966b1332],
3	effectiveness	NN	O	effectiveness	_	0	SENT_241	[p14l1997t1279r2150b1332, p14l170t1353r391b1402],
4	and	CC	O	and	_	0	SENT_241	[p14l427t1350r532b1402],
5	cost-effectiveness	NN	O	cost-effectiveness	conj_and	3	SENT_241	[p14l566t1349r1059b1403],
6	of	IN	O	of	_	0	SENT_241	[p14l1096t1349r1155b1402],
7	genotyping	VBG	O	genotype	prepc_of	3	SENT_241	[p14l1186t1353r1504b1417],
8	for	IN	O	for	_	0	SENT_241	[p14l1539t1350r1621b1402],
9	CYP2D6	NN	O	cyp2d6	prep_for	7	SENT_241	[p14l1657t1353r1911b1402],
10	for	IN	O	for	_	0	SENT_241	[p14l1947t1349r2030b1402],
11	the	DT	O	the	det	12	SENT_241	[p14l2064t1350r2150b1402],
12	management	NN	O	management	prep_for	3	SENT_241	[p14l170t1435r538b1488],
13	of	IN	O	of	_	0	SENT_241	[p14l567t1420r626b1473],
14	women	NNS	O	woman	prep_of	3	SENT_241	[p14l650t1441r861b1473],
15	with	IN	O	with	_	0	SENT_241	[p14l888t1421r1017b1473],
16	breast	NN	O	breast	nn	17	SENT_241	[p14l1046t1421r1217b1473],
17	cancer	NN	O	cancer	prep_with	3	SENT_241	[p14l1245t1441r1430b1473],
18	treated	VBN	O	treat	partmod	3	SENT_241	[p14l1456t1421r1656b1473],
19	with	IN	O	with	_	0	SENT_241	[p14l1683t1421r1812b1473],
20	tamoxifen	NN	O	tamoxifen	prep_with	18	SENT_241	[p14l1840t1421r2148b1473],
21	:	:	O	:	_	0	SENT_241	[p14l1840t1421r2148b1473],
22	a	DT	O	a	det	24	SENT_241	[p14l172t1512r201b1544],
23	systematic	JJ	O	systematic	amod	24	SENT_241	[p14l228t1495r522b1558],
24	review	NN	O	review	dep	20	SENT_241	[p14l548t1495r752b1544],
25	.	.	O	.	_	0	SENT_241	[p14l548t1495r752b1544],

1	Health	NNP	O	Health	nn	3	SENT_242	[p14l781t1491r977b1544],
2	Technol	NNP	O	Technol	nn	3	SENT_242	[p14l1001t1491r1233b1544],
3	Assess	NNP	O	Assess	_	0	SENT_242	[p14l1258t1493r1437b1544],
4	2011	CD	DATE	2011	num	3	SENT_242	[p14l1464t1495r1993b1556],
5	;	:	O	;	_	0	SENT_242	[p14l1464t1495r1993b1556],
6	15:101	CD	NUMBER	15:101	number	7	SENT_242	[p14l1464t1495r1993b1556],
7	-102	CD	NUMBER	-102	dep	3	SENT_242	[p14l1464t1495r1993b1556],
8	.	.	O	.	_	0	SENT_242	[p14l1464t1495r1993b1556],

1	34	CD	NUMBER	34	_	0	SENT_243	[p14l6t1626r91b1675],
2	.	.	O	.	_	0	SENT_243	[p14l6t1626r91b1675],

1	Del	NNP	O	Del	nn	3	SENT_244	[p14l171t1622r269b1675],
2	Re	NNP	O	Re	nn	3	SENT_244	[p14l303t1626r377b1675],
3	M	NN	O	m	_	0	SENT_244	[p14l411t1626r492b1687],
4	,	,	O	,	_	0	SENT_244	[p14l411t1626r492b1687],
5	Michelucci	NNP	PERSON	Michelucci	nn	6	SENT_244	[p14l528t1622r843b1675],
6	A	NNP	O	A	appos	3	SENT_244	[p14l877t1625r939b1687],
7	,	,	O	,	_	0	SENT_244	[p14l877t1625r939b1687],
8	Simi	NNP	PERSON	Simi	nn	9	SENT_244	[p14l976t1625r1099b1675],
9	P	NN	PERSON	p	appos	3	SENT_244	[p14l1133t1626r1183b1687],
10	,	,	O	,	_	0	SENT_244	[p14l1133t1626r1183b1687],
11	Danesi	NNP	PERSON	Danesi	nn	13	SENT_244	[p14l1219t1626r1413b1675],
12	R.	NNP	PERSON	R.	nn	13	SENT_244	[p14l1448t1626r1508b1675],
13	Pharmacogenetics	NNP	PERSON	Pharmacogenetics	appos	3	SENT_244	[p14l1545t1622r2060b1689],
14	of	IN	O	of	_	0	SENT_244	[p14l2096t1622r2154b1675],
15	anti-estrogen	NN	O	anti-estrogen	nn	16	SENT_244	[p14l172t1696r545b1760],
16	treatment	NN	O	treatment	prep_of	13	SENT_244	[p14l578t1708r856b1746],
17	of	IN	O	of	_	0	SENT_244	[p14l890t1693r949b1746],
18	breast	NN	O	breast	nn	19	SENT_244	[p14l980t1693r1151b1746],
19	cancer	NN	O	cancer	prep_of	16	SENT_244	[p14l1184t1713r1384b1746],
20	.	.	O	.	_	0	SENT_244	[p14l1184t1713r1384b1746],

1	Cancer	NNP	O	Cancer	nn	3	SENT_245	[p14l1423t1696r1623b1746],
2	Treat	NNP	O	Treat	nn	3	SENT_245	[p14l1656t1695r1811b1746],
3	Rev	NN	O	rev	_	0	SENT_245	[p14l1845t1697r1953b1746],
4	2012	CD	DATE	2012	num	3	SENT_245	[p14l1987t1696r2149b1757],
5	;	:	O	;	_	0	SENT_245	[p14l1987t1696r2149b1757],
6	38:442	CD	NUMBER	38:442	number	7	SENT_245	[p14l172t1767r533b1816],
7	-450	CD	NUMBER	-450	dep	3	SENT_245	[p14l172t1767r533b1816],
8	.	.	O	.	_	0	SENT_245	[p14l172t1767r533b1816],

1	35	CD	NUMBER	35	_	0	SENT_246	[p14l6t1897r91b1947],
2	.	.	O	.	_	0	SENT_246	[p14l6t1897r91b1947],

1	Sehrt	NN	O	sehrt	nn	2	SENT_247	[p14l172t1894r317b1947],
2	D	NN	O	d	dep	16	SENT_247	[p14l344t1898r410b1958],
3	,	,	O	,	_	0	SENT_247	[p14l344t1898r410b1958],
4	Meineke	NNP	O	Meineke	nn	5	SENT_247	[p14l438t1894r685b1947],
5	I	NNP	O	I	appos	2	SENT_247	[p14l713t1898r749b1958],
6	,	,	O	,	_	0	SENT_247	[p14l713t1898r749b1958],
7	Tzvetkov	NNP	O	Tzvetkov	nn	8	SENT_247	[p14l778t1894r1045b1947],
8	M	NNP	O	M	appos	2	SENT_247	[p14l1071t1898r1152b1958],
9	,	,	O	,	_	0	SENT_247	[p14l1071t1898r1152b1958],
10	Giiltepe	NNP	O	Giiltepe	nn	11	SENT_247	[p14l1183t1894r1405b1961],
11	S	NNP	O	S	appos	2	SENT_247	[p14l1434t1897r1480b1958],
12	,	,	O	,	_	0	SENT_247	[p14l1434t1897r1480b1958],
13	Brockmoller	NNP	PERSON	Brockmoller	nn	15	SENT_247	[p14l1510t1894r1865b1947],
14	J.	NNP	PERSON	J.	nn	15	SENT_247	[p14l1887t1898r1930b1960],
15	Carvedilol	NNP	PERSON	Carvedilol	appos	2	SENT_247	[p14l1962t1897r2150b1947, p14l172t1964r298b2017],
16	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_247	[p14l356t1964r864b2032],
17	and	CC	O	and	_	0	SENT_247	[p14l925t1964r1028b2017],
18	pharmacodynamics	NNS	O	pharmacodynamic	conj_and	16	SENT_247	[p14l1085t1964r1645b2032],
19	in	IN	O	in	_	0	SENT_247	[p14l1705t1968r1758b2016],
20	relation	NN	O	relation	prep_in	16	SENT_247	[p14l1815t1964r2037b2017],
21	to	TO	O	to	_	0	SENT_247	[p14l2094t1979r2150b2017],
22	CYP2D6	NN	O	cyp2d6	nn	25	SENT_247	[p14l173t2038r427b2088],
23	and	CC	O	and	_	0	SENT_247	[p14l464t2035r568b2088],
24	ADRB	NN	O	adrb	nn	25	SENT_247	[p14l602t2037r790b2087],
25	pharmacogenetics	NNS	O	pharmacogenetic	prep_to	20	SENT_247	[p14l825t2035r1357b2102],
26	.	.	O	.	_	0	SENT_247	[p14l825t2035r1357b2102],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_248	[p14l1395t2035r1951b2102],
2	2011	CD	DATE	2011	num	1	SENT_248	[p14l1987t2039r2149b2100],
3	;	:	O	;	_	0	SENT_248	[p14l1987t2039r2149b2100],
4	12:783	CD	NUMBER	12:783	number	5	SENT_248	[p14l176t2110r533b2158],
5	-795	CD	NUMBER	-795	dep	1	SENT_248	[p14l176t2110r533b2158],
6	.	.	O	.	_	0	SENT_248	[p14l176t2110r533b2158],

1	Movement	NNP	O	Movement	nn	2	SENT_249	[p14l1501t2268r1615b2287],
2	Disorders	NNPS	O	Disorders	_	0	SENT_249	[p14l1625t2268r1731b2290],
3	,	,	O	,	_	0	SENT_249	[p14l1625t2268r1731b2290],
4	Vol	NNP	O	Vol	appos	2	SENT_249	[p14l1741t2268r1779b2287],
5	.	.	O	.	_	0	SENT_249	[p14l1741t2268r1779b2287],

1	28	CD	NUMBER	28	_	0	SENT_250	[p14l1790t2268r1822b2290],
2	,	,	O	,	_	0	SENT_250	[p14l1790t2268r1822b2290],
3	No.	NN	O	no.	appos	1	SENT_250	[p14l1834t2268r1869b2287],
4	2	CD	NUMBER	2	dep	1	SENT_250	[p14l1880t2268r1898b2290],
5	,	,	O	,	_	0	SENT_250	[p14l1880t2268r1898b2290],
6	2013	CD	DATE	2013	number	7	SENT_250	[p14l1909t2268r1963b2287],
7	215	CD	NUMBER	215	appos	4	SENT_250	[p14l2058t2262r2111b2287],

